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ABSTRACT 
 
The general aim of this PhD project was to investigate the integrated use of 
physicochemical and in vitro data for predicting the toxicological hazard of chemicals in 
animals. This was achieved in two stages: firstly, by developing two types of model for 
acute dermal and ocular toxicity - structure-activity relationships (SARs) based on 
easily calculated physicochemical properties, and prediction models (PMs) based on 
experimentally derived physicochemical or in vitro data; and secondly, by evaluating 
the tiered testing approach to hazard classification, in which different classification 
models (CMs) are applied sequentially before animal testing is conducted. The thesis 
therefore reports the development and assessment of CMs for skin irritation, skin 
corrosion and eye irritation, as well as the outcome of simulations in which these 
models were incorporated into tiered testing strategies for these toxicological endpoints. 
The results show that the tiered testing approach to hazard classification provides a 
reliable means of reducing and refining the use of animals, without compromising the 
ability to classify chemicals. In addition to developing the above-mentioned CMs, 
regression models for corneal permeability were developed, and the relationship 
between corneal permeability and eye irritation was investigated. 
 
The thesis also describes the development and assessment of a novel statistical method 
called embedded cluster modelling (ECM), which generates elliptic models of 
biological activity from embedded data sets. The combined use of this method with the 
existing method of cluster significance analysis (CSA) is illustrated through the 
development of SARs for eye irritation potential.  
 
Finally, novel applications of the bootstrap resampling method were investigated. In 
particular, algorithms based on this method are shown to provide a means of assessing: 
a) the minimal variability associated with the Draize rabbit tests for skin and eye 
irritation; and b) the variability in Cooper statistics (commonly used to summarise the 
performance of two-group CMs) that arises from chemical variation.  
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1.1 BACKGROUND TO THE PROJECT 
 
In the attempt to protect human health against the potentially adverse effects of 
chemicals, numerous national and international laws require toxicity tests to be 
performed on products of various kinds, including industrial chemicals, pesticides, 
foodstuffs, cosmetics and pharmaceuticals. A toxicity test is any procedure for 
determining toxicological hazard, which is the inherent potential of a chemical to cause 
toxicity. The risk of a given chemical to a group of society (e.g. consumers) is assessed 
by combining information on chemical hazard with information on the exposure of that 
group to the chemical in question. 
 
Traditionally, the potentially adverse effects of chemicals on human health have been 
assessed by testing on living animals, even though this practice has been widely 
criticised on both scientific and ethical grounds. Nowadays, the availability of 
alternative methods for toxicity testing, which do not rely on the use of living animals, 
promises not only to improve the scientific basis of toxicological assessments, but also 
to protect animals from painful or distressing procedures. The ‘alternatives’ concept is 
attributed to Russell & Burch (1959), who defined three types of alternative procedure: 
reduction alternatives, which obtain a comparable level of information from the use of 
fewer animals, or more information from the same number of animals; refinement 
alternatives, which alleviate or minimise potential pain, suffering and distress; and 
replacement alternatives, which permit a given purpose to be achieved without using 
animals. The three types of alternative procedure are referred to collectively as the 
‘Three Rs’.  
 
The Three Rs were enshrined in European law in 1986, when the European Council 
passed Directive 86/609/EEC (EC, 1986), requiring that alternative methods are used 
instead of living animals whenever scientifically feasible. This directive, which was 
incorporated into British law by means of the Animals (Scientific Procedures) Act 
(Home Office, 1986), applies not only to the use of animals for toxicity and potency 
testing, but also to the use of animals in fundamental biological and medical research.  
 
To overcome the limitations of individual alternative methods, it is widely accepted that 
the reduction, refinement and eventual replacement of animal use in toxicology will 
depend on the development of suitable integrated testing strategies. These are 
strategically-designed combinations of methods whose application in a stepwise and/or 
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parallel fashion is intended to provide the most effective way of predicting toxicological 
hazard, while at the same time minimising the use of animals. While the need for 
integrated toxicity testing may be widely accepted, a considerable amount of research is 
still required to develop and evaluate specific approaches. The general purpose of this 
PhD project was to contribute to the conceptual development of this field by 
investigating the integrated use of physicochemical and in vitro data for predicting in 
vivo endpoints for skin and eye toxicity. This was achieved in two stages: firstly, by 
developing two types of model for acute dermal and ocular toxicity - structure-activity 
relationships (SARs) based on easily calculated physicochemical properties, and 
prediction models (PMs) based on experimentally derived physicochemical or in vitro 
data; and secondly, by evaluating the tiered testing approach to hazard classification. 
The project was carried out under the ægis of the School of Pharmacy and Chemistry at 
Liverpool John Moores University, and was funded by the European Centre for the 
Validation of European Methods (ECVAM), which is part of the European 
Commission’s Joint Research Centre. 
 
1.2 OVERVIEW OF THE THESIS 
 
The thesis is divided into three parts: Part I contains a general introduction to the field 
of research; Part II summarises the research, with each chapter taking the format of a 
scientific article; and the appendices in Part III contain various computer routines 
written during the project (Appendix A), and a list of the author’s publications 
(Appendix B). All figures and tables are located, in that order, at the end of their 
respective chapters, since many of them were considered to be too large to be 
incorporated comfortably within the body of the text. 
 
The first chapter in Part I, chapter 2, describes the animal methods used for the 
regulatory assessment of acute local toxicity to the skin and eye, and reviews the 
various computer-based, physicochemical and in vitro methods that have been 
developed to predict the results of the animal tests. Chapter 2 also explains the concept 
of integrated testing strategy. 
 
Since some of the models developed in this project were based on physicochemical 
properties calculated with specialised software packages, chapter 3 provides a survey of 
these properties, and describes the computer algorithms used for their estimation. In 
addition to the models based on physicochemical data, additional models were 
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developed from in vitro data, generated by methods described in chapter 2. All models 
were developed with statistical methods, which are described in chapter 4, along with 
various data resampling methods. 
 
In Part II of this thesis, chapter 5 illustrates how a particular data resampling method, 
bootstrap resampling, can be applied in the field of alternative method development. In 
particular, bootstrap resampling was used to estimate the uncertainty inherent in Cooper 
statistics, which are commonly used to assess the performance of two-group 
classification models, and to analyse the variability of animal data, which places an 
upper limit on the predictive ability of any model. 
 
Chapter 6 describes a novel statistical method, called embedded cluster modelling, 
which was developed in this project to derive elliptic models of biological activity, i.e. 
classification models that separate toxic from non-toxic chemicals by means of an 
elliptic boundary. The usefulness of this method is illustrated by its application to an 
eye irritation data set. 
 
With a view to developing an integrated testing strategy for acute local toxicity, new 
models for predicting skin irritation and corrosion potential are described in chapter 7, 
and new models for eye irritation are described in chapter 9. In addition to these 
classification models for toxic potential, regression models were developed to predict 
the ability of chemicals to penetrate across the cornea. This work is described in chapter 
8, along with an investigation into the relationship between corneal penetration and eye 
irritation. 
 
Some of the models presented in chapters 7 and 9 were integrated in the form of 
stepwise testing strategies for skin irritation and corrosion, and for eye irritation, 
respectively. Chapter 10 describes how these strategies were evaluated by simulating 
the possible outcomes obtained when the strategies were applied to real data. In addition 
to simulating the strategic approach now adopted by the Organisation for Economic 
Cooperation and Development (OECD), described in chapter 2, an alternative approach 
was also investigated. 
 
Finally, chapter 11 summarises the findings and conclusions of this project in the 
context of existing knowledge. In addition, some perspectives are offered regarding the 
conceptual basis of integrated testing, and an assessment is made of current research 
needs and future prospects. 
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2.1 INTRODUCTION 
 
In this project, the use of physicochemical and in vitro data for predicting toxicological 
hazard was investigated by focusing on the prediction of acute local effects to the skin 
and to the eye. Two types of acute skin toxicity were considered: skin irritation (irritant 
contact dermatitis [ICD]), a reversible inflammatory response, and skin corrosion, the 
irreversible destruction of the skin tissue. In addition, acute eye irritation/corrosion was 
considered. 
 
This chapter describes the animal methods used to assess, and the alternative methods 
used to predict, acute dermal and ocular toxicity. In addition, a summary is given of 
animal and alternative methods for skin and eye penetration, since these processes are 
also relevant to the prediction of acute dermal and ocular toxicity. 
 
2.2 THE BIOLOGICAL BASIS OF ACUTE LOCAL TOXICITY 
 
2.2.1 Physiology of the skin 
 
As illustrated in Figure 2.1, the skin is composed of three layers: the epidermis (outer 
layer), the dermis (middle layer), and the subcutaneous tissue (inner layer). 
 
The epidermis 
The epidermis is about 30-300 µm thick, depending on anatomical site, and is divided 
into four anatomical layers: the basal layer (stratum germinativum), the spiny (or prickle 
cell) layer (stratum spinosum), the granular layer (stratum granulosum), and the horny 
layer (stratum corneum). The basal layer is the innermost epidermal layer and contains 
the stem cells from which all keratinocytes are derived. Lying above the basal layer is 
the spiny layer, which acquires its name from the spiky appearance produced by the 
intercellular bridges (desmosomes) that connect adjacent cells. The next layer is called 
the granular layer because the cells contain keratohyalin granules. The outermost 
epidermal layer, the stratum corneum, is composed of corneocytes, dead epithelial cells 
that are filled with a protein, keratin, which waterproofs and toughens the skin. The 
corneocytes are flat and hexagonal in shape, and overlap to form the ‘bricks’ in a 
‘bricks-and-mortar’ arrangement of cells. The ‘mortar’ is a complex mixture of lipids, 
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including ceramides, free fatty acids, and cholesterol and its sulphate derivative 
(Bronaugh et al., 1982). The lipids form structured arrays of bilayers, with characteristic 
phase transition temperatures (Bronaugh & Maibach, 1985). In addition to 
keratinocytes, which account for approximately 95% of the epidermal cell population, 
the epidermis also contains melanocytes, Langerhans cells and Merkel cells. 
Melanocytes, which are interspersed among the basal cells, are dendritic cells that 
produce melanin, a pigment which imparts colour to the skin and protects it from the 
effects of ultraviolet radiation; Langerhans cells, which are also dendritic cells, are 
scattered throughout the spiny layer, where they play a role in the immune responses 
characteristic of skin irritation (and skin sensitisation); and Merkel cells are found in the 
basal layer, where they play a role in sensory perception. 
 
The dermis 
The dermis (or corium), which is 20-30 times thicker than the epidermis, is composed of 
connective tissue through which sensory nerves, blood vessels and lymph vessels 
thread. In humans, the dermis projects into the overlying epidermis in ridges called 
papillæ. Nerves which extend through the dermis and end in the papillæ are sensitive to 
pressure, pain, cold and warmth. The dermis also provides the base for sweat glands, oil 
glands, hair follicles, and nail beds.  
 
The major component of dermal connective tissue is collagen, an extra-cellular fibrous 
protein which provides strength to the skin. Another fibrous protein, elastin, provides 
elasticity to the skin. The fibrous bundles are surrounded by an extra-cellular gel-like 
matrix called ground substance, consisting primarily of water, ions, and complex 
carbohydrates attached to proteins (proteoglycans).  
 
The dermis contains at least three types of cells: fibrocytes, histiocytes and mastocytes. 
Fibrocytes synthesise the elastic fibres and ground substance. Histiocytes are 
macrophages, i.e. cells that engulf and destroy cellular debris and invading micro-
organisms. Mastocytes, or mast cells, are located near blood vessels, and contain 
substances (e.g. histamine) that are released during inflammation. 
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The subcutaneous tissue 
The subcutaneous tissue is a layer of loose connective tissue, consisting mostly of 
adipocytes arranged into collagen-bound lobules. This layer cushions the skin, provides 
insulation, and serves as a nutritional storage depot. 
 
2.2.2 Physiology of the eye 
 
The eye is a complex structure (Figure 2.2). This description will focus on the tissues 
that are most commonly referred to in toxicological studies.  
 
The outermost covering of the eyeball is composed of two dense fibrous tissues that are 
continuous with each other: the transparent cornea, which covers the front part of the 
eye, and the opaque sclera, which covers the rest of the eye. The transparency of the 
cornea is due to a regular arrangement of collagen fibres (see below). Certain chemicals 
may disrupt this regular structure, making the cornea opaque and impairing vision. The 
surface of the cornea (and of the eyelids) is covered with a thin mucous membrane, the 
conjunctiva. The conjunctiva and the sclera are both vascularised, and may therefore 
become inflamed upon contact with irritant chemicals. In contrast, the cornea contains 
no blood vessels (except at its margins), but it contains many nerves, making it sensitive 
to pain or touch. The conjunctiva is lubricated by a tear film made up of three layers: a) 
an inner mucous (mucin) layer, which coats the surface of the cornea; b) a middle 
aqueous layer, which keeps the eyes moist; and c) an outer lipid layer, which reduces 
the evaporation of water from the surface of the eye. 
 
Behind the cornea is the anterior chamber, filled with a clear, transparent fluid called the 
aqueous humour. At the back of the anterior chamber is the iris, a circular muscle which 
opens and closes to regulate the amount of light entering the eye through the pupil, an 
opening at the centre of the iris. The aqueous humour flows through the pupil into the 
posterior chamber, a small space between the iris and the lens. The aqueous humour 
provides nutrition for the lens and the cornea, both of which are devoid of blood vessels, 
and removes waste products. Behind the lens is a much larger cavity filled with a clear 
jelly-like substance, the vitreous humour, which maintains the spherical shape of the 
eyeball. 
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The cornea 
The cornea, which is about 20 mm in diameter, contains five distinguishable layers: the 
epithelium (outer covering), Bowman's membrane, the stroma (substantia propria), 
Descemet's membrane, and the endothelium (inner lining). The corneal epithelium, 
which is a continuation of the epithelium of the conjunctiva, is made up of about six 
layers of cells. The superficial layer is shed continuously, and the layers are renewed by 
multiplication of the cells in the basal layer of the epithelium. The stroma accounts for 
about 80 percent of the thickness of the cornea, and is composed of collagen fibres 
which run parallel to form sheets (lamellæ). In the human eye, the lamellae are about 
1.5 to 2.5 μm thick, and there are about 200 lamellæ in the stroma. Between the 
lamellae lie the corneal corpuscles, cells which synthesise new collagen. Bowman's 
membrane, which lies above the stroma and below the epithelium, is really a part of the 
stroma, in which the collagen fibrils are arranged in a less orderly fashion. Beneath the 
stroma is Descemet’s membrane, which is about 5 to 10 μm thick. Descemet’s 
membrane is composed of a different type of collagen, secreted by the single layer of 
flattened cells that make up the endothelium.  
 
2.2.3 Mechanistic basis of acute skin toxicity 
 
Skin penetration 
The barrier properties of the skin are considered to reside in its outer layer, the stratum 
corneum, and chemicals are thought to diffuse through the intercellular lipid-containing 
spaces in this layer, rather than across the corneocytes (Howes et al., 1996). Chemicals 
penetrating by this route will pass sequentially across various bilayers, and will 
therefore come into contact with regions which are both hydrophilic and lipophilic. 
Therefore, it is not surprising that the predominant physicochemical factors that have 
been found to describe skin permeability are partitioning behaviour and molecular size 
(see below, § 2.4.9).  
 
Passive diffusion through intercellular lipid channels is not the only means of skin 
penetration. Other pathways include hair follicles (Hueber et al., 1994) and sweat ducts 
(Cullander & Guy, 1991). In addition, some corrosive chemicals penetrate the skin by 
lysing or solubilising the cells and macromolecules in their path. 
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Skin irritation  
Chemically induced skin irritation is mainly associated with inflammation (erythema 
and œdema) in the dermis, although epidermal effects may also be observed, such as 
pigmentary alterations, scaling (shedding of flakes), and fissuring (formation of cracks). 
 
Skin irritation is said to result from an indirect chemical action, since irritant chemicals 
act by triggering the release of inflammatory mediators from corneocytes in the lower 
stratum corneum and from keratinocytes, Langerhans cells and melanocytes in the 
viable epidermis. It is then the inflammatory mediators that initiate and control the 
inflammatory response. The initial release of inflammatory mediators can be the result 
of direct cytotoxic action, but some chemicals elicit inflammatory mediator release in 
the absence of cell damage (Lawrence et al., 1997). 
 
While the biochemical details of the inflammatory response are not completely 
understood, the release of interleukin-1 alpha (IL-1α) and tumour necrosis factor alpha 
(TNF-α) are considered to be primary events. The release of these ‘primary’ cytokines 
leads to the sythesis and release of ‘secondary’ cytokines which play a role in 
maintaining the inflammatory response. The biochemistry of skin inflammation is 
reviewed elsewhere (Williams & Kupper, 1996; Corsini & Galli, 2000).  
 
Skin corrosion  
Chemically induced skin corrosion is associated with the destruction and irreversible 
alteration of the skin at the site of contact. It is manifested by ulceration (the loss of 
epidermis and part or all of the dermis), bleeding and subsequent scar formation 
(Emmett, 1986).  
 
Most corrosive chemicals are thought to act by solubilisation of macromolecules in the 
stratum corneum, which may lead to cell lysis (Gordon et al., 1994). A minority of 
corrosive chemicals are thought to act as irritants, with the corrosive reaction 
developing as a consequence of biochemically mediated keratinocyte necrosis (Lewis & 
Botham, 1994). Finally, surfactants, which are commonly used as ingredients in 
cosmetic formulations, are thought to act by solubilisation of the stratum corneum 
(Barratt et al., 1998). 
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2.2.4 Mechanistic basis of acute eye toxicity 
 
The mechanisms which lead to eye irritation and corrosion are less well documented 
than the corresponding mechanisms for skin irritation and corrosion. Nevertheless, there 
is evidence that the inflammatory response of the human conjunctiva is mediated by 
cytokines (Gamache et al., 1997). The human cornea (which contains blood vessels 
only at its edges) is also reported to release cytokines during inflammation (Torres et 
al., 1994). The destruction of cells that occurs in eye corrosion probably occurs by the 
same direct chemical mechanisms that account for skin corrosion. Also, just as some 
skin corrosives appear to act by an irritant-like mechanism, there is also evidence that 
corrosion in the cornea is associated with cytokine expression (Planck et al., 1997), 
although this could be a consequence rather than a cause. Despite these similarities, the 
mechanisms by which chemicals penetrate into the eye are likely to be different from 
the mechanisms of skin penetration, due to the presence of a tear film, and to anatomical 
differences between the conjunctiva and cornea on the one hand, and the stratum 
corneum on the other. 
 
2.3 ANIMAL METHODS  
 
2.3.1 Percutaneous absorption 
 
Although many animal species have been used for studying skin absorption, the rat has 
probably been used most frequently (Howes et al., 1996). The animal is killed at the end 
of the experiment, and the extent of percutaneous absorption is estimated from the 
known amount of chemical applied to the skin, and from determination of the total 
amount excreted and of the amounts left on the skin and in the body. 
 
In Europe, the assessment of percutaneous absorption for regulatory purposes is carried 
out in the context of acute dermal toxicity testing. At the international level, a draft 
OECD guideline is currently being considered (OECD, 1994). This guideline 
recommends using the rat, but the use of other species is not excluded.  
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2.3.2 The Draize rabbit skin test 
 
Data on skin irritation and corrosion are required by various regulatory authorities. 
Current regulations include the European Union (EU) directive on dangerous substances 
(EC, 1993), and the United Nations regulation on the labelling of packaged chemicals 
for international transport purposes. Current guidelines include OECD Test Guideline 
404 (OECD, 1992), and the EC guideline for non-clinical dermal tolerance testing of 
medicinal products (EC, 1998). 
 
These regulations and guidelines are based on the Draize rabbit skin test (Draize et al., 
1944). In this test, the dorsal area of the trunk of the experimental animal is clipped free 
of hair or fur, and 0.5 ml of liquid (or 0.5 g of solid) test substance is applied, under a 
semi-occlusive patch, to a surface area of about 6 cm2. After an exposure period of up to 
4 hours, the test substance is removed from the skin. In the case of pharmaceuticals, the 
duration of administration is determined by the proposed conditions of administration in 
clinical use (EC, 1998). The exposed skin is evaluated at specified time intervals for up 
to 21 days, using the formation of œdema (grades 0-4) and erythema/eschar (grades 0-4) 
as endpoints for irritation, and the production of irreversible full-thickness necrosis as 
the endpoint for corrosion.  
 
In the EU and OECD classification systems, the erythema/eschar and œdema tissue 
scores are used directly to classify chemicals as skin irritants or severe skin irritants (see 
below, § 2.3.4). Within the cosmetics industry, however, chemicals are often ranked for 
skin irritation potential on the basis of a composite tissue score, the primary irritation 
index (PII), defined as follows: 
 
PII = [Σ erythema (24, 48, 72h) + Σ œdema (24, 48, 72h) ] / 3 N (Equation 2.1) 
 
where N is the number of animals in the experimental group, and the PII takes values 
from 0 to 8. 
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2.3.3 The Draize rabbit eye test 
 
For regulatory purposes, the Draize rabbit eye test (Draize et al., 1944) is the method of 
choice for the assessment of eye irritation hazard (EC, 1993; OECD, 1987). In this test, 
0.1ml of liquid (or, in the case of solids, a maximum of 0.1g) is instilled into the rabbit 
eye, and effects on the conjunctiva, cornea and iris are observed at fixed time intervals 
for up to 21 days. At each observation point, the following endpoints are scored 
subjectively on a scale of 0 to a maximum of 4: conjunctival redness, oedema, and 
discharge; corneal opacity and area involved; and iritis.  
  
In the EU (EC, 1983) and OECD (1998) classification systems, some of the tissue 
scores are used directly to classify chemicals as eye irritants or severe eye irritants (see 
below, § 2.3.4). Within the cosmetics industry, however, it is more usual to use a 
composite tissue score, called the modified maximum average score (MMAS), which 
has a minimum value of zero (no irritancy) and a maximum of 110 (extreme irritancy). 
The MMAS is calculated from tissue scores in the conjunctiva, cornea and iris, 
observed in three or more rabbits, at 24, 48 and 72 hours following instillation of the 
test substance. For each rabbit, a weighted Draize score (WDS) is calculated at each 
time-point, using the following weighting scheme devised by Draize et al. (1944):  
 
WDS =  2(R+C+D) + 5(O x A) + 5(I)     (Equation 2.2) 
 
where R is conjunctival redness, C is conjunctival chemosis (œdema), D is conjunctival 
discharge, O is corneal opacity, A is the area of cornea involved, and I is iritis. R and D 
are scored on a scale of 0-3; C, O and A from 0-4; and I from 0-2. The maximum WDS 
for a given rabbit, observed at any of the three time-points (24, 48 and 72 hours), is the 
total Draize score (TDS), and the average of these maximum scores over all rabbits in 
the experimental group is the maximum average score (MAS). The term ‘modified’ in 
MMAS refers to the fact the first observations were carried out 24 hours after 
instillation, rather than sooner. 
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2.3.4 Hazard classification of chemicals  
 
Classification of skin irritants 
The EU classification system (EC, 1983) has a single class of skin irritancy, denoted by 
the risk phrase R38. A chemical is classified as R38 if it causes ‘significant’ 
inflammation which persists for at least 24 hours following an exposure period of up to 
4 hours. The inflammation is treated as significant if one or more criteria are fulfilled, 
one of them being that the mean value of the erythema scores, or of the œdema scores, 
calculated at 24, 48 and 72 hours, over all animals tested, should be ≥ 2. An additional 
criterion allows an R38 classification to be assigned, if an irritant effect (e.g. scaling or 
discolouration) is observed in at least two animals at the end of the observation period. 
 
The OECD classification system (OECD, 1998) distinguishes between irritants (class 2) 
and mild irritants (class 3). Class 2 corresponds approximately with R38, except that the 
threshold is a little higher (the mean erythema/eschar or œdema score should be > 2.3), 
and the mean values can be calculated from the scores on any three consecutive days (to 
account for delayed reactions). As in the EU system, ‘significant’ inflammation at the 
end of the observation period can be taken into account. Less irritating chemicals are 
placed into class 3, if their mean erythema or œdema scores have a mean value > 1.5, 
but less than 2.3, on three consecutive days.  
 
Classification of skin corrosives 
European regulations (EC, 1983) require classification according to risk phrases, 
determined according to whether a chemical causes corrosion after it has been applied 
for 3 minutes (R35) or 4 hours (R34). In the OECD classification system (OECD, 
1998), R35 and R34 correspond to corrosive subclasses 1A and 1C, respectively. The 
OECD system also allows for an intermediate classification 1B, for chemicals which 
cause corrosion after following an application of 1 hour. 
  
Classification of eye irritants and corrosives 
Chemicals are classified as eye irritants if they produce reversible effects in the rabbit 
eye, and as seriously damaging to the eyes if they produce irreversible effects. 
Irreversible effects include not only corrosive effects, such as the destruction of cornea 
or conjunctiva, but also persistent indication of impairment of sight. It should be noted 
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that chemicals that have been classified as skin corrosives are not tested for ocular 
effects, since they are also assumed to be corrosive to the eye.  
 
The European Union classification system (EC, 1993) allows for two classes of acute 
eye toxicity: R36 for (moderate) irritants, and R41 for severe irritants and corrosives. 
The criteria for assigning these risk phrases are awkward, since they differ according to 
whether three or more animals have been used in the Draize test (Table 2.1). 
 
The OECD classification system (OECD, 1998) also has two classes, but these are 
simpler to assign (Table 2.2). Class A is assigned to chemicals with irreversible effects 
(severe irritants and corrosives), and Class B to chemicals with reversible effects. An 
additional Class B1 is optional for chemicals whose irritant effects reverse within 7 days 
of application. The OECD scheme is also more humane, being based on the use of a 
maximum of three animals per test substance.   
 
Finally, it should be noted that regulatory classification systems are subject to changes, 
which is an important consideration when developing or evaluating models for 
predicting animal-based classifications. For example, the 17th Amendment to the 
Dangerous Substances Directive (EC, 1992) introduced a change in the criteria for 
serious eye damage: the observation of irreversible eye damage at the end of a 21-day 
observation period became sufficient for an R41 classification to be assigned, 
irrespective of the extent of that damage, whereas previously, R41 was only assigned if 
the appropriate thresholds were exceeded (Table 2.1).  
 
2.4 ALTERNATIVE METHODS 
 
2.4.1 Terminology 
 
Alternative methods and prediction models 
An alternative method is any method which serves to replace, reduce or refine the use of 
an existing animal procedure. Such methods include: a) computer-based methods 
(mathematical models and expert systems; b) physicochemical methods, in which 
physical or chemical effects are assessed in systems lacking cells; and, most typically, 
c) in vitro methods, in which biological effects are observed in cell cultures, tissues or 
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organs. To obtain meaningful results with physicochemical and in vitro test systems, it 
is necessary to have a means of extrapolating the physicochemical or in vitro data to the 
in vivo level. To achieve this, Bruner et al. (1996) introduced the concept of prediction 
model (PM), defined as an algorithm which converts the results of one or more 
alternative methods into a prediction of in vivo toxicity. A PM could be a classification 
model for predicting toxic potential (e.g. EU risk phrases), or it could be a regression 
model for predicting toxic potency (e.g. Draize scores). 
 
The usefulness of an alternative method for regulatory purposes is formally assessed by 
performing an interlaboratory validation study. An alternative method is judged valid 
for a specific purpose (e.g. the classification of chemicals on the basis of skin 
corrosivity) if it meets pre-defined criteria of reliability and relevance (Balls & Karcher, 
1995). In this context, ‘reliable’ means that the data generated by the alternative method 
are reproducible (within and between laboratories), and ‘relevant’ means that the 
method is associated with a PM of sufficient predictive ability. 
 
Structure-activity relationships and integrated models 
One type of mathematical model discussed in this thesis is the structure-activity 
relationship (SAR), defined as any mathematical model for predicting biological 
activity from the structure and/or physicochemical properties of a chemical. In the 
literature, a distinction is generally drawn between quantitative SARs (QSARs) and 
(qualitative) SARs. Some workers use the term QSAR to indicate that a quantitative 
measure of chemical structure is used, in contrast to the SAR, which is simply an 
association between a specific molecular (sub)structure and biological activity (e.g. 
Livingstone, 1995). Confusingly, other workers use the modifier ‘quantitative’ to denote 
the fact that the biological activity is based on a quantitative, rather than a qualitative, 
scale (e.g. McKinney et al., 2000). In this thesis, the term SAR will be used without 
distinction to refer to any method which relates physicochemical properties to biological 
activity.  
 
A subtle distinction can be made between SARs and the PMs associated with 
physicochemical tests. The distinction is that while any PM (associated with a 
physicochemical test) could also be called a SAR, not all SARs could also be called 
PMs. For example, SARs can also be based on theoretical descriptors (e.g. topological 
 17
indices) or on experimental properties that are themselves more easily predicted than 
measured (e.g. the octanol-water partition coefficient).  
 
The term ‘structure-property relationship’ (SPR) is sometimes used in distinction to 
SAR, to denote models that predict physicochemical properties (e.g. aqueous solubility), 
rather than biological activities. However, some workers use the term ‘SAR’ for both 
kinds of model (e.g. Barratt, 1995a). Another term which is often used is ‘structure-
permeability relationship’ (also abbreviated SPR; e.g. Cronin et al., 1999). In this thesis, 
SPR will be used to denote a structure-permeability relationship, i.e. any mathematical 
model that enables a permeability coefficient (Kp) to be predicted from one or more 
physicochemical properties.  
 
Finally, it should be noted that some workers have reported SARs for in vivo effects, 
based not only on chemical structure/properties, but also on in vitro endpoints (e.g. 
Barratt et al., 1996). The present author suggests that such models are distinguished 
from PMs and SARs by the term ‘integrated model’ (IM).  
 
2.4.2 In vitro methods for skin penetration 
 
Percutaneous absorption can be studied in vitro by measuring the diffusion of chemicals 
across excised (human or animal) skin. A draft guideline for in vitro percutaneous 
absorption is being considered by the OECD (1994), since there is good evidence that in 
vitro data are predictive of both human and animal data (Scott et al., 1992; ECETOC, 
1993). Nevertheless, for some chemicals, the in vitro/in vivo correlations have been 
poor, with the in vitro method usually underestimating absorption (e.g. Bronaugh & 
Stewart, 1984). In vitro methods for percutaneous absorption are reviewed in Howes et 
al. (1996). 
 
2.4.3 In vitro methods for skin corrosion 
 
The use of in vitro methods to assess skin corrosion is allowed for in several regulations 
and international guidelines. For example, the Dangerous Substances Directive (EC, 
1993) states that: “...classification can be based on the results of validated in vitro tests.” 
Similarly, OECD Test Guideline 404 (OECD, 1992) includes the following statement: 
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“...it may not be necessary to test in vivo materials for which corrosive properties are 
predicted on the basis of results from in vitro tests.” This section will describe three in 
vitro methods for skin corrosion, two of which are referred to in Part II of this thesis. 
 
Transcutaneous electrical resistance assay 
The transcutaneous electrical resistance (TER) assay was developed by Oliver and 
coworkers (Barlow et al., 1991; Oliver et al., 1986, 1988). In this method, test materials 
are applied for up to 24 hours to the epidermal surfaces of skin discs taken from the 
pelts of shaved and humanely killed young rats. Corrosive materials are identified by 
their ability to produce a loss of normal stratum corneum integrity and barrier function, 
which is measured as a reduction in the inherent TER below a predetermined threshold 
level (5kΩ); irritant and non-irritant substances do not reduce the TER below the 
threshold level. 
 
Skin2 
The Skin2TM model ZK1350 (Advanced Tissue Sciences Inc., La Jolla, CA, USA) is a 
three-dimensional human skin model with dermal, epidermal and corneal layers. The 
test material is applied to the stratum corneum for 10 seconds, and the extent of cell 
damage, as determined by the MTT reduction assay, is used to assess the degree of 
corrosivity (Perkins & Osborne, 1993; De Wever & Rheins, 1994; Perkins et al., 1996). 
MTT is a derivative of tetrazolium bromide, and its colour change upon reduction is 
used as an assay of mitochondrial function (and therefore cell viability). 
 
EPISKIN 
EPISKINTM (SADUC, Biomatériaux Imedex, Chaponost, France; the production rights 
now belong to L’Oréal) is a three-dimensional human skin model comprising a 
reconstructed epidermis with a functional stratum corneum. Its use for skin corrosivity 
testing involves topical application of test materials to the surface of the skin for 3, 60 
and 240 minutes, and the subsequent assessment of their effects on cell viability, using 
the MTT assay.  
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Validation status of in vitro tests for skin corrosion  
The abilities of the three in vitro skin corrosivity methods (and one physicochemical 
method, CORROSITEXTM; see below) to distinguish between corrosive and non-
corrosive chemicals were assessed during an ECVAM validation study (Barratt et al., 
1998; Fentem et al., 1998). All four tests showed acceptable reproducibilities, but only 
the TER and EPISKIN assays met the criteria for relevance. The regulatory acceptance 
of EPISKIN and TER at the European level took place in February 2000, and the 
protocols for these methods were incorporated into Annex V (Testing Methods) of the 
Dangerous Substances Directive in June 2000 (EC, 2000).  
 
2.4.4 In vitro methods for skin irritation 
This section will provide a brief description of the three main types of in vitro method 
used for skin irritation testing: keratinocyte cultures, reconstituted human skin models, 
and organ cultures. The current status of these methods is reviewed in Robinson et al. 
(1999) and in van de Sandt et al. (1999).  
 
Keratinocyte cultures 
Keratinocyte cultures (based on isolated cells or cell lines) have been used with a 
variety of endpoints for studying the cytotoxic effects of chemicals on skin cells. In 
early studies, endpoints for basal cytotoxicity were used, such as MTT reduction and 
neutral red uptake. More recently, attention has focussed on the use of more specific, 
mechanistically based endpoints, such as the release of IL-1 and prostaglandin (PG)-E2. 
In general, it appears that reasonable agreement between in vitro cytotoxicity data and 
in vivo irritation scores/classifications is only observed with specific groups of related 
compounds, such as surfactants (Osborne & Perkins) and N-alkyl sulphates (Wilhelm et 
al., 1994). However, due to absence of a corneum stratum in keratinocyte cultures, they 
tend to be over-predictive of skin irritation measured in vivo. 
 
Reconstituted human skin models 
In contrast to simple monolayer keratinocyte cultures, reconstituted human skin models 
are multi-layered, differentiated keratinocyte cultures, which exhibit the main 
characteristic features of the native epidermis, including the cuboidal appearance of the 
basal cell layer, and the presence of the spiny, granular and horny layers. The 
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intercellular space of the stratum corneum has a lipid composition similar to that of its 
native counterpart (van de Sandt et al., 1999). The epidermal surface of these systems is 
exposed to the air, so test substances can be applied directly. In this respect, human skin 
models have an advantage over monolayer keratinocyte cultures, which are immersed in 
culture medium, since some test substances are insoluble in water. A variety of 
endpoints have been used in reconstructed systems, including MTT reduction and 
cytokine release (Coquette et al., 1999). 
 
Currently, three human skin models are commercially available: a) EPISKIN; b) 
EpiDermTM (MatTek, Ashland, MA, USA); and c) SKINETHICTM (Skinethic 
Laboratories, Nice, France). EPISKIN is based on the skin model developed by Tinois 
et al. (1991); EpiDerm was developed by Cannon et al. (1994); and SKINETHIC is 
based on the model developed by Rosdy & Clauss (1990). Other human skin models 
have also been reported (e.g. Boyce et al., 1990; Bell et al., 1991). 
 
Organ cultures 
Organ cultures based on skin explants from animals and humans represent the most 
relevant model for skin irritation testing, since all skin layers and cell types are present. 
The dermal side of the organ culture is immersed in cell culture medium, while the 
surface of the stratum corneum is exposed to the air, thus permitting the topical 
application of test chemicals. Several toxicological endpoints have been employed, 
including cell viability, the release of inflammatory mediators, histomorphology, and 
epidermal cell proliferation. A limitation of these systems is that they can only be used 
for short exposures (up to 3 days) to test substances, because of the brief survival time 
of the tissue in vitro (van de Sandt et al., 1999).  
 
Validation status of in vitro methods for skin irritation 
Progress in the development and validation of in vitro methods for skin irritation has 
been slower than in the case of methods for skin corrosion. This is probably due to the 
greater complexity of the irritant response in vivo: inflammatory effects (erythema and 
œdema) are the final manifestations of a chain of molecular and cellular events, and 
depend on the endothelial cells of surface blood vessels, which do not exist in vitro. 
Nevertheless, a number of promising models based on ‘earlier’ endpoints are currently 
being evaluated in an ECVAM-funded prevalidation study. The models being evaluated 
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are EPISKIN, two other human skins models (EpiDerm and PREDISKINTM), and the 
non-perfused pig ear model.  
 
2.4.5 In vitro methods for eye penetration 
 
The penetration of chemicals into the eye is generally studied in the context of ocular 
pharmacology (rather than ocular toxicology), the aim of such studies being to 
maximise the delivery of ocular drugs (e.g. anti-glaucoma drugs) to the appropriate 
target tissues in the eye. Most of these studies have employed isolated corneas or scleral 
tissue (a compilation of studies is given by Prausnitz & Noonan [1998]), although a 
limited number of studies have used isolated conjunctivas (e.g. Kompella et al., 1999).  
 
2.4.6 In vitro methods for eye irritation 
 
A number of in vitro methods for eye irritation have been developed and evaluated in 
multi-centre validation studies. At present, however, no single method, or combination 
of methods, has been found to meet all the requirements of the regulatory authorities. 
This section will provide a brief introduction to those methods which are referred to in 
Part II of the thesis. Detailed descriptions of these tests are given in Balls et al. (1995), 
and their current validation status is described in Balls et al. (1999).  
 
A number of in vitro tests for eye irritation are based on simple cell cultures, including: 
a) the detection of hæmolysis and protein denaturation in red blood cells (RBCs); b) the 
determination of neutral red uptake (NRU) in fibroblasts (e.g. murine 3T3 cells); c) the 
determination of fluorescein leakage (FL) across an epithelial monolayer (Madin-Darby 
canine kidney [MDCK] cells); and d) the measurement of metabolic activity 
(production of acid metabolites) in fibroblasts (e.g. murine L929 cells), using the silicon 
microphysiometer (SM). 
 
Another group of tests are referred to as ex vivo tests, since they are based on isolated 
tissues. These tests include: a) the assessment of effects in the isolated rabbit eye (IRE) 
and the isolated chicken eye (ICE); b) the measurement of opacity and permeability in 
the bovine cornea (the bovine cornea opacity and permeability [BCOP] test); and c) the 
subjective scoring of hæmorrhage, lysis and coagulation in the vascularised 
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chorioallantoic membrane (CAM) of embryonated chicken eggs (the hen’s egg test on 
the chorioallantoic membrane [HETCAM]). The endpoints used in all of these tests are 
summarised in Table 2.3. 
 
Finally, for completeness, it should be noted that there is a third group of in vitro tests: 
the human tissue equivalents. For example, the EpiOcularTM system (MatTek 
Corporation, MA, USA) consists of human-derived epidermal keratinocytes cultured to 
form a stratified epithelium similar to that found in the human cornea (Stern et al., 
1998). 
 
2.4.7 Physicochemical methods for skin irritation and corrosion 
 
Use of pH, pKa and acid/alkali reserve measurements 
One approach to the determination of skin irritation and corrosion has been based on the 
determination of pH (a measure of the acidity/alkalinity of substances in aqueous 
solution, defined as the negative logarithm of the hydrated proton concentration), or on 
the combined use of pH and acid/alkali reserve, the latter being a purported measure of 
buffering capacity. The acid reserve of a substance is defined as the amount (in grams) 
of sodium hydroxide required to bring 100g of acidic test substance (in a 10% solution 
or suspension) up to a pH of 4. The alkali reserve is defined as the amount (in grams) of 
sodium hydroxide equivalent to the amount of sulphuric acid required to bring a 100g of 
alkaline test substance (in a 10% solution or suspension) down to a pH of 10. Further 
details on the generation and use of acid/alkali reserve measurements are given in 
Young et al. (1988). 
 
To predict skin corrosion potential from pH alone, OECD Test Guideline 404 (1992) 
recommends the following PM: 
 
If the pH of a substance ≤ 2, or if pH ≥ 11.5, it is likely to be corrosive.  
 
No guidance is provided in the 1987 version of this guideline on the concentration at 
which the pH should be measured.  
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Regarding the combined use of pH and acid/alkali reserve measurements, Young & 
How (1994) recommended the following PMs: 
 
If pH - acid reserve/12 ≤ -0.5, or if pH + alkali reserve/12 ≥ 14.5, the substance is likely 
to be corrosive. 
 
If pH - acid reserve/6 ≤ 1, or if pH + alkali reserve/6 ≥ 13, the substance is likely to be 
irritant. 
 
To apply this PM, it was recommended that pH measurements are carried out  on a 10% 
(w/w) solution for solid test substances, and on the undiluted liquid for liquid 
substances. An evaluation carried out by the author (Worth et al., 1998) indicates that 
the PM based on pH and acid/alkali reserve measurements is no more predictive of skin 
corrosion potential than the PM based on pH measurements alone, at least in the case of 
single chemicals. The acid/alkali reserve method may, however, be useful for predicting 
the corrosion potential of mixtures, especially those containing ionic salts (A.P. Walker, 
personal communication). 
 
The use of the acid dissociation constant (pKa) for predicting skin irritation has been 
reported by Nangia et al. (1996). These workers used a modified Draize scale (with 
tissue scores ranging from 0 to 5) to rank the human skin irritancy of 12 basic 
compounds having similar in vitro penetration rates. The following PM was reported: 
 
log (VIS) = 0.17 pKa – 1.44      (Equation 2.3) 
n = 12, r = 0.84, s and F not given 
 
where VIS is the visual irritation score (the modified Draize score). Similarly, in a study 
by Berner et al. (1988), the human skin irritancy of a series of four benzoic acidic 
compounds was reported to correlate with their pKa values.  
 
CORROSITEX 
CORROSITEXTM (InVitro International, Irvine, CA, USA) is a physicochemical 
method for skin corrosion based upon the determination of the time required for a test 
material to pass through a biobarrier membrane (a reconstituted collagen matrix, 
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constructed to have physicochemical properties similar to rat skin). If the test substance 
alters the biobarrier sufficiently to be able to pass through it, a colour change is 
produced in a liquid (the ‘chemical detection system’), located directly below the 
biobarrier. The time required for this change to occur (the ‘breakthrough time’) is 
reported to be inversely proportional to the degree of corrosivity of the test material 
(Fentem et al., 1998). 
 
2.4.8 Physicochemical methods for eye irritation 
 
Use of pH, pKa and acid/alkali reserve measurements 
The combined use of pH and acid/alkali reserve measurements for predicting eye 
irritation potential was reported to be useful by Régnier & Imbert (1992). In contrast, an 
evaluation by the author (Worth & Fentem, 1999) found no evidence for the additional 
usefulness of acid/alkali reserve measurements over pH measurements alone. However, 
the two studies applied different PMs to different data sets, which could account for the 
different conclusions. 
 
The use of the acid dissociation constant (pKa) for predicting eye irritation has been 
reported by Sugai et al. (1991). These workers studied a homogeneous set of 10 
salicylates (2-hydroxybenzoic acids) and reported a significant correlation between pKa 
and the weighted cornea score (WCS): 
 
WCS = -31 pKa + 144.1      (Equation 2.4) 
n = 10, r = -0.73, s and F not given 
 
The correlation between pKa and the weighted conjunctival score was not found to be 
significant. 
 
EYTEX 
EYTEXTM is a physicochemical method for eye irritation based on the detection of 
protein precipitation in an artificial matrix, which is assumed to mimic opacity 
formation in the cornea. Protein precipitation is assayed as the turbidity of the EYTEX 
reagent, using a spectrophotometer. 
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Human cornea model 
Recently, the development of an artificial human cornea, containing epithelial, stromal 
and endothelial layers, was reported (Griffith et al., 1999). This system could prove to 
be a valuable model for predicting eye irritation. 
 
2.4.9 Mathematical models 
 
Membrane penetration as a partition-diffusion process 
The transport of chemicals across biological membranes is generally modelled as a 
partition-diffusion process: i.e. the penetration rate of a chemical is considered to 
depend partly on the extent to which it partitions into the membrane phase, and partly 
on its ability to diffuse through that phase.  
 
Experimentally, transmembrane flux is generally determined by fixing the concentration 
gradient across a membrane of known surface area. Initially, there will be a non-linear 
concentration gradient across the membrane, but following a lag-time (t), the 
concentration gradient will be linear, and a steady-state flux will be attained. From 
Fick’s laws of diffusion, it can be shown that the steady-state flux across an isotropic 
(homogeneous) membrane is given by Equation 2.5 (see Flynn, 1990, for a 
mathematical derivation): 
 
J = Km. D. (A/L). ΔC        (Equation 2.5) 
 
where J is the transmembrane flux (mg/s), Km is the (dimensionless) membrane-solvent 
partition coefficient, D is the diffusion coefficient (diffusivity) of the penetrant (cm2/s), 
A is the area of membrane (cm2), L is diffusion path length (cm), and ΔC is the 
concentration gradient across the membrane (mg/cm3). The permeability coefficient, Kp, 
is defined by Equation 2.6: 
 
Kp = Km. (D/L)       (Equation 2.6) 
 
where Kp is the permeability coefficient of the penetrant (cm/s). Thus, if a biological 
membrane is treated (for simplicity) as an isotropic membrane, and the diffusion path 
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length is approximated by the membrane thickness h, Equation 2.5 can be rewritten as 
follows: 
 
J = Kp. D. (A/h). ΔC       (Equation 2.7)  
 
where A, h and ΔC are under experimental control, and D can be calculated from the 
lag-time t (the time taken for a steady-state flux to be achieved) by using Equation 2.8: 
 
D = h2/6.t         (Equation 2.8) 
 
In some studies, it is assumed that the diffusion coefficient is constant for all permeants, 
in which case D can be calculated from the intercept [equal to log(D/h)] of a plot of 
logKm against logKp. However, according to Potts and Guy (1992), this can lead to an 
overestimation of Kp for small substances, which have relatively high values of Km, due 
to the inverse relationship that exists between the diffusion coefficient and permeant 
size (Lieb & Stein, 1971). 
 
Finally, it should be noted that the permeability coefficient Kp is dependent on the 
solvent used in the diffusion experiment (due to the dependence of Kp on Km). 
Therefore, SARs should ideally be developed from data obtained with a common 
solvent. This is usually chosen to be water, because this does not damage the 
membrane.  However, water is not a suitable solvent for highly lipophilic substances, 
which is why cosmetic and pharmaceutical formulations often contain penetration 
enhancers (Guy et al., 1990).  
 
Structure-permeability relationships for skin penetration 
Early attempts to derive SPRs were based simply on the logarithm of the octanol-water 
partition coefficient (logP), which produced reasonable models for certain homologous 
series, such as alcohols (Scheuplein, 1965), steroids (Scheuplein et al., 1969), and 
phenols (Roberts et al., 1977). More recently, Kirchner et al. (1997) reported SPRs 
based on logP with r2 values > 0.7, but these only applied to subsets of chemicals falling 
within defined ranges of molar volume. Notably, the model based on a heterogeneous 
data set of 114 chemicals showed a poor fit to the data (r2=0.32). 
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Since it appears that reliable SPRs based on logP alone cannot be derived for 
heterogeneous groups of chemicals, most recent studies have considered additional 
predictor variables. A common approach has been to develop SPRs based on logP and 
molecular weight (MW). Perhaps the most commonly cited SPR based on logP and MW 
is the one derived by Potts & Guy (1992), who analysed a data set of in vitro skin 
permeability coefficients published by Flynn (1990): 
 
log Kp = 0.71 log P - 0.0061 MW - 6.3    (Equation 2.9) 
n = 93, s = 0.710, r = 0.82, r2 = 0.67 
 
where logKp is the logarithm of the permeability coefficient across excised human skin 
(in units of cm/sec). 
 
Similar models have been reported by other workers (Kasting et al., 1987; Bronaugh & 
Barton, 1993; Cronin et al., 1999). An SPR based on logP and molecular volume (MV) 
has also been reported (Barratt, 1995a), which is essentially the same, given the high 
collinearity between MV and MW. 
 
A different approach has been to derive SPRs based on fragmental constants, in which 
organic molecules are broken into fragments, with each fragment then being assigned a 
value for its contribution to the Kp (Pugh & Hadgraft, 1994). This approach provides a 
way of assessing how the introduction of specific functional groups will affect skin 
permeability.  
 
Abraham et al. (1995) applied the solvatochromic approach to the prediction of Kp, i.e. 
Kp was treated as a function of the so-called ‘solvatochromic parameters’, which 
express the steric, electronic and hydrogen-bonding properties of a solute (Equation 
2.10): 
 
log Kp = -5.33 - 0.57 π2 -0.51 Σα2H -3.37 Σβ2H + 1.77 Vx  (Equation 2.10) 
n = 25, s =0.26, r= 0.98, r2 =0.96      
 
where π2 is the dipolarity/polarisability; Σα2H and Σβ2H are descriptors for hydrogen 
bond acidity and basicity; and Vx is the McGowan characteristic volume. 
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This approach was further developed by Pugh et al. (1996), who separated Kp into two 
terms, the partition coefficient between water and the stratum corneum (Ksc), and a 
diffusion term (D/h). They then showed that the partition coefficient could be predicted 
from logP (Equation 2.11), whereas the diffusion term could be predicted from the 
hydrogen bond donor (α) and acceptor (β) abilities (Equation 2.12): 
 
log Ksc = -0.024 + 0.59 logP      (Equation 2.11) 
n = 45, s not given, r2 = 0.84 
 
log (D/h) = -1.327 -1.30 α - 2.57 β     (Equation 2.12) 
n = 31, s =0.179, r2 =0.85 
 
Alternatively, the permeability coefficient can be predicted directly by using Equation 
2.13 (Pugh et al., 1996): 
 
log Kp = -1.09 + 0.508 logP -1.26 α - 2.84 β    (Equation 2.13) 
n = 31, s =0.155, r2 =0.96 
 
 
Structure-permeability relationships for eye penetration 
SPRs for predicting the transport of substances across ocular tissues do not appear to be 
as widely reported as SPRs for skin penetration. A number of SPRs for corneal 
permeability have been derived for congeneric series, including β-blocking agents 
(Schoenwald & Huang, 1983) and steroids (Schoenwald & Ward, 1978; Grass et al., 
1988). In these studies, a parabolic relationship between the corneal permeability 
coefficient and logP (or logD, the logarithm of the distribution coefficient) was 
observed. However, some chemicals within these congeneric series deviated from the 
parabolic curves. 
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More recently, Yoshida & Topliss (1996) published an SPR (Equation 2.14) with a high 
correlation coefficient (r = 0.9), derived from a data set consisting mostly of steroids 
and β-blockers: 
 
log Kp = -3.55 - 0.478 ΔlogP + 0.105logD     (Equation 2.14) 
n = 26, s =0.282, r= 0.92, r2 =0.84 
 
where logD is the logarithm of the distribution coefficient at pH 7.65, and ΔlogP is 
logPoctanol – logPalkane. In cases where experimental data for ΔlogP were missing, 
Yoshida & Topliss used a solvation equation to predict ΔlogP from five solvatochromic 
parameters (R2, a term representing molar refraction; π2, a descriptor for 
dipolarity/polarisability; Σα2H and Σβ2H, descriptors for hydrogen bond acidity and 
basicity; and Vx, the McGowan characteristic volume). To apply this SPR to most 
chemicals of interest, it would therefore be necessary to obtain values for the five solute 
descriptors, in addition to logD values. In this project, an attempt was made to derive 
SPRs for corneal permeability which are based on more readily accessible descriptor 
variables. This work is described in Chapter 8.   
 
Structure-activity relationships for skin irritation and corrosion 
Relatively few SAR studies for skin irritation have been reported in the literature. 
Barratt (1996a) reported a SAR for predicting the PII of organic chemicals, but this had 
little predictive value (r2 =0.42). In the same study, discriminant analysis was shown to 
discriminate between irritant and non-irritant chemicals, defined by EU classification 
criteria, with an accuracy of 67%. However, an explicit classification model was not 
reported.  
 
Hayashi et al. (1999) reported two SARs for predicting the molar-weighted PII of 
phenols. One model, based on absolute hardness, was proposed for chemicals with 
negative lowest unoccupied molecular orbital (LUMO) energies, whereas the other 
model, based on the logarithm of the octanol-water partition coefficient (logP), was 
proposed for chemicals with positive LUMO energies. These models had correlation 
coefficients of 0.72 and 0.82, respectively (i.e. r2 values of 0.52 and 0.67).  
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In a recent study by Smith et al. (2000), best subsets regression and linear discriminant 
analysis were applied to a data set of 42 esters, for which human skin irritation data 
were obtained and 19 physicochemical variables were calculated. Best subsets 
regression was used to select variables for subsequent inclusion in discriminant models. 
A total of 10 models were reported, each one being derived from the data for the 13 
irritant esters and the data for 13 non-irritant esters, these having been randomly 
selected with replacement from the set of 26 non-irritant esters. The best (most 
frequently selected) variables were water solubility (lower for irritants than non-
irritants), a dispersion parameter (higher for irritants), a hydrogen-bonding parameter 
(higher for irritants), the sum of partial positive charges (lower for irritants), and density 
(lower for irritants). The discriminant model based on all five parameters had a 
sensitivity of 85% and a specificity of 92%.  
 
Various SARs for skin corrosion have been reported by Barratt and colleagues (Barratt, 
1996a; Barratt, 1996b; Whittle et al., 1996; Barratt et al., 1998). On the whole, the 
SARs presented in these studies take the form of principal component (PC) plots, which 
are based on physicochemical properties and show a separation between corrosive (C) 
and non-corrosive (NC) chemicals. Explicit classification models were not presented. 
Rather than modelling a heterogeneous group of chemicals, separate analyses were 
performed for acids, bases, electrophiles and neutral organics (defined as uncharged 
molecules which lack the potential to react covalently and which do not ionise under 
biological conditions [M.D. Barratt, personal communication]). The most recent 
presentation of this approach is given in Barratt et al. (1998). In addition to PC analyses, 
discriminant analysis and neural network analysis were also applied to the neutral and 
electrophilic chemicals (Barratt, 1996a) and to the acids, bases and phenols (Barratt, 
1996b). Finally, in another study (Barratt et al., 1996), PC plots for acids were based not 
only on physicochemical propertes, but also on in vitro cytotoxicity measurements in 
mouse 3T3 cells. The additional inclusion of the cytotoxicity variable helped to separate 
moderate (R34) corrosives from severe (R35) corrosives.  
 
Structure-activity relationships for eye irritation 
Cronin et al. (1994) applied linear regression analysis to a heterogeneous data set of 53 
organic liquids, to derive SARs for predicting the molar eye score (MES). This is the 
usual MMAS corrected for the number of molecules applied to the rabbit eye, and its 
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use as the response variable is justified on the grounds that biological responses 
produced by pure chemicals are expected to be proportional to the number of active 
molecules, rather than to the amount (in g or ml) of active substance. Although 23 
physicochemical properties were examined, it was found that statistically significant 
regression models could not be obtained for the complete set of chemicals. However, 
reasonable models could be obtained for the alcohols (Equation 2.15) and the acetates 
(Equation 2.16): 
 
MES = 2.06 logP + 4.13       (Equation 2.15) 
n = 9, s =1.89, r2 =0.72 
 
MES = -1.37 logP + 2.97       (Equation 2.16) 
n = 7, s =0.52, r2 =0.74 
 
where MES = molar eye score (molar MMAS). 
 
Abraham et al. (1998a) applied the solvatochromic approach to a data set comprising 38 
of the 53 organic liquids previously analysed by Cronin et al. (1994). Again, the MES 
was used as the response variable, but the authors argued that logP is not the most 
appropriate variable for describing the transfer of a liquid into an organic biophase. 
Instead, it was argued that this transfer process is equal to the product of the solubility 
of a vapour into hexadecane (L) and the saturated vapour pressure (Po), measured in 
ppm. Thus, instead of deriving a SAR based on logP, a model was based on logL and 
logPo. The solvatochromic parameters were also used as descriptor variables, giving the 
following SAR: 
 
log (MES/Po) = -6.97 – 0.17R2 +0.88π2 +3.83Σα2H +1.41Σβ2H + logL 
n = 38, s =0.46, r2 =0.89      (Equation 2.17) 
 
where R2 is the excess molar refraction (a term representing the tendency of a solute to 
interact through  n or π electrons); π2 is the dipolarity/polarisability; and Σα2H and Σβ2H 
are descriptors for hydrogen bond acidity and basicity. The authors chose to represent 
the response variable as log(MES/Po), instead of using log(MES) and adding logPo to 
the right-hand side of the equation. This may have been done to emphasise the fact that 
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the response is not the MES resulting from direct application of a liquid to the eye, but 
the MES resulting from exposure to the corresponding vapour. If logPo is added to both 
sides of Equation 2.17, it becomes apparent that six variables are being used to make 
predictions for 38 chemicals (i.e. there is a 16% chance that Equation 2.17 is a spurious 
correlation). In a subsequent study, Abraham et al. (1998b) claimed that the eye 
irritation threshold in humans (EIT), expressed in parts per million (ppm), can be 
calculated from the MES in rabbits by using the following equation: 
 
log (1/EIT) = log (MES/Po) - 0.66     (Equation 2.18) 
n = 8, r and s not given 
 
Equation 2.18 was used to calculate the EIT for 37 compounds for which human data 
were not available, and the 37 predicted EIT values were combined with 17 measured 
values to derive the following SAR for the EIT: 
 
log (1/ EIT) = -7.92 – 0.48R2 +1.42π2 +4.03Σα2H +1.22Σβ2H + 0.85logL 
n = 54, s =0.36, r2 =0.93      (Equation 2.19) 
 
A different approach to the prediction of the molar eye score was adopted by Kulkarni 
& Hopfinger (1999). In addition to calculating the usual intramolecular solute 
properties, these workers also used a molecular dynamics method to generate 
intermolecular membrane-solute interaction properties. SARs based on these properties 
were then derived by using a genetic algorithm, instead of traditional multiple linear 
regression. The following SAR had the highest r2 value:  
 
MES = -0.81 – 0.07 E – 0.48 F(H2O) + 0.35 κ3   (Equation 2.20) 
n = 16, s =0.41, r2 =0.92 
 
where E is the sum of the electrostatic and van der Waals interaction energies between 
the solute and the membrane (modelled as a dimyristoylphosphatidylcholine 
monolayer); F(H2O) is  the free energy of solvation of the solute in water; and κ3 is the 
third-order kappa index. The 16 chemicals used to derive the model were aliphatic and 
aromatic hydrocarbons, and aliphatic ketones, alcohols and acetates. 
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In addition to the derivation of regression models, a number of attempts have been made 
to derive classification models for eye irritation. For example, Cronin et al. (1994) 
applied linear discriminant analysis to the data set of 53 organic liquids, but found no 
linear combination of physicochemical properties capable of discriminating between 
irritant (I) and non-irritant (NI) chemicals (as defined by EU classification criteria). 
However, in a PC plot based on all 23 variables, the I chemicals appeared to form an 
embedded cluster within the NI chemicals. 
 
The phenomenon of embedded clustering of irritant chemicals was investigated further 
by Cronin (1996), this time by using the technique of cluster significance analysis 
(CSA) to determine whether the embedded clustering was statistically significant. Out 
of a total of 23 physicochemical descriptors, it was reported that the five most 
significant, in terms of the embedded clustering of 52 organic liquids, were logP, logP2, 
the heat of formation, dipole moment, and the zero-order valence connectivity index. 
Similarly, an embedded cluster of eye irritants was apparent in a PC plot of 57 neutral 
organic chemicals, based on logP, dipole moment, and the second and third principal 
inertial axes (Barratt, 1997). 
 
The physicochemical determinants of eye irritation potential were also investigated by 
Rosenkranz et al. (1998). In comparison with non-irritant chemicals, these workers 
reported that irritant chemicals have significantly lower molecular weights, higher 
aqueous solubilities, lower logP values, and greater molecular orbital energy gaps 
(absolute hardness values). On the basis of the last-named observation, the authors 
concluded that chemical reactivity does not appear to be a requirement for eye irritation. 
Rosenkranz et al. also used their Multi-CASE expert system to identify biophores 
(substructures which occur with a significantly greater frequency in irritants than in 
non-irritants) and biophobes (substructures which occur significantly more frequently in 
non-irritants). The major structural determinants included primary, secondary and 
tertiary amine groups (i.e. basic groups), as well as carboxylate, organosulphate and 
sulphonate groups (i.e. acidic groups). Other groups were also reported, but their 
mechanistic significance is unclear, and they may even represent statistical artefacts. In 
this study, 202 chemicals were classified as I or NI according to the system of Smyth & 
Carpenter (1946), but an additional 94 chemicals were classified according to the EU 
system, so an imbalance was introduced into the analyses. 
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The analyses described above aimed to predict the eye irritation potency or potential of 
non-surfactant chemicals, so it is of interest that a recent investigation has focused on 
surfactants (Patlewicz et al., 2000). In this study, neural network analysis was used to 
show that the MAS of cationic surfactants shows a positive, non-linear correlation with 
surfactant concentration and critical micelle concentration, and a negative non-linear 
correlation with logP. Contrary to expectation, a positive correlation with molecular 
volume was also found. The trained neural network was able to predict about 70% of 
the variance in the training set, which is probably as much as could be expected, given 
the variability in the rabbit data. However, apart from highlighting a few useful 
predictor variables, this study is of limited usefulness, since it does not provide a 
prediction model for converting such variables into predictions of the MAS.  
 
2.5 INTEGRATED TESTING STRATEGIES 
 
Due to the limitations of individual alternative methods for predicting toxicological 
hazard, there is a growing emphasis on the use of integrated approaches (Barratt et al., 
1995). This has led to the concept of the ‘integrated testing strategy’, which has been 
defined as follows (Blaauboer et al., 1999): 
 
“An integrated testing strategy is any approach to the evaluation of toxicity which 
serves to reduce, refine or replace an existing animal procedure, and which is based on 
the use of two or more of the following: physicochemical, in vitro, human (e.g. 
epidemiological, clinical case reports), and animal data (where unavoidable), and 
computational methods, such as (quantitative) structure-activity relationships ([Q]SAR) 
and biokinetic models.” 
 
Since integrated testing strategies are based on the use of different types of information, 
they are expected to be particularly successful at predicting in vivo endpoints which are 
too complex in biochemical and physiological terms for any single method to 
reproduce. 
 
A particular type of integrated testing strategy is the so-called tiered (stepwise or 
hierarchical) testing approach to hazard classification. This is based on the sequential 
use of data derived from alternative methods (structure-activity relationships, biokinetic 
models, physicochemical methods and in vitro tests), and existing information, before 
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any animal testing is performed. In addition to providing a means of implementing the 
Three Rs, tiered testing schemes are intended to optimise the use of existing knowledge 
and resources, while maximising the accuracy of predicted classifications. An important 
feature in the design of such strategies is that chemicals which are predicted to be toxic 
in an early step are classified without further assessment. Conversely, chemicals which 
are predicted to be non-toxic proceed to the next step for further assessment. In this 
way, it is intended that toxic chemicals will be identified by non-animal methods, while 
the animal test(s) performed at the end of the stepwise procedure will merely serve to 
confirm predictions of non-toxicity made in previous steps. 
 
Various tiered testing strategies been proposed in the literature for acute local toxicity,  
including skin irritation/corrosion (Basketter et al., 1994; Botham et al., 1998), skin 
sensitisation (Basketter et al., 1995), and eye irritation (Spielmann et al., 1996). One 
proposal combines the prediction of acute local and systemic toxicity into a single 
strategy (Barratt et al., 1995). 
 
At the regulatory level, stepwise approaches for classifying skin irritants and corrosives, 
and for classifying eye irritants and corrosives, are allowed for in OECD Test 
Guidelines 404 (OECD, 1992) and 405 (OECD, 1987), respectively, although no 
particular strategies are specified in these guidelines. Testing strategies proposed at an 
OECD workshop in January 1996 (OECD, 1996) were adopted, with minor 
amendments, by the OECD in November 1998 (OECD, 1998). The OECD testing 
strategies for skin irritation/corrosion, and for eye irritation/corrosion, are reproduced in 
Figures 2.3 and 2.4, respectively. 
 
The author has evaluated the tiered testing approach to hazard classification, as it 
applies to the prediction of acute dermal and ocular toxicity (Worth et al., 1998; Worth 
& Fentem, 1999). A development of this work is reported in Chapter 10. 
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Figure 2.1 Anatomy of the skina 
 
 
 
Footnote to Figure 2.1 
 
aTaken from Wikimedia Commons 
(https://commons.wikimedia.org/wiki/Category:Human_skin#/media/File:Anatomy_of_the_ski
n.jpg) under the Creative Commons Attribution-ShareAlike 3.0 Unported (CC BY-SA 3.0) 
licence.  
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Figure 2.2 Anatomy of the eyea 
 
 
 
Footnote to Figure 2.2 
 
aTaken from Wikimedia Commons 
(https://commons.wikimedia.org/wiki/File:Three_Main_Layers_of_the_Eye.png) under the 
Creative Commons Attribution-ShareAlike 3.0 Unported (CC BY-SA 3.0) licence.  
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Figure 2.3 The OECD tiered testing strategy for skin irritation and corrosiona   
 
Step   Parameter    Finding  Conclusion                          
 
1a Existing human or animal ⇒  Corrosive  Classify as corrosive 
 experience 
⇓     
Not corrosive or no 
data 
⇓ 
1b Existing human or animal ⇒  Irritant   Classify as irritant 
 experience 
⇓ 
Not irritant or no 
data 
⇓ 
1c Existing human or animal ⇒  Not corrosive or  No further testing 
 experience    irritant 
⇓     
No data 
⇓ 
2a Structure-activity relationships or ⇒ Corrosive  Classify as corrosive
 structure-property relationships 
⇓ 
Not corrosive or no 
data 
⇓ 
2b Structure-activity relationships or ⇒ Irritant   Classify as irritant 
 structure-property relationships 
⇓ 
Not irritating or no data 
⇓ 
3 pH with buffering   ⇒ pH < 2 or >11.5  Classify as corrosive 
⇓ 
Not pH extreme or no 
data 
⇓ 
4 Existing dermal data in   ⇒ Yes  Classify as corrosive/irritant 
animals indicate no need for     
 animal testing      
⇓ 
No indication or no data 
⇓ 
5 Valid and accepted in vitro dermal ⇒ Positive response  Classify as corrosive 
 corrosion test  
⇓ 
Negative response or 
no data 
⇓ 
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Figure 2.3 cont’d. The OECD tiered testing strategy for skin irritation and 
corrosiona   
 
 
Step   Parameter    Finding  Conclusion                          
 
6 Valid and accepted in vitro  ⇒ Positive response  Classify as irritant 
 dermal irritation test 
⇓ 
Negative response or  
no data 
⇓ 
7          In vivo dermal corrosion  ⇒ Corrosive response Classify as corrosive
 test (1 animal) 
⇓ 
Negative response  
⇓ 
8 In vivo dermal irritation  ⇒ Irritant response  Classify as irritant 
 test (3 animals total)   
⇓ 
Negative response ⇒ No further testing 
⇓ 
9 When it is ethical to perform  ⇒ Irritant response  Classify as irritant 
 human patch testing     
⇓ 
Not as above   ⇒ Non-irritant response No further testing 
 
 
 
 
Footnote to Figure 2.3 
 
aTaken from OECD (1998) with minor modifications. 
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Figure 2.4 The OECD tiered testing strategy for eye irritation and corrosiona 
 
Step Parameter    Finding  Conclusion                          
 
1a Data relating to historical human ⇒  Severe eye damage  Classify in Class A 
or animal experience   ⇒  Eye irritant   Classify in Class B 
    
⇓     
No or don’t know 
⇓ 
1b Data relating to historical human ⇒ Skin corrosive   Classify in Class A 
or animal experience      
  ⇓ 
No or don’t know 
⇓ 
1c Data relating to historical human ⇒ Skin irritant  Classify in Class B
 or animal experience    
⇓     
No or don’t know 
⇓ 
2a Structure-activity relationships or ⇒ Severe eye damage Classify in Class A
 structure-property relationships 
⇓ 
No or don’t know 
⇓ 
2b Structure-activity relationships or ⇒ Εye irritant  Classify in Class B 
 structure-property relationships 
⇓ 
No or don’t know 
⇓ 
2c Structure-activity relationships or ⇒ Skin corrosive  Classify in Class A 
 structure-property relationships 
⇓ 
No or don’t know 
⇓ 
3 pH/acid or alkaline reserve ⇒ pH < 2 or pH >11.5 Classify in Class B 
⇓     
2 < pH < 11.5 
(no buffering potential) 
⇓ 
4 Other information indicating the ⇒ Yes   Classify in Class A 
material is a dermal corrosive  
⇓ 
No  
⇓ 
5 Is a valid in vitro test available ⇒ No   Go to step 6 
to assess severe damage to eyes  
  ⇓ 
Negative response or no data 
⇓ 
5a In vitro test for severe   ⇒ Severe eye damage Classify in Class A 
eye irritation  
  ⇓ 
Not a severe eye irritant 
  ⇓ 
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Figure 2.4 cont’d. The OECD tiered testing strategy for eye irritation and 
corrosiona 
 
Step Parameter    Finding  Conclusion                          
 
 
6 Is a valid in vitro test available ⇒ No, but in vitro test for  Go to step 8 
for eye irritation    severe eye irritancy 
was negative 
⇓ 
⇒ No, in the absence of Go to step 7 
    any in vitro test 
⇓ 
Yes 
   ⇓ 
6a In vitro eye irritation test  ⇒ Eye irritant  Classify in Class B 
  ⇓ 
No indication of eye irritant properties 
⇓ 
7 Experimentally assess skin corrosion 
potential 
(see testing strategy for  
skin irritation/corrosion) 
⇓ 
8 1 rabbit eye test   ⇒ Serious eye damage Classify in Class A 
  ⇓ 
No indication of eye irritant properties 
⇓ 
9 1 or 2 further rabbits  ⇒ Eye irritant  Classify in Class B 
⇓ 
 Not an eye irritant  
 
 
 
Footnote to Figure 2.4 
 
aTaken from OECD (1998) with minor modifications. Chemicals in Class A have irreversible 
effects, whereas the effects of Class B chemicals are reversible. 
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Table 2.1 European Union classification system for eye irritation/corrosion 
 
 R36 (Irritating to eyes) R41 (Risk of serious damage to eyes)c 
 3 animalsa 4-6 animalsb 3 animalsa 4-6 animalsb
   
Corneal opacity ≥ 2.0 but <3.0 ≥ 2.0 but <3.0 ≥ 3.0 ≥ 3.0 
Iris lesion ≥ 1.0 but <2.0 ≥ 1.0 but ≤1.5 ≥ 2.0 > 1.5 
Conjunctiva 
redness  
≥ 2.5 ≥ 2.5
Conjunctiva 
chemosis 
≥ 2.0 ≥ 2.0
 
aThe classification is assigned if the mean tissue effect (averaged over the 24h, 48h and 72h 
time-points) is greater than or equal to the threshold value in at least two of the three animals.  
  
bThe classification is assigned if the mean tissue effect (averaged over the three time-points and 
over the six animals) is greater than or equal to the threshold value. 
 
cA classification of R41 is also assigned if, in at least one animal, one of the eye effects has not 
reversed at the end of the observation period. 
 
 
 
Table 2.2 OECD classification system for eye irritation/corrosion 
 
 Category Ba Category Ab 
Corneal opacity ≥ 1.0 ≥ 3.0
Iris lesion ≥ 1.0 > 1.5
Conjunctiva redness  ≥ 2.0
Conjunctiva chemosis ≥ 2.0
 
Classifications A and B are assigned if the mean tissue effect (averaged over the 24h, 48h and 
72h time-points) is greater than or equal to the threshold value in at least two of three tested 
animals.  
 
aAll effects have to be reversible within 21 days of treatment. The subcategory of B1 can be 
used for chemicals considered to be mildly irritating to the eyes, i.e. chemicals whose eye 
effects are reversible within 7 days of treatment. 
 
bCategory B is also applicable if, in at least one animal, an eye effect has not reversed, or is not 
expected to reverse, within 21 days of treatment. 
 
 
 43
Table 2.3 In vitro endpoints for eye irritation 
 
Test Endpoint(s)
  
Silicon microphysiometer test MRD50 - the concentration of test substance 
required to produce a 50% reduction in the 
metabolic acidification rate of L929 fibroblasts 
Red blood cell haemolysis 
test 
Dlow - the lowest concentration causing 
denaturation of hæmoglobin 
 Dmax - the maximum percentage denaturation seen 
at any concentration tested 
 H50 - the concentration causing 50% hæmolysis 
Neutral red uptake test NRU50 - the concentration which causes 50% 
inhibition of neutral red uptake into 3T3 cells 
Fluorescein leakage test FL20 - the concentration which causes 20-% 
fluorescein leakage across a layer of MDCK cells  
HETCAM method subjective measures of hæmorrhage, lysis and 
coagulation in the chorioallantoic membrane of 
embryonated chicken eggs 
Bovine corneal opacity/ 
permeability (BCOP) test  
BCOP score - subjective measure of opacity and 
permeability in bovine corneas 
Isolated, enucleated chicken 
eye test 
Measures of corneal swelling (% of untreated 
control), corneal opacity (score) and fluorescein 
retention (score) in the cornea of enucleated 
chicken eyes 
Isolated, enucleated rabbit 
eye test 
Measures of corneal swelling (% of untreated 
control) and corneal opacity (score) in the cornea 
of enucleated rabbit eyes, taken at two time points 
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3.1 INTRODUCTION 
 
A wide variety of physicochemical properties have been used as descriptor variables in 
structure-activity relationships (SARs), to express the shape, size, partitioning 
behaviour, and reactivity of chemicals (Dearden, 1990). In many cases, these properties 
can be determined experimentally or estimated by calculation. A special group of 
properties are the so-called topological descriptors, which can be derived from chemical 
graph theory alone. The emphasis of this chapter is on the algorithms and computer 
methods that can be used to calculate physicochemical descriptor variables, and on the 
interpretation of these properties. 
 
3.2 SUBSTITUENT PROPERTIES 
 
Substituent constants can be used as predictor variables when the goal of the 
investigation is to derive a SAR for a congeneric series of substances, i.e. a set of 
molecules whose structures differ only in terms of a few substituents on a parent 
molecule. The use of substituent constants is based on the assumption that the type of 
biological activity is determined by the common substructure, and that the substituents 
merely serve to modulate the size of the biological effect. A compilation of substituent 
constants is given in Hansch et al. (1995), and illustrations of their use are given in 
Hansch & Leo (1995). 
 
3.2.1 Hansch constant 
 
The hydrophobic constant (π) was introduced by Hansch et al. (1962) in an attempt to 
quantify the effect of substituents on the partitioning behaviour of phenoxyacetic acids: 
 
π = logP (R) – logP (H)       (Equation 3.1) 
 
 
where logP (R) and logP (H) are the logarithms of the octanol-water partition coefficient 
for the substituted phenoxyacetic acid (R-PhOCH2COOH) and the unsubstituted acid 
(PhOCH2COOH), respectively.  
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3.2.2 Hammett constant 
 
The Hammett electronic constant (σ) quantifies the electronic effect of a substituent on 
the dissociation of benzoic acid (Reaction 3.1), and is defined by Equation 3.2: 
 
PhCOOH ↔ PhCOO - + H+       (Reaction 3.1) 
σ = log Ka (R) - log Ka (H) = log (Ka (R)/ Ka (H))   (Equation 3.2) 
 
where Ka (R) = equilibrium constant of the substituted acid, and Ka (H) = equilibrium 
constant of the unsubstituted acid. A generalised form of this equation, known as the 
Hammett equation (Hammett, 1937), is used to generalise the use of σ to other chemical 
reactions involving aromatic species: 
 
log (K (R) / K (H)) = ρσ       (Equation 3.3) 
 
where ρ is a constant for a given reaction (equal to unity for the dissociation of benzoic 
acids), σ is the substituent constant, and K is the equilibrium constant for the reaction of 
interest.  
 
A given substituent is likely to have different σ values, depending on whether it is in the 
ortho, meta or para position to the ionisation centre. Therefore, σo, σm and σp values 
have been produced to describe ortho, meta and para effects, respectively. The σo values 
have proven more difficult to obtain reliably, due to variability in short-range steric and 
hydrogen-bonding effects, and therefore tend to be situation specific. 
 
3.2.3 Taft constant 
 
The Taft steric constant (Es) quantifies the effect of a substituent (R) on the hydrolysis 
(Reaction 3.2) of a methyl ester ( RCOOMe), and is defined by Equation 3.4: 
 
RCOOMe + H2O ↔ RCOOH + MeOH    (Reaction 3.2) 
Es = log k (R) - log k (Me) = log (k (R)/ k (Me))     (Equation 3.4) 
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where k (R) = rate constant for the hydrolysis of RCOOMe, and log k (Me) = rate constant 
for the hydrolysis of the MeCOOMe. 
 
3.2.3 Sterimol parameters 
 
The sterimol parameters, developed by Verloop et al. (1976), characterise the shape and 
volume of a substituent: L is the length of the substituent; B1-B4 are measures of width 
in four directions perpendicular to L, defined in such a way that they are mutually 
perpendicular and that B1≤ B2≤ B3≤ B4; B5 is the maximum width perpendicular to L. 
 
 
3.3 WHOLE-MOLECULE PROPERTIES 
 
If a SAR is to be derived for a heterogeneous group of substances, i.e. a set of 
substances with no common, parent structure, it will be necessary to use whole-
molecule properties as the predictor variables. In addition, whole–molecule properties 
may be necessary to model the activity of a congeneric series, if the classical substituent 
constants prove to be irrelevant or insufficient. 
 
 
3.3.1 Octanol-water partition coefficient 
 
The octanol-water partition coefficient (P) expresses the relative affinity of two 
immiscible phases (octanol and water) for a given solute, and is widely used as a 
measure of hydrophobicity. By definition, P is the ratio of the solute concentration in 
the non-polar phase (octanol) to the solute concentration in the polar phase (water), at 
equilibrium: 
 
P = [solute]o / [solute]w      (Equation 3.5) 
 
where [solute]o is the equilibrium concentration of the solute in octanol; and [solute]w is 
the equilibrium concentration of the solute in water. 
 
The partition coefficient is generally expressed as its common logarithm (logP). A 
substance with a logP of zero has an equal affinity for both phases, whereas a negative 
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logP value indicates that the solute has a greater affinity for water, and a positive value 
indicates a greater affinity for octanol.  
 
logP = log {[solute] o / [solute]w} = log [solute]o – log [solute]w (Equation 3.6) 
 
When used as a predictor variable, logP is commonly interpreted as a measure of the 
ease with which the solute can traverse lipid membranes. If a substance has a low logP 
value, it does not readily enter membranes, whereas if it has a high logP value, it has a 
tendency to stay inside them. Thus, only substances with intermediate logP values can 
readily traverse membranes (by passive diffusion). 
 
The first method for calculating logP, developed by Hansch and Fujita (1964), was 
based on the addition of the hydrophobic substituent constant (π) to the measured logP 
of a parent compound. This approach was based on two assumptions: a) that π values 
are additive; and b) that the hydrogen atom has a π value of zero. Subsequently, it was 
shown that π values are not strictly additive (Fujita et al., 1964), and that the π value of 
hydrogen is not zero, which means that the error in the calculated logP increases with 
the number of π values summed. Furthermore, the method was limited to the derivation 
of logP from a parent structure whose logP was already known. To address these 
shortcomings, subsequent methods have adopted a fragmental approach, in which the 
molecule of interest is broken down into a number of substructures, and the 
hydrophobic constants for these fragments are summed, taking non-additivity into 
account by using correction factors. The first of these fragmental methods was 
published by Nys & Rekker (1973). Nowadays, a number of commercially-available 
software packages have implemented (in different ways) the fragmental approach. 
Examples include the TSAR package (Oxford Molecular, UK), which uses the atomic 
fragment method of Viswanadhan (Viswanadhan et al., 1989); and the KOWWIN 
software (Syracuse Research Corporation, NY, USA), which uses a method based on 
atomic and larger group fragments (Meylan & Howard, 1995). A different approach, 
based on quantum mechanical calculations, is the molecular orbital approach of Bodor 
(Bodor et al., 1989). A comprehensive survey of different methods for predicting logP 
is given in Buchwald & Bodor (1998). 
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3.3.2 Dissociation constant 
 
Strictly speaking, calculations of logP are only accurate for non-ionisable substances, or 
for ionisable substances in their uncharged forms. If the substance of interest contains n 
ionisable groups, it will exist as a mixture of 2n different ionic forms (microspecies), 
each of which will have its own partition coefficient. In such cases, a more appropriate 
predictor variable is the octanol-water distribution coefficient (logD), which is defined 
as the ratio of the total concentration in octanol to the total concentration in water: 
 
log D = log ⎟⎟⎠
⎞
⎜⎜⎝
⎛
∑
∑
iw
io
c
c
       (Equation 3.7) 
 
where cio is the concentration of the i-th microspecies in octanol, and ciw is the 
concentration of the i-th microspecies in water. 
 
For substances containing a single ionisable group, logD can be calculated from the pKa 
of the substance and from the pH of the aqueous solution. A simple algorithm for 
predicting the logD of acids is given by Equation 3.8 (Scherrer & Howard, 1977):  
 
log D = log P – log (1+10 pH-pKa)     (Equation 3.8) 
 
For substances containing multiple ionisation groups, the logD calculation needs to be 
based on the partition coefficients and ionisation constants of all microspecies. Several 
commercially-available software packages perform such calculations by using 
empirically-derived equations; examples include ACD/LogD Suite and ACD/logD 
Batch (Advanced Chemistry Development Inc., Canada), and PrologD (CompuDrug 
Chemistry Ltd, Hungary). The PrologD algorithm is described in Csizmadia et al. 
(1997). 
 
 
3.3.3 Acid-base dissociation constant 
The acid-base dissociation (ionisation) constant (Ka) is a measure of the strength of a 
weak acid - the larger the Ka value, the stronger the acid. It is defined (Equation 3.9) as 
the equilibrium constant for the dissociation of the acid (HA) in water (Reaction 3.3): 
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HA (aq) ↔ H+ (aq) + A- (aq)  (Reaction 3.3) 
 
Ka = 
[ ( )][ ( )]
[ ( )]
H aq A aq
HA aq
+ −
      (Equation 3.9) 
 
Since Ka is generally a large negative number, it is more usual to use pKa, the negative 
logarithm of Ka. Thus, the smaller the pKa value of a substance, the more it is acidic:  
 
pKa =  - log Ka       (Equation 3.10) 
 
Algorithms for predicting pKa adopt a fragmental approach. For example, the ACD/pKa 
algorithm, implemented in the ACD/pKa software (Advanced Chemistry Development 
Inc., Canada), decomposes the molecule of interest into ionisable substructures, and the 
pKa value of each substructure is calculated by using empirically-derived Hammett-type 
equations (equations in which pKa is derived from electronic substituent constants), 
taking the molecular environment of each ionisable group into account. Another 
fragmental approach, based on the method of Perrin (Perrin et al., 1981), has been 
implemented in the pKalc software (CompuDrug Chemistry Ltd, Hungary). 
 
3.3.4 Aqueous solubility 
 
The aqueous solubility (S) of a substance, defined as the maximum concentration of the 
substance that will dissolve in pure water at a specified temperature, provides a measure 
of hydrophilicity. The logarithm of the aqueous solubility at 25oC for neutral species 
can be calculated from logP and the melting point (MP). For example, Yalkowsky & 
Valvani (1980) reported the following equation: 
 
log S = 0.87 - 1.05 logP - 0.012 MP      (Equation 3.11) 
n = 155, s = 0.308, r2 = 0.98 
 
where S is the aqueous solubility (mol/l), and MP is the melting point in degrees 
Celsius. 
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The WSKOWIN software (Syracuse Research Corporation, NY, USA) uses two 
equations: 
 
logS = 0.796 - 0.854 logP - 0.00728 MW + C   (Equation 3.12) 
logS = 0.693 - 0.960 logP - 0.0092(MP-25) - 0.00314 MW + C  (Equation 3.13) 
 
where S is the aqueous solubility (mol/l), MW is the molecular weight (g/mol), MP is 
the melting point, and C is a correction term. Different corrections are applied for 
different chemical classes. Equation 3.12 is used in the absence of a measured melting 
point, whereas Equation 3.13 is used when a measured melting point is available. The 
WSKOWIN methodology is described in more detail in Meylan et al. (1996). Because 
aqueous solubilty is (inversely) correlated with logP to such a large extent, statistical 
models only need to be based on one of these descriptors, to avoid collinearity problems 
(redundancy and parameter instability). 
 
3.3.5 Hydrogen-bonding 
 
The simplest way of modelling hydrogen bonding, first reported by Fujita et al. (1977), 
is to use an indicator variable, set to one if the substance (or substituent) is capable of 
forming a hydrogen bond, and set to zero otherwise. Another approach, suggested by 
Charton & Charton (1982), is to count the total number of hydrogen bonds a substance 
(or substitutent) is capable of making, with a possible subdivision into hydrogen bond 
donors and acceptors. Hydrogen bond counts for whole molecules can be calculated 
with the MOLCONN-Z software (Hall Associates Consulting, MA, USA), in which 
case the number of hydrogen bond donors is the number of hydrogen atoms attached to 
an electronegative atom (O or N), and the number of hydrogen bond acceptors is the 
number of atoms carrying a lone pair.  
 
Various quantitative descriptors of hydrogen-bonding potential have also been 
proposed. Kamlet et al. (1983) introduced terms for hydrogen-bond donor acidity (α) 
and hydrogen-bond acceptor basicity (β), derived from the effects of solvents on the 
ultraviolet and visible spectra of solutes. A different approach, developed by Abraham 
and coworkers (Abraham, 1993), is based on scales of hydrogen-bond acidity (α2H and 
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Σα2Η) and basicity (β2H and Σβ2Η), obtained by measuring hydrogen-bonding 
equilibrium constants in tetrachloromethane. 
 
To avoid the need for experimentally determined descriptors, Cramer et al. (1993) 
proposed the use of four hydrogen-bonding descriptors, based on quantum-mechanical 
calculations: a) the most negative partial charge on any atom in the molecule (Q-); b) the 
most positive partial charge on any hydrogen atom (Q+); c) the energy of the highest 
occupied molecular orbital (ΕHOMO); and d) the energy of the lowest unoccupied 
molecular orbital (ΕLUMO). The first two descriptors represent the ionic contribution to 
the hydrogen bond, whereas the second two descriptors represent the covalent 
contribution. The hydrogen-bonding donor capacity of a substance is described Q+ and 
ΕLUMO, whereas the hydrogen-bonding acceptor capacity is described by Q– and ΕHOMO. 
 
 
3.4 TOPOLOGICAL INDICES 
 
Topological indices are numerical descriptors of molecular topology. They represent an 
attempt to quantify some aspect of the two-dimensional structure of a molecule, so that 
this can be related to its physicochemical and biological properties. A wide variety of 
topological indices have been proposed in the literature (reviewed by Sabljic, 1990), of 
which the most widely used have probably been the molecular connectivity indices.  
 
The concepts of the ‘molecular graph’ and the ‘distance matrix’ are of particular 
importance in understanding the derivation of topological indices. A molecular graph is 
a topological object that models the connectivity of atoms (vertices) in a molecule. If 
the distance (Dij) between any two atoms (i and j) is taken to be the number of bonds 
separating them, the distance matrix of the molecular graph is a symmetric N x N matrix 
containing all of the Dij distances, where N is the number of atoms. In general, only 
heavy (non-hydrogen) atoms are considered. For example, the hydrogen-suppressed 
graph of 2-methyl butane (Figure 3.1) can be used to generate its corresponding distance 
matrix (Table 3.1). 
 
 
 53
3.4.1 Molecular connectivity indices 
 
Molecular connectivity (χ) indices are topological descriptors that encode structural 
features such as size, branching, unsaturation, heteroatom content and cyclicity (Kier & 
Hall 1986; Hall & Kier, 1991). They are derived by decomposing the molecular 
structure into fragments, and are represented by the following generic symbol: 
 
m
t
vχ  
 
where m is the order of the index (number of bonds in the structural fragment), and t is 
the type of fragment into which the structure has been decomposed. Four types of 
fragment are distinguished by the right-side subscript t: continuous path-type fragments 
(p), clusters (c), path clusters (pc), and chains (ch). If there is no right-side subscript, the 
index is assumed to be a path-type index. The presence of the right-side superscript v 
indicates that the index is of the valence type, and its absence indicates that the index is 
of the simple type. In valence indices, the presence of heteroatoms is taken into account, 
whereas in simple indices, heteroatoms are treated as carbon atoms.  
 
To calculate the molecular connectivity indices, the molecule is first represented by its 
hydrogen-suppressed graph. Each atom is assigned two descriptors: a sigma electron 
descriptor (δ) and a valence electron descriptor (δv). The sigma electron descriptor 
(simple delta value) is equal to the number of neighboring non-hydrogen atoms, and is 
given by: 
 
δ = σ - h        (Equation 3.14) 
 
where σ is the number of sigma electrons and h is the number of hydrogen atoms. The 
simple delta values of the heavy atoms in a molecule are used to calculate the simple 
molecular connectivity indices. The valence electron descriptor is given by: 
 
δ v = (Zv - h) / (Z - Zv -1)       (Equation 3.15) 
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where Zv is the number of the valence electrons, Z is the number of all electrons (i.e. the 
atomic number), and h is the number of hydrogen atoms. The valence delta values are 
used to calculate the valence molecular connectivity indices. 
 
The next step is to decompose the molecular skeleton into fragments of a particular size 
(order) and type (path, cluster, path/cluster, or chain), depending on the connectivity 
index being calculated. The zero-order connectivity indices, 0χ and 0χv, are based on 
single-atom fragments, and are defined as: 
 
0χ  = ∑ (δi)-0.5        (Equation 3.16) 
0χv = ∑ (δiv)-0.5       (Equation 3.17) 
 
where the summation is over all heavy (non-hydrogen) atoms (i). The zero-order 
valence connectivity index (0χv) is reported to correlate with molecular weight (Protic & 
Sabljic, 1989). 
 
The first-order connectivity indices are calculated by decomposing the molecular 
skeleton into two-atom fragments, and are defined as: 
 
1χ = ∑ (δi * δj)-0.5       (Equation 3.18) 
1χv = ∑ (δiv * δjv)-0.5       (Equation 3.19) 
 
where i and j refer to two adjacent atoms. It is implicit that these indices are of the path 
type, since there is no other way of connecting two atoms but in a linear fashion. The 
simple first-order index, 1χ, is reported to correlate with molecular surface area (Sabljic, 
1987). 
 
The second-order (2χ) molecular connectivity indices are calculated by: 
 
2χ = ∑ (δi * δj * δk)-0.5       (Equation 3.20) 
2χv = ∑ (δiv * δjv * δkv)-0.5      (Equation 3.21) 
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where i, j and k correspond to three consecutive non-hydrogen atoms. Again, these are 
necessarily path-type indices. 
 
For molecular connectivity indices having an order of three or more, it is necessary to 
specify whether the index is of the path-type (t=p), cluster-type (t=c), or chain type 
(t=ch). In cluster indices, all bonds are connected to a common central atom. For 
example, the third-order cluster molecular connectivity indices (m=3, t=c) are 
calculated by decomposing the molecular structure into tert-butane-like fragments, 
which have three bonds joined to a common atom: 
 
3χC = ∑ (δi * δj * δk * δl)-0.5      (Equation 3.22) 
 
where i, j, k and l are non-hydrogen atoms in the subgraph, and the summation is over 
all t-butane type subgraphs in the molecule. The cluster indices describe the degree of 
branching in a molecule: their values increase with the degree of branching. 
 
The path/cluster indices also describe the degree of branching in a molecule, their 
values increasing with the degree of branching. The simplest of these indices is the 
fourth-order path/cluster molecular connectivity index (4χpc). It is calculated by 
decomposing the molecular structure into isopentane-like fragments, which consist of 
four adjacent bonds between non-hydrogen atoms, three of which are joined to the same 
non-hydrogen atom:  
 
4χPC = ∑ (δi * δj * δk * δl * δm)-0.5     (Equation 3.23) 
 
where i, j, k, l and m are non-hydrogen atoms in the subgraph, and the summation is 
over all isopentane type subgraphs in the molecule.  
 
The chain molecular connectivity indices (χch) provide a measure of cyclicity and the 
degree of substitution present on any rings. The simplest chain indices are third-order 
indices, calculated by decomposing the chemical graph into cyclopropane-like 
subgraphs. The sixth-order chain indices are derived from benzene-like fragments, 
whereas the seventh-order indices correspond to mono-substituted benzene rings.  
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3.4.2 Difference molecular connectivity indices 
 
It is desirable that the descriptors used in a SAR model are orthogonal. In the case of 
molecular connectivity indices, collinearity is unlikely to pose a significant problem if 
the data set consists of diverse molecular structures. However, if the set of molecules 
covers a large range in molecular size and/or there is not a high degree of structure 
diversity, a significant degree of collinearity could arise. The main cause of collinearity 
is the significant contribution of molecular size to the constitution of the chi indices. 
Therefore, to address the collinearity problem, Kier & Hall introduced the difference 
connectivity indices, i.e. simple and valence path indices from which the contribution of 
size is subtracted, so that the salient aspects of structure (branching, cyclisation, 
heteroatom content, heteroatom position) are emphasised (Kier & Hall, 1991). The 
difference connectivity indices are defined by Equation 3.24 for simple path indices, 
and by Equation 3.25 for valence path indices: 
 
dmχn = mχp - mχn       (Equation 3.24) 
dmχnv = mχpv - mχnv       (Equation 3.25)  
 
where mχn is the simple path index, and mχnv is the valence path index, for the 
unbranched, acyclic graph that has the same size as the given molecule. The indices mχn 
and mχnv are defined for each order of path index. 
 
3.4.3 Delta connectivity and sum connectivity indices 
 
The simple connectivity indices encode only sigma electrons, whereas the valence 
connectivity indices encode pi and lone pair electrons in addition to sigma electrons. 
Therefore, subtraction of the simple connectivity index from the corresponding valence 
index of the same order results in an index that encodes only pi and lone pair elections. 
This index is called the delta connectivity (Δχ) index: 
 
Δ mχt = mχtv - mχt       (Equation 3.26) 
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where t denotes the four types of connectivity indices (p, c, pc and ch). The sum 
connectivity (Σχ) index is given by Equation 3.27: 
 
∑ mχt = mχtv + mχt       (Equation 3.27) 
 
In general, the sum connectivity index is orthogonal to the delta connectivity index of 
the same order, so the combined use of the delta and sum connectivity indices 
represents another way of reducing collinearity in the data set. 
 
3.4.4 Molecular shape (kappa) indices  
 
Attributes of molecular shape are encoded into shape indices (kappa values), derived 
from the counts of one-bond (1P), two-bond (2P) and three-bond (3P) fragments in the 
molecular structure (Kier, 1985 & 1990). The values of the kappa indices are calculated 
from the path count mP and from the number of atoms (A) in the molecular structure. 
The first-order and second-order kappa indices are defined by Equations 3.28 and 3.29, 
respectively. The definition of the third-order kappa index depends on whether the 
number of atoms is even (Equation 3.30) or odd (Equation 3.31): 
 
1κ = A (A-l)2 / (1P)2       (Equation 3.28) 
2κ = (A-1)(A-2)2 / (2P)2      (Equation 3.29) 
3κ = (A-2)(A-3)2/(3P)2       (Equation 3.30) 
3κ = (A-1)(A-3)2/(3P)2       (Equation 3.31) 
  
The first-order kappa index is claimed to encode cyclicity, whereas the second-order 
and third-order indices are said to encode spatial density (star-graph likedness), and 
centrality of branching, respectively  (Kier, 1990). 
 
The presence of atoms other than sp3-hybridised carbon can be taken into consideration 
in the above equations by replacing mP with mP+ α, and A with A+α, where: 
 
α = {r(x) / r(C[sp3])} – 1      (Equation 3.32) 
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r(x) is the covalent radius of atom x, and r(C[sp3]) is the covalent radius of carbon in 
the sp3-hybridised state. The resulting kappa values are designated as mκα. 
 
In the case of small molecules, certain mP quantities may be equal to zero, which is 
problematic in that the kappa indices calculated by the above equations would be 
infinite. To overcome this problem, the kappa values of such molecules are arbitrarily 
fixed. For example, the 1P value is zero for any molecule represented by a single point 
in its chemical graph, such as methane. In this case, a 1κ value of 1 is adopted, since, for 
straight chain molecules, 1κ is generally equal to A. The calculation of 2κ values leads 
to zero values for molecules comprising just one or two heavy atoms, such as methane 
and ethane. In these cases, 2κ values of 0 and 1 are proposed for methane and ethane, 
respectively. Similarly, the 3κ values calculated from the above equations are zero for 
methane, ethane, and propane, while the value for butane is 4.000, which is the same as 
for pentane. More useful values of 3κ values for these molecules are defined as: zero for 
methane, 1.450 for ethane, 2.000 for propane, and 3.378 for butane.  
 
3.5 MOLECULAR MODELLING 
 
A number of physicochemical properties that are useful predictor variables cannot be 
estimated from one-dimensional or two-dimensional representations of molecular 
structure, but need to be estimated from the three-dimensional structures of molecules. 
Examples of such properties include solvent-accessible surface areas and volumes, and 
electronic properties, such as dipole moment, frontier orbital energies, and partial 
atomic charges. For simplicity, the calculation of such properties is generally performed 
on an energy-minimised molecular structure (i.e. a structure in which the net effect of 
all intra-molecular forces is a minimum), even though the active forms of molecules 
may actually be higher-energy conformations. To further simplify these calculations 
(called single-point calculations), the minimum-energy structure is often determined for 
the gas-phase (i.e. solvent effects are ignored).  
 
There are two main approaches to energy minimisation and single point calculation - 
molecular mechanics and quantum mechanics. Molecular mechanics is mathematically 
the simpler (and computationally the quicker) procedure, but it is also less accurate. It is 
appropriate for the calculation of properties that are not dependent on the distribution of 
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electronic charge in the molecule (e.g. surface area and volume). For the calculation of 
electronic properties, it is necessary to resort to quantum mechanical methods, among 
which semi-empirical methods are the simplest, and ab initio methods are the more 
complex. To reduce the time needed for a quantum mechanical minimisation, it is 
common to perform a molecular mechanical minimisation first, to produce an 
approximate conformation which can be optimised by the quantum mechanical method. 
 
3.5.1 Molecular mechanics 
 
The methods of molecular mechanics treat molecules as hard spherical particles (atoms) 
connected by springs (bonds) of different elasticities. Nuclei and electrons are not 
considered, so electronic properties cannot be calculated. The energy of the molecule is 
calculated as the sum of energies corresponding to bond stretching, bending (bond angle 
deformation), torsion (rotation of adjacent groups about a common bond), and non-
bonding interactions (van der Waals interactions and coulombic interactions). In 
addition, the energy due to intra-molecular hydrogen bonding and out-of-plane bending 
may also be considered. Each of these energies is described by a potential energy 
function. The sum of all energy terms, parameterised with respect to a well-defined data 
set,  is called a force field. 
 
Force fields can be divided into two main groups. In the first type of force field, all 
atoms are considered in the energy calculation, including hydrogen atoms. This is called 
an ‘all atom’ approach, and is appropriate for the modelling of small molecules. In the 
second type of force field, most of the hydrogen atoms are not explicitly considered, but 
are accounted for implicitly by carbon atoms with an expanded van der Waals radius. 
The only hydrogen atoms considered explicitly are those having the potential to 
participate in hydrogen bonding. This is known as the ‘united atom’ approach, and is 
used to decrease the computational time needed to model large biological molecules 
(especially proteins and nucleic acids). A commonly used all-atom force field is MM2 
(Allinger, 1977), and a commonly used united-atom force field is AMBER (Weiner et 
al. 1984). 
 
To minimise the energy (optimise the geometry) of a molecule, a force field is chosen 
and applied to the input conformation. The total energy is calculated, the conformation 
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is then altered in an attempt to reduce energy, and the total energy is computed again. 
This process is repeated until a minimum energy is found. There are several 
mathematical algorithms for carrying out energy minimisation. For example, the 
steepest descents and conjugate gradients algorithms alter the molecular conformation 
by searching for the minimum value of the energy gradient (the first derivative of the 
total energy with respect to the atomic coordinates of the molecule). In contrast, the 
Newton-Raphson method also considers the second derivative of the energy function to 
find the minimum energy. The steepest descents and conjugate gradients methods are 
quicker, and are appropriate when the input conformation is far away from its minimum 
energy conformation. Newton-Raphson methods are slower, and are only appropriate 
for structures that are close to their energy minimum. 
 
Having found a minimum energy conformation, it is not always certain whether this 
represents the global minimum or a local minimum. A number of methods address ‘the 
problem of the global minimum’ by generating an alternative starting structure, carrying 
out energy minimisation, and comparing the resulting ‘minimum’ energy with the 
original one. This process continues until conformation space has been searched with 
sufficient thoroughness (according to some predefined criterion). Methods that generate 
multiple starting geometries can be divided into deterministic searches, which cover 
conformation space systematically, and stochastic searches, which explore conformation 
space in a random manner. A number of these methods are compared in Saunders et al. 
(1990). 
 
3.5.2 Quantum mechanics 
 
Theoretical background 
The energy of an isolated molecule can be obtained by solving the Schrödinger equation 
(Schrödinger, 1926), which (in its time-independent and non-relativistic form) can be 
written as:  
 
ψHˆ = ψE         (Equation 3.33) 
 
where Hˆ is the Hamiltonian operator, ψ is the wavefunction, and E is the energy of the 
system (relative to the state in which the component atoms are infinitely separated and 
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at rest). The Hamiltonian operator expresses a mathematical procedure which is applied 
to the wavefunction to calculate the total energy of the molecule. The wavefunction 
itself describes the distribution of particles (nuclei and electrons) in space, and is 
therefore a function of spatial coordinates. According to the Born interpretation, the 
square of ψ (for a given particle) at a given point in space can be interpreted as the 
probability of finding the particle at that point.  
 
Since the masses of the nuclei are much larger than those of the electrons, and their 
velocities much smaller, the problem of solving the Schrödinger equation can be 
simplified by separating it into two parts: an electronic part, describing the motions of 
the electrons in a field of fixed nuclei, and a nuclear part, describing the motions of the 
nuclei. The total molecular wavefunction is considered to be the product of an electronic 
and a nuclear wavefunction. The advantage of this approach, known as the Born-
Oppenheimer approximation, is that only the electronic wavefunction needs to be 
solved. A further approximation, the independent electron approximation, simplifies the 
total electronic wavefunction for a many-electron system (molecule) as the sum of one-
electron molecular wavefunctions. Thus, the one-electron Hamiltonian operator is a 
mathematical procedure for generating the kinetic and potential energies of an electron 
in a field of fixed nuclei.  
 
In general, there is more than one acceptable solution to the Schrödinger equation, so it 
is usual to derive a set of different electronic wavefunctions, each of which is associated 
with an energy. Each wavefunction can be regarded as the mathematical description of a 
one-electron molecular orbital, and the energy associated with that wavefunction can be 
regarded as the energy required to remove an electron from that orbital.  
 
The molecular wavefunction for an electron can be expressed as the product of a spatial 
function and a spin function. Neglecting electron-electron interactions, the spatial 
function is usually expressed as a linear combination of known one-electron 
wavefunctions, called a basis set. Typically, the one-electron wavefunctions in the basis 
set take the mathematical form of atomic orbitals, and the expansion is called a linear 
combination of atomic orbitals (LCAO):  
 
ψi =∑ cij φj        (Equation 3.34) 
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where ψi = the (spatial) molecular wavefunction of electron i; φj are the one-electron 
wavefunctions (atomic orbitals) in the basis set; and cij are the coefficients that 
determine the contribution of each atomic wavefunction to the molecular wavefunction. 
The goal of LCAO methods is to find the coefficients cij that best approximate the 
molecular wavefunction ψi. According to the variational principle, this is equivalent to 
finding the coefficients that minimise the energy of the molecular wavefunction for a 
given choice of Hamiltonian and basis set. Without going into mathematical details, the 
energy Ei of electron i is calculated from a number of integrals involving the basis 
functions φj. Two types of integral are distinguished: coulomb integrals and overlap 
integrals. A coulomb integral can be interpreted as the ionisation energy for a one-
electron molecular orbital, and an overlap integral as a measure of the spatial overlap 
between two atomic orbitals. Semi-empirical methods omit or approximate some of 
these integrals (to speed up the calculation), whereas ab initio methods evaluate all of 
the integrals (involving the chosen basis set) . 
 
The independent electron approximation means that interactions between electrons are 
neglected, an approximation which becomes increasingly unreliable as the number of 
electrons in the system increases. Electron interactions include not only coulombic 
repulsions, but also Pauli interactions. i.e. the tendency for two electrons of opposite 
spin to attract each other, while electrons of the same spin repel each other.  
 
To partially account for coulombic interactions, Hartree & Fock proposed that the total 
electronic wavefunction could still be regarded as the product of one-electron basis 
functions, except that the Hamiltonian should be replaced by an effective Hamiltonian 
(called a Fock operator), which takes into account the average field effect due to all 
other electrons in the molecule. Thus, the Fock operator describes a two-electron 
system, in contrast to the one-electron system described by the conventional 
Hamiltonian operator. The Hartree-Fock treatment introduces a third type of integral 
into the energy calculation, called the exchange (or resonance) integral, which has no 
simple physical interpretation. Again, the LCAO method is used to determine the 
coefficients cij that best determine ψi (i.e. the minimum value of Ei)  However, a paradox 
arises because the Fock operator is dependent on the coefficients cij. The paradox is 
solved by using an iterative procedure in which the coefficients are first estimated and 
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used to solve the equations for ψi. A new Fock operator is determined from the derived 
coefficients cij, and the process is repeated until the coefficients cij generated during an 
iteration are identical to those used as input for that iteration. This is called the Hartree-
Fock Self-Consistent Field (HF-SCF) procedure, of which there are two types: 
Restricted Hartree-Fock (RHF) and Unrestricted Hartree-Fock (UHF). In a RHF 
procedure, the two electrons in a particular molecular orbital are constrained to have the 
same molecular orbital coefficients. This is the appropriate method for closed shell 
molecules (in which all electrons are paired). In a UHF procedure, the two electrons in a 
particular molecular orbital are allowed to have different coefficients, which is 
appropriate for open shell molecules (which have unpaired electrons), such as free 
radicals. 
 
The HF-SCF procedure does not fully account for all electron-electron interactions. In 
part, this is because each electron in the molecule is considered to experience the 
average electrical field of the remaining electrons, rather than the instantaneous forces 
due to electron movement. In addition, the Pauli effect is not considered. These effects 
are referred to collectively as electron correlation (a term expressing the idea that 
electrons move in a mutually dependent manner). The difference between the true 
energy and the Hartree-Fock energy is called the correlation energy. 
  
A variety of post-Hartree Fock methods have been devised to calculate the correlation 
energy. For example, configuration interaction (CI) methods allow for the possibility 
that electrons are occasionally excited to energy levels higher than the ground state. 
These methods construct the molecular wavefunction from a multiple set of electron 
assignments in a manner analogous to the LCAO approach. Other post-Hartree Fock 
methods include Møller-Plesset Perturbation Theory, in which the difference between 
the correlated Hamiltonian and the Hartree-Fock Hamiltonian is expressed as a Taylor 
expansion of energy terms (Alberts & Handy, 1985), and Density Functional Theory, in 
which molecular orbital energy is calculated as a function of electron density integrated 
over all space (Labanowski & Andzelm, 1991). 
 
Semi-empirical methods 
Semi-empirical methods are based on a number of approximations to simplify the 
problem of solving the Schrödinger equation for a many-electron system: a) only 
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valence orbitals are included in their basis functions (i.e. core orbitals are ignored); b) 
some of the integrals are neglected or approximated; and c) electron correlation is 
accounted for implicitly through parameterisation, rather than explicitly. The methods 
differ in terms of: a) the basis sets they use; b) the parameterisation of their basis 
functions; and c) the specific integrals they neglect or approximate. 
   
The first molecular orbital method to be proposed, Hückel Theory (HT), is an LCAO 
method in which σ electrons, σ-π interactions, and electron-electron repulsions are 
ignored (Hückel, 1931). Integrals that are not ignored are given fixed empirical values. 
HT is limited to predicting the energies of conjugated systems and gives no information 
about molecular structure. Extended Hückel Theory (EHT), developed by Hoffman 
(1963), can be used to produce qualitative descriptions of molecular orbitals. However, 
for most quantitative purposes, EHT has been superseded by more-recent methods. 
 
More-recent semi-empirical methods are based on the ‘neglect of differential overlap’ 
(NDO) approximation, i.e. they neglect two-electron integrals involving different 
atomic orbitals. In decreasing order of approximation, NDO methods include: a) 
Complete Neglect of Differential Overlap (CNDO; Pople & Beveridge, 1970); b) 
Intermediate Neglect of Differential Overlap (INDO; Pople et al., 1967); and c) 
Modified Intermediate Neglect of Differential Overlap (MINDO; Bingham et al., 1975). 
 
Current semi-empirical methods are based on the ‘neglect of diatomic differential 
overlap’ (NDDO) approximation, in which two-electron integrals are considered if they 
involve atomic orbitals on the same atom. Such methods include: a) Modified Neglect 
of Differential Overlap (MNDO; Dewar and Thiel, 1977); b) Austin Model 1 (AM1; 
Dewar et al., 1985); and c) Parametric Model 3 (PM3), a reparameterised version of 
AM1 (Stewart, 1989a & 1989b).  
 
Ab initio methods 
Like the semi-empirical methods discussed above, the most common ab initio methods 
are based on the LCAO approximation. Unlike semi-empirical methods, ab initio 
methods use basis functions that take account of core electrons in addition to valence 
electrons, and they evaluate all integrals in the calculation of the molecular 
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wavefunction. For this reason, ab initio methods take longer than semi-empirical 
methods and, at present, are limited to modelling smaller molecules. 
 
There are two types of basis function - Slater-type orbitals (STOs), which provide an 
accurate representation of hydrogen-like orbitals, and Gaussian-type orbitals (GTOs), 
which are less accurate. In STOs, the electron density decays as an exponential function 
of distance, whereas in GTOs, the electron density decays as an exponential function of 
the squared distance. Ideally, the basis functions used by ab initio methods would be 
STOs, similar to those used by semi-empirical methods. However, since ab initio 
calculations are more computer-intensive than semi-empirical ones, and GTOs are 
easier to manipulate mathematically than STOs, the usual approach is to approximate 
the latter by sums of the former. The approximation of STOs by GTOs has given rise to 
the so-called STO-NG basis sets, in which each basis function is constructed from N 
GTOs. A unique feature of the STO-NG method is that the exponential coefficients for 
all atomic orbitals in a given shell are constrained to be identical, to simplify the 
calculation of integrals involving the basis functions. A minimal basis set contains only 
one basis function per atomic orbital; for example, there is just one basis function for H 
and He (corresponding to the 1s orbital), and 5 basis functions for Li to Ne 
(corresponding to the 1s, 2s and three 2p orbitals). STO-3G has become a standard for 
minimal basis calculations. 
 
More-elaborate basis sets are the so-called split-valence basis sets, which have different 
basis functions for core orbitals and for valence orbitals (Binkley et al., 1980). For 
example, the 6-31G basis set uses six GTOs to approximate core orbitals, three GTOs 
for the 2s and 2p (inner) valence orbitals, and one GTO for the 3s and 3p (outer) valence 
orbitals. The 6-31G basis set is said to be a valence-double-zeta (VDZ) basis set, 
because two basis functions are used for each valence atomic orbital. Triple zeta (TZ) 
and quadruple zeta (QZ) basis sets have also been developed, representing valence 
atomic orbitals with three and four basis functions, respectively.  
 
For even greater accuracy, it is necessary to incorporate basis functions capable of 
representing orbital polarisation. These are denoted with asterisks; for example, the 6-
31G* is the basis set for 6-31G to which d-orbital functions have been added to account 
for the polarisation of heavy atoms, and the 6-31G** basis set is the 6-31G* basis set 
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supplemented with p-orbital functions to account for the polarisation of hydrogen atoms 
(as well as heavy atoms). Finally, augmented basis sets contain so-called diffuse 
functions to accommodate loosely held electrons. These basis sets are designated by the 
addition of a plus sign to basis set designator (e.g. 6-31G+) 
 
Thus, the success of an ab initio calculation depends upon the choice of an appropriate 
basis set for the molecule of interest. Ideally, the largest available basis set, with the 
most extended set of polarisation and diffuse functions, would be used. In practice, 
however, a compromise is required, since the time required for a calculation increases 
with the fourth power of the number of basis functions.  
 
3.5.3 Conformation-dependent properties 
 
Solvent-accessible surface area and molecular volume 
The solvent-accessible surface is defined by the loci of the centre of a solvent molecule 
(typically  water), when this molecule is ‘rolled over’ the molecular surface defined by 
the van der Waals radii of the molecule’s constituent atoms. The area of the solvent-
accessible surface is generally expressed in Å2, and the volume enclosed by this surface 
in Å3. Both of these properties may be regarded as measures of molecular size.  
 
Dipole moment 
The dipole moment of an electric dipole (pair of charges of opposite sign [± q] 
separated by a distance [r]) is a vector having the magnitude q.r and the direction of the 
line from the negative to the positive charge. Dipole moment is measured in coulomb 
metres (Cm), or in debyes (D), where 1D=3.338x10-30 Cm. 
 
The dipole moment of a molecule (μ) is the vector sum of the dipole moments of its 
constituent electric dipoles: 
 
μ = ∑ qi ri        (Equation 3.35) 
 
where qi  is the charge on atom i, and ri is the distance of atom i from the origin (centre 
of charge or centre of mass). The bold font is used to denote a vector quantity. 
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It is generally the magnitude of this vector (μ), referred to hereafter as DM, that is used 
as a descriptor in SARs, although the magnitude of one or more of the vector’s 
components (along the x, y and z cartesian axes) can also be used, if all molecules in the 
data set have been aligned with their first inertial axis parallel to the x axis, and their 
second and third inertial axes parallel to y and z axes, respectively.  
 
Apart from being a measure of polarity, the physicochemical interpretation of DM is not 
well-established. One possibility is that DM expresses the extent to which a molecule, 
having entered a lipid membrane, diminishes the electric field across it. The rationale 
for this is that electric dipoles are known to align themselves anti-parallel to externally 
applied electric fields. Any reduction of the electrical gradient across a cell membrane 
could affect the transport of charged species into and out of the cell. An alternative 
hypothesis is that DM expresses the tendency of molecules to accumulate at the 
interface of the lipid bilayer. Such an accumulation has been proposed to increase the 
lateral pressure within the bilayer, thereby altering the ratio of open to closed ion 
channels (Cantor, 1997). In support of this idea, molecular dynamics simulations 
indicate that molecules of increasing polarity are more likely to accumulation at the 
bilayer interface (Pohorille & Wilson, 1996).  
 
Frontier orbital energies 
Molecular orbital methods yield a set of energy levels in which all the available 
electrons are accommodated. The highest filled energy level is called the Highest 
Occupied Molecular Orbital (HOMO). The next higher energy level, which is 
unoccupied because no more electrons are available, is the Lowest Unoccupied 
Molecular Orbital (LUMO). On the basis of Koopmans theorem, the HOMO and 
LUMO of a molecule can be approximated as its ionisation energy and electron affinity, 
respectively (Koopmans, 1933). In addition, HOMO can be used as a descriptor of 
basicity or nucleophilicity, and LUMO as a descriptor of acidity or electrophilicity.  
 
Frontier orbital energies can be used to derive other descriptors. For example, the 
absolute hardness (η) of a molecule is defined as half the difference between the 
energies of the LUMO and the HOMO: 
 
η = ½ (ELUMO - EHOMO)      (Equation 3.36) 
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Absolute hardness has been inversely correlated with chemical reactivity (Pearson, 
1993). Similarly, the absolute electronegativity (χ) is half the sum of the HOMO and 
LUMO energies: 
 
χ = ½ (EHOMO + ELUMO)      (Equation 3.37) 
 
Electron density and related properties 
Quantum-mechanical methods can be used to display the electron density contours of a 
molecule as a means of visualising possible sites of electrophilic attack. For quantitative 
information, partial atomic charges can be calculated. These properties can also be used 
to calculate the dipole moment of a molecule, or to determine the hydrogen-bonding 
descriptors (Q+ and Q-).  
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Figure 3.1. Hydrogen-suppressed graph of 2-methyl butanea 
 
 
Footnote to Figure 3.1 
 
aStructural Formula is CH3CH(CH3)CH2CH3 
 
 
 
 
Table 3.1. Distance matrix of the hydrogen-suppressed graph of 2-methyl butane 
 
 
 1 2 3 4 5 
1 0 1 2 3 2 
2 1 0 1 2 1 
3 2 1 0 1 2 
4 3 2 1 0 3 
5 2 1 2 3 0 
 
1 2 3 4
5
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4.1 INTRODUCTION 
 
The first step in the development of models for predicting chemical toxicity is to obtain 
or compile a suitable toxicological data set. A toxicological data set can be thought of as 
a 2 x 2 data matrix, in which the objects (rows) are chemicals, and the variables 
(columns) are physicochemical and/or in vitro properties, along with one or more in 
vivo endpoints of toxicity. Due to the presence of multiple variables, such data sets are 
said to be multivariate, and their analysis requires the use of multivariate statistical 
methods. The first step in a multivariate analysis usually consists of an investigation 
into the structure of the data matrix, to determine whether any of the variables correlate 
strongly with other variables, and whether any observations are similar to other 
observations with respect to their values along one or more variables. This step, which 
is sometimes called ‘exploratory data analysis’, enables redundancies to be removed 
from the data set before any models are derived. Several methods for performing 
exploratory data analysis are described in Section 4.2. Having removed redundancies 
from the toxicological data set, it is possible to derive models for predicting chemical 
toxicity from physicochemical and/or in vitro properties. In this thesis, such models are 
either classification models (CMs) or regression models, depending on whether the 
toxicological effect of interest is categorical or continuous, respectively. Statistical 
methods for developing classification models are described in Section 4.3, and methods 
for developing regression models are described in Section 4.4. Section 4.5 provides a 
summary of several resampling methods that are sometimes used in conjunction with 
classification and regression methods. Numerous textbooks explain in more detail the 
methods of univariate statistics (e.g. Caulcutt, 1991) and multivariate statistics (e.g. 
Tabachnick & Fidell, 1996). Other texts review the applications of statistical analysis in 
chemistry and pharmacology (e.g. Livingstone, 1995), and in toxicology (e.g. ECETOC, 
1998b).    
 
4.2 EXPLORATORY DATA ANALYSIS 
 
4.2.1 Principal components analysis and factor analysis 
 
Principal components analysis (PCA) and factor analysis (FA) are used to convert a data 
set having three or more variables into a data set having fewer variables, while 
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minimising the loss of explained variance. The new variables are called principal 
components (PCs) in the case of PCA, and factors in the case of FA, although in the 
following discussion, only the term factor is used, for simplicity. In PCA and FA, the 
factors are derived in such a way that: a) the factors are linear combinations of the 
original variables, the first factor being the one that explains the largest proportion of 
variance in the original data set, with subsequent factors explaining decreasing parts of 
the remaining variance; and b) all factors are orthogonal to (uncorrelated with) one 
another. If the objects are plotted as a cluster in multi-dimensional space, the first factor 
can be thought of as the longest straight line that crosses the cluster, and the second 
factor can be thought of as the second longest straight line traversing the cluster that is 
orthogonal to the first factor. The numbers in the transformed data set are called 
principal component scores (in the case of PCA) or factor scores (in the case of FA). 
The loadings on a given factor, which reflect the relative contributions made by the 
original variables to the factor, are simply the Pearson correlation coefficients between 
each variable and that factor.  
 
In terms of matrix algebra, PCA and FA can be regarded as processes in which the 
original variable matrix (N objects [rows] x P variables [columns]) is transformed into a 
factor scores matrix (N objects [rows] against Q factors [columns]) and a factor loadings 
matrix (P variables [rows] against Q factors [columns]). The factor loadings matrix is 
the matrix of correlations between variables and factors, and can be used to interpret the 
meaning of each factor. The factor scores matrix (F) is generated from the original 
variables matrix (Z), according to Equation 4.1: 
 
F = Z . B  (Equation 4.1) 
 
where B is a matrix of regression weights called the factor score coefficients matrix 
(variables x factors). In this equation, the factor scores in F and the variables in Z are 
autoscaled, i.e. standardised by subtraction of the mean and division by the standard 
deviation.  
 
The condition of orthogonality places a restriction on the constitution of the factors, but 
it has the advantage that there is no multi-collinearity in the transformed data set, i.e. the 
different factors explain different parts of the variance and could therefore be used as 
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truly independent variables in subsequent analyses. For example, the use of principal 
components as predictor variables in multiple regression (principal components 
regression [PCR]) is sometimes favoured, because the addition (or removal) of a PC 
variable from the regression model does not alter the coefficients of the other variables. 
The disadvantage of PCR, however, is that the PC variables are less interpretable than 
the original variables, and the PC loadings based on a single sample might not reflect 
those in the corresponding population. 
 
Factors may be difficult to interpret when they are associated with a large number of 
original variables. To overcome this difficulty, the factors can be rotated, in the hope 
that they become more closely aligned with a smaller number of original variables, and 
therefore more amenable to interpretation. Rotation does not lead to a reduction in the 
proportion of variance explained by the factors. A commonly used type of rotation is 
varimax rotation, which maximises the variance of the loadings within factors (high 
loadings become higher and low loadings become lower). This is accompanied by a 
redistribution of variance between factors, so that successive factors account for similar 
proportions of the total variance. Another type of rotation, quartimax rotation, does for 
variables what varimax rotation does for factors, i.e. it maximises the variance of the 
loadings within variables. Thus, varimax rotation operates on the columns of the loading 
matrix (variables x factors), whereas quartimax rotation operates on the rows. Finally, a 
third type of orthogonal rotation, called equamax, simultaneously operates on both the 
columns and rows of the loading matrix. 
 
Assessing the importance of principal components or factors 
The number of factors extracted from a given data set is either the number of objects 
(rows) or the number of variables (columns) in the data matrix, whichever is the 
smaller. Before factors are extracted from the data set, the original variables can be 
autoscaled (standardised by subtraction of the mean then division by the standard 
deviation). Each autoscaled original variable has a mean of zero and a variance of one, 
and therefore contributes one unit of variance to the overall variance of the autoscaled 
data set. The matrix of the autoscaled variables is called the correlation matrix (in 
distinction to the variance/covariance matrix of unscaled original variables). By 
performing PCA or FA on the correlation matrix, the importance of a factor can be 
judged from its eigenvalue (proportion of variance explained). According to one rule-of-
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thumb, the Kaiser criterion, a factor is important (worth retaining) if its eigenvalue is 
greater than one; otherwise, the factor does not account for more variance than any one 
of the original variables. 
 
Differences between principal components analysis and factor analysis 
The main difference between PCA and FA is that in PCA, all of the variance in the 
original variables is used in the analysis, whereas in FA, only the variance that each 
variable has in common with the other variables is used, with unique variance being 
excluded from the analysis. The proportion of variance that a particular variable shares 
with all other variables is called the communality (a value between 0 and 1),  so the 
unique variance of a variable is its total variance minus its communality. The 
communalities in FA are determined by an iterative procedure, typically by using the 
squared multiple correlation coefficient of a variable with all other variables as the 
starting values in the iteration.  
 
4.2.2 Cluster analysis 
 
Cluster analysis (CA) refers to a variety of methods for visualising and quantifying the 
similarity between different objects (cluster analysis of objects) or variables (cluster 
analysis of variables). The methods work by placing the objects (or variables) in multi-
dimensional space and by grouping objects (or variables) according to the distance 
between them. A number of distance measures can be used, such as the Euclidean 
distance (the geometric distance in multi-dimensional space) for objects, and the 
Pearson correlation coefficient for variables. The results of cluster analysis are generally 
visualised in the form of a dendrogram. 
 
One way in which clustering algorithms are distinguished is by the number of links they 
allow. The simplest types of clustering algorithm proceed by the formation of single 
links, i.e. only two objects (or variables) are joined together in any one step.  
 
Clustering algorithms also differ in the way in which objects (or variables) are grouped. 
In non-hierarchical clustering, the links between objects (or variables) can be broken, 
whereas in hierarchical clustering, the links are never broken. An example of non-
hierarchical clustering is K-means clustering. In this method, the user determines the 
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number (K) of clusters to be formed, and the algorithm assigns objects to the K clusters 
in such a way that the variability between clusters is maximised, and the variability 
within clusters is minimised. The K objects used to start the clustering process can 
either be randomly selected (by the program), or specifically chosen (by the user). 
Hierarchical clustering algorithms can either be agglomerative, in which case the 
individual objects (or variables) initially form their own clusters, before being grouped 
into larger ones, or they can be divisive, in which case the first cluster, containing all of 
the objects (or variables), splits into smaller clusters.  
 
The choice of clustering method depends on the purpose of the investigation. If it is 
known a priori that there should be a specific number of final clusters, then K-means 
clustering would be the preferred method, whereas hierarchical clustering is more 
appropriate when the final number of clusters is unknown. Finally, a less commonly 
used type of clustering method is two-way joining, in which objects and variables are 
clustered simultaneously. 
 
4.2.3 Correspondence analysis 
 
Correspondence analysis is a technique for determining whether there is a relationship 
between two or more categorical variables in a frequency (contingency) table. If there 
are two categorical variables, the rows and columns in the two-way frequency table 
could be regarded as the predictor and response variables, respectively. Two-way tables 
are analysed by simple correspondence analysis, whereas multi-way frequency tables, 
composed of three or more variables, are analysed by multiple correspondence analysis. 
A comprehensive description of correspondence analysis and its applications is 
provided in Greenacre (1984, 1993).  
 
By analogy with physical objects, the frequency table is considered to have a certain 
mass, distributed across the cells in proportion to their relative frequencies. The total 
row and column frequencies are therefore referred to as the row mass and column mass, 
respectively. The term ‘inertia’ is used to denote the moment of inertia, which is a 
measure of the distribution of mass in a physical object, defined as the integral (over 
distance) of the mass times the squared distance to the centroid. Bodies with a small 
moment of inertia have their mass distributed close the centroid, whereas bodies of the 
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same mass with a large moment of inertia have their mass distributed further away from 
the centroid. In correspondence analysis, the inertia of a table is defined by the 
following equation: 
 
Inertia = 
N
2χ   (Equation 4.2) 
 
where χ2 is the Pearson chi-square value; and N is the total sum of frequencies in the 
table (grand total). The chi-square statistic is defined as: 
 
χ2 = ( )2∑ −E EO  (Equation 4.3) 
 
where O is the observed frequency in a cell; and E is the expected frequency in a cell. If 
there is no relationship between the rows and columns, the expected frequency in each 
cell is equal to the respective column total times the row total, divided by the grand 
total. The chi-square value is a measure of the extent to which the actual frequencies 
depart from their expected values. 
 
Correspondence analysis works by decomposing the total inertia in a frequency table 
into a number of dimensions. The dimensions are extracted in such a way that: a) the 
distances between the row or column coordinates are maximised; and b) successive 
dimensions are orthogonal to one another and account for decreasing proportions of the 
total chi-square. The relative importance of each dimension is denoted by its eigenvalue. 
The maximum number of dimensions extracted from a two-way table is equal to the 
number of columns minus 1, or the number of rows minus 1, depending on which is the 
smaller.  
 
The first step in correspondence analysis is to standardise the contingency table. The 
frequency in each cell is divided by the grand total, so that the sum of frequencies (now 
called relative frequencies) across all cells is equal to one. The next step depends on 
whether the goal of the analysis is to: a) compare rows in terms of columns; b) compare 
columns in terms of rows; or c) examine the relationship between columns and rows. In 
the first case, the row profile matrix is used, which means that the relative frequencies 
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in each row are scaled so that their sum across all columns is equal to one. Each entry nij 
in the row profile matrix can be interpreted as the conditional probability that a case 
belongs to column j, given that it also belongs to row i. In the second case, the column 
profile matrix is analysed, in which case the relative frequencies in each column are 
scaled so that their sum across all rows equals one. In both cases, a two-dimensional 
plot of the first two factors can be used to display the similarity between rows or 
columns, which is represented by the proximity of the points corresponding to the row 
or column profiles. Because there is a geometric correspondence between the row and 
column profile plots, the two plots can be merged into a biplot, containing points for 
both row and column profiles. In the biplot representation, row and column points lying 
in the same direction from the origin are positively correlated, while those lying in 
opposite directions are negatively associated (Devillers & Karcher, 1990).  
 
The quality of a point (row or column profile) is defined as the ratio of the squared 
distance of the point from the origin in the chosen number of dimensions, over the 
squared distance from the origin in the space defined by the maximum number of 
dimensions. The quality of a point is a measure of how well the inertia of that point is 
accounted for by the chosen number of dimensions. The proportion of the total inertia 
accounted for by the respective point (which is independent of the chosen number of 
dimensions) is given by the relative inertia.  
 
The cosine² value (cos2 θ) for a given point along a given dimension is a measure of the 
correlation between the point and the dimension. If cos2 θ is high, this means that the 
angle between the profile vector and the given dimension is low, i.e. the profile vector 
lies in the direction of the dimension and therefore correlates well with it. An alternative 
way of expressing this is to say that the dimension contributes highly to the inertia of 
the point. This is referred to as a relative contribution, because cos2 θ is independent of 
the mass of the point. If the mass of the point is taken into account by multiplying this 
with its squared distance (along the dimension) from the origin, this gives the absolute 
contribution of the point to the inertia of the axis. The meaning of a given dimension 
can be interpreted from the profile vectors that have high absolute contributions.  
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4.3 DEVELOPMENT OF CLASSIFICATION MODELS 
 
In this project, classification models were derived for predicting categories of skin and 
eye irritation potential, such as EU classifications. This section describes three methods 
for deriving classification models: linear discriminant analysis, logistic regression and 
classification tree analysis. 
 
4.3.1 Linear discriminant analysis 
 
Linear discriminant analysis (LDA) is used to determine which variables discriminate 
between two or more pre-defined groups, and to derive classification models for 
predicting the group membership of new observations.  
 
The simplest type of LDA, two-group LDA, can be thought of as a method that 
generates a linear boundary between two groups of objects. The nature of the boundary 
depends on how many predictor variables are used: one variable generates a point 
boundary (a cut-off value); two variables give rise to a straight line boundary; and three 
variables result in a planar boundary. In the case of four or more variables, the boundary 
will be a hyperplane.  
 
To discriminate between two groups, a linear discriminant function (LDF) that passes 
through the centroids (geometric centres) of the two groups is generated: 
 
LDF = a + b1.x1 + b2.x2 + ... + bp.xp (Equation 4.4) 
  
where a is a constant, and b1 to bp are the regression coefficients for p variables. The 
LDF can also be written in standardised form:  
 
D = beta1.z1 + beta2.z2 + ... + betap.zp (Equation 4.5) 
 
where D is the standardised LDF, beta1 to betap are the standardised regression 
coefficients, and z1 to zp are the standardised variables. The variables that contribute 
most to the prediction of group membership are ones with the largest, standardised 
regression coefficients. The mean of D over all objects is zero, because the mean of 
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each variable, when standardised, is zero. Therefore, an object can be classified into one 
group if its D score is greater than zero, and into the other group if its D score is less 
than zero. 
 
The linear boundary between the two groups can be thought of as a function that is 
orthogonal (perpendicular) to the LDF. Since there are an infinite number of orthogonal 
surfaces, the most obvious choice is the boundary that is equidistant from the two 
centroids; this is called ‘LDA with equal prior probabilities’. Alternatively, the 
boundary can be shifted along the direction of the LDF towards one of the two centroids 
so that objects of unknown group membership are more likely to be assigned to one 
group rather than the other. This is called ‘LDA with unequal prior probabilities’, and is 
appropriate when it is known, a priori, that there are different proportions of objects in 
the different groups (in the population).  
 
When LDA is used to distinguish between three or more groups, it is likely that more 
than a single LDF will be required. For example, in three-group LDA, one of the LDFs 
could be used to discriminate between group one and groups two and three combined, 
whereas the other LDF could be used to discriminate between groups two and three. In 
this case, the two linear boundaries would be non-parallel. In the less usual situation 
where a single LDF is sufficient to distinguish between three groups, the two boundaries 
would be parallel to one another (but would dissect the LDF at different points).  
 
In principle, standardised LDFs (D scores) can be used to assign objects to three or 
more groups, although in practice, classification functions are generally used instead. 
There will be as many classification functions as there are groups, and each object will 
be assigned to the group for which it has the highest classification score. Classification 
scores are computed according the following equation: 
 
Si = ci + wi1.x1 + wi2.x2 + ... + wip.xp  (Equation 4.6) 
 
where the subscript i denotes the respective group; the subscripts 1, 2, ..., p denote the p 
variables; ci is a constant for the i'th group; wij is the weight for the jth variable in the 
computation of the classification score for the ith group; xj is the observed value for the 
respective object for the jth variable; and Si is the resultant classification score.  
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To calculate the probability that a given object belongs to a given group, the 
Mahalanobis distance is used. This is the distance of the object from the group centroid 
in the multi-dimensional space defined by the predictor variables. The Mahalanobis 
distance is an appropriate measure of distance when the variables making up the 
multidimensional space are correlated; if the predictor variables are uncorrelated, it is 
the same as the Euclidean distance. The calculation of this ‘posterior probability’ is 
based not only on the Mahalanobis distance, but also on the prior probabilities. 
  
Assumptions of linear discriminant analysis 
The LDA method makes the following assumptions:  
1) the predictor variables are interval or ratio variables (i.e. they are either measured on 
an interval scale, which enables a ranking of objects and a comparison of the sizes 
of differences between them, or they are measured on a ratio scale, which has the 
same properties as an interval scale, and the additional property that the scale 
contains an absolute zero). 
2) the assumption of multivariate normality: the scores on the predictor variables have 
been independently and randomly sampled from a population having a multivariate 
normal distribution. 
3) the assumption of equal variance/covariance matrices: the different groups have the 
same variance/covariance matrix. In graphical terms, this means that the objects in 
each group should form a multidimensional ‘cloud’ of the same shape, size and 
orientation. 
 
If the assumption of multivariate normality is violated, this does not so much invalidate 
the classification model as reduce its predictive power, i.e. departures from normality do 
not necessarily lead to type I errors (in which the null hypothesis of no discrimination 
between groups is falsely rejected) but could lead to a reduced ability to classify objects 
when the model is applied to independent data. In contrast, heterogeneity of the 
variance/covariance matrices is likely to be more important, since objects are more 
likely to be classified into the group with greatest dispersion.  
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Canonical discriminant analysis 
Canonical discriminant analysis is a variant of LDA in which the LDFs are derived in 
such a way that they are orthogonal (independent). The first function provides the 
largest contribution to the discrimination between groups, the second function provides 
second largest and non-overlapping discrimination, and so on. The maximum number of 
functions will be equal to the number of groups minus one, or the number of variables 
in the analysis, whichever is smaller.  
 
Stepwise discriminant analysis 
When numerous variables are available for analysis, stepwise discriminant analysis can 
be used to identify the best subset of variables for classifying objects, and to build a 
discriminant model based on these variables. In forward stepwise analysis, all variables 
are evaluated in the first step to determine which one provides the most significant and 
unique discrimination between groups. Once this variable has been included in the 
model, all remaining variables are evaluated to determine which one provides the next 
best discrimination. The procedure continues until the addition of a new variable does 
not significantly improve the discrimination between groups. Backward stepwise 
analysis starts by including all variables in the model and proceeds by eliminating, at 
each step, the variable that contributes least to the prediction of group membership. The 
stepwise procedure is directed by statistical criteria, such as the user-specified F-to-enter 
and F-to-remove values. The F value for a variable is a measure of the extent to which it 
makes a unique contribution to the prediction of group membership. During forward 
stepping, a variable will only be added to the model if its F value is greater than the F-
to-enter value, and during backward stepping, a variable will only be removed from the 
model if its F value is less than the F-to-remove value. A variable that has entered a 
model during forward stepping will be removed if the subsequent entry of another 
variable results in the F value of the former falling below the F-to-remove value. 
Similarly, a variable that has been removed during backward stepping will be re-
entered, if the removal of another variable results in the F value of the former being 
greater than the F-to-enter value. 
  
It is important to bear in mind that stepwise discriminant analysis capitalises on chance 
effects, since the greater the number of variables that can be included or excluded, the 
greater the possibility that one of these variables may appear significant or insignificant 
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simply as a result of the particular object values for that variable. Therefore, the 
significance level associated with the F statistic at each step does not reflect the type I 
error rate.  
 
4.3.2 Logistic regression 
 
Logistic regression can be used to predict, on the basis of one or more predictor 
variables, the probability that a given object will belong to two or more groups. If there 
are two groups (e.g. toxic and non-toxic), binary logistic regression is used, whereas if 
there are three or more groups, a choice has to be made between nominal and ordinal 
logistic regression. Nominal logistic regression is used when there is no natural ordering 
to the groups (e.g. irritant, neurotoxic and embryotoxic), whereas ordinal logistic 
regression is used when there is a rank ordering (e.g. non-toxic, weakly toxic and 
strongly toxic).  
 
Binary logistic regression 
In the simplest type of logistic regression, binary logistic regression, the probability (p1) 
of an object belonging to group 1, and the probability (p2) of it belonging to group 2, is 
given by: 
 
ln (p1/p2) = b0 + b1.x1 + b2.x2 + ... + bn.xn  (Equation 4.7) 
 
where (p1/p2) is called the odds ratio and ln (p1/p2) the logit transform of p1; xn is the nth 
predictor variable; and bn is the coefficient of the nth predictor variable. In this equation, 
the logit transform is being used to relate the probabilities of group membership to a 
linear function of the predictor variables. The parameters of the logistic model (b0 to bn) 
are derived by the method of maximum likelihood, i.e. the parameters are chosen in 
such a way that, given that the ‘true model’ is assumed to be a logistic function, the 
chosen (population) parameters are the ones that maximise the probability (i.e. 
likelihood) that the actual response values would have been generated by taking a 
random sample from the population. Provided that all observations are independent of 
one another (i.e. there is no serial correlation between them), the likelihood of observing 
the sample of response values is the geometric sum of the probabilities of observing the 
individual response values. Instead of expressing the likelihood of the model in terms of 
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a geometric sum (product of probabilities), it is customary to take the natural logarithm 
of the likelihood (the log-likelihood), which then becomes a function of the arithmetic 
sum of individual probabilities. Thus, algorithms for logistic regression work by 
maximising the log likelihood of a model, which is equivalent to minimising its 
negative log-likelihood. 
 
The probabilities of group membership can also be expressed directly in terms of the 
predictor variables: 
 
p1 = exp(b0 + b1.x1 + ... + bn.xn) / {1 + exp(b0 + b1.x1 + ... + bn.xn)}  (Equation 4.8) 
 
p2 = 1 /{1 + exp(b0 + b1.x1 + ... + bn.xn)}  (Equation 4.9) 
 
The regression coefficients b1 to bn can be used in combination with the constant b0 to 
define a model for classifying objects into one of the two groups. The basis of such a 
model is that an object with an equal probability of belonging to the two groups has 
p1=p2, which means that ln (p1/p2) = 0, and (from Equation 4.7) that: 
 
b0 + b1.x1 + ... + bn.xn = 0 (Equation 4.10) 
 
Therefore, the surface defined by Equation 4.7 in the multi-dimensional space defined 
by x1 to xn is the linear boundary between objects in group 1 and objects in group 2. An 
object will be assigned to group 1 or to group 2 according to the following rules: 
 
Classify into group 1 if: b0 + b1.x1 + ... + bn.xn  > 0 (Equation 4.11) 
Classify into group 2 if: b0 + b1.x1 + ... + bn.xn  < 0 (Equation 4.12) 
 
Assumptions of binary logistic regression 
Logistic regression makes the assumption that a link function (in this case, the logit 
transform) can be used to relate the probabilities of group membership to a linear 
function of the predictor variables. It is also assumed that the observations are 
independent, but (unlike in the case of linear regression) it is not assumed that they are 
normally distributed.  
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Ordinal and nominal logistic regression 
Ordinal logistic regression is similar to binary logistic regression except that the link 
function is: 
 
ln (pij / (1-pij)) (Equation 4.13) 
 
where pj is the cumulative probability that object i is in group j or lower. A single 
logistic function is derived with k constants (where k is the total number of groups 
minus one). For example, if there are three groups, there will be two constants. The first 
constant can be used to define the cut-off value (along the linear combination of 
predictor variables) between group 1 and groups 2 and 3 combined, whereas the second 
constant can be used to define the cut-off value between groups 1 and 2 combined and 
group 3. 
In the case of nominal logistic regression, the number of logistic functions is one less 
than the number of groups. One of the groups is taken to be a reference group (group 
zero), so that the first logistic function can be used to predict the probability that an 
object will belong to group 1 rather than group zero, and the second logistic function 
can be used to predict the probability that an object will belong to group two rather than 
to group zero.   
 
4.3.3 Classification tree analysis 
 
A classification tree (CT) is used to predict the group membership of objects on the 
basis of one or more predictor variables. The tree consists of a set of decision rules, 
applied in a sequential manner, until each object has been assigned to a specific group. 
The first decision rule, applied at the ‘root node’ of the tree to the values of all objects 
along one or more predictor variables, has two possible outcomes: objects are either sent 
to a terminal node (leaf), which assigns a class, or to an intermediate node, which 
applies another decision rule. Ultimately, all objects are sent to a terminal node and 
assigned a class. In the simplest type of classification tree, the splits are binary (each 
parent node is attached to two daughter nodes) and the decision rules are univariate 
(based on a single variable). Classification trees can be based on continuous or discrete 
predictor variables, or on a mixture of both (when univariate splits are used), and the 
trees are generally constructed by recursive partitioning (i.e. a given predictor variable 
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can be used in more than one decision rule). One of the advantages of CTs is that they 
are non-parametric classifiers, i.e. no assumptions are made about the distributions of 
the variables. Thus, CT analysis can be used as a method of last resort, when the 
assumptions of LDA and BLR have not been satisfied. 
 
Classification tree algorithms 
Two commonly used algorithms for constructing classification trees are CART 
(Classification and Regression Trees), developed by Breiman et al. (1984), and QUEST 
(Quick, Unbiased, Efficient Statistical Trees), developed by Loh & Shih (1997). CART 
finds optimal univariate splits by carrying out an exhaustive search of all possible splits, 
whereas QUEST finds optimal univariate or multivariate splits by applying a modified 
form of discriminant analysis. It has been claimed (Loh & Shih, 1997) that the CART 
algorithm is biased toward selecting predictor variables having more levels, whereas 
QUEST lacks this bias, and is therefore more appropriate when some predictor variables 
have few levels and other predictor variables have many levels. 
 
Criteria for predictive accuracy 
The optimal classification tree is one that minimises costs. If the prior probabilities of 
objects belonging to the different classes are set proportional to the class sizes (i.e. 
proportion of objects belonging to each class in the sample is considered to reflect the 
corresponding proportion in the population), and if misclassification costs are set equal 
for every class, ‘minimising costs’ is equivalent to minimising the overall proportion of 
misclassified objects. If, however, the prior probabilities are set equal or set (differently) 
according to previous knowledge, or if different misclassification costs are used, then 
minimising costs does not correspond exactly with minimising the misclassification 
rate. Unequal misclassification costs are used when one kind of misclassification is 
considered ‘worse’ than another; for example, incorrectly predicting a toxic chemical to 
be non-toxic might be considered worse than incorrectly predicting a non-toxic 
chemical to be toxic. In such a case, misclassifications of the former type could be 
penalised more than misclassifications of the latter, when assessing the accuracy of 
classification.       
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Selecting optimal splits 
Decision tree classifiers differ in the way they select splits for partitioning the training 
set into subsets. 
 
If QUEST-style discriminant-based univariate splitting is used, the algorithm first 
selects the best terminal node to split and determines which predictor to use, and then 
determines a cut-off value along that predictor. For each terminal node, p-levels are 
computed for significance tests of the relationship between class membership and the 
levels of each predictor variable. For categorical predictors, the chi-square test of 
independence is used, whereas for ordered predictors, analysis of variance (ANOVA) is 
used. The predictor variable producing the smallest p-level is chosen to split the 
corresponding node. Further details are given in Loh & Shih (1997). To determine the 
cut-off value of the split, a two-means clustering algorithm (Hartigan & Wong, 1978) is 
used for ordered predictors. This determines the means of two ‘superclasses’ for the 
node, and chooses the split closest to a superclass mean. For categorical predictors, 
dummy-coded variables representing the levels of the categorical predictor are 
transformed into a set of non-redundant ordered predictors. The procedures for ordered 
predictors are then applied and the obtained split is ‘mapped back’ onto the original 
levels of the categorical variable. 
 
If QUEST-style discriminant-based multivariate (linear combination) splits are used, the 
predictors must be on at least interval scales. The method works by treating the 
continuous predictors from which linear combinations are formed in a manner similar to 
the way categorical predictors are treated in discriminant-based univariate splitting. The 
continuous predictors are transformed into a new set of non-redundant (continuous) 
predictors, ‘superclasses’ are found, and the split closest to a superclass mean is 
obtained. Finally, the results are ‘mapped back’ onto the original continuous predictors 
to produce a univariate split on a linear combination of predictor variables.  
 
If CART-style univariate splitting is used (on categorical or ordered predictor 
variables), all possible splits for each predictor variable at each node are examined to 
find the split producing the largest improvement in goodness-of-fit. The more 
homogeneous (less heterogeneous) in terms of class distribution the daughter nodes 
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compared to the parent node, the better the improvement in goodness-of-fit, i.e. the 
greater the reduction in node heterogeneity.  
 
A commonly used measure of homogeneity is deviance. A perfectly homogenous node, 
in which all objects are of the same class, has a deviance of zero, whereas nodes of 
increasing heterogeneity have increasingly positive deviances. The deviance of a node i 
is given by: 
 
Di = -2 ik
k
ik pn log∑  (Equation 4.14) 
 
where nik is the number of observations in terminal node i of class k; and pik is the 
probability of an observation at node i belonging to class k (the relative frequency of 
class k at node i). Another measure of homogeneity, the Gini index, is defined by the 
following equation:  
 
Ginii = 1 - ∑
k
ikp
2)(  (Equation 4.15) 
 
where Ginii = the Gini index of node i; and pik is the probability of an observation at 
node i belonging to class k. This equals zero for a node containing objects all of the 
same class, and becomes increasingly positive for nodes of increasing impurity. 
 
Determining when to stop splitting 
If a classification tree is grown until all terminal nodes are pure, the resulting tree is 
likely to overfit the data, and will therefore have a lower accuracy of classification when 
applied to new objects. The user can therefore apply a stopping rule so that splitting 
stops at nodes that are either pure, or (in the case of nodes containing more than one 
class) have no more than a specified number of objects. Alternatively, splitting can be 
stopped at nodes that are either pure or contain no more objects than a specified fraction 
of the objects. Other strategies include specifying the size of the tree to be grown (i.e. 
the number of terminal nodes), or defining the minimum heterogeneity that a node must 
have in order to be split.  
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Selecting the ‘best’ tree 
Even when the user applies a stopping rule, the resulting tree may not be the ‘best’ tree, 
in the sense of maximising accuracy of classification while at the same time minimising 
complexity. Thus, procedures have been devised for pruning trees, i.e. for successively 
‘snipping off’ the least important splits until the best tree is produced. In minimal cost-
complexity pruning, a nested sequence of optimally pruned subtrees is generated as the 
tree of maximum size (determined by the stopping criterion) is pruned to the root node. 
The sequence is optimally pruned since, for every size of tree in the sequence, there is 
no other tree of the same size with lower costs. The learning sample (resubstitution) cost 
decreases as the size of the tree increases. However, the cost generally decreases slowly 
as the first terminal nodes are removed, until a point is reached when the cost rises 
rapidly upon removal of additional nodes. This turning point can be used to define the 
best-sized tree. Alternatively, if cross-validation is performed at each step of the pruning 
process (minimal cost-complexity cross-validation pruning), the cross-validated costs 
can be used to identify the best tree in the sequence. Generally, the cross-validated (CV) 
cost falls slowly to a minimum value as terminal nodes are removed, and then rises 
rapidly as the last few nodes are removed. Thus, the best tree can be defined as the tree 
closest to the minimum, i.e. the tree with the minimum CV cost. Alternatively, Breiman 
et al. (1984) suggested that the best-sized tree can be identified as the smallest tree 
whose CV cost does not exceed the cost of the minimum CV cost tree plus one standard 
error of this tree’s CV cost.  
 
4.3.4 Assessing the goodness-of-fit of classification models 
 
The goodness-of-fit of a two-group CMs can be assessed in terms of its Cooper statistics 
(Cooper, 1979), which can be calculated from a 2 x 2 contingency table (Table 4.1), 
using the definitions given in Table 4.2. A Minitab macro for calculating the Cooper 
statistics is given in Appendix A1. 
 
The statistics sensitivity, specificity and concordance are generally of most interest 
when assessing the performance of a CM, since they provide measures of its ability to 
detect known toxic chemicals (sensitivity), non-toxic chemicals (specificity) and all 
chemicals (accuracy or concordance). The false positive and false negative rates can be 
calculated from the specificity and sensitivity, as shown in Table 4.2. 
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The other two statistics, the positive and negative predictivities, are of more interest 
when focussing on the effects of individual chemicals. These statistics can be thought of 
as conditional probabilities: if a chemical is predicted to be toxic, the positive 
predictivity gives the probability that it really is toxic; similarly, if a chemical is 
predicted to be non-toxic, the negative predictivity gives the probability that it really is 
non-toxic. 
 
Strictly, the Cooper statistics should only be used for two-group CMs. If there are three 
or more levels of the categorical response, other statistics should be used. An example is 
the kappa (κ) statistic, a chance-corrected accuracy that takes a value of zero when there 
is no agreement, and a value of one when there is perfect agreement, and is defined as 
follows: 
 
κ = (O – E) / (1-E)       (Equation 4.16) 
 
where O is the observed accuracy; and E is the accuracy expected by chance. 
 
4.4 DEVELOPMENT OF REGRESSION MODELS 
 
Linear regression models probably account for most of the SARs that have been 
published. This section describes three types of linear regression analysis: simple and 
multiple linear regression, which have been the traditional methods of choice, and 
canonical correlation and partial least squares (PLS) regression, which have gained 
popularity more recently. 
 
4.4.1 Simple and multiple linear regression 
 
In simple (ordinary) linear regression, the response variable is treated as a linear 
function of a single predictor variable: 
 
yˆ  = mx + c (Equation 4.17) 
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where yˆ is the predicted value of the response variable; x is the value of predictor 
variable; m is the slope of straight line; and c is the intercept of straight line on y axis. 
This equation, which is used to predict raw scores of the response variable, can be 
rewritten in standardised form, in which the predictor and response variables have 
means of zero and standard deviations of one: 
 
xy zrz .ˆ =  (Equation 4.18) 
 
where yz
) is the predicted value of the standardised response zy; r is the Pearson 
correlation coefficient between x and y; and zx is the standardised form the predictor 
variable x. 
 
In multiple linear regression (MLR), the response variable (y) is treated as a linear 
function of two or more predictor variables (x1-xn). The linear models derived by MLR 
are the equations of a plane or a hyperplane, depending on whether there are two or 
more predictor variables, respectively: 
 
y = m1x1 + m2x2 + ....+ mnxn + c  (Equation 4.19) 
 
When this equation is written in its standardised form, the regression coefficients (m1-
mn) are called beta weights or partial regression coefficients. The advantage of 
expressing the equation in standardised form is that the absolute values of the beta 
coefficients give the rank order of importance of the predictor variables. The relative 
importance of any two predictor variables can be obtained by taking the ratio of the 
squares of their respective beta weights. In contrast, the regression coefficients in the 
raw score form of the equation do not indicate the relative contributions of different 
predictor variables to the response variable.  
 
Assumptions of linear regression analysis 
Apart from the obvious assumption of a linear relationship existing between the 
response variable and the predictor variable(s), linear regression analysis is based on the 
following assumptions:  
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1) the predictor variables are on an interval or ratio scale 
2) there is no error in the predictor variables 
3) the residuals (differences between predicted and observed response values) are 
normally distributed about each predicted value of the response variable (the 
assumption of normality) 
4) the variance of the residuals is the same at different predicted values of the response 
variable (the assumption of homoscedasticity or absence of heteroscedasticity) 
5) the residuals at different values of the response variable should not depend on the 
order in which observations were made (the assumption of independence or absence 
of autocorrelation). 
 
The assumptions of normality and homoscedasticity can be checked by various kinds of 
residual analysis. For example, a histogram of residuals should indicate whether the 
residuals are approximately normally distributed, and a plot of residuals against 
predicted values should indicate whether heteroscedasticity occurs. The assumption of 
independence may or may not need to be checked depending on how the data are 
collated. At one extreme, if a series of observations are performed on a single object or 
individual (e.g. a human volunteer), there is a possibility that later observations are 
affected by earlier ones. At the other extreme, if measurements relating to a series of 
chemicals are taken from different literature sources, it would be reasonable to assume 
that the data were independent. The degree of autocorrelation can be quantified by using 
the Durbin-Watson statistic, which takes on a value of 2 (in a range of 0 to 4) in the 
ideal case of no autocorrelation.  
 
In practice, it is not always possible to determine whether an assumption has been 
satisfied (for example, if there are fewer than 20 observations, normality tests may fail 
to detect non-normality even when it exists). In other cases, violations may be detected, 
but not considered to be of any practical importance (for example, if there are a large 
number of observations [100 or more], normality tests may be oversensitive and reject 
the assumption of normality even though a frequency histogram looks normal). 
Moreover, when there is a large number of observations, statistical tests such as the t-
test and F-test (which are used to assess the significance of linear regression models) are 
considered to be robust to departures from normality (Lindman, 1974). In practice, then, 
one or more assumptions may appear to be violated, so the question to be addressed is 
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not so much whether the assumptions have been obeyed, but to what extent they have 
been violated, and whether, as a consequence, the model is invalid (i.e. the 
mathematical structure of the model is ‘incorrect’), or simply of reduced predictive 
quality (i.e. the model structure is ‘correct’, but the parameters have not been 
optimised).  
 
Assessing the goodness-of-fit of linear regression models 
The variance in the response variable is expressed as the total sum of squares (TSS), 
which can be divided into the variance attributed to the model (the explained sum of 
squares [ESS]), and the variance attributed to the prediction error (the residual sum of 
squares [RSS]). The TSS is defined as the sum of the squared differences between the 
observed values of the dependent variable ( iy ) and their mean ( y ); the ESS is the sum 
of the squared differences between the predicted values of the dependent variable ( iyˆ ) 
and the mean of the observed values ( y ); and the RSS is the sum of the squared 
differences between the observed values ( iy ) and the predicted values ( iyˆ ). These 
statistics are summarised in Table 4.3, along with the explained mean square (EMS) and 
the residual mean square (RMS). Linear regression models are usually derived by the 
method of least squares, which optimises the goodness-of-fit by maximising the ESS 
and minimising the RSS.  
 
The strength of linear correlation between the descriptor variable(s) and the response 
variable is expressed by the Pearson correlation coefficient (r) for simple regressions, 
and by the coefficient of determination (R2) for multiple regressions: 
 
r = 
TSS
ESS
 
 (Equation 4.20)
 
R2 = ESS/TSS = 1- (RSS/TSS) (Equation 4.21) 
 
Because the R2 value is never negative, all chance fluctuations of the sample R around 
the population R are converted into positive fluctuations of the sample R2 above the 
population R2. In other words, R2 tends to be overestimated, and the degree of 
overestimation increases with decreasing sample size and increasing number of 
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variables. To correct for this chance-mediated inflation, the “adjusted R2 value” can be 
used: 
 
R2(adj) = 1- [(1-R2) (n-1/n-p-1)]  (Equation 4.22) 
 
where R2(adj) is the adjusted R2; n is the number of observations; and p is the number 
of predictor variables in the equation. 
 
The prediction error is expressed by the standard error of the estimate (s): 
 
s = RMS  = (
$ )y y
n p
i i−
− −
∑ 2
1  
(Equation 4.23) 
 
where n is the number of observations; and p is the number of predictor variables in the 
equation. The standard error of the estimate is not a standard error in the conventional 
sense of the term (standard deviation of a sample divided by the square root of the 
number of observations), but is a measure of the standard deviation about the regression 
line (or surface). The standard error of the estimate can be used to define a prediction 
band about the regression line (or surface); for example, a 95% prediction interval is the 
region in which 95% of the observations in the population are expected to lie. In 
contrast, the 95% confidence interval is the region around the regression line (surface) 
where the ‘true’ regression line is expected to lie with a 95% probability. The 
confidence interval depends not only on the prediction error (i.e. the standard error of 
the estimate), but also on the error in estimating the intercept of the true regression line 
along the response variable, and the error in estimating the slope of the true regression 
line. The latter source of error becomes more pronounced as the predictor values deviate 
more from their average value, which results in the confidence band being bowed about 
the sample regression line.  
 
Assessing the statistical significance of linear regression models 
The statistical significance of a regression model can be assessed by means of the Fisher 
(F) statistic, which is defined as the ratio of the explained mean square (EMS) to the 
residual mean square (RMS): 
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F = 
RMS
EMS  = 
)1(
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pnR
−
−−  (Equation 4.24) 
 
where EMS = (ESS / p) and RMS = (RSS / n-p-1). The greater the F value of an 
equation, the greater its statistical significance. An equation is considered to be 
statistically significant if the observed F value is greater than the tabulated value for the 
chosen level of significance (typically, the 95% level). The tabulated value depends not 
only on the significance level, but also on the two degrees of freedom for F, υ1 and υ2, 
where υ1 = p, and υ2 = n-p-1. If an equation is reported to be significant at the 95%  
level, this means that there is a 5% chance (or less) that the equation is not significant, 
i.e. does not explain any more variance in the response variable than is explained by the 
random scatter of the dependent variable about its mean value. 
 
The statistical significance of an individual variable in a regression can be assessed by 
means of the t statistic, which is defined as the ratio of the variable’s regression 
coefficient to the standard deviation of the coefficient:  
 
t = b/sb = 
21
2
R
nR
−
−  (Equation 4.25) 
 
where b is the regression coefficient of the variable; and sb is the standard deviation of 
the regression coefficient, given by: 
 
sb = ( )∑ − 2xx
s
i
  (Equation 4.26) 
 
The greater the t value of a predictor variable, the greater its statistical significance. The 
t statistic is determined in a similar way to the F statistic, except that t tables have only 
one degree of freedom, corresponding to the RMS (i.e. υ = n-p-1). If a variable is said to 
be statistically significant at the 95% level, this means that there is a 5% (or smaller) 
chance that the regression coefficient of the variable is not significantly different from 
zero. 
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Strictly speaking, the F and t statistics are only meaningful if the assumptions of 
normality, independence and homoscedasticity are obeyed, although departures become 
less important as the number of degrees of freedom increases (Lindman, 1974). 
 
Even if an equation and its predictor variables are judged to be significant by the t and F 
statistics, there is still a possibility that the equation is a ‘chance relationship’. For 
example, if there are fives times as many objects as variables, there is a 20% (1 in 5) 
chance that the relationship is based on chance alone. Clearly, to avoid the derivation of 
chance relationships, the ratio of objects to variables should be kept as high as possible. 
Topliss & Costello (1972) recommended a minimum ratio of five objects for every 
variable.  
 
Stepwise multiple regression 
If there is a choice of predictor variables for inclusion in a multiple regression equation, 
several techniques can be used to select the ones that maximise the goodness-of-fit. An 
example is stepwise regression, which can proceed by forward stepping or backward 
stepping. In forward stepping, the initial model contains only one predictor variable, all 
other variables being excluded. In the first step, one of the excluded variables is added, 
this being the variable that improves the fit of the model (i.e. increases the r2 value) 
more than the other excluded variables. This process is repeated in subsequent steps 
until a fixed number of variables have been included, or until a pre-defined fit has been 
achieved. In backward stepping, the initial model contains all possible predictor 
variables, and each step results in the loss of one variable, this being the variable that 
minimises the reduction in the fit of the model. Again, the procedure is continued until a 
fixed number of variables are present in the final equation or until a desired fit has been 
achieved. If a particular variable is considered to be an important predictor (on the basis 
of prior knowledge), it can be ‘forced’ into the final equation, irrespective of its 
contribution to the explained variance in the data set under investigation.  
 
4.4.2 Canonical correlation 
 
Canonical correlation is a method for relating a set of continuous predictor variables to a 
set of continuous response variables. The method works by correlating a linear 
combination (weighted sum) of the predictor variables with a linear combination of the 
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response variables. Each linear combination is called a canonical variate, and the two 
canonical variates that are correlated form a pair of canonical variates. The weights in 
the two canonical variates forming a pair are chosen in such a way that the canonical 
correlation is maximised. The squared correlation coefficient between the two canonical 
variates is called the root or eigenvalue (λ), and can be interpreted as the proportion of 
overlapping variance between the two canonical variates. There will be as many pairs of 
canonical variates extracted as there are predictor variables or response values, 
depending on which is the smaller. Successively extracted pairs of canonical variates 
are orthogonal, and have decreasing eigenvalues. 
 
Statistical significance of canonical variates 
To assess the statistical significance of canonical correlations, the significance of all 
canonical pairs is assessed first. The significance of all roots except the first one is then 
assessed, and so on, until the significance of the final root is assessed. Thus, if the 
combination of all roots is found to be significant, but the set of roots remaining after 
removal of the first one is insignificant, it would be concluded that only the first root is 
significant. In general, the statistical test used to determine whether a set of roots is 
significant is the chi square test: 
 
χ2 = - [n-1-(p+q+1/2)] ln Λ (Equation 4.27) 
 
where n is the number of objects; p is the number of predictor variables; q is the number 
of response variables; and Λ is the product (∏) of differences between eigenvalues (λ) 
and one, taken across all canonical correlations: 
 
Λ = ∏ (1-λ) (Equation 4.28)
  
Interpretation of canonical variates 
The meaning of a given canonical variate can be interpreted from its canonical weights 
(the coefficients in the linear combination of variables that defines the canonical 
variate). The larger the absolute value of a canonical weight, the greater is the respective 
variable's unique positive or negative contribution to the canonical variate. 
Alternatively, a canonical variate can be interpreted from its canonical factor loadings 
(the correlation coefficients between the canonical variate and the variables from which 
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it is derived). The proportion of variance extracted from a set of variables by a canonical 
variate is the sum of squared canonical factor loadings divided by the number of 
variables in the set. If the proportion of variance extracted by a canonical variate is 
multiplied by the squared correlation coefficient for the pair (the eigenvalue), this gives 
the redundancy in the canonical variate. This is the proportion of variance extracted by 
the canonical variate from the variables in the other set of variables.  
  
To obtain reliable estimates of the canonical factor loadings for the most significant 
canonical pair only, Stevens (1986) recommended that the ratio of objects to variables 
should be at least 20. To obtain reliable estimates for two canonical roots, Barcikowski 
& Stevens (1975) recommended a ratio of objects to variables of at least 40.  
 
Assumptions of canonical correlation 
The significance test applied to the canonical correlations is based on the assumption 
that the variables in the population (from which the sample was drawn) have a 
multivariate normal distribution. Multivariate normality is the assumption that all 
variables and all linear combinations of variables are normally distributed. It is also 
assumed that the canonical variate scores show linearity and homoscedasticity. 
 
4.4.3 Partial least squares regression 
 
PLS regression is a linear regression method for predicting one or more response 
variables from two or more predictor variables. The method works by forming two sets 
of components (latent variables or factors), one set being derived from the predictor 
variables, and the other set from the response variables. The components are derived in 
such a way that: a) the components in each set are orthogonal to one another; and b) the 
response components are maximally correlated with the predictor components. The 
purported advantages of PLS regression over traditional multiple linear regression are 
that it can be used to derive regression models when there are fewer observations than 
predictor variables, and when predictor variables are highly correlated. A description of 
the PLS algorithm is provided in Geladi & Kowalski (1986). 
 
In terms of matrix algebra, PLS regression derives a linear model: 
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Y=XB+E (Equation 4.29) 
 
where Y is the response variable matrix (n objects by q variables); X is the predictor 
variable matrix (n objects by p variables); B is the regression coefficient matrix (p by q 
variables); and E is a matrix of residuals having the same dimensions as Y. The 
variables in X and Y are usually standardised. 
 
The t factors extracted from X can be related to the predictor variables by Equation 
4.30, and the u factors extracted from Y can be related to the response variables by 
Equation 4.31: 
 
T=XW (Equation 4.30) 
U=YC (Equation 4.31) 
 
where T is the (n by t) factor score matrix derived from the predictor variables; W is a (p 
by t) matrix of  T factor loadings; U is the (n by u) factor score matrix derived from the 
response variables; and C is a (q by u) matrix of U factor loadings. The weights in W 
are computed so that they maximise the correlation between the predictor variables and 
the U scores, and the weights in C are computed to maximise the correlation between 
the response variables and the T scores. This is achieved by an iterative procedure (e.g. 
NIPALS [non-linear iterative partial least squares]), in which factors (t and u) are 
calculated one pair at a time.  
 
 
4.5 RESAMPLING METHODS 
 
In resampling methods, the data points of a toxicological data set are sampled (at 
random, in many cases), with a view to assessing, for example, the statistical 
significance or predictivity of a model. Resampling methods are iterative procedures. 
During each iteration, objects are selected from the data set, and a statistic of interest is 
calculated on the basis of data for the chosen objects. The statistic calculated during 
each iteration is generally stored, so that at the end of the iterative procedure, a 
sampling distribution of the statistic can be generated, and inferences can be made about 
the population for which the data set represents a sample. If the resampling process is 
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carried out with replacement, this means that during each iteration, the selected objects 
are not removed from the data set, and can therefore be selected more than once. 
Conversely, if resampling is performed without replacement, this means that once an 
object has been selected, it is removed from the data set, and cannot be selected again 
during the same iteration.  
 
4.5.1 Cross-validation 
 
The goodness-of-fit of a statistical model provides a measure of how well the model fits 
the data in its training set. The predictivity of the model (i.e. its ability to make 
predictions for an independent [external] set of data) will almost certainly be worse than 
the goodness-of-fit. Thus, statistical models should ideally be assessed by using 
independent data (external validation). However, a shortage of reliable data often means 
that all available data are used for model development, leaving none for external 
validation. Therefore, various cross-validation techniques have been developed to 
enable a more realistic (but probably still optimistic) performance of the predictive 
capacity of statistical models to be assessed by resampling a single training set. In the 
simplest type of cross-validation, called the leave-one-out (LOO) procedure, each object 
is omitted once in turn, and predicted from a model derived from the remainder of the 
data set. The predicted values of the dependent variable are then compared with the 
measured values so that a variety of cross-validated statistics can be derived, such as the 
predicted residual sum of squares (PRESS) and the cross-validated R2 (Q2): 
 
PRESS = ∑ − 2)ˆ( iyy  (Equation 4.32) 
 
Q2 = 1 – (PRESS / TSS)
 
(Equation 4.33) 
 
Instead of leaving out every object in turn, it is possible to omit a larger proportion of 
the objects, either in a fixed or random manner. 
  
Cross-validation provides more realistic measures not only of model performance, but 
also of model robustness (stability); if a model is robust, its regression coefficients are 
insensitive to the omission of data points. For the purposes of this project, Minitab 
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macros were written to calculate the cross-validated R2 for simple and multiple linear 
regressions (Appendix A2). 
 
4.5.2 Cluster significance analysis 
 
If chemicals are classified into two groups (active/inactive or toxic/non-toxic) and are 
plotted on a box plot (one variable), or on a scatter plot (two or more variables), it 
sometimes appears that the chemicals in one group form an ‘embedded cluster’ 
surrounded by the chemicals in the other group, the ‘diffuse cluster’. Typically, the 
active (or toxic) chemicals form the embedded cluster, and the inactive (or non-toxic) 
chemicals form the diffuse cluster, indicating that for each of the chosen variables, there 
is an optimum range of values for the biological response to occur.  
 
The statistical significance of an embedded cluster can be assessed by cluster 
significance analysis (CSA). The first algorithms for CSA, proposed by McFarland & 
Gans (1986a, 1986b), were based on an index of cluster tightness called the ‘mean 
squared distance’ (MSD), defined as the sum of the squared (Euclidean) distances 
between all possible pairs of data points, divided by the number of such pairs. Since the 
MSD of a cluster is proportional to its variance, Rose & Wood (1998) proposed an 
algorithm for CSA that uses variance as the measure of cluster tightness.  
  
Algorithm for Cluster Significance Analysis 
The first step in CSA is to calculate the tightness of the observed cluster, using its 
variance as the index of cluster tightness. The variance of a single variable is given by: 
 
variance = 
( )x x
n
−
−
∑ 2
1
 (Equation 4.34) 
 
where x  is the variable under consideration, x  is the mean value of x , and n is the 
number of data points in the cluster. In the case of two or three variables, the total 
variance is calculated as the sum of the variances of the individual variables, which is 
valid as long as the variables are measured on the same scale. This is achieved by 
standardisation (subtraction of the mean, and division of the difference by the standard 
deviation). 
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The second step is the generation of the sampling distribution of variances (or weighted 
variances) for the data set. To avoid the need to identify all possible combinations of 
chemicals, random sampling is carried out irrespective of whether the data set is small 
or large. The number of active chemicals in the data set is counted, and this number is 
randomly sampled, without replacement, from the total set of chemicals. The variance 
of each random combination (subset of chemicals) is then calculated. If the variance of 
the random subset is less than or equal to the variance of the embedded cluster, a 
counter (which starts the sampling procedure with a value of zero) is increased by one. 
Thus, when the specified number of random subsets has been sampled, the value of the 
counter corresponds to the number of times that a random subset had a variance less 
than or equal to the variance of the embedded cluster. It is important to note that while 
the chemicals in each subset are sampled without replacement (to ensure that a given 
chemical can only be selected once), the subsets themselves are selected with 
replacement, so a given subset of chemicals could be selected more than once. 
  
In the third step, the probability (p-value) that the observed embedded cluster could 
have arisen by chance is given by: 
 
p-value  = n / N (Equation 4.35) 
 
where n is the number of randomly generated subsets that are at least as tight as the 
observed embedded cluster; and N is the total number of randomly selected clusters. If 
the p-value ≤ 0.05, it is concluded (at the 95% significance level) that the observed 
cluster has not arisen by chance. 
 
The fourth step is the calculation of the confidence interval (CI) for the p-value, which 
is simply the CI for a proportion, given by: 
 
CI =  p - k 
p p
n
( )1 −
 
-  0.5/n  to  p + k
p p
n
( )1 −
 + 0.5/n (Equation 4.36) 
 
where k is the critical value for a two-tailed significance test based on the normal 
distribution. A 95% CI is calculated by using k=1.96, and a 99% CI by using k=2.58.  
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For the purposes of this project, the CSA algorithm was coded in the form of three 
Minitab macros, appropriate for carrying out CSA in one, two and three dimensions, 
respectively (Appendix A3). 
 
Variable selection in cluster significance analysis 
In extensions of their original algorithms, McFarland & Gans (1990; 1994), introduced 
stepwise procedures for automatically selecting the most significant combinations of q 
variables (where q ≥ 2) from a set of n variables (where n > q). For example, to evaluate 
the significance of seven physicochemical descriptors for predicting the sweetness of 
sulphamate compounds (McFarland & Gans, 1990), the p-value for the seven-variable 
combination was determined first, and then variables were deleted one at a time. If the 
removal of a single variable from a given q-variable combination reduced the p-value, 
the remaining combination of (q-1) variables would be entered into the subsequent step, 
whereas if the p-value increased or stayed the same, the effect of removing a different 
variable would be assessed instead.  
 
Stepwise procedures such as this enable the relative significance of different q-variable 
combinations to be determined (where q is a fixed number), but they do not indicate 
whether the addition or removal of a variable results in a significant change in the 
significance of clustering. To overcome this shortcoming, Rose & Wood (1998) 
proposed a forward stepwise algorithm in which the significance of adding a new 
variable is assessed in terms of its ‘conditional p-value’. This algorithm, called ‘CSA 
with conditional probabilities’, is an extension of the authors’ simplified algorithm for 
CSA. It works by randomly generating a large number of subsets (e.g. 100,000) of the 
total set of compounds, and by storing the variance of each subset (along each variable) 
in a matrix. This matrix, which summarises the sampling distribution of the variances, 
has as many rows as there are randomly selected subsets of compounds, and as many 
columns as there are variables. The first variable to be selected is simply the variable 
which has the smallest p-value. To select the second variable, the variances in the 
column vector corresponding to the first variable are arranged in order of increasing 
size, with the remaining column vectors (corresponding to the remaining variables) 
being sorted in parallel. This results in row sN of the first column vector (where s is the 
significance level and N is the number of random subsets) having a variance 
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approximately equal to the observed variance. Then, a fixed number of rows on either 
side of this row are taken as a subset from the matrix corresponding to the sorted 
sampling distribution. The second variable to be selected is simply the variable in this 
sub-matrix that has the lowest p-value. This process is continued until the addition of a 
variable results in a conditional p-value that exceeds the chosen significance level 
(typically, 0.05). At this point, the addition of new variables is no longer considered to 
contribute significantly to the tightness of the embedded cluster. In effect, stepwise CSA 
with conditional probabilities works by ‘zooming in’ on subsets of the sampling 
distribution matrix where previously selected variables are not significant.  
 
CSA with conditional probabilities, performed according to the Rose & Wood algorithm 
(1998), requires a large number of random subsets to be generated. The current author 
suggests that a simpler and quicker algorithm could be based directly on the p-values for 
the different variable combinations, without the need to generate a large number of 
random subsets. To determine whether the addition a new variable results in a 
significant difference of clustering tightness, a ‘conditional’ probability could be 
calculated by determining whether the difference between the p-value obtained in n 
dimensions is significantly different from the p-value obtained in n+1 dimensions. The 
null hypothesis is that the two p-values are the same, and the test statistic is given by the 
following equation: 
 
Test statistic = p p
p p n n
1 2
1 21 1 1
−
− +( )[( / ) ( / )]  (Equation 4.37) 
 
where p1 is the larger p-value (presumably for n variables) and p2 is the smaller p-value 
(presumably for n+1 variables); p = (p1 + p2)/2 (i.e. the mean p-value); n1 is the number 
of random samples generated for the calculation of p1; and n2 is the number of random 
samples generated for the calculation of p2. If the test statistic ≥ 1.96, then it can be 
concluded at the 95% confidence level that there is a significant difference between the 
two p-values, and if the statistic ≥ 2.58, the same conclusion can be reached at the 99% 
significance level. These values are the critical values taken from the normal 
distribution. Clearly, the method could operate in either a forward or backward manner, 
with systematic addition (in a forward procedure) or deletion (in a backward procedure) 
of one variable at a time.  
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Variants of cluster significance analysis 
For the analysis of embedded data sets in which the biological activity is measured on a 
continuous scale rather than a dichotomous scale, Rose & Wood (1998) introduced the 
concept of ‘generalized’ CSA (GCSA). Algorithms for GCSA work by using weighted 
variances for each variable, i.e. by taking all chemicals into consideration, rather than a 
subset, and by allowing each chemical to contribute to the variance in proportion to its 
activity. A Minitab macro for performing GCSA is given in Appendix A4. 
 
Another type of CSA, developed by Rose et al. (1991), is ‘single class discrimination 
using principal component analysis’ (SCD-PCA). This method maximises the variance 
of the diffuse cluster with respect to the variance of the embedded cluster, and therefore 
improves the ability to discriminate between compounds in the two clusters.  
 
Finally, another variant of CSA, called ‘rank distance clustering’ (RDC) simplifies the 
calculation of cluster tightness by ranking the distances of all compounds from the 
centroid, and by comparing the sum of ranks for the active cluster with the sum of ranks 
that would be expected by chance (Rose & Wood, 1998) 
 
4.5.3 Bootstrap resampling 
 
Bootstrap resampling is a statistical method for making inferences about an unknown 
population on the basis of a single sample (Efron & Tibshirani, 1993). The basic 
premise of the method is that the sample is representative of the population from which 
it was drawn, i.e. it is assumed that each observation in the sample had an equal 
probability of being selected from the population. Since there is only one sample, 
bootstrapping simulates what would happen if the population were resampled by 
randomly resampling the sample. The sample is sampled with replacement, i.e. if there 
are n observations in the sample, n observations are randomly selected from the sample 
in such a way that any given observation can be picked any number of times between 
zero and n. Every time a random selection of observations is made, a statistic of interest 
is calculated on the basis of these observations. If the resampling procedure is 
performed a large number of times, the resulting bootstrap distribution of the statistic is 
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assumed to approximate its true sampling distribution. Therefore, the bootstrap 
distribution can be used to estimate confidence limits for population parameters.  
 
Standard bootstrap method 
The simplest method for obtaining bootstrap confidence limits is called the standard 
bootstrap method. According to this method, if the sample statistic is denoted by T, and 
the corresponding population parameter is denoted by θ, then the 95% confidence 
interval (CI) for θ is given by Equation 4.38: 
 
95% CI for θ = bootstrap mean ± 1.96 sB  (Equation 4.38) 
 
where ‘bootstrap mean’ is the mean value of the bootstrap distribution of T; and sB is 
the standard deviation of the bootstrap distribution of T. For this equation to be valid, it 
is necessary that: a) the bootstrap distribution of T is approximately normal; and b) T is 
an unbiased estimate of θ, i.e. the bootstrap mean equals the estimate based on the 
original sample. No assumptions are made about the distribution of observations in the 
population. 
 
The bias in the estimator T can be calculated as the difference between the bootstrap 
mean and the original sample mean: 
 
Bias (T) = bootstrap mean - sample mean (Equation 4.39) 
  
If the sample statistic (T) turns out to be a biased estimate of the population parameter 
(θ), the bias can be accounted for by centering the 95% CI for θ on the bias-corrected 
estimate of the population mean, i.e. Equation 4.40 would be used instead of Equation 
4.38: 
 
Bias-corrected 95% CI for θ = (sample mean - bias) ± 1.96 sB (Equation 4.40) 
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Percentile-based bootstrap methods 
If the bootstrap distribution of estimates (T) shows a significant departure from the 
normal distribution (for example, if there is strong skewness or kurtosis), the standard 
bootstrap method will not give accurate confidence limits. In such a case, a better 
approach is to calculate percentiles from the bootstrap distribution. The 95% CI for the 
population parameter θ is then given by two values that encompass 95% of the 
bootstrap distribution. According to the simple percentile method, these would be the 
values that exceed 2.5% and 97.5%, respectively, of the bootstrap distribution. The 
simple percentile method makes the assumption that a transformation of T exists such 
that the transformed variable is normally distributed. Although the mathematical form 
of the transformation does not need to be known, the transformation is assumed to be 
monotonic, i.e. the ordering of the transformed bootstrap estimates from the smallest to 
the largest value is assumed to correspond to the ordering of the untransformed 
bootstrap estimates. 
 
If T is a biased estimator of θ, i.e. if the mean of the bootstrap distribution is not equal 
to the estimate based on the original sample, then it is more appropriate to use the bias-
corrected percentile method. In this method, the number of times (n) that the bootstrap 
estimate (TB) exceeds the sample estimate (T) in N bootstrap samples is counted, so that 
the probability (p) of TB being greater than T is given by n/N. The next step is the 
calculation of Zp, the value of the standard normal distribution that is exceeded with a 
probability of p. The value of Zp is used to calculate two proportions, PL and PH: 
 
PL = φ (2Zp – 1.96)  (Equation 4.41) 
PH = φ (2Zp + 1.96) (Equation 4.42) 
 
where φ (z) is the proportion of the standard normal distribution that is less than z. 
 
Finally, the values of PL and PH are used to calculate the 2.5th and 97.5th percentiles, i.e. 
the lower and upper values in the bootstrap distribution corresponding to cumulative 
probabilities of 0.025 and 0.975, respectively: 
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Lower 95% CL = INVCDF{φ(2Zp – 1.96)} (Equation 4.43) 
Upper 95% CL = INVCDF{φ(2Zp + 1.96)} (Equation 4.44) 
 
where CL is the confidence limit; and INVCDF(p) is the value in the bootstrap 
distribution corresponding to a cumulative probability of p. 
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Table 4.1 A 2 x 2 contingency table 
  Predicted class 
  Toxic Non-toxic Marginal totals 
Observed (in vivo)  
class 
Toxic a b a+b 
Non-toxic c d c+d 
Marginal totals a+c b+d a+b+c+d 
 
 
Table 4.2 Definitions of the Cooper statistics 
Statistic Definition:  “the proportion (or percentage) of the … 
 
sensitivity toxic chemicals (chemicals that give positive results 
in vivo) which the CM predicts to be toxic.” 
= a/(a+b) 
 
specificity non-toxic chemicals (chemicals that give negative 
results in vivo) which the CM predicts to be non-
toxic.” 
= d/(c+d) 
 
concordance or accuracy chemicals which the CM classifies correctly.” = (a+d)/(a+b+c+d) 
positive predictivity chemicals predicted to be toxic by the CM that give 
positive results in vivo.” 
= a/(a+c) 
negative predictivity chemicals predicted to be non-toxic by the CM that 
give negative results in vivo.” 
= d/(b+d) 
false positive  
(over-classification) rate 
non-toxic chemicals that are falsely predicted to be 
toxic by the CM.”  
= c/(c+d) 
= 1 - specificity 
false negative  
(under-classification) rate 
toxic chemicals that are falsely predicted to be non-
toxic by the CM.” 
= b/(a+b) 
= 1 - sensitivity 
 
Footnote to Table 4.2 
CM = classification model 
 
 
Table 4.3 Variance components used in linear regression analysis 
Statistic Definition Degrees of freedoma 
  
Total sum of squares  (TSS) 2)( yyi −∑  n-1 
Explained sum of squares  (ESS) ( $ )y yi −∑ 2  p 
Residual sum of squares (RSS) ( $ )y yi i−∑ 2  n-p-1 
Explained mean square  (EMS) ESS/p  
Residual mean square   (RMS)  RSS/n-p-1  
 
Footnote to Table 4.3 
a n = number of observations; p = number of variables 
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5.1 INTRODUCTION 
 
As described in chapter 4, bootstrap resampling is a statistical method for making 
inferences about an unknown population on the basis of a single sample. This chapter 
describes the use of novel bootstrap resampling algorithms to analyse the variability in: 
a) Cooper statistics, which vary according to the chemicals included in the classification 
model (CM) test set; and b) Draize test endpoints, which are subject to biological 
variability (between rabbits) and to temporal variability (between observation points). 
The bootstrap method can also be used to assess the variability in model parameters, as 
illustrated in Chapters 6 and 8 for CMs and regression models, respectively. 
 
5.2 BOOTSTRAP ANALYSIS OF COOPER STATISTICS 
 
5.2.1 Introduction 
 
As described in chapter 4, the predictive abilities of two-group CMs are often expressed 
in terms of their Cooper statistics (Cooper et al., 1979). These statistics are often 
reported without any indication of their uncertainty, making it impossible to judge 
whether the predicted classifications are significantly better than would be expected by 
chance, or significantly better than the predictions made by a different CM. To address 
this problem, the aim of the work described in this section was to develop a means of 
expressing the uncertainty associated with Cooper statistics. As described below, this 
was achieved by formulating bootstrap resampling routines that derive 95% confidence 
intervals (CIs) for the various Cooper statistics. The usefulness of these bootstrapping 
routines is illustrated by constructing CIs for the Cooper statistics of four alternative 
tests for skin corrosion (the rat skin transcutaneous electrical resistance [TER] assay, 
EPISKINTM, Skin2TM and CORROSITEXTM), and for four two-step sequences in which 
each in vitro test is used in combination with a physicochemical test for skin corrosion 
based on pH measurements. 
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5.2.2 Method  
 
Coding of the bootstrap resampling algorithms 
As described in chapter 4, bootstrap CIs can be derived by various methods, including 
the standard method, the simple percentile method, and the bias-corrected percentile 
method. To compare the use of these methods, bootstrap algorithms were coded in the 
form of two macros for use with the Minitab software package (Minitab Inc., State 
College, PA).  
 
The first macro, the ‘bootstrapping macro’ (Appendix A5), generates bootstrap 
distributions and calculates the standard 95% CIs of three Cooper statistics: 
concordance, sensitivity and specificity. To reduce the time taken for the macro to run, 
bootstrap distributions are not calculated for the false positive and false negative rates, 
since these distributions can be derived from the corresponding bootstrap distributions 
for specificity and sensitivity, respectively (see chapter 4). To carry out the simple 
percentile method, it is sufficient to calculate the 2.5th and 97.5th percentiles of the 
bootstrap distributions generated by the bootstrapping macro. 
 
The bootstrapping macro works by counting the total number of chemicals in the data 
set, and by randomly sampling, with replacement, this number of chemicals from the 
data set. This procedure is carried out N times (where N is a number defined by the 
user) to generate N bootstrap samples. Each bootstrap sample consists of: a) the known 
classification for each chemical selected; and b) predicted classifications made by 
different laboratories, possibly on different occasions (experimental runs). The two sets 
of classifications (known and predicted) are used to calculate the Cooper statistics. The 
distribution of a given statistic over the N bootstrap samples gives the bootstrap 
distribution of that statistic, and the 95% confidence interval of each Cooper statistic is 
calculated from the bootstrap distribution by using Equation 4.38. Since the 
bootstrapping macro generates a different bootstrap distribution for each laboratory/run 
combination, the user can calculate the Cooper statistics obtained by individual 
laboratories (by averaging over all experimental runs with that laboratory) or by all 
laboratories taken together (by averaging over all of the laboratory/run combinations). If 
only one set of predicted classifications is available, this is treated as the first 
laboratory/run combination. 
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A second Minitab macro, the ‘percentile macro’ (Appendix A6), performs the bias-
corrected percentile method. This macro applies the algorithm described in Chapter 4 to 
calculate bias-corrected percentiles, which can then be applied to the bootstrap 
distributions already generated by the bootstrapping macro to derive the bias-corrected 
confidence limits.  
 
Calculation of Cooper statistics for four in vitro skin corrosion tests 
To calculate 95% CIs for the Cooper statistics of the TER, EPISKIN, Skin2 and 
CORROSITEX assays, the Minitab macros were applied to a heterogeneous data set of 
60 chemicals (Table 5.1). These chemicals, which were the test chemicals in the 
ECVAM Skin Corrosivity Validation Study (Barratt et al., 1998; Fentem et al., 1998), 
cover a range of physical forms and chemical classes. The validation study was 
designed so that the TER, Skin2 and CORROSITEX tests would classify the 60 
chemicals on two occasions (runs) in each of three laboratories, i.e. a total of 360 
(60x2x3) predicted classifications, whereas the EPISKIN assay would classify the 
chemicals on three occasions in each of three laboratories, i.e. a total of 540 (60x3x3) 
predicted classifications. In practice, the actual number of in vitro classifications for 
Skin2 and CORROSITEX differed from 360. In the case of Skin2, 50 of the 60 
chemicals were tested on just one occasion by one of the laboratories, which resulted in 
310 Skin2classifications being available for comparison with the in vivo classifications. 
In the case of the CORROSITEX assay, 26 of the 60 chemicals were found to be 
incompatible with the test system by one or more laboratories, and were therefore not 
tested by these laboratories. As a result, 229 CORROSITEX classifications were 
available for comparison with the in vivo classifications. The bootstrapping macro was 
written to automatically exclude missing and non-qualifying observations during the 
calculation of Cooper statistics. 
 
To compare the various bootstrap methods, the 95% CIs for the Cooper statistics of 
TER, EPISKIN, Skin2 and CORROSITEX were also calculated, not only by the 
standard bootstrap method, but also by the simple and bias-corrected percentile 
methods. In each case, random resampling was carried out 1000 times. When the 
standard bootstrap method was applied, the bias in each bootstrap mean was calculated 
by using Equation 4.39 (see chapter 4).  
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Calculation of Cooper statistics for four two-step sequences of tests 
The standard bootstrap method was used to calculate CIs for the Cooper statistics of 
two-step sequences based on the use of a pH test followed by one of the following 
methods: a) the TER assay; b) the EPISKIN assay; c) the Skin2 assay; or d) the 
CORROSITEX assay. Predicted classifications of skin corrosion potential based on pH 
measurements were taken from Worth et al. (1998) and are reproduced in Table 5.1. To 
determine whether the four stepwise sequences are significantly more predictive than 
the four stand-alone in vitro tests, t-tests for independent samples were used to compare 
the ‘sequential’ bootstrap distributions with their corresponding ‘stand-alone’ 
distributions, using a p-level of 0.01.  
 
5.2.3 Results 
 
The data set of 60 chemicals is presented in Table 5.1, which also gives the in vivo 
classifications of skin corrosion potential (C/NC) and the average (most frequent) in 
vitro classifications made by each test method.  
 
Bootstrap analysis of the Cooper statistics for four in vitro tests 
A separate bootstrap distribution for each Cooper statistic of each in vitro test was 
generated (i.e. a total of 20 distributions). An illustrative example is the bootstrap 
distribution of the concordance of EPISKIN, represented by a frequency histogram in 
Figure 5.1, and by a cumulative probability distribution in Figure 5.2. 
 
The results obtained by applying the standard bootstrap method to the 20 distributions 
are presented in Table 5.2, which also gives the Cooper statistics calculated from the 
original data set of in vitro and in vivo classifications. The ‘original values’ correspond 
very closely with the mean values of the bootstrap distributions, which means that there 
is little or no bias (bootstrap mean – original value) in the bootstrap mean values. For 
example, there is a bias of -1% in the concordance, sensitivity and specificity of the 
TER assay, which means that the corresponding population parameters are likely to be 
1% higher than the values based on the sample of 60 chemicals. In the case of EPISKIN 
and CORROSITEX, the Cooper statistics show no bias, whereas in the case of Skin2, 
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the concordance and sensitivity are positively biased, and the false negative rate is 
negatively biased.  
  
The 20 bootstrap distributions were used to derive 95% CIs by the simple and bias-
corrected percentile methods (Table 5.3). The median values obtained by the simple 
percentile method are identical to the mean values obtained by the standard bootstrap 
method (Table 5.2) in all but six cases. In these cases (specificity and false positive rate 
of TER; sensitivity and false negative rate of Skin2; sensitivity and false negative rate of 
CORROSITEX), the median value differs from the mean value by just one percent. The 
high level of agreement between the median and mean values means that the bootstrap 
distributions are not skewed to a significant extent. 
 
The bias-corrected percentile CIs can be compared with the standard CIs by comparing 
the bias-corrected lower and upper percentiles with 0.025 and 0.975, respectively. It can 
be seen that the bias-corrected percentiles for EPISKIN and CORROSITEX are closer 
to the 0.025 and 0.975 than are the bias-corrected percentiles for TER and Skin2. This 
indicates that the Cooper statistics for EPISKIN and CORROSITEX are less biased than 
are the corresponding statistics for TER and Skin2, which is in accordance with the 
estimates of bias made by subtracting the original sample values from the bootstrap 
mean values (Table 5.2). In the case of TER, the lower and upper bias-corrected 
percentiles for concordance, sensitivity and specificity are higher than 0.025 and 0.975, 
respectively, which means that the 95% CIs for the Cooper statistics are shifted to 
higher values. This is in accordance with the negative bias estimated by the standard 
bootstrap method. In the case of Skin2, the lower and upper confidence limits for 
concordance and sensitivity are shifted to lower values, which is consistent with the 
positive bias estimated by the standard bootstrap method. In the case of Skin2, bias-
corrected percentiles for specificity could not be calculated. The reason for this is that 
all of the values in the bootstrap distribution are 100%, so the proportion of bootstrap 
estimates exceeding the specificity derived from the original sample (100%) is zero. 
Since one of the steps in the algorithm calculates the inverse cumulative density 
function of this proportion for a standard normal distribution, which is not defined when 
the proportion is zero, the algorithm is not applicable in this case (and the macro 
terminates with an error message). 
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Bootstrap analysis of the Cooper statistics for four sequences of alternative methods 
The bootstrap estimates of the Cooper statistics, obtained by applying the standard 
bootstrap method to the four stepwise sequences are presented in Table 5.4, which also 
gives the Cooper statistics based on the original sample of 60 chemicals. Again, there is 
little or no bias in the Cooper statistics, indicating that the values based on the original 
sample are good approximations of their ‘true’ values.  
 
In Table 5.5, a comparison is made, for each of the four in vitro tests, between the 
Cooper statistics (the bootstrap mean values) relating to its stand-alone use and the 
corresponding statistics relating to its use in sequence with the pH test. Although, in 
practice, the pH test would be carried out before the in vitro test, these statistics would 
be the same irrespective of the order in which the two tests are carried out, since the 
decision rule is effectively ‘if at least one of the two tests predicts a chemical to be 
corrosive, then assume it is corrosive; if both tests predict the chemical to be non-
corrosive, then assume it is non-corrosive’. The data in Table 5.5 show that the 
performances of the TER and EPISKIN tests in combination with the pH test are better 
than their individual performances, as judged by statistically significant increases in the 
concordance, sensitivity and specificity. The increases in the latter two statistics are 
paralleled by decreases in the false negative and positive rates, respectively. In the case 
of the Skin2 test, the concordance and sensitivity are increased when used in 
combination with the pH test, but the specificity is decreased. However, the increase is 
sensitivity is much greater (25%) than the decrease in specificity (6%). In the case of the 
CORROSITEX assay, the apparent benefits of combining its use with the pH test are 
not statistically significant, except for a slight increase in specificity from 76% to 78%. 
 
5.2.4 Discussion 
 
The uncertainty in the Cooper statistics of a CM can be attributed to several sources, 
relating to the choice of: a) test chemicals; b) laboratories; c) parameters in the CM; and 
d) mathematical form of the CM. In this study, the bootstrap distributions were 
generated to reflect the variability arising from the choice of test chemicals only. This is 
justified on the basis that the majority of the uncertainty in the predictions made by the 
TER, EPISKIN, Skin2 and CORROSITEX assays results from chemical variation, 
rather than from inter-laboratory and intra-laboratory variation, as demonstrated by the 
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statistical analyses carried out during the ECVAM validation study (Fentem et al., 
1998). This approach assumes that the mathematical form and the parameters (cut-off 
values) of the CM are ‘correct’. Bootstrap resampling can also be used to assess the 
uncertainty in CM parameters by reparameterising the model of interest on the basis of 
each random sample, thereby generating a bootstrap distribution of the parameter. This 
approach has been adopted, for example, in the development of SARs for eye irritation 
potential (Worth & Cronin, 2000a). The most intangible source of uncertainty, however, 
lies in the mathematical form of the model. 
 
The key assumption made by bootstrap resampling methods is that the sample is 
representative of the population. In this study, the data set of 60 chemicals is assumed to 
represent a population of industrial chemicals and consumer product ingredients 
comprising acids, bases, neutral organics, phenols, inorganic salts, electrophiles and 
surfactants. It is difficult, if not impossible, to determine the validity of this assumption, 
but it is more likely to be reasonable for chemicals that are more numerous in the data 
set (e.g. the organic acids) than for less numerous chemicals (e.g. the surfactants). 
 
Several bootstrap algorithms were compared in this study. The simplest algorithm is the 
standard bootstrap method, which is applicable if the bootstrap distribution is 
approximately normal. If the bootstrap distribution shows a significant departure from 
normality, one of the percentile-based methods should be used instead. In general, the 
calculation of percentile confidence limits requires more bootstrap samples than does 
the calculation of standard confidence limits, because of the need to estimate accurate 
percentage points for the bootstrap distribution, instead of just estimating the mean and 
standard deviation of the bootstrap distribution (Efron & Tibshirani, 1993). In this 
study, the three bootstrap algorithms were applied to bootstrap distributions containing 
1000 samples. It was noticed, however, that 100 random samples gave essentially the 
same results with the standard bootstrap method. The CIs obtained by the three 
bootstrap methods were comparable, because the individual bootstrap distributions were 
approximately normal. In such cases, the standard bootstrap method is clearly the 
simplest method of choice.  
 
In validation studies for alternative methods, the bootstrap distributions of Cooper 
statistics could be used to compare the predictive abilities of different in vitro tests, 
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provided that the different tests have been applied to a common set of chemicals, and 
have been shown to be reproducible. In the case of two in vitro tests (i.e. two CMs), the 
statistics could be compared by using the t-test, whereas in the case of three or more 
PMs, one-way analysis of variance (ANOVA) could be used. In principle, the t-test and 
ANOVA are only applicable to variables that are normally distributed. However, since 
the number of random samples making up each bootstrap distribution can be set at 100 
or more, the Cooper statistics derived from these distributions can be expected to follow 
a normal distribution, in accordance with the central limit theorem. 
 
Another, perhaps more meaningful, application of bootstrap resampling in a validation 
study would be to compare the predictive abilities of individual test methods with a set 
of pre-defined performance criteria. In the ECVAM validation study on in vitro tests for 
skin corrosion (Barratt et al., 1998; Fentem et al., 1998), the management team of the 
study decided that for a given test to be valid, it should correctly identify at least 70% of 
the corrosive chemicals in the test set, i.e. the sensitivity of the test should be ≥ 70%. In 
‘bootstrap language’, this criterion could be expressed as “at least 95% of the bootstrap 
estimates of sensitivity should be greater than or equal to 70%”. To take an example, the 
sensitivity of EPISKIN is 83%, but the 95% CI ranges from 69% to 96% (Table 5.2). It 
turns out, however, that 96% of the values in this range have a sensitivity greater than or 
equal to 70%, so the EPISKIN test could be said to satisfy the ‘bootstrap criterion for 
sensitivity’. Conversely, only 58% of the bootstrap estimates for sensitivity of 
CORROSITEX have a value greater than or equal to 70%, so this test would not satisfy 
the ‘bootstrap criterion for sensitivity’. 
 
Similarly, the Cooper statistics in Table 5.4 show that the four two-step sequences of 
tests all have a sensitivity greater then or equal to 70%. However, it is also apparent that 
the sensitivities of the sequences involving Skin2 and CORROSITEX have lower 95% 
confidence limits that are less than 70%. It turns out that just 55% of the values in 
bootstrap distribution for the sensitivity of the Skin2 sequence are greater than or equal 
to 70%. Similarly, in the case of the CORROSITEX  sequence, just 60% of the values 
are greater than or equal to the threshold value. Thus, neither Skin2 nor CORROSITEX 
used in combination with the pH test could be said to satisfy the ‘bootstrap criterion for 
sensitivity’. 
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5.2.5 Conclusions 
 
In conclusion, the bootstrap resampling method can be used to assess at least some of 
the uncertainty associated with Cooper statistics. It can therefore be used to compare the 
predictive capacities of different CMs with each other, or with benchmark values that 
define an acceptable predictive performance. The standard bootstrap method could be a 
useful tool during the validation of alternative methods and strategies that predict 
toxicological hazard. In particular, it could help judgements to be made when the 
observed Cooper statistics for an alternative method or strategy are only marginally 
better than the acceptance criteria established for the study. The results of this study 
regarding four in vitro tests for skin corrosion concur with those made by the 
management team of an ECVAM validation study. In addition, the results indicate that 
the performances of three tests, the TER, EPISKIN and Skin2 assays, are enhanced 
when they are used in combination with a simple pH test. 
 
5.3 BOOTSTRAP ANALYSIS OF DRAIZE TEST ENDPOINTS 
 
5.3.1 Introduction 
 
As described in chapter 2, the acute dermal and ocular effects of chemicals are generally 
assessed by performing the Draize skin and eye tests, respectively. Since the animal 
data obtained in these tests are used to develop and validate alternative methods for skin 
and eye irritation, it is important to assess the inherent variability of the data, since this 
places an upper limit on the predictive performance that can be expected of any model. 
Therefore, the first objective of the study reported in this section was to estimate the 
variability arising from the use of different animals and time-points, and to use the 
estimates of variability to determine the capacities of the Draize skin and eye irritation 
tests to ‘predict their own results’.  
 
The results of the Draize skin and eye irritation tests are often expressed in terms of the 
PII and the MMAS, respectively. Since these are both composite measures of toxicity, 
derived by averaging specific tissue effects, alternative methods could be designed to 
reproduce the more fundamental endpoints, rather than the more complex ones. 
However, since there may be a certain amount of redundancy between the specific 
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tissue effects, it may be unnecessary to develop models for predicting all of them. 
Therefore, the second objective of this study was to examine the relationships between: 
a) the two skin irritation effects (erythema and œdema) from which the primary 
irritation index (PII) is derived; and b) the six eye irritation effects (conjunctival 
erythema, œdema and discharge; corneal opacity and area; iritis) from which the 
weighted Draize score (WDS) and modified maximum average score (MMAS) are 
derived. 
 
5.3.2 Method 
 
Variability of Draize skin scores 
A data set of 143 chemicals (Table 5.6) was compiled from the ECETOC skin irritation 
data bank (ECETOC, 1995). For each chemical, the Draize skin scores for erythema and 
œdema, obtained at three time-points (24h, 48h & 72h), were entered into an Excel 
spreadsheet. Subsequently, the data were copied into Minitab spreadsheets so that there 
was one Minitab spreadsheet per chemical. The data in each Minitab spreadsheet took 
the following format, with a maximum of 36 columns (2 skin effects x 3 time-points x 6 
rabbits) containing the animal data: 
 
Rabbit 1 Rabbit 2 Rabbit 3 … 
Erythema  Œdema  Erythema  Œdema  
24h 48h 24h 48h 72h 24h 48h 72h 72h 24h 48h 72h    
               
 
A Minitab macro was written (Appendix A7) to bootstrap the tissue scores in this 
format, taking into account the number of rabbits for which there were data. For 
example, if tissue scores are available for three rabbits, each iteration of the macro 
selects, at random and with replacement, 9 erythema and 9 œdema scores. Bootstrap 
estimates of erythema and œdema are then generated by averaging the appropriate set of 
9 scores. The bootstrap estimate of the PII is calculated by adding the bootstrap 
estimates of erythema and œdema, in accordance with Equation 2.1 (see chapter 2). This 
procedure is repeated N times, where N is a number specified by the user. In this study, 
the bootstrap routine was performed 1000 times.  
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The bootstrap estimates of the PII were compared with the ‘conventional’ PII values 
calculated from the sample data, to determine whether any of the sample PII values 
were biased, i.e. needed a correction to better approximate their ‘true’ population mean 
values. 
 
The variability in the erythema, œdema and PII values were measured in terms of the 
bootstrap standard deviation (SD) and the bootstrap coefficient of variation (CV), the 
latter being equal to the bootstrap SD divided by the bootstrap mean. To assess the 
ability of the Draize skin test to ‘predict itself’, a simulation was performed in which 
1000 PII values, taking values from 0 to 8 Draize units, were randomly generated from 
a uniform distribution. From these ‘observed’ PII values, ‘predicted’ PII values were 
generated according to Equation 5.1. 
 
Predicted PII = observed PII + 2 E (Equation 5.1) 
 
where E is the (positive or negative) error, randomly generated from a normal 
distribution with a SD equal to the maximum value of the bootstrap SD. The Pearson 
correlation coefficient (r) and the coefficient of determination (r2) were then calculated 
for the linear relationship between the predicted and the observed PII values. 
 
Relationships between Draize skin endpoints 
To examine the relationships between six skin irritation endpoints (2 types of skin effect 
for each of 3 time-points), a data set of 176 objects (143 chemicals, plus 33 multiple 
observations) was used (Table 5.6). For each object, mean tissue scores were obtained 
by averaging, across all rabbits, the tissue scores for each effect/time-point combination. 
The six skin irritation endpoints were used to construct a matrix plot, and were 
subjected to Spearman correlation analysis.  
 
Variability of Draize eye scores 
A data set of 92 chemicals (Table 5.7) was compiled from the ECETOC eye irritation 
data bank (ECETOC, 1998a). For each chemical, the Draize eye scores for conjunctival 
erythema, œdema and discharge, for corneal opacity and area, and for iritis, obtained at 
three time-points (24h, 48h & 72h), were entered into an Excel spreadsheet. 
Subsequently, the data were copied into Minitab spreadsheets so that there was one 
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Minitab spreadsheet per chemical. The data in each Minitab spreadsheet took the 
following format, with a maximum of 108 columns (6 eye irritation effects x 3 time-
points x 6 rabbits) containing the animal data: 
 
Conjunctival erythema Conjunctival œdema Conjunctival discharge … 
Rabbit 1  Rabbit 2 … Rabbit 1 Rabbit 2 …  
24h 48h 72h    24h 48h 72h   
           
 
A Minitab macro was written (Appendix A8) to bootstrap the tissue scores in this 
format, taking into account the number of rabbits for which there were data. For 
example, if there are three rabbits, each iteration of the macro samples, at random and 
with replacement, 9 scores of each eye effect. Bootstrap estimates of the six eye effects 
are then generated by averaging the appropriate set of 9 scores. The bootstrap estimate 
of the WDS is calculated as a weighted sum of the six endpoints, in accordance with 
Equation 2.2 (see chapter 2). This procedure is repeated N times, where N is a number 
specified by the user. A maximal WDS, intended to provide a theoretical upper limit for 
the MMAS, is estimated by applying Equation 2.2 to the maximal values of the 
bootstrap distributions for the six eye effects.  
 
The variability in the six eye irritation effects and in the WDS was measured in terms of 
the bootstrap SD and CV. To assess the ability of the Draize eye test to ‘predict itself’, a 
simulation was performed in which 1000 WDS values, taking values from 0 to 110, 
were randomly generated from a uniform distribution. From these ‘observed’ WDS 
values, ‘predicted’ WDS values were generated according to Equation 5.2. 
 
Predicted WDS = observed WDS + 2 E (Equation 5.2) 
 
where E is the (positive or negative) error, randomly generated from a normal 
distribution with a SD equal to the maximum value of the bootstrap SD. The correlation 
between the predicted and the observed WDS values was assessed in terms of the 
Pearson correlation coefficient (r) and the coefficient of determination (r2). 
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Relationships between Draize eye endpoints 
To examine the relationships between 18 eye irritation endpoints (6 types of effect for 
each of 3 time-points), a data set of 94 objects (92 chemicals plus two replicates) was 
used. For each object, mean tissue scores were obtained by averaging, across all rabbits, 
the tissue scores for each effect/time-point combination. The 18 eye irritation endpoints 
were used to examine the relationships between: a) the six eye effects (averaged over 
the three time-points); and b) the weighted conjunctival, corneal and iridial endpoints at 
each time-point (see chapter 2 for details of the Draize weighting scheme). 
 
5.3.3 Results 
 
Variability of Draize skin scores 
The results obtained by bootstrapping the Draize skin scores are summarised in Table 
5.6. The bootstrap SD varies from 0 to 1 Draize unit, corresponding to 95% CIs of up to 
± 2 Draize units. The bootstrap CV ranges from 0 to 97%. Very few of the bootstrap 
distributions are skewed, as indicated by the fact that nearly all bootstrap mean values 
are identical to the corresponding median values.  
 
For 23 of the chemicals taken from the ECETOC skin irritation data bank (ECETOC, 
1995), there was more than one data sheet, which meant that more than one set of 
Draize skin scores could be derived. For example, there are four data sheets for hexyl 
salicylate, associated with PII values of 3.4, 3.7, 4.2 and 3.3 (in order of presentation). 
All four data sheets were supplied to ECETOC by the same industrial company. The 
application of one-way ANOVA to the four bootstrap distributions for the PII of hexyl 
salicylate revealed that these values are significantly different (p<0.05). Subsequent 
analysis of the four erythema distributions, and of the four œdema distributions, 
revealed that the variability in the PII of hexyl salicylate is related to the variability in 
œdema, but not erythema. The œdema scores in the fourth data sheet were the least 
variable. The variability in the PII of hexyl salicylate, obtained by bootstrapping the 
tissue scores in the fourth data sheet, is illustrated in Figure 5.3 
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Comparison of the bootstrap estimates of the PII with the PII values calculated from the 
sample data revealed that the PII values for six of the 143 chemicals are biased (Table 
5.8), i.e. there is a difference between the bootstrap PII and the sample PII. This 
suggests that the sample PII values of these six chemicals should be corrected to more 
accurately represent their ‘true’ (population) values (see Table 5.8). The correlation 
between the observed and predicted PII values is illustrated in Figure 5.4; the r value 
was found to be 0.7, which corresponds to an r2 value of 0.57. 
 
Relationships between Draize skin endpoints 
A matrix plot (Figure 5.5) of the six skin endpoints indicates that rectilinear 
relationships exist between the erythema endpoints, and between the œdema endpoints. 
As for the relationship between erythema and œdema at each time-point, it appears that 
any given value of erythema corresponds to a range of œdema values falling below a 
certain threshold. Conversely, for any given œdema value, there appears to be a range of 
œdema values lying above a certain threshold. In other words, if one knows the 
erythema value at a given time-point, one could predict the maximal œdema value at 
that time-point, whereas knowledge of the œdema value would permit prediction of a 
minimal erythema value. 
 
Spearman correlation analysis of the six skin irritation endpoints for 176 observations 
(Table 5.9) revealed that each pairwise combination of variables is significantly 
correlated (p<0.001). In particular, the three erythema variables are highly correlated 
with each other (r = 0.86-0.96), as are the œdema variables (r=0.87-0.94). The 
correlations between the erythema and œdema variables tend to be lower (r=0.74-0.86). 
 
Variability of Draize eye scores 
The results obtained by bootstrapping the Draize eye scores are summarised in Table 
5.7. The bootstrap SD of the WDS varies from 0 to 8 Draize units, corresponding to 
95% CIs of up to ± 16 units. The bootstrap CV of the WDS ranges from 3 to 96%. 
Some of the bootstrap distributions are skewed, as indicated by the fact that their mean 
values differ from their median values.  
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The maximal WDS, obtained by bootstrap resampling 1000 times, was generally found 
to be greater than or equal to the MMAS, calculated from original sample data. 
However, contrary to expectation, for 9 chemicals (shaded in Table 5.7), the maximal 
WDS was slightly smaller than the MMAS. The tissue scores for these chemicals were 
therefore bootstrapped again, this time by randomly sampling 5000 times. In each case, 
this resulted in the maximal WDS being equal to the MMAS. The fact that the number 
of bootstrap samples needed to be increased for the MMAS values of these chemicals to 
fall within the range of their resampled WDS is an indication of how unrepresentative 
their MMAS values are. In other words, the MMAS for these chemicals is calculated 
from a set of tissue scores that has a small probability of being selected during the 
bootstrapping procedure.   
 
In the cases of two chemicals (xylene and methyl amyl ketone) taken from the eye 
irritation data bank (ECETOC, 1998a), there was more than one data sheet, which 
meant that more than one set of Draize eye scores could be derived. For example, the 
two data sheets for heptanone (methyl amyl ketone), correspond to mean WDS values 
of 4.7 and 7.5, respectively. The application of t-tests (for independent samples) to the 
two bootstrap distributions for the WDS revealed that these values are significantly 
different (p<0.05). Analysis of the unpaired distributions for the six eye effects showed 
that the difference between the two WDS values is related to differences in the 
assessment of conjunctival effects (erythema, œdema and discharge). However, there 
are no significant differences, between the two data sheets, in the assessments of corneal 
effects (opacity and area) and iritis. The tissue scores in the first data sheet are more 
variable than those in the second. The bootstrap distribution of the WDS for heptanone, 
obtained using the data in the second data sheet, is illustrated in Figure 5.6. The 
correlation between the observed and predicted WDS values is illustrated in Figure 5.7; 
the r value was found to be 0.90, which corresponds to an r2 value of 0.81. 
 
Relationships between Draize eye endpoints 
A matrix plot (Figure 5.8) of the six eye irritation effects, in which each effect is 
averaged over three time-points and all rabbits in the experimental group, indicates that 
while there is relatively little scatter between the three conjunctival effects (erythema, 
œdema and discharge), the scatter is more pronounced between the two corneal effects 
(opacity and area), and between iritis and all other effects. Spearman correlation 
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analysis (Table 5.10) revealed that each pairwise combination of effects is significantly 
correlated (r ≥ 0.75; p<0.01).  
 
A matrix plot (Figure 5.9) of the weighted tissue scores for the conjunctiva, cornea and 
iris, in which each weighted score is averaged over all rabbits separately for each time-
point, indicates that rectilinear relationships exist between the weighted conjunctival 
scores, and between the weighted corneal scores, obtained at the three time-points. 
However, the scatter between the weighted iris scores is so great that no relationship can 
be ascertained. Spearman correlation analysis (Table 5.11) revealed that the three 
conjunctival endpoints are strongly and significantly correlated (r=0.85-0.90; p<0.01), 
as are the three corneal endpoints (r=0.86-0.93; p<0.01). The correlations between the 
three iridial endpoints are slighly weaker (r=0.67-0.85), albeit statistically significant 
(p<0.01).  
 
The WDS for each time-point was calculated by summing the weighted conjunctival, 
corneal and iridial scores for the same time-point. The matrix plot in Figure 5.10 and the 
Spearman correlations in Table 5.12 show that these are strongly and significantly 
related (0.86-0.99; p<0.01), with each other and with the maximal value of the WDS, 
obtained at any of the three time-points. Furthermore, the strongest correlation is 
between the WDS obtained at 24h and the maximal WDS, suggesting that most of the 
chemicals investigated exert their maximal effects in the rabbit eye within the 24 hours 
following exposure. 
 
5.3.4 Discussion 
 
The PII and the MMAS are both composite measures of acute local toxicity in that they 
are derived from two or more ‘fundamental’ types of tissue effect. It is interesting to 
note, however, that the two measures are based on a different rationale. The PII is 
intended to reflect an average skin effect, where the average is taken over three time-
points and over all rabbits in an experimental group. In contrast, the MMAS is intended 
to reflect the maximal value of the WDS that can be obtained at any time-point. The 
reason for the different rationale may be that toxicologists are interested in the worst 
possible effects of chemicals, when assessing eye irritation, but are satisfied with the 
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more representative, mean effect when assessing skin irritation Alternatively, the 
different rationale may be based on nothing more than historical precedent.  
 
A more consistent approach to the assessment of acute local toxicity would be to use the 
PII (which by definition is an average over three time-points and all rabbits) and the 
mean WDS (i.e. the WDS averaged over three time-points and all rabbits). In fact, the 
variability of the Draize eye test, which has been widely commented on (e.g. Earl et al., 
1997) may in part be due to the fact the MMAS is unrepresentative of the spectrum of 
possible WDS values. The use of bootstrap resampling to explore the variability in the 
WDS shows that the MMAS is a value located towards the far end of the right tail of the 
bootstrap distribution. In the case of a few chemicals, the MMAS was so extreme that 
resampling had to be carried out 5000 times to be captured within the bootstrap 
distribution. Another criticism of the MMAS (and the WDS) is the Draize weighting 
scheme itself - since corneal effects account for 80 out of a total of 110 Draize units, the 
variability in the corneal scores is amplified. The use of an alternative measure of eye 
irritation, based on an unweighted sum of tissue effects, would be analogous to the use 
of the PII for skin irritation. 
 
In this study, the SD associated with the PII was found to range from 0 to 1 Draize 
units, whereas the SD associated with the WDS was found to be as large as 8 Draize 
units. These values reflect the variability in the Draize skin and eye tests arising from 
the use of different animals and time-points within a single experiment, and not from 
differences within or between laboratories, which are expected to result in larger 
variabilities. Indeed, in a study of the intra-laboratory results of four chemicals, Blein et 
al. (1991) reported SDs for the MMAS of 0-14, and in a study of the inter-laboratory 
variability of nine chemicals, Weil & Scala (1971) reported SD values for the MMAS of 
0-30. Thus, the results of this study can be considered to reflect the minimal variability 
inherent in the Draize skin and eye tests.  
 
Using the bootstrap SD values to simulate the abilities of the skin and eye tests to 
predict their own results, the skin test predicted the PII with an r2 of 0.57, and the eye 
test predicted the mean WDS with an r2 of 0.81. These values define upper limits to the 
performances of models for the PII and the WDS (and presumably the MMAS), 
respectively. Thus, if a model for the PII has an r2 greater than 0.57, it is probably over-
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fitting its training set. Similarly, the best possible model for the WDS is expected to 
have an r2 of 0.81. 
 
In the case of a few chemicals, multiple data sheets of tissue scores were available in the 
ECETOC reports, so analysis of the bootstrap distributions has enabled conclusions to 
be drawn about the source of intra-laboratory variability, in terms of observations on 
specific tissues. For example, it has been shown that the significant intra-laboratory 
variability between two independent measurements of the PII of hexyl salicylate is 
related to the variability in assessments of œdema, but not erythema. 
 
Finally, it should be noted that the bootstrap distributions of Draize tissue scores can 
also be used to determine the certainty with which chemicals have been classified on the 
basis of animal data, which is especially useful in the case of borderline chemicals. For 
example, in a comparison of the EU and OECD systems for classifying eye irritants, it 
was noted that ethanol is classified as a non-irritant by the EU system, but as an irritant 
by the OECD system (Prinsen, 1999). The reason is that there are differences between 
the EU and OECD systems in the cut-off values for conjunctival erythema and corneal 
opacity (see chapter 2). In the EU system, a chemical is classified as an eye irritant if its 
conjunctival erythema ≥ 2.5, or if its corneal opacity ≥ 2, whereas in the OECD system, 
the lower thresholds of 2.0 and 1.0 are used for erythema and opacity, respectively. The 
bootstrap resampling of the tissue scores for ethanol generated bootstrap mean values of 
2.1 and 1.1 for erythema and opacity, respectively. While these values just exceed the 
OECD cut-offs, they fall short of the EU cut-offs. Examination of the bootstrap 
distributions for ethanol revealed that 76% of the bootstrap estimates of erythema and 
opacity were greater than or equal to the OECD thresholds, whereas only 0.5% of the 
erythema estimates, and 0% of the opacity estimates, were greater than or equal to the 
EU thresholds. The identification of borderline chemicals (in terms of the boundaries 
imposed by a particular classification system) could be useful in the selection of 
validation study test chemicals, and in the definition of ‘reference standards’, i.e. 
chemicals of known toxic potency that are tested alongside chemicals of unknown 
potency with a view to rank ordering the test chemicals.      
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5.3.5 Conclusions 
 
On the basis of the results obtained in this study, it is concluded that: 
 
1) the bootstrap resampling of Draize tissue scores provides a useful means of 
exploring the variability resulting from the use of different animals (biological 
variability) and time-points (temporal variability); 
2) since tissue effects at different time-points are strongly correlated, it appears that 
most of the variability results from the use of different animals; 
3) the bootstrap distributions of Draize tissue scores can be used to assess the certainty 
with which chemicals have been classified; 
4) the Draize skin test could be refined by assessing œdema and erythema at the 24-
hour time-point only; 
5) the variability in Draize skin scores is such that no model for predicting the PII can 
be expected to have an r2 greater than 0.57; 
6) the use of a mean WDS in the Draize eye test would provide a more representative 
composite measure of eye irritation than the MMAS; 
7) the Draize eye test could be refined by assessing the conjunctival effects (erythema, 
œdema and discharge) and the corneal effects (opacity and area) at the 24-hour 
time-point only; it is unclear when the iris lesion should be assessed (if at all), since 
the correlations for this effect are associated with more scatter; 
8) the variability in Draize eye scores is such that no model for predicting the WDS or 
MMAS can be expected to have an r2 greater than 0.81. 
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Figure 5.1 Bootstrap distribution of the concordance of the EPISKIN test for 
   skin corrosion 
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Figure 5.2 Cumulative probability distribution of the concordance of the 
  EPISKIN test for skin corrosion 
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Figure 5.3 Bootstrap distribution of the primary irritation index of hexyl  
salicylate 
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Figure 5.4 Simulation of the ability of the Draize skin test to ‘predict itself’ 
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Figure 5.5 Matrix plot of 6 skin irritation endpoints obtained in the Draize 
skin test 
 
 
 
 
Footnote to Figure 5.5 
ERYTH_24 = erythema at 24h; ERYTH_48 = erythema at 48h; ERYTH_72 = erythema at 78h; 
OEDEM_24 = œdema at 24h; OEDEM_48 = œdema at 48h; OEDEM_72 = œdema at 72h. 
 
Each tissue score is a mean value, taken over all rabbits in the experimental group. 
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Figure 5.6 Bootstrap distribution of the weighted Draize score of heptanone 
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Figure 5.7 Simulation of the ability of the Draize eye test to ‘predict itself’ 
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Figure 5.8 Matrix plot of 6 eye irritation effects determined in the Draize eye  
test 
 
 
 
 
Footnote to Figure 5.8 
ERYTHEMA = conjunctival erythema (redness); OEDEMA = conjunctival œdema (chemosis); 
DISCHARG = conjunctival discharge; OPACITY = corneal opacity; AREA = area corneal 
lesion; IRITIS = iris lesion. 
 
Each tissue score is a mean value, taken over three time-points and all rabbits in the 
experimental group. 
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Figure 5.9 Matrix plot of 9 weighted tissue scores obtained in the Draize eye 
test 
 
 
 
 
Footnote to Figure 5.9 
WT_CONJ1 = weighted conjunctival score (2 x erythema x œdema x discharge) at 24h 
WT_CONJ2 = weighted conjunctival score (2 x erythema x œdema x discharge) at 48h 
WT_CONJ3 = weighted conjunctival score (2 x erythema x œdema x discharge) at 72h 
WT_CORN1 = weighted cornea score (5 x opacity x area) at 24h 
WT_CORN2 = weighted cornea score (5 x opacity x area) at 48h 
WT_CORN3 = weighted cornea score (5 x opacity x area) at 72h 
WT_IRIS1 = weighted iris score (5 x iritis) at 24h 
WT_IRIS2 = weighted iris score (5 x iritis) at 48h 
WT_IRIS3 = weighted iris score (5 x iritis) at 72h 
 
 
Each tissue score is a mean value, taken over all rabbits in the experimental group. 
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Figure 5.10 Matrix plot of 4 weighted tissue scores obtained in the Draize eye 
test 
 
 
 
 
 
Footnote to Figure 5.10 
WDS1 = weighted Draize score at 24h 
WDS2 = weighted Draize score at 48h 
WDS3 = weighted Draize score at 72h 
MAX_WDS = maximal value of the WDS obtained at any of the three time-points. 
 
The weighted Draize score is the sum of weighted conjunctival, corneal and iritis scores (see 
chapter 2) 
 
Each tissue score is a mean value, taken over all rabbits in the experimental group. 
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Table 5.1 In vitro and in vivo classifications of skin corrosion potential for 60  
chemicals 
 
 
CHEMICAL PREDICTED CLASSIFICATIONa IN VIVO
No Name pH TER EPISKIN Skin2 CORROSITEX CLASSb
             
1 Hexanoic acid C C C C NC C 
2 1,2-Diaminopropane C C C C C C 
3 Carvacrol NC C C NC NQ C 
4 Boron trifluoride dihydrate C C C C C C 
5 Methacrolein NC NC C C NC C 
6 Phenethyl bromide NC NC NC NC NQ NC 
7 3,3'-Dithiodipropionic acid NC NC NC NC NC NC 
8 Isopropanol NC NC NC NC NQ NC 
9 2-Methoxyphenol (guaiacol) NC NC C NC NQ NC 
10 2,4-Xylidine (2,4-dimethylaniline) NC C C NC NC NC 
11 2-Phenylethanol (phenylethyl alcohol) NC NC NC NC NQ NC 
12 Dodecanoic (lauric) acid  NC NC NC NC NQ NC 
13 3-Methoxypropylamine C C C C C C 
14 Allyl bromide NC C C NC NC C 
15 Dimethyldipropylenetriamine NC C C C C C 
16 Methyl trimethylacetate NC NC NC NC NQ NC 
17 Dimethylisopropylamine C C C C C C 
18 Potassium hydroxide (10% aq.) C C C C C C 
19 Tetrachloroethylene NC NC NC NC NC NC 
20 Ferric [iron (III)] chloride C C C NC C C 
21 Potassium hydroxide (5% aq.) C C C NC C NC 
22 Butyl propionate NC NC NC NC NQ NC 
23 2-tert-Butylphenol NC C C C NQ C 
24 Sodium carbonate (50% aq.) NC C NC NC C NC 
25 Sulphuric acid (10% wt.) C C C NC C C  
26 Isostearic acid NC NC NC NC NQ NC 
27 Methyl palmitate NC NC NC NC NQ NC 
28 Phosphorus tribromide C C C C C C 
29 65/35 Octanoic/decanoic acids NC C C NC NC C 
30 4,4'-Methylene-bis-(2,6-
ditertbutylphenol) 
NC NC NC NC NQ NC 
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Table 5.1 continued 
 
 CHEMICAL PREDICTED CLASSIFICATIONa IN VIVO
No Name pH TER EPISKIN Skin2 CORROSITEX CLASSb
             
31 2-Bromobutane NC C NC NC NQ NC 
32 Phosphorus pentachloride C C C C C C 
33 4-(Methylthio)-benzaldehyde NC NC NC NC NQ NC 
34 70/30 Oleine/octanoic acid NC NC NC NC NC NC 
35 Hydrogenated tallow amine NC NC NC NC NC NC 
36 2-Methylbutyric acid NC C C NC C C 
37 Sodium undecylenate (34% aq.) NC C C NC NC NC 
38 Tallow amine NC C NC NC NC C 
39 2-Ethoxyethyl methacrylate NC NC NC NC NQ NC 
40 Octanoic acid (caprylic acid) NC C C NC NC C 
41 20/80 Coconut/palm soap NC NC NC NC NC NC 
42 2-Mercaptoethanol, Na salt (46% aq.) C C NC NC C C 
43 Hydrochloric acid (14.4% wt.) C C C NC C C 
44 Benzyl acetone NC NC NC NC NQ NC 
45 Heptylamine C C NC C C C 
46 Cinnamaldehyde NC NC NC NC NC NC 
47 60/40 Octanoic/decanoic acids NC C C NC NC C 
48 Glycol bromoacetate (85%) C NC C C C C 
49 Eugenol NC NC NC NC NQ NC 
50 55/45 Octanoic/decanoic acids NC C C NC NC C 
51 Methyl laurate NC NC NC NC NQ NC 
52 Sodium bicarbonate NC C NC NC NC NC 
53 Sulphamic acid C C C NC C NC 
54 Sodium bisulphite NC C NC NC NC NC 
55 1-(2-Aminoethyl)piperazine C C NC NC C C 
56 1,9-Decadiene NC NC NC NC NQ NC 
57 Phosphoric acid C C C NC C C 
58 10-Undecenoic acid NC NC C NC NC NC 
59 4-Amino-1,2,4-triazole NC NC NC NC NQ NC 
60 Sodium lauryl sulphate (20% aq.) NC C NC NC NQ NC 
 
Footnote to Table 5.1 
aFor the pH test, predicted classifications were taken from Worth et al. (1998); for the four in 
vitro tests, the most frequently occurring in vitro classification, made across laboratories and 
runs, was taken from Fentem et al. (1998); bBased on the application of European Union 
classification criteria to Draize test data. 
 
C = corrosive; NC = non-corrosive; NQ = non-qualifying chemical; TER = transcutaneous 
electrical resistance assay. 
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Table 5.2 Predictive abilities (%) of the TER, EPISKIN, Skin2 and 
CORROSITEX tests calculated by the standard bootstrap method 
 
 
 
In vitro test Cooper 
statistic 
Bootstrap estimatesa Estimate 
from 
original 
data setb 
Bias Bias-
corrected 
estimate  
Mean 
value 
Lower 
limit 
Upper 
limit 
 
        
TER concordance 78 69 87 79 -1 80 
 sensitivity 87 76 97 88 -1 89 
 specificity 71 57 85  72 -1 73 
 false positives 29 15 43 28 1 27 
 false negatives 13 3 24 12 1 11 
        
EPISKIN concordance 81 73 90 81 0 81 
 sensitivity 83 69 96 83 0 83 
 specificity 80 69 91 80 0 80 
 false positives 20 9 31 20 0 20 
 false negatives 17 4 31 17 0 17 
        
Skin2 concordance 75 64 86 74 1 73 
 sensitivity 45 27 63 43 2 41 
 specificity 100 100 100 100 0 100 
 false positives 0 0 0 0 0 0 
 false negatives 55 37 73 57 -2 59 
        
CORROSITEX concordance 73 60 87 73 0 73 
 sensitivity 71 55 88 71 0 71 
 specificity 76 55 98 76 0 76 
 false positives 24 2 45 24 0 24 
 false negatives 29 12 45 29 0 45 
 
 
Footnote  to Table 5.2 
aEach set of bootstrap estimates (mean, lower value, upper value) is calculated from a bootstrap 
distribution based on 1000 random samples taken from the original data set of 60 chemicals. 
 
bThe set of 60 test chemicals used in the ECVAM Skin Corrosivity Validation Study (Fentem et 
al., 1998). 
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Table 5.3 Predictive abilities (%) of the TER, EPISKIN, Skin2 and CORROSITEX tests calculated by the simple and bias- 
  corrected percentile bootstrap methods 
 
In vitro test Cooper 
statistic 
Bootstrap estimatesa 
Simple percentile method Bias-corrected percentile method 
Median 
value 
Lower 
limitb 
Upper 
limitc 
Lower 
percentile 
Lower 
limit 
Upper 
percentile 
Upper 
limit 
         
TER concordance 78 68 86 0.044 69 0.987 88 
 sensitivity 87 75 95 0.061 78 0.991 96 
 specificity 72 56 83  0.033 57 0.981 85 
 false positives 28 17 44 0.019 15 0.967 43 
 false negatives 13 5 25 0.009 4 0.941 22 
         
EPISKIN concordance 81 72 89 0.020 71 0.969 89 
 sensitivity 83 68 95 0.028 69 0.978 95 
 specificity 80 68 91 0.027 68 0.977 91 
 false positives 20 9 32 0.024 9 0.974 32 
 false negatives 17 5 32 0.022 5 0.972 31 
         
Skin2 concordance 75 64 85 0.009 61 0.941 83 
 sensitivity 46 27 63 0.007 22 0.930 59 
 specificity 100 100 100 d d d d 
 false positives 0 0 0 d d d d 
 false negatives 54 37 73 0.073 42 0.993 80 
         
CORROSITEX concordance 73 60 86 0.020 59 0.969 85 
 sensitivity 72 53 86 0.016 52 0.962 85 
 specificity 76 55 97 0.020 53 0.970 97 
 false positives 24 3 45 0.030 3 0.980 47 
 false negatives 28 14 47 0.038 15 0.984 48 
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Footnote to Table 5.3 
 
aEach set of bootstrap estimates (median, lower value, upper value) is calculated from a bootstrap distribution based on 1000 random samples taken 
from the original data set of 60 chemicals. 
bBased on the 2.5th percentile (0.025) of the bootstrap distribution. 
cBased on the 97.5th percentile (0.975) of the bootstrap distribution. 
dThe bias-corrected percentile method does not work because the proportion of bootstrap estimates exceeding the specificity or false positive rate 
calculated from the original sample is 0. The inverse cumulative probability function is not defined for a probability of 0.  
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Table 5.4 Predictive abilities (%) of four two-step sequences, calculated by the standard  
bootstrap method 
 
Sequence of 
in vitro tests 
Cooper statistic Bootstrap estimatesa Estimate from 
original 
data setb 
Bias Bias-corrected 
estimate Mean 
value 
Lower 
limit 
Upper 
limit 
        
Sequence 1c concordance 83 74 93 83 0 83 
 sensitivity 96 89 100 96 0 96 
 specificity 73 58 88 73 0 73 
 false positives 27 12 42 27 0 27 
 false negatives 4 0 11 4 0 4 
        
Sequence 2d concordance 88 80 96 88 0 88 
 sensitivity 96 89 100 96 0 96 
 specificity 82 69 94 82 0 82 
 false positives 18 6 31 18 0 18 
 false negatives 4 0 11 4 0 4 
        
Sequence 3e concordance 83 74 93 83 0 83 
 sensitivity 70 53 88 70 0 70 
 specificity 94 86 100 94 0 94 
 false positives 6 0 14 6 0 6 
 false negatives 30 12 47 30 0 30 
        
Sequence 4f concordance 74 60 88 74 0 74 
 sensitivity 72 54 90 72 0 72 
 specificity 78 54 100 78 0 78 
 false positives 22 0 46 21 1 20 
 false negatives 28 10 46 28 0 28 
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Footnote to Table 5.4 
aEach set of bootstrap estimates (mean, lower value, upper value) is calculated from a bootstrap distribution based on 1000 random samples taken from 
the original data set of 60 chemicals. 
bThe set of 60 test chemicals used in the ECVAM Skin Corrosivity Validation Study. 
cBased on the sequential application of the pH test and the TER assay. 
dBased on the sequential application of the pH test and the EPISKIN assay. 
eBased on the sequential application of the pH test and the Skin2 assay. 
f Based on the sequential application of the pH test and the CORROSITEX assay. 
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Table 5.5 Comparison between the stand-alone and sequential use of each 
  alternative test  
 
In vitro test Cooper 
statistic 
Bootstrap mean estimates Significant 
differenceb ? Stand-alone test Sequencea
     
TER concordance 78 83 yes 
 sensitivity 87 96 yes 
 specificity 71 73 yes 
 false positives 29 27 yes 
 false negatives 13 4 yes 
     
EPISKIN concordance 81 88 yes 
 sensitivity 83 96 yes 
 specificity 80 82 yes 
 false positives 20 18 yes 
 false negatives 17 4 yes 
     
Skin2 concordance 75 83 yes 
 sensitivity 45 70 yes 
 specificity 100 94 yes 
 false positives 0 6 yes 
 false negatives 55 30 yes 
     
CORROSITEX concordance 73 74 no 
 sensitivity 71 72 no 
 specificity 76 78 yes 
 false positives 24 22 yes 
 false negatives 29 28 no 
 
 
Footnote to Table 5.5 
 
aStatistics refer to the use of each in vitro test in sequence with the pH test 
bAs judged by a t-test for independent samples (p<0.01), applied to the appropriate bootstrap 
distributions. 
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Table 5.6 Skin irritation data for 143 chemicals  
 
Chemical PIIa PIIb    Erythemab Œdemab 
No Name  mean median SD CV mean SD mean SD 
           
1 2-Methylbutyric acid >4 5.0 5.0 0.2 4.5 2.3 0.1 2.7 0.2 
2 10-Undecenoic Acid 2.4 2.4 2.4 0.2 6.8 1.8 0.1 0.6 0.1 
3 Ethyltriglycol methacrylate 0.2 0.2 0.2 0.1 61.1 0.2 0.1 0.0 0.0 
4 Ethylthioethyl methacrylate 0.6 0.6 0.6 0.2 28.7 0.6 0.2 0.0 0.0 
5 2-Ethoxyethyl methacrylate 1.6 1.6 1.6 0.2 10.9 1.6 0.2 0.0 0.0 
6 2-Methoxyethyl acrylate NG 7.1 7.2 0.7 9.7 3.6 0.3 3.5 0.4 
7 Benzyl alcohol [1] 1.6 1.6 1.6 0.3 17.5 1.3 0.2 0.2 0.1 
7 Benzyl alcohol [2] 1.8 1.8 1.8 0.2 12.1 1.4 0.1 0.4 0.1 
8a dl-Citronellol [1] 4.2 4.2 4.2 0.1 3.4 2.0 0.0 2.2 0.1 
8b dl-Citronellol [2] 4.0 4.0 4.0 0.2 5.9 2.0 0.0 2.0 0.2 
8c dl-Citronellol [3] 3.7 3.3 3.3 0.2 6.4 2.2 0.1 1.2 0.2 
9 Decanol 3.3 3.3 3.3 0.2 6.0 2.2 0.1 1.2 0.1 
10a Dihydromercenol [1] 3.7 1.6 1.6 0.2 14.4 1.3 0.2 0.2 0.1 
10b Dihydromercenol [2] 2.0 2.0 2.0 0.3 14.8 1.5 0.1 0.5 0.2 
11 2,6-Dimethyl-4-heptanol 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
12a Dipropylene glycol [1] 0.3 0.3 0.3 0.2 47.3 0.3 0.2 0.0 0.0 
12b Dipropylene glycol [2] 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
13a Geraniol [1] 3.7 3.7 3.7 0.2 4.3 2.0 0.0 1.7 0.2 
13b Geraniol [2] 3.3 3.3 3.3 0.3 9.1 2.1 0.1 1.2 0.2 
13c Geraniol [3] 2.9 2.9 2.9 0.1 4.8 1.9 0.1 1.0 0.1 
14 Geranyl dihydrolinalol 2.3 2.3 2.3 0.2 7.4 1.4 0.1 0.8 0.1 
15 Geranyl linalol 4.3 4.3 4.3 0.2 3.6 2.2 0.1 2.1 0.1 
16 α-Ionol 1.3 1.3 1.3 0.2 13.5 0.9 0.1 0.4 0.1 
17 β-Ionol 1.9 1.9 1.9 0.2 9.0 1.2 0.1 0.7 0.1 
18a Linalol [1] 3.3 3.3 3.3 0.2 6.6 1.9 0.1 1.9 0.1 
18b Linalol [2] 3.4 3.4 3.4 0.1 4.2 2.0 0.0 1.4 0.1 
18c Linalol [3] 2.1 2.1 2.1 0.2 11.5 1.7 0.1 0.4 0.1 
19 p-Mentha-1,8-dien-7-ol 3.3 3.3 3.3 0.2 5.8 2.0 0.0 1.3 0.2 
20 2-Methyl-4-phenyl-2-butanol 1.6 1.6 1.6 0.2 12.4 1.3 0.1 0.3 0.1 
21 Phenylethyl alcohol [1] 2.2 2.2 2.2 0.3 12.1 1.6 0.2 0.7 0.2 
21b Phenylethyl alcohol [2] 0.9 0.9 0.9 0.2 20.3 0.7 0.1 0.2 0.1 
22 Isopropanol 0.8 0.8 0.8 0.3 33.8 0.8 0.3 0.0 0.0 
23 Isostearyl alcohol 2.6 2.6 2.6 0.4 16.4 1.6 0.2 1.0 0.3 
24a α-Terpineol [1] 4.4 4.4 4.4 0.3 6.2 2.0 0.2 2.4 0.2 
24b α-Terpineol [2] 4.8 4.7 4.8 0.2 4.3 2.2 0.1 2.6 0.2 
24c α-Terpineol [3] 4.0 4.0 4.0 0.3 8.1 1.9 0.1 2.1 0.3 
25 p-tert-Butyl 
dihydrocinnamaldehyde 
2.4 2.4 2.4 0.4 15.1 1.6 0.2 0.8 0.2 
26 Isobutyraldehyde 0.1 0.1 0.1 0.1 49.4 0.1 0.1 0.0 0.0 
27 Cinnamaldehyde 3.7 3.7 3.7 0.2 4.2 2.0 0.0 1.7 0.1 
28 Citrathal 3.6 3.6 3.6 0.2 6.3 2.0 0.0 1.7 0.2 
29a Cyclamen aldehyde [1] 5.1 5.1 5.1 0.2 3.6 2.2 0.1 2.9 0.1 
29b Cyclamen aldehyde [2] 4.2 4.2 4.2 0.2 3.9 2.0 0.0 2.2 0.2 
29c Cyclamen aldehyde [3] 4.8 4.6 4.6 0.2 3.7 2.0 0.0 2.6 0.2 
29d Cyclamen aldehyde [4] 3.4 3.4 3.4 0.1 4.0 2.0 0.0 1.4 0.1 
30 2,4-Decadienal 4.8 4.8 4.8 0.2 5.0 2.3 0.1 2.5 0.2 
31 2,4-Dimethyl-3-cyclohexene-1-
carboxaldehyde 
3.2 3.2 3.2 0.1 3.3 2.0 0.0 1.2 0.1 
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Table 5.6 continued  
 
Chemical PIIa PIIb    Erythemab Œdemab 
No Name  mean median SD CV mean SD mean SD 
           
32 3,7-Dimethyl-2,6-nondien-1-al 
(Ethyl citral) 
3.8 3.8 3.8 0.1 2.9 2.0 0.0 1.8 0.1 
33 2,4-Dimethyltetrahydro 
benzaldehyde 
2.8 2.8 2.8 0.2 8.2 1.9 0.1 0.9 0.2 
34 2-Ethylhexanal 3.9 3.9 3.9 0.1 3.6 2.0 0.0 1.9 0.1 
35 Heptanal 5.0 5.0 5.0 0.2 4.9 3.0 0.2 2.0 0.1 
36 2,4-Hexadienal 7.1 7.1 7.1 0.2 2.6 3.6 0.1 3.5 0.1 
37a α-Hexyl cinnamic aldehyde [1] 4.0 4.0 4.0 0.2 5.4 2.0 0.0 2.0 0.2 
37b α-Hexyl cinnamic aldehyde [2] 4.0 4.0 4.0 0.1 2.8 2.0 0.0 2.0 0.0 
37c α-Hexyl cinnamic aldehyde [3] 2.6 2.6 2.6 0.2 8.5 1.8 0.1 0.8 0.1 
38 Hydroxycitronellal [1] 1.1 1.1 1.1 0.2 16.2 0.9 0.1 0.2 0.1 
38 Hydroxycitronellal [2] 0.9 0.9 0.9 0.2 26.8 0.8 0.2 0.1 0.1 
39a Lilestralis (lilial) [1] 4.6 4.6 4.6 0.3 6.0 2.0 0.2 2.6 0.2 
39b Lilestralis (lilial) [2] 3.6 3.6 3.6 0.2 6.1 1.9 0.1 1.7 0.2 
40 3-Methylbutyraldehyde 2.8 2.8 2.9 0.3 11.6 1.6 0.2 1.3 0.2 
41 2,5-Methylene-6-propyl-3-cyclo-
hexen-carbaldehyde 
2.4 2.4 2.4 0.2 9.6 1.8 0.1 0.6 0.2 
42 Nonanal 3.5 3.4 3.5 0.2 4.7 2.0 0.0 1.4 0.1 
43 2-Phenylpropionaldehyde 2.9 2.9 2.9 0.2 5.9 2.0 0.0 0.9 0.2 
44 p-Isopropylphenylacetaldehyde 2.3 2.3 2.3 0.4 19.0 1.3 0.2 0.9 0.3 
45 Salicylaldehyde 2.5 2.5 2.5 0.3 11.9 1.5 0.1 1.0 0.2 
46 Tetrahydrogeranial 2.6 2.6 2.6 0.2 6.2 1.9 0.1 0.7 0.1 
47 4-Tricyclo-decylindene-8-butanal 3.3 3.3 3.3 0.3 9.9 2.1 0.1 1.2 0.3 
48 Methacrolein 4.1 4.1 4.1 0.2 4.5 2.0 0.0 2.1 0.2 
49 Erucamide 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
50 N,N-Diethylaminopropylamine NG c c c c c c c c 
51 N,N-Dimethylbenzylamine NG c c c c c c c c 
52 Dimethylbutylamine 5.1 5.1 5.1 0.1 1.4 4.0 0.0 1.1 0.1 
53 Dimethylisopropylamine 5.6 5.6 5.6 0.1 2.5 4.0 0.0 1.6 0.1 
54 Dimethyldipropylenetriamine  NG c c c c c c c c 
55 Heptylamine 6.7 6.7 6.7 0.3 4.4 4.0 0.0 2.7 0.3 
56 3-Methoxypropylamine 6.7 6.7 6.7 0.3 4.1 4.0 0.0 2.7 0.3 
57 Oleyl propylene diamine dioleate 3.7 3.7 3.7 0.7 20.0 2.1 0.3 1.5 0.5 
58 2,4-Xylidine 1.4 1.4 1.4 0.2 11.6 1.0 0.0 0.4 0.2 
59 Allyl bromide 7.2 7.2 7.2 0.3 3.9 4.0 0.0 3.2 0.3 
60 2-Bromobutane 2.4 2.5 2.4 0.4 14.6 1.8 0.1 0.7 0.3 
61 1-Bromo-4-chlorobutane 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
62 1-Bromo-2-chloroethane 2.3 2.3 2.3 0.4 15.7 1.8 0.1 0.5 0.3 
63 1-Bromo-4-fluorobenzene 0.3 0.3 0.3 0.2 47.1 0.3 0.2 0.0 0.0 
64 1-Bromohexane 4.0 4.0 4.0 0.4 9.7 2.4 0.2 2.4 0.2 
65 1-Bromopentane 4.4 4.5 4.4 0.8 18.0 2.7 0.3 1.8 0.6 
66 2-Bromopropane 1.4 1.4 1.4 0.2 15.8 1.4 0.2 0.0 0.0 
67 1,6-Dibromohexane 0.9 0.9 0.9 0.2 27.5 0.9 0.2 0.0 0.0 
68 1,3-Dibromopropane 1.9 1.9 1.9 0.1 5.5 1.9 0.1 0.0 0.0 
69 Phenethyl bromide 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
70 Dichloromethane 5.7 5.7 5.7 0.2 2.7 4.0 0.0 1.7 0.2 
71 Tetrachloroethylene 5.7 5.7 5.7 0.2 3.9 4.0 0.0 1.7 0.2 
72 1,1,1-Trichloroethane 5.2 5.2 5.2 0.4 8.3 3.7 0.3 1.5 0.2 
73 Trichloroethylene 5.4 5.4 5.4 0.2 3.1 4.0 0.0 1.4 0.2 
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Table 5.6 continued 
 
Chemical PIIa PIIb    Erythemab Œdemab 
No Name  mean median SD CV mean SD mean SD 
           
74 Allyl heptanoate 2.1 2.1 2.1 0.2 7.7 1.7 0.1 0.4 0.1 
75 Allyl phenoxyacetate 0.4 0.4 0.4 0.1 28.1 0.3 0.1 0.1 0.1 
76a Benzyl acetate [1] 1.6 1.6 1.6 0.4 26.6 1.0 0.3 0.6 0.2 
76b Benzyl acetate [2] 0.8 0.8 0.8 0.2 23.9 0.8 0.2 0.0 0.0 
77a Benzyl benzoate [1] 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
77b Benzyl benzoate [2] 1.6 1.1 1.1 0.3 29.1 0.9 0.2 0.2 0.1 
78a Benzyl salicylate [1] 0.3 0.3 0.3 0.2 46.7 0.3 0.2 0.0 0.0 
78b Benzyl salicylate [2] 0.8 0.7 0.8 0.2 23.6 0.6 0.1 0.2 0.1 
79a Isobornyl acetate [1] 3.9 3.9 3.9 0.1 0.0 1.9 0.1 2.0 0.0 
79b Isobornyl acetate [2] 3.5 3.5 3.5 0.2 5.3 1.9 0.1 1.6 0.1 
80 Butyl propionate 1.1 1.1 1.1 0.1 13.3 1.1 0.1 0.0 0.0 
81a Diethyl phthalate [1] 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
81b Diethyl phthalate [2] 0.2 0.2 0.2 0.1 60.7 0.2 0.1 0.0 0.0 
82 2-Ethylhexylcocoate 1.7 1.7 1.7 0.2 12.8 0.9 0.1 0.8 0.1 
83 2-Ethylhexylpalmitate 0.6 0.6 0.6 0.2 30.7 0.6 0.2 0.0 0.0 
84 Ethyl tiglate 1.2 1.2 1.1 0.2 16.7 1.0 0.1 0.1 0.1 
85 Ethyl trimethyl acetate 0.5 0.4 0.4 0.1 25.2 0.4 0.1 0.0 0.0 
86 Glycolbromoacetate 7.7 7.7 7.7 0.3 ND 4.0 0.0 3.7 0.3 
87 Heptyl butyrate 1.8 1.7 1.8 0.2 12.4 1.5 0.2 0.2 0.1 
88a Hexyl salicylate [1] 3.4 3.4 3.4 0.2 5.0 2.0 0.0 1.4 0.2 
88b Hexyl salicylate [2] 3.7 3.7 3.7 0.2 4.9 2.0 0.0 2.0 0.0 
88c Hexyl salicylate [3] 4.2 4.2 4.2 0.2 4.6 2.0 0.0 2.2 0.2 
88d Hexyl salicylate [4] 3.3 3.3 3.3 0.1 4.0 2.0 0.0 1.3 0.1 
89a Linalyl acetate [1] 3.7 3.7 3.7 0.2 4.2 1.9 0.1 1.8 0.1 
89b Linalyl acetate [2] 2.9 2.9 2.9 0.2 7.9 1.9 0.1 1.0 0.2 
90 Methyl caproate 2.8 2.8 2.8 0.2 7.5 1.7 0.2 1.1 0.1 
91 Methyl laurate 3.9 3.9 3.9 0.1 2.5 2.0 0.0 1.9 0.1 
92 Methyl linoleate 3.1 3.1 3.1 0.6 18.4 1.9 0.3 1.2 0.3 
93 Methyl 2-methylbutyrate 0.7 0.7 0.7 0.1 18.4 0.6 0.1 0.0 0.0 
94 Methyl palmitate 4.6 4.6 4.6 0.5 10.2 2.6 0.2 2.0 0.3 
95 Methyl stearate 2.1 2.1 2.1 0.5 25.2 1.5 0.2 0.7 0.3 
96 Methyl trimethyl acetate 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
97 Isopropyl myristate 1.2 1.2 1.2 0.1 11.6 1.0 0.0 0.2 0.1 
98 Isopropyl palmitate 1.4 1.4 1.4 0.3 18.9 1.2 0.1 0.2 0.1 
99 Isopropyl isostearate 0.1 0.1 0.1 0.1 90.3 0.1 0.1 0.0 0.0 
100a α-Terpinyl acetate [1] 3.6 3.6 3.6 0.2 18.7 1.9 0.1 1.7 0.2 
100b α-Terpinyl acetate [2] 4.3 4.3 4.3 0.1 3.1 2.0 0.0 2.3 0.1 
100c α-Terpinyl acetate [3] 2.8 2.7 2.8 0.3 12.0 1.7 0.1 1.0 0.2 
101 Eucalyptol 2.3 2.2 2.3 0.1 4.3 1.9 0.1 0.4 0.1 
102 Octanoic acid 4.4 4.5 4.4 0.4 8.9 3.0 0.5 1.4 0.3 
103 Isostearic acid 4.3 4.3 4.3 0.4 10.4 1.9 0.2 2.4 0.3 
104 3-Chloro-4-fluoronitrobenzene 1.7 1.7 1.7 0.2 10.7 1.3 0.1 0.3 0.1 
105 Fluorobenzene 0.1 0.1 0.1 0.1 97.4 0.1 0.1 0.0 0.0 
106 2-Fluorotoluene 0.1 0.1 0.1 0.1 95.3 0.1 0.1 0.0 0.0 
107 cis-Cyclooctene 1.9 2.1 2.1 0.4 19.4 1.7 0.3 0.4 0.2 
108 1,9-Decadiene 3.0 3.0 3.0 0.0 0.0 2.0 0.0 1.0 0.0 
109 1,5-Hexadiene 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
110 1,13-Tetradecadiene 1.7 1.6 1.6 0.3 18.4 1.3 0.2 0.2 0.1 
111 Benzyl acetone 1.2 1.0 1.0 0.4 36.5 0.8 0.3 0.2 0.1 
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Table 5.6  continued 
  
Chemical PIIa PIIb    Erythemab Œdemab 
No Name  mean median SD CV mean SD mean SD 
           
112 Diacetyl 0.6 0.6 0.6 0.1 19.4 0.6 0.1 0.0 0.0 
113 cis-Jasmone 2.6 2.6 2.6 0.3 11.2 1.7 0.1 1.7 0.1 
114 Isolongifolene ketone 3.0 3.0 3.0 0.5 15.5 1.9 0.1 1.1 0.4 
115 Methyl lavender ketone 
(1-hydroxy-3-decanone) 
3.8 3.8 3.8 0.2 6.1 2.2 0.1 1.6 0.2 
116 2,3-Dichloropropionitrile 2.0 2.0 2.0 0.0 0.0 2.0 0.0 0.0 0.0 
117 3-Diethylaminopropionitrile 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
118 Carvacrol >4 5.7 5.7 0.3 5.5 4.0 0.0 1.7 0.3 
119 2-tert-Butyl phenol 5.7 5.7 5.7 0.1 2.0 4.0 0.0 1.7 0.1 
120 Eugenol 2.9 2.9 2.9 0.1 4.2 1.9 0.1 1.0 0.1 
121 2-Methoxyphenol (guaiacol) 2.4 2.4 2.4 0.2 8.6 1.8 0.1 0.6 0.1 
122 4,4'-Methylene bis (2,6-ditert-butyl 
phenol) 
0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
123 Dimethyl disulphide 3.0 3.0 3.0 0.3 8.4 1.8 0.1 1.2 0.2 
124 Dipropyl disulphide 2.6 2.6 2.6 0.2 8.8 2.6 0.2 0.0 0.0 
125 3-Mercapto-1-propanol 1.1 1.1 1.1 0.2 19.4 0.8 0.1 0.3 0.1 
126 4-(Methylthio)benzaldehyde 0.9 0.9 0.9 0.2 20.8 0.9 0.2 0.0 0.0 
127 Glycerol tri-isostearate 0.7 0.7 0.7 0.2 23.6 0.7 0.2 0.0 0.0 
128 6-Butyl-2,4-dimethyldihydropyrane 2.0 2.0 2.0 0.2 8.9 1.7 0.1 0.3 0.1 
129 Decylidene methyl anthranilate 2.1 2.1 2.1 0.2 8.7 1.5 0.1 0.5 0.1 
130 2,6-Dimethyl-2,4,6-octatriene 3.0 3.0 3.0 0.2 6.0 2.0 0.0 1.0 0.2 
131 1-Formyl-1-methyl-4(4-methyl-3-
penten-1-yl)-3-cyclohexane 
3.3 3.3 3.3 0.2 5.5 2.0 0.0 1.3 0.2 
132a d-Limonene [1] 3.6 3.6 3.6 0.2 4.7 2.0 0.0 1.6 0.2 
132b d-Limonene [2] 3.3 3.2 3.3 0.2 5.4 1.9 0.1 1.3 0.2 
133 Linalol oxide 2.6 2.6 2.6 0.1 3.2 2.0 0.0 0.6 0.1 
134a Cinnamyl alcohol [1] 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
134b Cinnamyl alcohol [2] 0.5 0.5 0.5 0.2 34.6 0.5 0.1 0.1 0.1 
135 2,4-Dinitromethylaniline 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
136a Dimethylbenzylcarbinyl acetate [1] 1.2 1.2 1.2 0.1 11.7 1.0 0.0 0.2 0.1 
136b Dimethylbenzylcarbinyl acetate [2] 1.4 1.4 1.4 0.3 21.5 0.9 0.2 0.5 0.2 
137 Dodecanoic (lauric) acid 0.4 0.4 0.4 0.2 38.2 0.4 0.2 0.0 0.0 
138 2-Chloronitrobenzene 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
139 3-Methylphenol 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
140 3,3'-Dithiopropionic acid 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
141 Glycerol triundecanoate 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
142 4-Amino-1,2,4-triazole 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
143 Tonalid 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 
 
Footnote to Table 5.6 
 
aThe conventional PII, calculated from the original data (ECETOC, 1995). 
bBootstrap estimates, obtained by resampling the original data. 
 
CV = coefficient of variation; SD = standard deviation; ND = not defined (denominator of 
zero); NG = not given in the ECETOC report (1995) since tissue scores were available for fewer 
than three animals; PII = primary irritation index. 
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Table 5.7  Eye irritation data for 92 chemicals 
 
Chemical MMASa WDSb Mean Mean Mean Mean Mean Mean 
No Name  mean median max SD CV Erythema Œdema Discharge Opacity Area Iritis
              
1 Methyl trimethyl acetate 2.7 1.9 1.9 3.1 0.4 22.2 0.6 0.3 0.1 0.0 0.0 0.0 
2 Ethyl trimethyl acetate 3.8 2.3 2.3 4.5 0.6 26.5 0.6 0.4 0.1 0.2 0.2 0.0 
3 Butyl acetate 7.5 3.2 3.1 8.1 0.7 21.0 1.0 0.3 0.3 0.2 0.2 0.0 
4 Cellosolve acetate 15.0 6.1 5.7 21.8 2.2 35.8 1.2 0.7 0.5 0.4 0.5 0.0 
5 Ethyl acetate 15.0 5.6 5.4 15.6 1.5 26.7 1.3 0.6 0.3 0.4 0.3 0.1 
6 Ethyl-2-methyl acetoacetate 18.0 13.3 13.4 18.4 2.1 15.4 1.2 0.9 1.3 0.9 1.4 0.0 
7 Methyl cyanoacetate 27.7 20.6 20.2 33.1 2.6 12.7 3.0 2.1 1.0 0.4 1.3 1.0 
8 Methyl acetate 39.5 25.1 24.6 44.2 5.7 22.7 2.2 2.1 1.8 1.3 1.3 0.8 
9 Isopropyl isostearate 1.3 0.4 0.4 1.3 0.3 64.1 0.2 0.0 0.0 0.0 0.0 0.0 
10 2,2-Dimethylbutanoic acid 44.7 40.0 39.9 49.5 3.2 8.0 2.0 0.7 1.1 1.5 4.0 0.5 
11 2-Ethoxyethyl methacrylate 0.0 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 0.0 0.0 
12 Ethyl thioethyl methacrylate 0.0 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 0.0 0.0 
13 Ethyl triglycol methacrylate 0.0 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 0.0 0.0 
14 Nonyl acrylate 0.0 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 0.0 0.0 
15 Nonyl methacrylate 0.0 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 0.0 0.0 
16 Iso-octyl acrylate 0.7 0.2 0.2 1.1 0.2 96.3 0.1 0.0 0.0 0.0 0.0 0.0 
17 Heptyl methacrylate 1.3 0.4 0.4 1.6 0.3 61.6 0.2 0.0 0.0 0.0 0.0 0.0 
18 Trifluoroethyl methacrylate 1.3 0.4 0.4 1.8 0.3 63.3 0.2 0.0 0.0 0.0 0.0 0.0 
19 Allyl methacrylate 5.8 3.0 3.0 6.2 0.7 24.4 0.8 0.3 0.2 0.0 0.1 0.1 
20 Glycidyl methacrylate 28.0 14.4 13.9 31.5 5.4 37.8 1.5 1.2 0.6 0.8 1.4 0.4 
21 2-Methoxyethyl acrylate 45.0 25.5 25.0 49.0 6.5 25.5 2.3 2.7 1.4 1.9 1.0 0.6 
22 2,6-Dichlorobenzoyl chloride 23.8 22.3 22.4 26.3 1.4 6.0 2.6 1.6 1.7 1.0 2.2 0.0 
23 Isostearyl alcohol 0.0 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 0.0 0.0 
24 3-Methoxy-1,2-propanediol 0.0 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 0.0 0.0 
25 2,4-Pentanediol 1.3 0.9 0.9 1.8 0.3 36.9 0.4 0.0 0.0 0.0 0.0 0.0 
26 Propylene glycol 1.3 0.6 0.6 1.4 0.2 36.5 0.3 0.0 0.0 0.0 0.0 0.0 
27 Glycerol 1.7 0.6 0.6 1.3 0.2 38.4 0.3 0.0 0.0 0.0 0.0 0.0 
28 Isomyristyl alcohol 4.0 2.0 2.0 5.1 0.9 42.9 0.5 0.5 0.1 0.0 0.0 0.0 
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Table 5.7  Eye irritation data for 92 chemicals 
 
Chemical MMASa WDSb Mean Mean Mean Mean Mean Mean 
No Name  mean median max SD CV Erythema Œdema Discharge Opacity Area Iritis
              
29 2,2-Dimethyl-3-pentanol 8.3 4.5 4.2 11.9 1.8 39.2 0.8 0.3 0.0 0.8 0.6 0.0 
30 2-Methyl-1-pentanol 13.0 10.7 10.4 20.1 2.7 25.3 1.1 0.7 0.0 1.1 1.2 0.0 
31 Cyclopentanol 21.7 18.7 18.6 24.8 1.9 10.0 2.0 1.9 1.0 1.2 1.4 0.0 
32 Ethanol 24.0 18.0 17.7 40.7 5.3 29.4 2.1 1.3 0.7 1.1 1.3 0.4 
33 Propan-2-ol (isopropanol ) 28.3 17.6 17.0 35.3 4.6 26.1 2.3 1.6 0.8 0.7 1.1 0.8 
34 Octanol 30.5 38.0 38.0 50.7 5.1 13.3 2.2 2.5 1.1 1.7 2.8 0.7 
35 Furfuryl hexanolc 41.0 43.5 43.8 65.0 1.7 3.9 1.3 1.3 0.3 2.3 2.7 1.3 
36 2-Ethyl-1-hexanol 44.0 27.2 26.6 54.1 6.1 22.4 2.1 1.9 0.8 1.8 1.5 0.7 
37 Isobutanol 51.3 44.6 44.9 61.1 6.0 13.4 2.4 2.3 1.4 2.1 2.6 1.1 
38 Butanol 60.3 40.3 40.4 63.5 6.8 16.8 2.4 2.1 1.6 2.0 2.4 0.7 
39 Hexanol 64.8 53.7 53.8 68.6 5.2 9.8 2.7 2.5 2.5 2.2 2.9 1.3 
40 Butyl cellosolve 68.7 68.1 68.2 88.0 4.5 6.6 2.3 2.8 2.4 2.3 4.0 1.3 
41 Cyclohexanol 79.8 78.6 78.8 83.8 2.0 2.5 2.4 2.5 2.2 2.9 4.0 1.2 
42 4-Carboxybenzaldehyde 50.3 46.1 46.1 60.4 4.1 8.9 3.0 1.3 1.3 1.8 3.1 1.4 
43 4,4'-Methylene bis (2,6-
ditertbutylphenol) 
0.0 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 0.0 0.0 
44 4-Bromophenetole 1.3 0.4 0.4 1.3 0.3 61.0 0.2 0.0 0.0 0.0 0.0 0.0 
45a 2-Xylene [1] 1.5 1.2 1.2 2.7 0.5 38.7 0.2 0.4 0.0 0.0 0.0 0.0 
45b 2-Xylene [2] 9.0 6.5 6.5 9.0 0.6 9.1 1.2 1.7 0.4 0.0 0.0 0.0 
46 3-Chloro-4-fluoronitrobenzene 1.7 0.8 0.8 1.8 0.3 36.4 0.3 0.1 0.0 0.0 0.0 0.0 
47 1,3-Diisopropylbenzene 2.0 1.1 1.1 1.9 0.2 21.5 0.6 0.0 0.0 0.0 0.0 0.0 
48 1-Methylpropylbenzene 2.0 0.7 0.7 1.3 0.2 32.0 0.3 0.0 0.0 0.0 0.0 0.0 
49 3-Ethyltoluene 2.3 1.8 1.8 2.6 0.2 12.4 0.8 0.0 0.1 0.0 0.0 0.0 
50 2,4-Difluoronitrobenzene 4.7 4.2 4.1 7.3 0.8 18.5 1.3 0.4 0.4 0.0 0.0 0.0 
51 Styrene 6.8 3.2 3.2 5.4 0.7 21.1 0.7 0.6 0.3 0.1 0.1 0.0 
52 Toluene 9.0 7.3 7.3 9.2 0.7 8.9 1.5 1.4 0.7 0.0 0.0 0.0 
53 4-Fluoroaniline 69.8 47.2 47.2 63.0 4.6 11.0 2.7 2.2 1.7 1.6 4.0 0.6 
54 Pyridine 48.0 46.1 46.3 55.1 3.3 7.1 2.9 3.3 1.3 2.7 1.9 1.2 
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Table 5.7  Eye irritation data for 92 chemicals 
 
Chemical MMASa WDSb Mean Mean Mean Mean Mean Mean 
No Name  mean median max SD CV Erythema Œdema Discharge Opacity Area Iritis
              
55 2-Bromobutane 0.0 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 0.0 0.0 
56 1-Bromo-4-chlorobutane 0.0 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 0.0 0.0 
57 Octyl bromide 0.0 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 0.0 0.0 
58 Hexyl bromide 1.3 0.4 0.4 1.6 0.3 63.5 0.0 0.0 0.2 0.0 0.0 0.0 
59 Amyl bromide 2.0 1.1 1.1 2.0 0.3 29.3 0.6 0.0 0.0 0.0 0.0 0.0 
60 1,6-Dibromohexane 2.0 0.7 0.7 1.6 0.3 48.3 0.2 0.1 0.0 0.0 0.0 0.0 
61 Isopropyl bromide 2.7 1.1 1.1 2.9 0.5 42.0 0.3 0.2 0.0 0.0 0.0 0.0 
62 1,4-Dibromobutane 4.0 1.4 1.3 4.9 0.9 67.0 0.3 0.3 0.0 0.0 0.0 0.0 
63 1,5-Dibromopentane 4.0 1.8 1.8 4.0 0.6 35.2 0.6 0.3 0.0 0.0 0.0 0.0 
64 1,3-Dibromopropane 4.0 1.3 1.3 4.0 0.6 48.5 0.3 0.3 0.0 0.0 0.0 0.0 
65 Ethyleneglycol diethylether 0.0 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 0.0 0.0 
66 Isostearic acid 3.3 1.5 1.6 3.6 0.6 39.5 0.6 0.0 0.2 0.0 0.0 0.0 
67 3,3-Dimethylpentane 0.0 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 0.0 0.0 
68 3-Methylhexane 0.7 0.2 0.2 0.8 0.1 64.9 0.1 0.0 0.0 0.0 0.0 0.0 
69 2-Methylpentane 2.0 0.8 0.8 2.0 0.3 35.8 0.3 0.0 0.1 0.0 0.0 0.0 
70 1,9-Decadiene 2.0 0.9 0.9 1.6 0.2 26.2 0.4 0.0 0.0 0.0 0.0 0.0 
71 Dodecane 2.0 0.8 0.8 2.1 0.3 34.4 0.4 0.0 0.0 0.0 0.0 0.0 
72 1,5-Dimethylcyclooctadiene 2.8 1.3 1.3 3.3 0.3 24.0 0.6 0.0 0.1 0.1 0.1 0.0 
73 cis-Cyclooctene 3.3 2.2 2.2 3.0 0.3 12.2 1.1 0.0 0.0 0.0 0.0 0.0 
74 Methylcyclopentane 3.7 2.3 2.3 4.2 0.5 22.8 0.8 0.1 0.2 0.0 0.0 0.0 
75 1,5-Hexadiene 4.7 2.4 2.4 4.7 0.5 21.2 0.9 0.2 0.1 0.0 0.0 0.0 
76 Di-iso-butyl ketone 
(2,6-dimethyl-4-heptanone) 
0.7 0.2 0.2 1.1 0.2 93.5 0.1 0.0 0.0 0.0 0.0 0.0 
77 Methyl isobutyl ketone 
(4-methylpentan-2-one) 
4.8 2.1 2.0 4.7 0.5 22.4 0.8 0.2 0.0 0.1 0.1 0.0 
78a Methyl amyl ketone [1] 10.5 4.7 4.5 12.1 1.9 40.4 0.9 0.6 0.3 0.3 0.3 0.1 
78b Methyl amyl ketone [2] 16.3 7.5 7.4 15.1 1.5 20.2 1.2 1.2 0.8 0.3 0.3 0.1 
79 Methyl ethyl ketone (butanone) 50.0 27.0 26.7 53.2 6.0 22.1 2.1 2.2 2.3 1.3 1.7 0.6 
 154
Table 5.7  Eye irritation data for 92 chemicals 
 
Chemical MMASa WDSb Mean Mean Mean Mean Mean Mean 
No Name  mean median max SD CV Erythema Œdema Discharge Opacity Area Iritis
              
80 Acetone 65.8 50.6 50.7 64.5 4.8 9.3 2.8 2.5 2.7 1.9 2.9 1.3 
81 3-Chloropropionitrile 13.7 4.5 4.3 17.0 1.8 41.1 0.6 0.3 0.2 0.7 0.4 0.1 
82 Diethylaminopropionitrile 62.3 50.1 49.9 65.0 6.1 12.2 3.0 2.6 2.4 3.5 1.7 1.0 
83 2-Ethylhexylthioglycolate 0.0 0.0 0.0 0.0 0.0 ND 0.0 0.0 0.0 0.0 0.0 0.0 
84 4-Methylthiobenzaldehyde 0.0 0.4 0.4 2.2 0.4 95.6 0.1 0.1 0.0 0.0 0.0 0.0 
85 Iso-octylthioglycolate 0.7 0.2 0.2 1.1 0.2 91.8 0.1 0.0 0.0 0.0 0.0 0.0 
86 Dipropyl disulphide 1.3 0.9 0.9 2.0 0.3 36.7 0.4 0.0 0.0 0.0 0.0 0.0 
87 Thiodiglycol 5.3 2.4 2.4 6.7 1.1 47.1 0.5 0.3 0.3 0.0 0.0 0.0 
88 1,2,3-Trimercaptopropane 8.7 6.2 6.2 10.7 1.6 25.1 1.3 1.5 0.3 0.0 0.0 0.0 
89 Ethylthioglycolate 24.7 11.6 11.0 33.4 5.7 48.8 1.2 0.8 0.4 1.0 0.8 0.5 
90 Methylthioglycolate 53.0 36.4 36.2 57.7 7.7 21.1 2.4 1.8 1.3 2.2 1.9 0.9 
91 Glycerol tri-isostearate 2.0 0.7 0.7 2.0 0.3 47.3 0.3 0.0 0.0 0.0 0.0 0.0 
92 γ-Butyrolactone 43.0 36.2 36.2 52.8 4.5 12.3 2.2 2.1 1.3 1.9 2.2 0.8 
 
 
Footnote to Table 5.7 
 
aModified maximum average score (MMAS) values taken from ECETOC eye irritation data bank (ECETOC, 1998a). 
bBootstrap estimates of the weighted Draize score. 
cData were only available for one rabbit in ECETOC (1998a). 
 
CV = coefficient of variation; SD = standard deviation; ND = not defined (denominator of zero). 
Shading indicates chemicals for which the maximal WDS < MMAS 
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Table 5.8 Chemicals for which the PII is biased   
Chemical Bootstrap PIIa Conventional PIIb Bias Bias-corrected estimate of PII 
     
Citronellol [3] 3.7 3.3 0.4 2.9 
Cyclamen aldehyde 4.8 4.6 0.2 4.4 
Benzyl benzoate 1.6 1.1 0.5 0.6 
Cis-cyclooctene 1.9 2.1 -0.2 2.3 
1,13-Tetradecadiene 1.7 1.6 0.1 1.5 
Benzyl acetone 1.2 1.0 0.2 0.8 
 
 
Footnote to Table 5.8 
 
PII = primary irritation index 
 
Citronellol [3] refers to the third data sheet for citronellol in the ECETOC report. 
aThe mean value of the bootstrap distribution for PII. 
bThe PII calculated from the original sample of data. 
 
 
 
Table 5.9 Spearman correlations between six skin irritation endpoints shown 
in Figure 5.5  
                                                 
      
 Erythema 
24h 
Erythema 
48h 
Erythema 
72h 
Œdema 
24h 
Œdema 
48h 
      
Erythema 48h 0.90     
Erythema 72h 0.86 0.96    
Oedema 24h 0.79 0.83 0.84   
Oedema 48h 0.75 0.84 0.86 0.93  
Oedema 72h 0.74 0.80 0.84 0.87 0.94 
 
 
Table 5.10 Spearman correlations between six eye irritation effects shown 
in Figure 5.8 
 
 
 Conjunctival 
erythema 
Conjunctival 
œdema 
Conjunctival 
discharge 
Corneal 
opacity 
Corneal 
area 
      
Conjunctival œdema 0.88     
Conjunctival discharge 0.88 0.88    
Corneal opacity 0.82 0.84 0.82   
Corneal area 0.83 0.83 0.83 0.98  
Iritis 0.75 0.77 0.79 0.86 0.84 
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Table 5.11 Spearman correlations between the weighted tissue scores shown in Figure 5.9  
 
 Conjunctiva 
24h 
Conjunctiva 
48h 
Conjunctiva 
72h 
Cornea 
24h 
Cornea 
48h 
Cornea 
72h 
Iris 
24h 
Iris 
48h 
         
Conjunctiva 48h 0.90        
Conjunctiva 72h 0.85 0.90       
Cornea 24h 0.81 0.84 0.85      
Cornea 48h 0.74 0.79 0.80 0.92     
Cornea 72h 0.69 0.74 0.81 0.86 0.93    
Iris 24h 0.68 0.69 0.73 0.80 0.76 0.73   
Iris 48h 0.66 0.69 0.74 0.80 0.80 0.77 0.85  
Iris 72h 0.53 0.58 0.66 0.67 0.68 0.73 0.67 0.76 
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Table 5.12 Spearman correlations between the weighted Draize scores shown in 
Figure 5.10 
 
 
 
 WDS 24h WDS 48h WDS 72h 
    
WDS 48h 0.91   
WDS 72h 0.86 0.90  
max WDS 0.99 0.92 0.87 
 
 
Footnote to Table 5.12 
 
WDS = weighted Draize score. 
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6.1 INTRODUCTION 
 
If chemicals are classified into two groups (active/inactive or toxic/non-toxic) and are 
plotted on a box plot (one variable), or on a scatter plot (two or more variables), 
sometimes it appears that the chemicals in one group form an ‘embedded cluster’ 
surrounded by the chemicals in the other group, the ‘diffuse cluster’. Typically, the 
active (or toxic) chemicals form the embedded cluster, and the inactive (or non-toxic) 
chemicals form the diffuse cluster, indicating that for each of the chosen variables, there 
is an optimal range of values for the biological response to occur. An example of 
embedded clustering in toxicology is provided by chemicals that are irritating to the 
eye: embedded clusters of irritants have been observed among diffuse clusters of non-
irritants in several SAR studies (Cronin et al., 1994; Cronin, 1996; Barratt, 1997; Worth 
& Fentem, 1999).  
 
Although a set of active (or toxic) chemicals may appear to form an embedded cluster 
when inspected visually on a scatter plot, the occurrence of embedded clustering can 
only be concluded with statistical significance if the method of cluster significance 
analysis (CSA) indicates that the apparent embedded cluster is unlikely to have arisen 
by chance. The method of CSA is described in detail in Chapter 4. 
 
If the application of CSA indicates that the embedded cluster of active chemicals is 
statistically significant, it is then desirable to derive a classification model (CM) for 
classifying chemicals as active (toxic) or inactive (non-toxic). To derive such a CM, the 
technique of embedded cluster modelling (ECM) was devised by the author (Worth & 
Cronin, 1999). If only one variable is found to be significant by CSA, ECM can be used 
to identify the upper and lower cut-off values of the variable between which embedded 
chemicals are predicted to lie: 
 
CI for embedded chemicals = x  ± (1.96 σ)    (Equation 6.1) 
 
where CI is the 95% confidence interval for embedded chemicals; x is the mean value 
of the physicochemical descriptor x for the active (toxic) chemicals; and σ is the 
corresponding standard deviation. In Equation 6.1, the factor of 1.96 is intended to 
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capture 95% of the active (toxic) chemicals, assuming that these are normally 
distributed in the x direction.  
 
In the case of two or more significant variables, ECM treats the boundary of the 
embedded cluster as an ellipse in two or more dimensions, so that the active (toxic) 
chemicals can be identified as those lying inside the elliptic boundary, whereas the 
inactive (non-toxic) chemicals can be identified as those located outside the ellipse. The 
equation for a two-dimensional (2D) ellipse is given by Equation 6.2: 
 
(x-h)2 / α2 + (y-k)2 / β2 = 1      (Equation 6.2) 
 
where x and y define all points on the 2D ellipse; h and k are the coordinates of the 
centre of the ellipse along the x and y cartesian axes, respectively; and α and β are the 
dimensions (radial axes) of the ellipse parallel with the x and y cartesian axes, 
respectively. The centre of the ellipse (h, k) is defined as the centroid of the embedded 
cluster, and the radial axes of the ellipse (α and β) are proportional to the standard 
deviations in the x and y directions (1.96 σx, and 1.96 σy). In Equation 6.2, the factor of 
1.96 is intended to capture 95% of the active (toxic) chemicals within the ellipse, 
assuming that these are normally distributed in the x and y directions.  
 
The aim of the work presented in this chapter was to illustrate how the methods of CSA 
and ECM can be used in combination to generate elliptic CMs from embedded data sets. 
This work was carried out as a follow-up to the original description of ECM (Worth & 
Cronin, 1999). It was presented at the 3rd World Congress on Alternatives and Animals 
in the Life Sciences (Worth & Cronin, 2000a), and subsequently at a meeting of the 
UK-QSAR and ChemoInformatics Group (October 20, 1999; SmithKline Beecham 
Pharmaceuticals, Essex, UK).  
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6.2 METHOD 
 
6.2.1 Collection and treatment of in vivo data 
 
A data set of 73 organic chemicals (Table 6.1) was constructed by using chemicals 
reported in the ECETOC reference chemicals data bank (ECETOC, 1998a). Chemicals 
were selected if they were organic liquids belonging to one of the following chemical 
classes: aliphatic hydrocarbons; aromatic compounds; aliphatic alcohols, ethers, esters, 
and ketones (including γ-butyrolactone); alkyl bromides; and sulphur-containing 
compounds. Solids were excluded, because the exposure of the rabbit eye to these 
substances is not comparable to that of organic liquids (Balls et al., 1999). In addition, 
acids, acid precursors and alkalis were excluded, because these are generally applied as 
diluted aqueous solutions (rather than as neat liquids), and are likely to act by a pH-
dependent mechanism. A CM for predicting eye irritation potential on the basis of pH is 
proposed in chapter 9.  
 
Modified maximum average score (MMAS) values were taken directly from the 
ECETOC data bank. The method for calculating the MMAS is explained in Chapter 2. 
In the case of methyl amyl ketone (2-heptanone), there are two entries in the ECETOC 
data bank, so the average of the two MMAS values (10.5 and 16.3) was taken (i.e. 
13.4).  
 
Chemicals with a MMAS greater than, or equal to 4.0, were classified as irritant (I), and 
chemicals with MMAS values less than 4.0 were classified as non-irritant (NI). The cut-
off value between I and NI chemicals was chosen as the median MMAS of the 73 
chemicals, to produce a balanced training set (containing 37 I and 36 NI chemicals). 
Clearly, different threshold values could be employed, depending on the purpose of the 
investigation. For example, Kay & Calandra (1962) defined irritants as chemicals 
having a MMAS ≥ 0.5, whereas Spielmann et al. (1996) defined severe irritants as 
chemicals having a MMAS > 59. 
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6.2.2 Calculation of physicochemical descriptors  
 
Various physicochemical properties were calculated from the molecular structures of 
the 73 chemicals, as represented by their one-dimensional SMILES notations 
(Weininger, 1988). The logarithm of the octanol-water partition coefficient (logP) was 
calculated by using KOWWIN for Windows (Syracuse Research Corporation, Syracuse, 
NY, USA), which uses a fragment-based method to predict logP (Meylan & Howard, 
1995). In addition, the following molecular topology indices were calculated with the 
MS-DOS program, Molconn-Z (Hall Associates Consulting, Quincy, MA, USA): 
simple and valence path molecular connectivity indices of orders 0 to 4; simple and 
valence cluster molecular connectivity indices of orders 3 and 4; fourth-order simple 
and valence path-cluster molecular connectivity indices; differences in simple and 
valence path molecular connectivity indices; kappa indices of orders 1 to 3; kappa alpha 
indices of orders 0 to 3; and the flexibility index. These topological indices are 
considered to encode information about the size, shape, branching and heteroatom 
contents of molecules (Kier & Hall, 1986). Molecular weight (MW) was also calculated 
with the Molconn-Z program. In addition, dipole moment, molecular surface area and 
molecular volume were calculated by using HyperChem 5.1 for Windows (Hypercube 
Inc., Gainesville, FL, USA). The chemical structures were geometry-optimised by the 
successive application of HyperChem's MM+ molecular mechanics force field, which is 
based on the MM2 force field (Allinger, 1977), followed by the AM1 semi-empirical 
method (Dewar et al., 1985). 
 
6.2.3 Cluster significance analysis and embedded cluster modelling 
 
A visual inspection of all pairwise combinations of descriptors, using matrix plots 
indicated that the embedded clustering of irritant chemicals is most apparent in the two-
dimensional scatter plot of logP against dV1 (Figure 6.1). The second variable, dV1, 
stands for ‘the first-order difference valence connectivity index’, and is simplified 
notation for the more usual d1χv, which is defined as follows (Kier & Hall, 1986):  
 
d1χv = 1χPv - 1χNv        (Equation 6.3) 
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where 1χPv is the first-order valence path index for the molecule of interest; and 1χNv is 
the first-order valence path index for the unbranched, acyclic graph that has the same 
size as the given molecule. This topological index, which is claimed to be size-
independent (Kier & Hall, 1986), appears to provide a measure of the degree of 
branching and/or cyclicity in a molecule - its numerical value is close to zero for linear, 
acyclic structures, and becomes increasingly negative as the number of branches or 
rings in the molecule increases (Figure 6.2).  
 
To carry out CSA in the Minitab package (Minitab Inc., State College, PA, USA), three 
macros were written to perform CSA in one, two and three dimensions, respectively 
(see Appendix A3). The macro for 2D CSA was used to assess the statistical 
significance of the embedded cluster along logP and dV1, and a 2D elliptic model was 
derived by ECM, again by using a purpose-written macro (see Appendix A9). The 
variabilities in the model parameters (the centroid and radial axes of the ellipse) were 
assessed from their bootstrap distributions, derived from 1000 random samples of the 
logP and dV1 values for the irritant chemicals. 
 
6.2.4 Assessment of model performance 
 
The ability of the elliptic model to correctly distinguish between irritant and non-irritant 
chemicals was determined by comparing the predicted classifications (I/NI) with the 
observed (pre-defined) classifications for the 73 chemicals. Calculations of the 
sensitivity, specificity, concordance, the positive and negative predictivities, and the 
false positive and negative rates, were performed with Minitab 11 for Windows, using a 
purpose-written macro (see Appendix A1).  
 
6.3 RESULTS 
 
The application of CSA to the complete data set indicated that embedded clustering 
along logP and dV1 was highly significant (p<0.01), even without the removal of 
outliers. Following the removal of five irritant outliers (isomyristyl alcohol, 1,5-
dibromopentane, 1,4-dibromobutane, 1,3-dibromopropane, and 2,4-dinitrofluoro 
benzene), the application of ECM generated the following PM: 
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classify an undiluted, organic liquid as an eye irritant if: 
 
(logP-1.07)2 / 2.062 + (dV1 + 0.98)2/0.992 ≤ 1   (Equation 6.4) 
 
The 2D ellipse described by this model is illustrated in Figure 6.1. 
 
When the elliptic model was used to classify the 73 organic liquids, 18 chemicals were 
misclassified. Ten chemicals were false negatives (isomyristyl alcohol, 1,5-
dibromobutane, 1,4-dibromobutane, 1,3-dibromopropane, ethanol, methyl cyanoacetate, 
cellosolve acetate [2-ethoxyethanol acetate], ethyl-2-methyl acetoacetate, 4-
fluoroaniline, and 2,4-difluoronitrobenzene), and eight chemicals were false positives 
(2-xylene, di-isobutyl ketone, 4-methylthiobenzaldehyde, ethyl trimethyl acetate, 
methyl trimethyl acetate, ethylene glycol diethyl ether, 2,4-pentanediol, and propylene 
glycol). The Cooper statistics are summarised in Table 6.2. 
 
The bootstrap distributions of the model parameters are approximately normal, as 
judged by subjective impression (for example, Figures 6.3 and 6.4), and by the 
Anderson-Darling normality test. Therefore, the 95% CIs (Table 6.3) could be 
calculated by using Equation 6.5: 
 
95% CI = bootstrap mean ± (1.96 SD)     (Equation 6.5) 
 
where SD is the standard deviation of the appropriate bootstrap distribution. The fact 
that the parameter estimates based on the full data set (i.e. the parameter values 
incorporated in the elliptic model) are so close (to within 0.04 units or less) to the mean 
values of the bootstrap distributions indicates that the parameter estimates are unbiased, 
i.e. the sample of chemicals is representative of the population from which it is drawn. 
 
6.4 DISCUSSION 
 
The aim of this work was to illustrate how the combined use of CSA and ECM can 
generate PMs from embedded data sets, by using an endpoint employed in eye irritation 
testing. For the purposes of this study, the distinction between eye irritants and non-
irritants was based simply on the MMAS. Clearly, other distinctions could be used, such 
 165
as those specified in EU regulations (EC, 1993) or in the OECD guidelines on eye 
irritation testing (OECD, 1998). 
 
The elliptic model of eye irritation potential is based on two variables (logP and dV1), 
and indicates that neat organic liquids (excluding acids and alkalis) are only irritant to 
the eye if their logP and dV1 values fall in a critical range. The first variable, logP, 
provides a measure of the tendency of chemicals undergo passive diffusion across 
biological membranes: if the logP of a substance is too high, it will remain 
preferentially within the membranes of the eye, whereas if the logP is too low, it will 
remain preferentially in the aqueous media surrounding membranes, e.g. in the tear film 
covering the eye. LogP was also found to be an important descriptor variable in the 
embedded clustering of eye irritants in previous SAR studies (Cronin et al., 1994; 
Cronin, 1996; Barratt, 1997; Worth & Fentem, 1999). 
 
The second variable, dV1, is a size-independent measure of molecular topology. Since it 
appears that dV1 is related to the degree of branching and/or cyclicity in a molecule 
(Figure 6.2), the importance of dV1 in the elliptic model indicates that organic liquids 
must have an intermediate degree of branching/cyclicity to be irritant to the eye. This 
interpretation is reminiscent of the observation by Barratt (1997) that the second and 
third principal inertial axes are important descriptors in the embedded clustering of 
neutral organic chemicals, which suggests that only chemicals with a certain cross-
sectional area are irritant. While the two models are mechanistically similar, they are 
not exactly the same. The topological index dV1 is claimed to be size-independent (Kier 
& Hall,1986), whereas the second and third principal inertial axes are, by definition, 
size-dependent. 
 
Given the physicochemical interpretations of logP and dV1, the elliptic model can be 
said to describe partition rather than reactivity. In other words, the model probably 
identifies the chemicals that are likely to cross the conjunctiva into the cornea, but does 
not necessarily identify which of those chemicals elicit a biological response in the 
cornea (effects in the cornea account for 73% of the MMAS). Consistent with this 
interpretation is the fact that the model predicts eight non-irritant chemicals to be 
irritant. Three of these chemicals (2-xylene, ethyl trimethyl acetate and propylene 
glycol) are close to the elliptic boundary, so their predicted classifications are best 
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regarded as equivocal. The model also predicts ten irritant chemicals to be non-irritant. 
Five of these chemicals (isomyristyl alcohol, 1,5-dibromopentane, 1,4-dibromobutane, 
1,3-dibromopropane, and 2,4-dinitrofluorobenzene) were omitted from the training set, 
so it is not surprising that they are misclassified by the elliptic model. The other five 
false negatives (ethanol, methyl cyanoacetate, cellosolve acetate, ethyl-2-methyl 
acetoacetate, and 4-fluoroaniline) are close to the elliptic boundary. Incidentally, 
ethanol and ethyl-2-methyl acetoacetate are classified as non-irritant by the EU 
classification system (EC, 1993), but as irritant by the OECD system (OECD, 1998). If 
the elliptic model of eye irritation potential were employed in a tiered testing strategy, 
such as the one adopted recently by the OECD (1998), the occurrence of false negatives 
would not be problematic, since these chemicals would be correctly identified as irritant 
in a subsequent step. In contrast, the generation of false positives would be problematic, 
since these chemicals would be over-labelled without further testing. This suggests that 
the elliptic model would either have to be modified to incorporate one or more reactivity 
parameters, or used in combination with an SAR based on such parameters. 
 
6.5 CONCLUSIONS 
 
This study provides further evidence for the occurrence of embedded clustering in eye 
irritation data sets, and illustrates how the combined use of CSA and ECM can generate 
CMs from such data sets. In addition, the bootstrap resampling method is shown to 
provide a useful means of estimating the uncertainty in model parameters. CMs of eye 
irritation potential, derived by the combined use of CSA and ECM could, if adequately 
validated, be used in a tiered testing approach to eye irritation, such as the one adopted 
by the OECD (1998). 
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Figure 6.1 Scatter plot of the logarithm of the octanol-water partition 
coefficient (logP) against the first-order valence-corrected difference 
path index (dV1) for 73 organic liquids  
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Footnote to Figure 6.1 
 
The following chemicals are identified: 1) isomyristyl alcohol; 2) 1,5-dibromobutane; 3) 1,4-
dibromobutane; 4) 1,3-dibromopropane; 5) ethanol; 6) methyl cyanoacetate; 7) cellosolve 
acetate; 8) ethyl-2-methyl acetoacetate; 9) 4-fluoroaniline; 10) 2,4-difluoronitrobenzene; 11) o-
xylene; 12) di-isobutyl ketone; 13) 4-methylthiobenzaldehyde; 14) ethyl trimethyl acetate; 15) 
methyl trimethyl acetate; 16) ethylene glycol diethyl ether; 17) 2,4-pentanediol; and 18) 
propylene glycol.  
 
I = irritant; NI = non-irritant. 
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Figure 6.2 Plot of the first-order difference valence connectivity index for 73 
organic liquids 
 
 
 
 
 
 
Footnote to Figure 6.2 
 
The chemical numbers correspond to those in Table 6.1. Solid circles denote irritant chemicals, 
open circles non-irritants 
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Figure 6.3 Bootstrap distribution of the elliptic centroid along logP for 32  
eye irritants  
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Figure 6.4 Bootstrap resampling distribution of the elliptic radius along logP 
for 32 eye irritants 
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Table 6.1 Names, MMAS values and physicochemical properties for 73 
organic chemicals  
 
No. Chemical MMAS Class logP dV1 
  
 Hydrocarbons     
1 3,3-Dimethylpentane 0.0 NI 3.67 -0.293 
2 3-Methylhexane 0.7 NI 3.71 -0.106 
3 2-Methylpentane 2.0 NI 3.21 -0.144 
4 1,9-Decadiene 2.0 NI 4.98 -0.781 
5 Dodecane 2.0 NI 6.23 0.000 
6 1,5-Dimethylcyclooctadiene 2.8 NI 4.82 -0.813 
7 cis-Cyclooctene 3.3 NI 3.94 -0.264 
8 Methylcyclopentane 3.7 NI 3.10 -0.020 
9 1,5-Hexadiene 4.7 I 3.02 -0.781 
      
 Aromatics     
10 4,4'-Methylene bis (2,6-ditertbutylphenol) 0.0 NI 8.99 -5.043 
11 4-Bromophenetole 1.3 NI 3.46 -1.665 
12 2-Xylene (1,2-dimethylbenzene) 1.5 NI 3.09 -1.087 
13 3-Chloro-4-fluoronitrobenzene 1.7 NI 2.66 -3.169 
14 1,3-Di-isopropylbenzene 2.0 NI 4.90 -1.206 
15 1-Methylpropylbenzene (2-phenylbutane) 2.0 NI 3.94 -1.022 
16 3-Ethyltoluene 2.3 NI 3.58 -1.032 
17 2,4-Difluoronitrobenzene 4.7 I 2.21 -3.535 
18 Styrene 6.8 I 2.89 -1.307 
19 Toluene 9.0 I 2.54 -1.004 
20 4-Fluoroaniline 69.8 I 1.28 -2.004 
21 Pyridine 48.0 I 0.80 -1.075 
      
 Alcohols     
22 Isostearyl alcohol (iso-octadecanol) 0.0 NI 7.64 -1.029 
23 3-Methoxy-1,2-propanediol 0.0 NI -1.15 -1.506 
24 2,4-Pentanediol 1.3 NI 0.13 -1.169 
25 Propylene glycol (1,2-propanediol) 1.3 NI -0.78 -0.797 
26 Glycerol 1.7 NI -1.65 -1.196 
27 Isomyristyl alcohol (iso-tetradecanol) 4.0 I 7.14 -0.144 
28 2,2-Dimethyl-3-pentanol 8.3 I 2.13 -1.005 
29 2-Methyl-1-pentanol 13.0 I 1.75 -0.695 
30 Cyclopentanol 21.7 I 1.43 -0.465 
31 Ethanol 24.0 I -0.14 -0.130 
32 Isopropanol (propan-2-ol) 28.3 I 0.28 -0.415 
33 Octanol 30.5 I 2.81 -0.688 
34 Furfuryl alcohol 41.0 I 0.45 -1.591 
35 2-Ethyl-1-hexanol 44.0 I 2.73 -0.756 
36 Isobutanol (butan-2-ol) 51.3 I 0.77 -0.500 
37 Butanol 60.3 I 0.84 -0.428 
38 Hexanol 64.8 I 1.82 -0.588 
39 Butyl cellosolve (2-butoxyethanol) 68.7 I 0.57 -1.165 
40 Cyclohexanol 79.8 I 1.92 -0.534 
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Table 6.1 continued 
 
No. Chemical MMAS Class logP dV1 
      
 Esters     
41 Methyl trimethyl acetate 2.7 NI 1.74 -1.699 
42 Ethyl trimethyl acetate 3.8 NI 2.23 -1.703 
43 Butyl acetate 7.5 I 1.85 -1.362 
44 Cellosolve acetate (2-ethoxyethyl acetate) 15.0 I 0.31 -1.913 
45 Ethyl acetate 15.0 I 0.86 -1.119 
46 Ethyl-2-methyl acetoacetate 18.0 I 0.21 -2.247 
47 Methyl cyanoacetate 27.7 I -0.47 -1.795 
48 Methyl acetate 39.5 I 0.37 -1.041 
49 Isopropyl isostearate 1.3 NI 9.07 -2.183 
      
 Ether     
50 Ethylene glycol diethyl ether 0.0 NI 0.77 -1.197 
      
 Ketones     
51 Di-iso-butyl ketone  
(2,6-dimethyl-4-heptanone) 
0.7 NI 2.56 -1.211 
52 Methyl isobutyl ketone 
(4-methylpentan-2-one) 
4.8 I 1.16 -0.991 
53 Methyl amyl ketone (2-heptanone) 13.4a I 1.73 -0.902 
54 Methyl ethyl ketone (butanone) 50.0 I 0.26 -0.686 
55 Acetone 65.8 I -0.24 -0.624 
56 γ-Butyrolactone 43.0 I -0.310 -0.972 
      
 Alkyl bromides     
57 2-Bromobutane 0.0 NI 2.58 0.039 
58 1-Bromo-4-chlorobutane 0.0 NI 2.90 0.392 
59 Bromooctane 0.0 NI 4.61 0.348 
60 Bromohexane 1.3 NI 3.63 0.335 
61 Bromopentane 2.0 NI 3.14 0.324 
62 1,6-Dibromohexane 2.0 NI 3.97 0.722 
63 Isopropyl bromide 2.7 NI 2.08 -0.027 
64 1,4-Dibromobutane 4.0 I 2.99 0.689 
65 1,5-Dibromopentane 4.0 I 3.48 0.709 
66 1,3-Dibromopropane 4.0 I 2.50 0.656 
      
 Sulphur-containing compounds     
67 2-Ethylhexylthioglycolate 0.0 NI 3.68 -1.611 
68 4-Methylthiobenzaldehyde 0.0 NI 2.31 -1.190 
69 Iso-octylthioglycolate 0.7 NI 3.68 -1.687 
70 Dipropyl disulphide 1.3 NI 3.84 1.553 
71 Thiodiglycol 5.3 I -0.62 -0.465 
72 Ethylthioglycolate 24.7 I 0.81 -1.123 
73 Methylthioglycolate 53.0 I 0.32 -1.083 
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Footnote to Table 6.1 
 
a13.4 is the mean of 10.5 and 16.3, the replicate MMAS values reported in ECETOC 
(1998a). 
 
dV1 = the first-order difference valence connectivity index; logP = the logarithm of the 
octanol-water partition coefficient; MMAS = modified maximum average score (taken 
from ECETOC, 1998a). 
 
 
Table 6.2 Ability of the elliptic model of eye irritation potential to classify 73  
organic chemicals 
 
Statistic Percent 
  
Sensitivity 73 
Specificity 78 
Concordance 75 
Positive predictivity 77 
Negative predictivity 74 
False positive rate 22 
False negative rate 27 
 
 
 
 
Table 6.3 Variability in the elliptic model parameters  
 
Parameter Estimate based on 
full data set 
Bootstrap 
mean 
Bootstrap 
standard 
deviation 
Bootstrap 
lower 95% 
CL 
Bootstrap 
upper 95% 
CL 
      
centroid 
along logP 
1.067 1.067 0.187 0.700 1.434 
centroid 
along dV1 
-0.983 -0.985 0.086 -1.154 -0.816 
radial axis 
along logP 
2.055 2.015 0.197 1.629 2.401 
radial axis 
along dV1 
0.986 0.958 0.129 0.705 1.211 
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7.1 OBJECTIVES 
 
The aim of the work presented in this chapter was to develop the CMs for predicting the 
skin irritation or corrosion potential of organic chemicals. In particular, the following 
types of model were sought: a) SARs based on physicochemical properties that are 
easily calculated; b) PMs based on measured pH values; and c) PMs based on in vitro 
data. The emphasis of this chapter is to describe the development and assessment of 
individual models, whereas the integrated use of classification models is discussed in 
Chapter 10. 
 
7.2 METHOD 
 
7.2.1 Collection and treatment of in vivo data 
 
Before developing SARs for skin corrosion, a data set of 277 organic chemicals (Table 
7.1) was constructed from a variety of literature sources (Barratt, 1995b, 1996a & 
1996b; ECETOC, 1995; NIH, 1999; Whittle et al., 1996). Chemicals taken from the 
ECETOC data bank (ECETOC, 1995) were classified for skin corrosion potential 
according to EU classification criteria (see Chapter 2); in the case of the chemicals 
taken from the other sources, the published classifications of corrosion potential were 
used. 
 
Before developing SARs for skin irritation, a data set of 139 organic chemicals (Table 
7.2) was compiled from the ECETOC data bank (ECETOC, 1995). These chemicals, 
which form a subset of the chemicals in Table 7.1, were classified for skin irritation 
potential in accordance with EU classification criteria (see Chapter 2).  For 21 of these 
chemicals, there was more than one data sheet in the ECETOC data bank, and therefore 
more than one primary irritation index (PII) value. In these cases, the PII with the 
smallest variability was taken, as judged by the size of the bootstrap interquartile range 
(see Chapter 5.2). In all cases, the PII was calculated by applying Equation 2.1 to the 
erythema and œdema scores obtained at three time-points (see Chapter 2.2). 
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7.2.2 Calculation of physicochemical properties 
 
The following physicochemical properties, which were considered to be possible 
predictors of acute skin toxicity, were calculated for the 277 chemicals in Table 7.1: 
molecular weight (MW), surface area (MSA) and volume (MV), logP, melting point 
(MP), surface tension (ST), pKa, the dermal permeability coefficient (Kp), dipole 
moment (DM), and the energies (ELUMO and EHOMO) of the lowest unoccupied molecular 
orbital (LUMO), and the highest occupied molecular orbital (HOMO). LogP, MP and 
Kp values were calculated with the Syracuse Research Corporation (SRC) KOWWIN, 
MPBPWIN and DERMWIN software packages (SRC, Syracuse, NY, USA), 
respectively, using the SMILES codes of the chemicals as the input. Values of MW and 
ST were calculated with the Advanced Chemistry Development (ACD) ChemSketch 
software, whereas pKa was calculated with the ACD pKa software (ACD, Toronto, 
Canada), using MOL files as the input. In the case of chemicals with more than one 
ionisable group, all pKa values were calculated. 
 
To calculate the steric (MSA and MV) and molecular orbital properties (DM, EHOMO, 
ELUMO), chemical structures were entered as SMILES codes into the TSAR (version 3.2) 
molecular spreadsheet (Oxford Molecular Ltd [OML], Oxford, England). The CORINA 
(version 3.21) program (OML) converted the corresponding 2D structures into 
approximate 3D conformations. These 3D structures were then optimised in two stages: 
firstly, by using the COSMIC force field in TSAR, and secondly, by using the AM1 
Hamiltonian in the VAMP (version 6.5) molecular orbital package (OML). The steric 
and molecular orbital properties were then calculated from the optimised 3D structures 
in VAMP. Predicted values of η and χ were calculated from EHOMO and ELUMO values 
by using Equations 3.36 and 3.37, respectively (see chapter 3). 
 
7.2.3 Development of structure-activity relationships 
 
A preliminary investigation of the skin corrosion data set was undertaken to detect any 
collinearities between potential predictor variables. Having eliminated redundant 
predictor variables, SARs were then derived by classification tree (CT) analysis, using 
the CART algorithm (Breiman et al., 1984) in STATISTICA 5.5 for Windows (Statsoft 
Inc., Tulsa, OK, USA). Equal prior probabilities were set for the two classes (C/NC or 
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I/NI), the Gini index was used as the measure of node homogeneity, and a minimum 
node size of 5 observations was used as the stopping rule (i.e. a node would only be 
split if it contained more than 5 observations). The best-sized tree in the sequence of 
optimally-pruned trees was identified by applying 10-fold cross-validation pruning and 
selecting the tree with the minimum cross-validated cost (see Chapter 4 for an 
explanation of CT analysis) .  
 
7.2.4 Development of prediction models 
 
All PMs were derived by CT analysis, using the settings described in section 7.2.3. To 
develop a PM for skin corrosion potential based on measured pH values, a data set of 75 
organic and inorganic chemicals (Table 7.3) was taken from Gordon et al. (1994). The 
PM obtained was validated by predicting the corrosivity classifications of a further 53 
chemicals (Table 7.4), for which pH data had been provided by BIBRA International 
(Croydon, UK). The pH data in Table 7.4 were also used to develop a PM for skin 
irritation potential.   
 
PMs based on in vitro endpoints were developed from the data obtained during the 
ECVAM Skin Corrosivity Validation Study (Barratt et al., 1998; Fentem et al., 1998) 
for the EPISKIN and rat skin transcutaneous electrical resistance (TER) assays. The 
EPISKIN data are cell viabilities, measured following treatment for 3 minutes, 1 hour 
and 4 hours; the TER data are electrical resistances measured across excised skin discs 
following their exposure for 2 and 24 hours (Table 7.4). 
 
7.2.5 Assessment of the models 
 
The two-group CMs were assessed in terms of their Cooper statistics (see § 4.3.4), 
which define an upper limit to predictive performance. In addition, cross-validated 
Cooper statistics, which provide a more realistic indication of a model’s capacity to 
predict the classifications of independent data, were obtained by applying three-fold 
cross-validation to the best-sized CTs. In the three-fold cross-validation procedure, the 
data set is randomly divided into three approximately equal parts, the CT is 
reparameterised using two thirds of the data, and predicted classifications are made for 
the remaining third of the data. The cross-validated Cooper statistics are the mean 
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values of the usual Cooper statistics, taken over the three iterations of the cross-
validation procedure.  
 
Finally, confidence intervals were calculated for the Cooper statistics, using a purpose-
written Minitab macro (Appendix A5). These calculations were performed to check 
whether the models derived had a predictive accuracy significantly greater than 50%. 
Confidence intervals were calculated for the standard Cooper statistics, but not for the 
cross-validated Cooper statistics, since the latter were obtained directly from 2x2 
contingency tables generated in STATISTICA 5.5 for Windows, which were not 
associated with a set of known and predicted classifications for the given set of 
chemicals. 
 
7.3 RESULTS 
 
7.3.1 Structure-activity relationships  
 
Preliminary data analysis 
The variables MW, MSA and MV were found to be strongly and significantly correlated 
in the data set of 277 chemicals (rMW-MSA = 0.89; rMW-MV = 0.93; rMV-MSA = 0.99; all p 
values < 0.001). Therefore, due to the relative ease of its calculation, MW was used in 
preference to MSA and MV, to avoid redundancy among predictor variables. Similarly, 
η and χ were significantly correlated (p<0.001) with ELUMO (r = 0.79 and –0.82 for η 
and χ, respectively). In this case, ELUMO was used in preference to η and χ, since these 
properties are derived from ELUMO (see chapter 3). 
 
Structure-activity relationships for skin corrosion  
A two-step decision rule was envisaged: in the first step, it was hypothesised that 
discrimination could be based on MP alone, on the grounds that chemicals existing as 
solids at skin temperature are not expected to be corrosive, whereas chemicals existing 
as liquids may or may not be, depending on other factors, which could be assessed in a 
second step. Separation of the 277 chemicals into two groups, one containing 88 
chemicals having predicted MPs greater than 37°C, and the other containing 189 
chemicals having predicted MPs less than or equal to 37°C, revealed that 74 of the 88 
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predicted solids (84%) are non-corrosive, as expected, whereas 14 of them (16%) are 
corrosive, contrary to expectation. 
 
The best variable for discriminating between corrosive and non-corrosive liquids, as 
judged by the application of CT analysis to the values of MW, logP, logKp, ST, DM, 
ELUMO, and EHOMO for the 189 liquids, was found to be logP. However, the CT predicted 
liquids with logP values greater than 1.32 to be non-corrosive, and liquids with logP 
values less than or equal to 1.32 to be corrosive. The direction of this inequality is 
contrary to expectation, since corrosive chemicals are generally expected to be more 
hydrophobic than non-corrosive chemicals, and therefore have higher, not lower, values 
of logP. A possible explanation for this finding is that logP is significantly correlated 
with MW (r=0.69, p<0.001), i.e. it is the smaller chemicals that are more likely to be 
corrosive, not the less hydrophobic ones. Therefore, logP was removed from the set of 
input variables, and CT analysis was applied again. This time, CT analysis identified 
MW as the best discriminating variable, with an optimal cut-off value of 123 g/mol. On 
this basis of this finding, SAR 1 was formulated for predicting the corrosion potential of 
organic liquids, and the variable selection procedure was stopped: 
 
If MW ≤ 123 g/mol, predict as C; otherwise predict as NC.   (SAR 1) 
 
Relationship between pKa and corrosion potential 
The acid dissociation constant, pKa, was not used as an input variable when selecting 
for predictors of skin corrosion potential, because values were only available for 97 of 
the 189 liquids (i.e. those chemicals having ionisable groups). These chemicals (Table 
7.5) can be divided according to chemical class, as follows: 27 carboxylic acids (26 C; 1 
NC), 34 bases (23 C; 11 NC), 22 alcohols (3 C; 19 NC) and 14 phenols (8C; 6 NC). The 
subset of carboxylic acids, containing mostly corrosives, and the subset of alcohols, 
containing mostly non-corrosives, were considered too unbalanced for the derivation of 
CMs. However, since alcohols are very weak acids (with pKa values of around 14-15), 
it was decided to merge the carboxylic acids with the alcohols, to form a larger subset of 
acids (now defined in a broader sense). In addition, the three corrosive alcohols 
(propargyl alcohol, 2-butyn-1,4-diol, and 2-hydroxyethyl acrylate) were removed, so the 
new data set comprised 46 acids (26 C; 20 NC), which was sufficiently well balanced 
for model development. The application of CT analysis to the data set of 46 acids 
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produced SAR 2. Similarly, the application of CT analysis to the subset of bases 
produced SAR 3. The Cooper statistics of SARs 2 and 3 are reported in Table 7.6. 
 
If the pKa of a carboxylic acid or alcohol ≤ 7.62, predict as C;  
otherwise, predict as NC.      (SAR 2) 
 
If the pKa of a base > 9.65, predict as C; otherwise, predict as NC.  (SAR 3) 
 
In the case of multi-functional compounds, pKa is taken to be the minimal pKa value in 
SAR 2, and the maximal pKa value in SAR 3. This prevents underestimation of the 
acidity of acids and the basicity of bases. 
 
Although CT analysis can also be used to determine a pKa cut-off value of 10.41 for 
phenols, above which they are predicted to be corrosive (with a sensitivity of 50%), and 
below which they are predicted to be non-corrosive (with a specificity of 100%), such a 
model was considered misleading on mechanistic grounds, since the phenols are weak 
acids with pKa values in the range 9.58 (3-methoxyphenol) to 11.34 (2-tert-
butylphenol), and yet such a model is analogous to the model for bases, implying that 
the corrosive effects of phenols results from their basicity. At the pH of the skin (about 
5.5), phenols exist predominantly in their undissociated form (Ar-OH), rather than in 
their phenoxide form (Ar-O-). It therefore seems unlikely that the corrosivity of phenols 
is based on a pH-dependent mechanism. 
 
 
 
Structure-activity relationships for skin irritation  
A similar approach was adopted for the development of SARs for skin irritation 
potential. Initially, the data set of 139 chemicals (Table 7.2) was divided into two 
groups, one containing 41 chemicals predicted to be solids, and the other containing 98 
chemicals predicted to be liquids. Of the 41 predicted solids, 28 (68%) are non-irritant, 
as expected, whereas 13 (32%) are irritants, contrary to expectation. The subsequent 
application of CT analysis to the data set of liquids, using MW, logP, logKp, ST, DM, 
ELUMO and EHOMO as input variables, identified ST as the best (and only) variable for 
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discriminating between I and NI chemicals, along which the optimal cut-off was found 
to be 35.8 dyne/cm. On this basis, the following SAR can be proposed: 
 
If ST ≤ 35.8 dynes/cm, predict as I; otherwise, predict as NI.  (SAR 4) 
 
The dyne is a unit of force equal to 10-5 Newtons (N). The ST in dynes/cm can be 
converted into N/m by dividing by 103. The Cooper statistics obtained by applying SAR 
4 are given in Table 7.6. 
 
7.3.2 Prediction models 
 
Prediction models based on pH data 
The application of CT analysis to the pH data in Table 7.3 produced the CT shown in 
Figure 7.1. The CT is interpreted by reading from the root node (node 1) at the top of 
the tree to the terminal nodes (nodes 2, 4 and 5) at the bottom. Before the splitting 
process begins, all 75 observations are placed in node 1. According to the first decision 
rule, which is applied to all observations, observations with pH values less than 2.4 are 
placed in node 2 and predicted to be corrosive; otherwise they are placed in node 3 and 
subjected to the second decision rule. According to the second rule, observations are 
placed in node 4 and predicted to be non-corrosive if they have pH values less than or 
equal to 10.9; otherwise, they are placed in node 5 and predicted to be corrosive. The 
numbers above each node show how many observations (chemicals) are sent to each 
node, and the histograms illustrate the relative proportions of corrosive and non-
corrosive chemicals in each node. The CT for skin corrosion potential can be 
summarised in the form of PM 1. Similarly, the CT for skin irritation potential (not 
shown) can be expressed as PM 2. 
 
If pH < 2.4 or if pH > 10.9, then predict as C; otherwise, predict NC. (PM 1) 
If pH < 4.4 or if pH > 9.2, then predict as I; otherwise, predict NI.  (PM 2) 
 
where pH is measured for a 10% solution (w/v in the case of liquids, and w/w in the 
case of solids. It is suggested that PM 1 is applied first, and that PM 2 is applied to those 
chemicals predicted to be NC by PM 1. The Cooper statistics obtained by applying PMs 
1 and 2, including the application of PM 1 to an independent test set, are given in Table 
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7.7. The independent data set consisted of 53 chemicals from the ECVAM Skin 
Corrosivity Study for which pH data had been obtained for a 10% solution (Table 7.4). 
 
Prediction models based on in vitro data 
The application of CT analysis to the EPISKIN data for 59 chemicals (Table 7.4) 
produced the following PMs:  
 
If the EPISKIN viability after 4h exposure < 36%, predict C;  
otherwise, predict NC.       (PM 3) 
 
If the EPISKIN viability after 4h exposure < 67%, predict I;  
otherwise, predict NI.       (PM 4) 
 
It is suggested that PM 4 is applied to chemicals predicted to be NC by PM 3.  
 
A PM for predicting skin corrosion potential was also derived from in vitro data 
obtained by the rat skin transcutaneous electrical resistance (TER) assay: 
 
If TER after 2h exposure < 8.8 kΩ, predict C; otherwise, predict NC.  (PM 5) 
 
The 2-hour endpoint was selected by the CT algorithm in preference to the 24-hour 
endpoint. A scatter plot of 2-hour vs 24-hour TER data showed no discrimination 
between I and NI chemicals, but this was not expected, since the TER assay is designed 
to detect chemicals with the potential to lyse the stratum corneum, but not chemicals 
that exert milder, inflammatory effects. The Cooper statistics obtained by applying PMs 
3, 4 and 5 are given in Table 7.7. 
 
7.4 DISCUSSION 
 
In this chapter, a number of CMs for predicting the skin irritation and corrosion 
potentials of organic and inorganic chemicals are reported. These models either take the 
form of SARs based on easily obtained or calculated physicochemical data, or the form 
of PMs based on physicochemical or in vitro measurements. Since PMs are based on 
experimental measurements, it is important that the data used to develop the PMs have 
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been obtained by a standardised protocol. The pH measurements analysed in this study 
are standardised in the sense that they refer to measurements obtained in a 10% aqueous 
solution. The in vitro data (TER and EPISKIN) were taken from a validation study in 
which the use of standardised protocols was a requirement.  
 
7.4.1 Contribution to existing knowledge  
 
An important consideration of this study was that the models developed should take the 
form of explicit and objective algorithms for predicting animal-based classifications of 
acute local toxicity. The value of such decision rules is that they can be applied by a 
range of users (e.g. industrial toxicologists who need to perform in-house risk 
assessments) without the need for specialised software. This kind of model is lacking in 
many of the previous studies described in Chapter 2. In one of these studies, linear 
discriminant analysis was used (Barratt et al., 1996a), but no attempt was made to 
define a linear model. In another study (e.g. Barratt et al., 1996b), models with excellent 
performance statistics were reported, but the models were derived by using neural 
network analysis, from which explicit decision rules could not be formulated. An 
argument that can be made against the development of explicit models is that they are 
necessarily based on the assumption of a particular mathematical form, which may not 
be correct; for example, in this chapter, all of the models are based on simple cut-off 
values along one or more predictor variables. Against this argument, one of the 
contentions of this thesis is that the ‘true’ form of a model may never be known (indeed, 
there may be no such thing as a true model). Therefore, a pragmatic choice must be 
made according to the following considerations: a) the model should be no more 
complicated than necessary; b) it should make sense in mechanistic terms; and c) it 
should meet one or more criteria of predictive performance. 
 
A similar approach has recently been reported by Gerner and colleagues, who 
developed decision rules on the basis of confidential industrial data (Gerner et al., 2000; 
Zinke et al., 2000). The main difference between the work of Gerner and colleagues and 
the work presented here is that the former is based on a series of exclusion rules to 
detect the absence of toxic potential (e.g. if MW > 1200 g/mol, then the substance has 
no local toxic effects). The emphasis of those papers was to describe the successful 
application of the decision rules, but very few rules were cited. 
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The results of this study confirm the importance of certain physicochemical properties 
previously reported to be useful predictors of skin corrosion potential (MP, MW, pKa 
and pH). In addition, a statistically significant relationship between ST and skin 
irritation potential was found. CMs developed on the basis of these properties were 
found to satisfy a minimal set of predictivity criteria, with the exception of the CM 
based on ST.  
 
LogP was also found to discriminate between corrosive and non-corrosive chemicals, 
but the direction of the separation was contrary to expectation: low logP values were 
associated with the presence of corrosion, whereas high logP values were associated 
with the absence of corrosion. An inverse relationship between corrosion potential and 
logP also emerged (but was not commented upon) in several PCA studies (Barratt, 
1995b; Barratt et al., 1998). It was decided that the apparent importance of logP may be 
a reflection of the importance of MW, resulting from the collinearity between logP and 
MW. It has been argued (e.g. Barratt, 1995b) that logP plays a role in skin corrosion on 
the basis that hydrophobic chemicals are more likely than hydrophilic ones to diffuse 
across the stratum corneum. However, if it is assumed that the rate-limiting step in the 
production of a corrosive response is the transfer of the applied chemical from its bulk 
phase (solid or liquid) into the skin, one could question the importance of logP on the 
grounds that this provides a measure of the ability of a chemical to partition between 
octanol and water, rather than between the neat substance and the stratum corneum, 
which would be the more appropriate partitioning process to model, given that in the 
Draize skin test, most liquids and solids are applied neat, rather than as aqueous 
solutions. In other words, the octanol-water partition coefficient may be a poor 
substitute for the liquid-stratum corneum partition coefficient.  
 
As far as the author is aware, the usefulness of the dermal permeability coefficient (Kp) 
for predicting acute skin toxicity has not been reported. In this study, no evidence was 
found for a relationship between Kp and any of the following: skin corrosion potential, 
skin irritation potential, or skin irritation potency (PII). A possible explanation for this is 
that corrosive chemicals do not need to diffuse through the stratum corneum to exert 
their effects in the viable epidermis - they can simply penetrate by lysis or 
solubilisation. Irritant chemicals, on the other hand, are expected to penetrate by 
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diffusion, so some relationship might be expected between the extent of irritancy and 
the degree of penetration. However, since irritant chemicals can initiate the 
inflammatory process by acting upon corneocytes in the lower stratum corneum 
(chapter 2), they do not have far to penetrate before triggering an irritant response. 
Thus, it is likely that all chemicals (irritant and non-irritant) will traverse the stratum 
corneum during the time-course of the animal test (1-3 days). 
 
PMs 1 and 2 were based on measured pH values. A PM for corrosion potential is 
already cited in the OECD Test Guideline for skin corrosion (see chapter 2). However, 
this does not provide any guidance on the concentration at which the pH measurements 
should be made. In this work, it is clearly stated that PMs 1 and 2 are based on pH 
measurements in a 10% solution (w/w for solids, w/v for liquids), and are being used to 
predict the corrosion potential (PM 1) or irritation potential (PM 2) of the neat 
substance. It is therefore possible that these PMs will over-predict the effects of 
substances applied to the skin as dilute solutions. As far as the author is aware, no 
model similar to PM 2 for the prediction of skin irritation potential has been published, 
although a PM based on the combined use of pH and acid-alkaline reserve 
measurements has been proposed (see Chapter 2). An advantage of the PMs based on 
pH over SAR based on pKa measurements is that the former are applicable to both 
inorganic and organic substances, and to mixtures, whereas the latter are only applicable 
to certain groups of pure organic chemicals. 
 
The other PMs cited in this chapter are based on in vitro data. The PM for skin 
corrosion based on EPISKIN measurements (PM 3) is similar to the one used in the 
ECVAM Validation Study (in which a cut-off value of 35% viability was adopted). The 
PM for skin irritation potential (PM 4) based on EPISKIN data is novel in that no such 
model has been published in the literature, as far as the author is aware. The PM for skin 
corrosion based on TER data (PM 5) is different from the one used in the ECVAM Skin 
Corrosivity Validation Study (Fentem et al., 1998) in that a cut-off value of 8.8 kΩ is 
proposed instead of 5 kΩ. In addition, PM 5 is less restrictive in that neutral organics 
and surfactants are included in the domain of the model, whereas the PM used in the 
validation study introduces an exception clause for these chemicals, to reduce the 
number of false positives.  
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7.4.2 Interpretation and assessment of the models 
 
The importance of MP can be related to the physical state of the substance under the 
conditions of Draize test. In this study, it was assumed that chemicals with a MP less 
than or equal to 37°C would exist as liquids in the test procedure, and that, in general, 
liquids would be more likely than solids to cause corrosion and irritation. The results 
confirm that there is indeed a relationship between physical state and the potential for 
acute skin toxicity. The fact that some solids are corrosive or irritant may relate to the 
fact that their MPs are not much higher than 37°C and that they exist as wax-like 
substances, which are more capable of penetrating into the skin than are solids with 
higher MPs. For example, carvacrol and thymol, which are both irritant and corrosive, 
have predicted MPs of 38°C and 38.1°C, respectively. In the case of other solids, such 
as benzene sulphonyl chloride (MP = 61°C), the corrosive response may be due to a 
more toxic derivative (e.g. benzene sulphonic acid).  
 
The importance of MW is probably related to the fact that small molecules are more 
likely to penetrate into the skin and cause corrosion than are larger chemicals. An 
alternative explanation could be that chemicals with lower MWs are applied in greater 
molar amounts than chemicals with higher MWs, since a fixed volume (or weight) of 
test substance is applied in the Draize test (see Chapter 2). Indeed, this could be 
regarded as a limitation in the protocol of the Draize test, which could be improved by 
adopting a fixed molar dose of the test substance. 
 
The acid dissociation descriptor, pKa, was found to be useful for predicting the 
corrosion potentials of organic acids (carboxylic acids and alcohols) and bases. Three 
alcohols (propargyl alcohol, 2-butyn-1,4-diol, 2-hydroxyethyl acrylate) were excluded 
from the training set of acids, since they were considered to be unrepresenatative of 
alcohols in general. The corrosivity of the first two alcohols, which are both α,β-
hydroxy alkynes, has been attributed to their oxidation to conjugated aldehydes, which 
then act as electrophiles (Barratt et al., 1998). The corrosivity of 2-hydroxyethyl 
acrylate can be associated with the presence of the acrylate group, rather than the 
hydroxy group, since acrylic acid is also corrosive.  
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It was hypothesised that ST might play a role in acute local toxicity, on the grounds that 
liquids with a low surface tension will have a greater tendency to spread across the skin 
surface and therefore be more toxic. While the results suggest that there is indeed an 
inverse relationship between ST and skin irritation potential, the CM based on ST did 
not have a satisfactory predictivity. Furthermore, no meaningful relationship between 
ST and skin corrosion potential could be derived, since the mean ST of the corrosive 
chemicals (38.6 dyne/cm) was not significantly different from the mean for non-
corrosives (38.1 dyne/cm) 
 
The acidicity/basicity descriptor pH provides a useful means of identifying substances 
that are irritant or corrosive to the skin by disrupting its pH balance (away from a value 
of about 5.5). It is noticeable that the cut-offs for PM 1 are further toward the extremes 
of the pH scale than are the corresponding cut-offs for PM 2, which is consistent with 
the fact that corrosion is a stronger effect than irritation. 
  
The performance of each CM is summarised in terms of its standard and cross-validated 
Cooper statistics (Table 7.6 for the SARs; Table 7.7 for the PMs). Strictly speaking, 
Cooper statistics should not be compared between different CMs, unless these models 
have been applied to the same set of data (i.e. if predicted classifications have been 
made for the same set of chemicals). However, if Cooper statistics are accompanied (as 
they are in Tables 7.6 and 7.7) by 95% confidence intervals (CIs) that reflect chemical 
variability, it is acceptable to compare the statistics between models. Thus, in principle, 
the CMs presented in Tables 7.6 and 7.7 could be compared. However, it was not the 
purpose of this study to compare the CMs with each another, but simply to determine 
whether each model is ‘acceptable’ for incorporation into a tiered testing strategy. It is 
therefore necessary to define what ‘acceptable’ means in this context. Firstly, it is 
necessary (but not sufficient) that the contingency table for each model should be 
statistically significant. Indeed, the χ2 values for all of the models reported in this 
chapter are significant. However, it is clear from the Cooper statistics that the models 
are not equally predictive, so additional criteria are required. A minimal requirement for 
any classification model is that its concordance, sensitivity and specificity should be 
significantly greater than 50%, i.e. the predicted classifications generated by the model 
should be more reliable than predictions obtained by chance alone. It can be seen that 
SAR 4, which predicts the skin irritation potential of liquids, has a specificity of 32% 
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and therefore an unacceptable false positive rate of 68%. However, SARs 1-3, and PMs 
1-5 are all acceptable, according to the above-mentioned criteria.  
 
7.4.3 Strategic use of the models 
 
To integrate the use of acceptable CMs, a stepwise assessment strategy can be 
formulated on the basis of two premises: a) corrosion potential should be identified 
before irritation potential, since corrosive chemicals are necessarily irritant, but non-
corrosives may be irritant or non-irritant; and b) the order of the steps should reflect the 
relative ease and cost of applying the CMs. Thus, the first step should be based on 
SARs, since these are the easiest CMs to apply, not being based on experimental data, 
and subsequent steps should be based on PMs, using physicochemical (pH) data before 
in vitro (EPISKIN) data. A general outline of this scheme is given in Figure 7.2, and a 
specific implementation is evaluated in Chapter 10. 
 
7.5 CONCLUSIONS 
 
From the results of this study, it is concluded that: 
 
1. The skin corrosion and irritation potentials of a diverse range of chemicals can be 
related to a few easily-obtained physicochemical properties (MP, MW, pKa, pH 
and ST). In particular, there is a tendency for solids to be non-corrosive and non-
irritant. Liquids are corrosive if they have sufficiently low MWs, or if they are acids 
or bases with sufficiently extreme values of pKa. In addition, there is a tendency for 
liquids to be irritant if they have a sufficiently low ST. However, an SAR based on 
ST was not sufficiently predictive, according to the minimal set of criteria adopted 
in this chapter.  
 
2. Acceptable PMs for skin corrosion and irritation potential can be derived from 
measured pH values, and from in vitro data obtained with the EPISKIN test. 
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Figure 7.1 Classification tree for distinguishing between corrosive and non-
corrosive chemicals on the basis of pH measurements 
 
 
 
Footnote to Figure 7.1 
 
C = corrosive; NC = non-corrosive. 
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Figure 7.2 Outline of a tiered assessment strategy for acute local toxicity 
 
Step 1: Apply SARs for corrosion ⇒ predict as C or NC 
⇓ 
NC or no prediction 
⇓ 
Step 2: Apply PM for corrosion based on pH data ⇒ predict as C or NC 
⇓ 
NC or no prediction 
⇓ 
Step 3: Apply PM for corrosion based on EPISKIN data ⇒ predict as C or NC 
⇓ 
NC 
⇓ 
Step 4: Apply PM for irritation based on pH data ⇒ predict I or NI 
⇓ 
NI or no prediction 
⇓ 
Step 5: Apply PM for irritation based on EPISKIN data ⇒ predict as I or NI 
⇓ 
NI 
⇓ 
Step 6: Perform Draize test ⇒ classify as C, I or NI 
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Table 7.1  Skin corrosion data set of 277 organic chemicals 
 
Chemical Source C/NC MP MW ST pKa1 pKa2 pKa3 
          
1 1-Naphthoic acid Barratt, 1996a NC 106.7 172.2 56.5 3.68   
2 1-Naphthol Barratt, 1996a NC 67.7 144.2 51.0 9.40   
3 2,3-Lutidine Barratt, 1996a NC -7.6 107.2 33.2 6.24   
4 2,3-Xylenol Barratt, 1996a C 25.4 122.2 37.2 10.42   
5 2,4,6-Trichlorophenol Barratt, 1996a NC 63.8 197.5 50.5 6.59   
6 2,4-Dichlorophenol Barratt, 1996a NC 46.8 163.0 47.8 8.05   
7 2,4-Dinitrophenol Barratt, 1996a NC 118.5 184.1 79.6 4.04   
8 2,4-Xylenol Barratt, 1996a C 25.4 122.2 37.2 10.61   
9 2,5-Dinitrophenol Barratt, 1996a NC 118.5 184.1 79.6 5.35   
10 2,5-Xylenol Barratt, 1996a C 25.4 122.2 37.2 10.42   
11 2,6-Xylenol Barratt, 1996a C 25.4 122.2 37.2 10.66   
12 2-Bromobenzoic acid Barratt, 1995b NC 81.6 201.0 53.7 2.85   
13 2-Butyn-1,4-diol Barratt, 1996b C 29.0 86.1 60.0 12.72 13.35  
14 2-Chlorobenzaldehyde Barratt, 1996b C 8.7 140.6 42.2    
15 2-Chloropropanoic acid Barratt, 1996a C 8.1 108.5 37.6 2.96   
16 2-Ethylphenol Barratt, 1996a NC 27.1 122.2 37.6 10.27   
17 2-Hydroxyethyl acrylate Barratt, 1996b C -15.9 116.1 35.4 13.85   
18 2-Mercaptoethanoic acid Barratt, 1996a C 18.8 92.1 48.5 3.73 10.60  
19 2-Naphthoic acid Barratt, 1996a NC 106.7 172.2 56.5 4.20   
20 2-Naphthol Barratt, 1996a NC 67.7 144.2 51.0 9.57   
21 2-Nitrophenol Barratt, 1996a NC 70.8 139.1 60.2 7.14   
22 2-Phenylphenol Barratt, 1996a NC 86.6 170.2 44.5 9.99   
23 3-Methylbutanal Barratt, 1996b NC -79.3 86.1 22.6    
24 3-Nitrophenol Barratt, 1996a NC 70.8 139.1 60.2 8.33   
25 3-Picoline Barratt, 1996a NC -25.9 93.1 34.0 5.52   
26 3-Toluidine Barratt, 1995b NC 11.6 107.2 39.5 4.72   
27 4-Ethylbenzoic acid Barratt, 1996a NC 73.5 150.2 43.4 4.35   
28 4-Methoxyphenol Barratt, 1996a NC 25.2 124.1 38.6 10.40   
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Table 7.1  Skin corrosion data set of 277 organic chemicals 
 
Chemical Source C/NC MP MW ST pKa1 pKa2 pKa3 
          
29 4-Nitrophenol Barratt, 1996a NC 70.8 139.1 60.2 7.23   
30 4-Nitrophenylacetic acid Barratt, 1996a NC 124.3 181.2 61.9 3.86   
31 4-Picoline Barratt, 1996a NC -25.9 93.1 34.0 5.94   
32 Acridine Barratt, 1995b NC 100.3 179.2 54.0 5.50   
33 Acrolein Barratt, 1996b C -94.6 56.1 20.1    
34 Acrylic acid Barratt, 1995b C -36.5 74.1 39.0 4.25   
35 Aminotris(methylphosphonic acid) Barratt, 1996a C 90.3 299.1 143.1 0.42 0.82 1.13 
36 Barbituric acid Barratt, 1996a NC 199.0 128.1 48.7 4.00 11.46 17.35 
37 Benzoic acid Barratt, 1996a NC 48.9 122.1 48.7 4.20   
38 Benzylamine Barratt, 1996a C -6.2 93.1 41.7 4.61   
39 Butyric acid Barratt, 1996a C 3.0 88.1 32.5 4.76   
40 Catechol Barratt, 1996a NC 45.7 110.1 57.1 9.50 12.84  
41 Citric acid Barratt, 1995b NC 169.2 192.1 103.9 2.93 4.23 5.09 
42 Cocoamine (dodecylamine) Barratt, 1995b C 35.1 185.4 29.9 10.67   
43 Cyanoacetic acid Barratt, 1996a C 38.0 85.1 57.0 2.47   
44 Cyclopropane carboxylic acid Barratt, 1996a C 13.0 86.1 57.9 4.78   
45 Decanoic acid Barratt, 1995b NC 62.7 172.3 33.1 4.79   
46 Formaldehyde Barratt, 1996b C -110.9 30.0 12.6    
47 Fumaric acid Barratt, 1996a NC 84.1 116.1 67.6 3.15 4.79  
48 Glycolic acid Barratt, 1996a NC 23.3 76.1 61.3 3.74 16.46  
49 Glyoxylic acid Barratt, 1996a C 16.1 74.0 50.2 2.61   
50 Hexylcinnamic aldehyde Barratt, 1996b NC 44.4 216.3 35.7    
51 Hydrogenated tallow amine (hexadecylamine) Barratt, 1996a NC 75.6 241.5 30.7 10.67   
52 Hydroquinone Barratt, 1996a NC 45.7 110.1 57.1 10.33 11.86  
53 Imidazole Barratt, 1995b NC 18.5 68.1 48.6 6.95 14.52  
54 Iodoacetic acid Barratt, 1996a C 29.6 186.0 58.5 3.17   
55 Isobutanal Barratt, 1996b NC -80.2 72.1 22.5    
56 Isobutyric acid Barratt, 1996a C -8.3 88.1 30.4 4.85   
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Table 7.1  Skin corrosion data set of 277 organic chemicals 
 
Chemical Source C/NC MP MW ST pKa1 pKa2 pKa3 
          
57 Isoeugenol Barratt, 1996a NC 61.9 164.2 38.9 10.15   
58 Isoquinoline Barratt, 1995b NC 37.6 129.2 46.6 5.37   
59 Kojic acid Barratt, 1996a NC 96.2 142.1 71.5 8.05 13.78  
60 Lactic acid Barratt, 1995b C 22.7 90.1 49.7 3.90 16.52  
61 Malic acid Barratt, 1996a NC 112.7 134.1 86.2 3.61 4.82 16.29 
62 Malonic (propanedioic) acid  Barratt, 1996a NC 73.3 104.1 70.5 2.92 5.61  
63 3-Cresol Barratt, 1995b C 15.7 108.1 38.8 10.07   
64 Methoxyacetic acid Barratt, 1996a C 8.7 90.1 35.5 3.54   
65 Methyl isothiocyanate Barratt, 1996b C -63.3 73.1 26.3    
66 Morpholine Barratt, 1995b C -15.2 87.1 29.2 8.97   
67 Myristic (tetradecanoic) acid Barratt, 1995b NC 99.7 228.4 33.3 4.78   
68 2-Cresol Barratt, 1995b C 15.7 108.1 38.8 10.31   
69 Oxalic (ethanedioic) acid Barratt, 1995b C 63.0 90.0 87.3 1.38 4.28  
70 4-Cresol Barratt, 1995b C 15.7 108.1 38.8 10.21   
71 Propargyl alcohol Barratt, 1996b C -49.0 56.1 37.9 13.21   
72 Propylphosphonic acid Barratt, 1996a C 28.3 124.1 48.9 2.43 8.10  
73 Pyridine Barratt, 1995b NC -44.5 79.1 35.2 5.32   
74 Pyruvic acid Barratt, 1996a C 28.2 88.1 42.6 2.65   
75 Quinoline Barratt, 1995b NC 37.6 129.2 46.6 4.97   
76 Salicylic acid Barratt, 1995b NC 93.8 138.1 64.4 3.01 13.70  
77 Succinic acid Whittle, 1996 NC 83.3 118.1 61.6 4.24 5.52  
78 Thymol Barratt, 1996a C 38.1 150.2 34.9 10.59   
79 trans-Cinnamic acid Barratt, 1995b NC 69.5 148.2 49.7 3.88   
80 3-Methoxyphenol Barratt, 1996a NC 25.2 124.1 38.6 9.58   
81 4-Ethylphenol Barratt, 1996a NC 27.1 122.2 37.6 10.25   
82 Phenol Barratt, 1995b C -2.3 94.1 40.9 9.86   
83 1,1,1-Trichloroethane ECETOC, 1995 NC -72.0 133.4 28.9    
84 1,13-Tetradecadiene ECETOC, 1995 NC -1.2 194.4 26.5    
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Table 7.1  Skin corrosion data set of 277 organic chemicals 
 
Chemical Source C/NC MP MW ST pKa1 pKa2 pKa3 
          
85 1,3-Dibromopropane ECETOC, 1995 NC -27.0 201.9 36.0    
86 1,5-Hexadiene ECETOC, 1995 NC -96.7 82.2 19.9    
87 1,6-Dibromohexane ECETOC, 1995 NC 7.9 244.0 35.2    
88 1,9-Decadiene ECETOC, 1995 NC -46.8 138.3 24.2    
89 10-Undecenoic Acid ECETOC, 1995 NC 71.5 184.3 33.4 4.78   
90 1-Bromo-2-chloroethane ECETOC, 1995 NC -58.0 143.4 30.4    
91 1-Bromo-4-chlorobutane ECETOC, 1995 NC -33.6 171.5 31.3    
92 1-Bromo-4-fluorobenzene ECETOC, 1995 NC -19.1 175.0 33.8    
93 1-Bromohexane ECETOC, 1995 NC -41.6 165.1 27.7    
94 1-Bromopentane ECETOC, 1995 NC -53.8 151.1 26.9    
95 1-Decanol ECETOC, 1995 NC 7.9 158.3 29.8 15.21   
96 1-Formyl-1-methyl-4(4-methyl-3-penten-1-yl)-3-
cyclohexane 
ECETOC, 1995 NC 46.5 208.4 34.2    
97 2,3-Dichloroproprionitrile ECETOC, 1995 NC -21.2 124.0 37.5    
98 2,4-Decadienal ECETOC, 1995 NC 6.0 154.3 31.1    
99 2,4-Dimethyl-3-cyclohexene-1-carboxaldehyde ECETOC, 1995 NC -10.1 138.2 34.4    
100 2,4-Dimethyltetrahydrobenzaldehyde ECETOC, 1995 NC -10.1 138.2 34.4    
101 2,4-Dinitromethylaniline ECETOC, 1995 NC 108.9 197.2 65.4 -3.46   
102 2,4-Hexadienal ECETOC, 1995 NC -56.2 96.1 26.4    
103 2,4-Xylidine ECETOC, 1995 NC 34.7 135.2 36.2 9.57   
104 2,5-Methylene-6-propyl-3-cyclo-hexen-carbaldehyde ECETOC, 1995 NC 15.2 164.3 39.5    
105 2,6-Dimethyl-2,4,6-octatriene ECETOC, 1995 NC -21.2 134.2 26.0    
106 2,6-Dimethyl-4-heptanol ECETOC, 1995 NC -38.1 144.3 26.6 15.31   
107 2-Bromobutane ECETOC, 1995 NC -78.1 137.0 24.6    
108 2-Bromopropane ECETOC, 1995 NC -91.0 123.0 23.1    
109 2-Chloronitrobenzene ECETOC, 1995 NC 48.8 157.6 48.3    
110 2-Ethoxyethyl methacrylate ECETOC, 1995 NC -25.2 158.2 27.9    
111 2-Ethylhexanal ECETOC, 1995 NC -42.3 128.2 25.7    
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Chemical Source C/NC MP MW ST pKa1 pKa2 pKa3 
          
112 2-Ethylhexylpalmitate ECETOC, 1995 NC 117.2 368.7 30.7    
113 2-Fluorotoluene ECETOC, 1995 NC -54.2 110.1 27.6    
114 2-Methoxyethyl acrylate ECETOC, 1995 C -56.2 128.2 23.7    
115 2-Methoxyphenol (guaiacol) Barratt, 1996a NC 25.2 124.1 38.6 9.97   
116 2-Methyl-4-phenyl-2-butanol ECETOC, 1995 NC 30.4 164.3 36.1 15.17   
117 2-Methylbutyric acid ECETOC, 1995 C 3.6 102.1 30.9 4.80   
118 2-Phenylethanol (phenylethylalcohol) ECETOC, 1995 NC 5.8 122.2 51.4 13.61 15.04  
119 2-Phenylpropanal (2-phenylpropionaldehyde) ECETOC, 1995 NC -10.0 134.2 34.3    
120 2-tert-Butylphenol ECETOC, 1995 C 36.9 150.2 32.9 11.34   
121 3,3'-Dithiopropionic acid ECETOC, 1995 NC 141.5 210.3 68.0 3.94 4.56  
122 3,7-Dimethyl-2,6-nonadienal ECETOC, 1995 NC -3.9 180.3 27.3    
123 3-Chloro-4-fluoronitrobenzene ECETOC, 1995 NC 44.2 175.6 45.9    
124 3-Diethylaminopropionitrile ECETOC, 1995 NC -0.4 126.2 32.1 9.16   
125 3-Mercapto-1-propanol ECETOC, 1995 NC -33.6 92.2 35.9 10.39 15.17  
126 3-Methoxypropylamine ECETOC, 1995 NC -40.4 89.1  9.73   
127 3-Methylphenol ECETOC, 1995 NC 15.7 108.1 38.8 10.07   
128 3-Methylbutyraldehyde ECETOC, 1995 NC -79.3 86.1 22.6    
129 4-(Methylthio)-benzaldehyde ECETOC, 1995 NC 28.6 152.2 43.3    
130 4,4'-Methylene-bis-(2,6-ditert-butylphenol) ECETOC, 1995 NC 208.5 424.7 33.5 12.39 13.10  
131 4-Amino-1,2,4-triazole ECETOC, 1995 NC 31.0 84.1 80.6 3.49   
132 4-Tricyclo-decylindene-8-butanal ECETOC, 1995 NC 233.9 494.9 37.1    
133 6-Butyl-2,4-dimethyldihydropyrane ECETOC, 1995 NC -2.3 168.3 35.0    
134 α-Hexyl cinnamic aldehyde ECETOC, 1995 NC 44.4 216.3 35.7    
135 α-Ionol ECETOC, 1995 NC 45.2 194.3 34.9 14.52   
136 Allyl bromide ECETOC, 1995 C -80.5 121.0 24.7    
137 Allyl heptanoate ECETOC, 1995 NC -10.8 170.3 28.4    
138 Allyl phenoxyacetate ECETOC, 1995 NC 36.5 192.2 36.2    
139 α-Terpineol ECETOC, 1995 NC 12.4 154.3 33.2 15.09   
140 α-Terpinyl acetate ECETOC, 1995 NC 21.5 196.3 31.8    
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Chemical Source C/NC MP MW ST pKa1 pKa2 pKa3 
          
141 Benzyl acetate ECETOC, 1995 NC -0.5 150.2 35.9    
142 Benzyl acetone ECETOC, 1995 NC 12.8 148.2 34.1    
143 Benzyl alcohol ECETOC, 1995 NC -5.4 108.1 40.7 14.36   
144 Benzyl benzoate ECETOC, 1995 NC 70.8 212.3 44.0    
145 Benzyl salicylate ECETOC, 1995 NC 115.5 228.3 51.4 8.11   
146 β-Ionol ECETOC, 1995 NC 54.5 194.3 35.8 14.41   
147 Butyl propanoate ECETOC, 1995 NC -44.6 130.2 25.8    
148 Carvacrol  ECETOC, 1995 C 38.1 150.2 34.9 10.37   
149 Cinnamaldehyde ECETOC, 1995 NC 0.0 132.2 38.9    
150 Cinnamyl alcohol ECETOC, 1995 NC 15.8 134.2 42.6 14.61   
151 cis-Cyclooctene ECETOC, 1995 NC -58.8 110.2 28.2    
152 cis-Jasmone ECETOC, 1995 NC 40.2 164.3 31.1    
153 Citrathal ECETOC, 1995 NC 4.8 226.4 27.1    
154 Cyclamen aldehyde ECETOC, 1995 NC 29.1 190.3 32.4    
155 Diacetyl ECETOC, 1995 NC -41.7 86.1 26.4    
156 Dichloromethane ECETOC, 1995 NC -89.5 84.9 23.1    
157 Diethyl phthalate ECETOC, 1995 NC -1.7 222.2 39.3    
158 Diethylaminopropylamine ECETOC, 1995 C 0.7 130.2 30.8 8.94 10.54  
159 Dihydromercenol ECETOC, 1995 NC -10.6 156.3 27.7 15.29   
160 Dimethyl disulphide ECETOC, 1995 NC -69.7 94.2 32.1    
161 Dimethylbenzylcarbinyl acetate ECETOC, 1995 NC 28.3 192.3 33.9    
162 Dimethyldipropylenetriamine ECETOC, 1995 C 40.4 159.3 33.2 7.36 9.56 10.30 
163 Dimethylisopropylamine ECETOC, 1995 C -95.4 87.2 21.0 9.91   
164 Dimethyl butylamine ECETOC, 1995 C -70.6 101.2 23.4 9.83   
165 Dipropyl disulphide ECETOC, 1995 NC -21.8 150.3 32.8    
166 Dipropylene glycol ECETOC, 1995 NC 6.1 134.2 36.4 14.18 14.80  
167 dl-Citronellol ECETOC, 1995 NC -12.2 156.3 28.5 15.13   
168 d-Limonene ECETOC, 1995 NC -40.8 136.2 25.8    
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Chemical Source C/NC MP MW ST pKa1 pKa2 pKa3 
          
169 Dodecanoic (lauric) acid ECETOC, 1995 NC 81.9 200.3 33.2 4.78   
170 Erucamide ECETOC, 1995 NC 183.4 337.6 33.4 16.61   
171 Ethyl thioethyl methacrylate ECETOC, 1995 NC -8.5 174.3 31.9    
172 Ethyl tiglate ECETOC, 1995 NC -53.9 128.2 26.1    
173 Ethyl triglycol methacrylate ECETOC, 1995 NC 51.3 246.3 31.5    
174 Ethyl trimethyl acetate ECETOC, 1995 NC -68.4 116.2 24.6    
175 Eucalyptol ECETOC, 1995 NC 8.1 154.3 32.4    
176 Eugenol ECETOC, 1995 NC 60.6 164.2 36.5 10.29   
177 Fluorobenzene ECETOC, 1995 NC -73.0 96.1 27.4    
178 Geraniol ECETOC, 1995 NC -10.8 154.3 29.1 14.57   
179 Geranyl dihydrolinalol ECETOC, 1995 NC 60.0 292.5 30.3 15.23   
180 Geranyl linalol ECETOC, 1995 NC 58.5 290.5 30.4 14.41   
181 Glycol bromoacetate ECETOC, 1995 C 1.2 303.9 48.4    
182 Heptanal ECETOC, 1995 NC -43.0 114.2 26.0    
183 Heptyl butyrate ECETOC, 1995 NC 1.7 186.3 28.7    
184 Heptylamine ECETOC, 1995 C -21.6 115.2 26.0 10.69   
185 Hexyl salicylate ECETOC, 1995 NC 99.7 222.3 40.6 8.17   
186 Hydroxycitronellal ECETOC, 1995 NC 23.4 172.3 31.6    
187 Isobornyl acetate ECETOC, 1995 NC 34.1 196.3 32.6    
188 Isobutyraldehyde ECETOC, 1995 NC -92.1 72.1 21.0    
189 Isopropanol ECETOC, 1995 NC -89.2 60.1 22.6 15.31   
190 Isopropyl isostearate ECETOC, 1995 NC 80.6 326.6 29.8    
191 Isopropyl myristate ECETOC, 1995 NC 44.4 270.5 29.6    
192 Isopropyl palmitate ECETOC, 1995 NC 72.0 298.5 30.0    
193 Isostearic acid ECETOC, 1995 NC 125.2 284.5 32.8 4.78   
194 Isostearyl alcohol ECETOC, 1995 NC 77.3 270.5 30.8 15.19   
195 Lilestralis/lilial ECETOC, 1995 NC 46.3 204.3 30.8    
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196 Linalol ECETOC, 1995 NC -11.4 154.3 28.2 14.51   
197 Linalol oxide ECETOC, 1995 NC 31.1 170.3 39.9 14.50   
198 Linalyl acetate ECETOC, 1995 NC -2.1 196.3 27.7    
199 Methacrolein ECETOC, 1995 C -90.6 70.1 20.8    
200 Methyl 2-methylbutyrate ECETOC, 1995 NC -68.4 116.2 24.6    
201 Methyl caproate ECETOC, 1995 NC -44.6 130.2 26.6    
202 Methyl laurate ECETOC, 1995 NC 23.2 214.4 29.3    
203 Methyl lavender ketone (1-hydroxy-3-decanone) ECETOC, 1995 NC 42.7 172.3 33.1 14.36   
204 Methyl linoleate ECETOC, 1995 NC 70.8 294.5 31.2    
205 Methyl palmitate ECETOC, 1995 NC 63.2 270.5 30.2    
206 Methyl stearate ECETOC, 1995 NC 81.6 298.5 30.5    
207 Methyl trimethyl acetate ECETOC, 1995 NC -62.5 116.2 24.1    
208 Decylidene methyl anthranilate ECETOC, 1995 NC 99.9 289.4 33.6 4.28   
209 N,N-Dimethylbenzylamine ECETOC, 1995 NC -12.8 135.2 32.7 8.80   
210 Nonanal ECETOC, 1995 NC -19.5 142.2 27.4    
211 Octanoic acid ECETOC, 1995 C 48.4 144.2 33.0 4.78   
212 Oleyl propylene diamine dioleate ECETOC, 1995 NC 142.1 324.6 32.7 8.73 10.79  
213 Phenethyl bromide ECETOC, 1995 NC 2.5 185.1 39.6    
214 p-Isopropylphenylacetaldehyde ECETOC, 1995 NC 18.4 162.2 33.3    
215 p-Mentha-1,8-dien-7-ol ECETOC, 1995 NC 11.1 152.2 32.1 14.51   
216 p-tert-Butyl dihydrocinnamaldehyde ECETOC, 1995 NC 46.3 190.3 31.5    
217 Salicylaldehyde ECETOC, 1995 NC 42.6 122.1 52.0    
218 Tetrachloroethylene ECETOC, 1995 NC -60.6 165.8 35.6    
219 Tetrahydrogeranial ECETOC, 1995 NC -30.0 156.3 26.1    
220 Tonalid ECETOC, 1995 NC 98.7 244.4 31.1    
221 Trichloroethylene ECETOC, 1995 NC -60.6 165.8 31.0    
222 1-(2-Aminoethyl)piperazine NIH, 1999 C 53.7 129.2 33.7 4.35 8.56 10.11 
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223 1,2-Diaminopropane NIH, 1999 C -22.9 74.1 33.8 6.80 9.92  
224 1,4-Diaminobutane NIH, 1999 C 0.9 88.2 35.8 9.26 10.68  
225 2,3-Dimethylcyclohexylamine NIH, 1999 C -11.1 127.2 26.3 10.70   
226 2-Ethylhexylamine NIH, 1999 C -21.0 129.3 27.4 10.75   
227 2-Mercaptoethanol NIH, 1999 C -45.6 78.1 37.0 9.74 15.06  
228 3-Diethylaminopropylamine NIH, 1999 C 0.7 130.2 30.8 8.94 10.54  
229 Acetic acid NIH, 1999 C -21.3 60.1 31.9 4.79   
230 Acetic anhydride NIH, 1999 C -95.1 102.1 29.1    
231 Acetyl bromide NIH, 1999 C -53.0 123.0 30.5    
232 Benzene sulphonyl chloride NIH, 1999 C 61.2 176.6 42.6    
233 Benzyl chloroformate NIH, 1999 C 11.6 170.6 41.0    
234 Bromoacetic acid NIH, 1999 C 29.2 139.0 51.3 2.73   
235 Bromoacetyl bromide NIH, 1999 C -1.7 201.9 45.6    
236 Butanoic acid NIH, 1999 C 3.0 88.1 32.5 4.76   
237 Butylamine NIH, 1999 C -58.8 73.1 25.3 10.69   
238 Butylbenzene NIH, 1999 NC -23.3 134.2 30.0    
239 Butyric anhydride NIH, 1999 C -44.6 158.2 30.9    
240 Chloroacetic acid NIH, 1999 C 10.9 94.5 41.9 2.65   
241 Crotonic acid NIH, 1999 C 2.4 86.1 34.2 4.80   
242 Cyanuric chloride NIH, 1999 C 68.8 184.4 64.3 -2.92   
243 Cyclohexylamine NIH, 1999 C -27.1 99.2 31.4 10.57   
244 Dichloroacetic acid NIH, 1999 C 24.2 128.9 47.0 1.37   
245 Dichloroacetyl chloride NIH, 1999 C -32.5 147.4 36.7    
246 Dichlorophenyl phosphine NIH, 1999 C -4.9 179.0 *    
247 Dicyclohexylamine NIH, 1999 C 27.7 181.3 33.1 11.43   
248 Diethylamine NIH, 1999 C -79.7 73.1 20.2 10.76   
249 Diethylene triamine NIH, 1999 C 17.8 103.2 39.3 3.60 8.98 10.16 
250 Dimethylcarbamyl chloride NIH, 1999 C -15.9 107.5 30.6 -1.85   
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Table 7.1  Skin corrosion data set of 277 organic chemicals 
 
Chemical Source C/NC MP MW ST pKa1 pKa2 pKa3 
          
251 Dodecyl trichlorosilane NIH, 1999 C 51.0 303.8 28.3    
252 Ethanolamine NIH, 1999 C -27.6 61.1 39.7 9.16 12.87  
253 Ethylene diamine NIH, 1999 C -23.8 60.1 36.8 6.77 9.89  
254 Formic acid NIH, 1999 C -25.0 46.0 35.8 3.74   
255 Fumaryl chloride NIH, 1999 C 6.8 153.0 40.6    
256 Hexanoic acid NIH, 1999 C 26.2 116.2 32.8 4.78   
257 Hexanol NIH, 1999 NC -37.9 102.2 27.9 15.37   
258 Maleic acid NIH, 1999 NC 84.1 116.1 67.6 3.15 4.79  
259 Maleic anhydride NIH, 1999 C -51.6 98.1 53.7    
260 Mercaptoacetic acid NIH, 1999 C 18.8 92.1 48.5 3.73 10.60  
261 Nonanol NIH, 1999 NC -3.2 144.3 29.5 15.22   
262 2-Anisoyl chloride NIH, 1999 C 36.7 170.6 38.2    
263 Octadecyl trichlorosilane NIH, 1999 C 107.7 387.9 29.6    
264 Octyl trichlorosilane NIH, 1999 C 8.1 247.7 26.9    
265 Pentanoyl (valeryl) chloride  NIH, 1999 C -42.4 120.6 27.8    
266 Phenyl acetyl chloride NIH, 1999 C 13.7 154.6 39.2    
267 Phenyl trichlorosilane NIH, 1999 C 5.8 211.6 31.6    
268 Propanoic acid NIH, 1999 C -9.0 74.1 32.3 4.79   
269 Pyrrolidine NIH, 1999 C -36.0 71.1 36.8 11.26   
270 Tetraethylenepentamine NIH, 1999 C 112.7 189.3 41.1 3.22 3.88 9.13 
271 Tributylamine NIH, 1999 NC 0.8 185.4 27.4 9.99   
272 Trichloroacetic acid NIH, 1999 C 26.7 163.4 53.0 1.10   
273 Trichlorotoluene NIH, 1999 NC 10.4 195.5 38.7    
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Table 7.1  Skin corrosion data set of 277 organic chemicals 
 
Chemical Source C/NC MP MW ST pKa1 pKa2 pKa3 
          
274 Triethanolamine NIH, 1999 NC 83.3 149.2 54.9 7.77 14.17 14.73 
275 Triethylene tetramine NIH, 1999 C 68.2 146.2 40.4 3.14 6.60 9.53 
276 Trifluoroacetic acid NIH, 1999 C -24.0 114.0 21.9 0.67   
277 Undecanol NIH, 1999 NC 18.7 172.3 30.1 15.20   
 
 
 
Footnote to Table 7.1 
 
C = corrosive; MP = melting point (°C); MW = molecular weight (g/mol); NC = non-corrosive; 
pKa(n) = the nth value of the negative logarithm of the acid dissociation constant; ST = surface tension. 
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Table 7.2 Skin irritation data set of 139 organic chemicals 
 
Chemicala C/NC I/NI Erythema Oedema PII 
       
1 2-Methylbutyric acid NC I 2.3 2.7 5.0 
2 10-Undecenoic Acid NC NI 1.8 0.6 2.4 
3 Ethyltriglycol methacrylate NC NI 0.2 0.0 0.2 
4 Ethylthioethyl methacrylate NC NI 0.6 0.0 0.6 
5 2-Ethoxyethyl methacrylate NC NI 1.6 0.0 1.6 
6 2-Methoxyethyl acrylate C I 3.6 3.5 7.1 
7 Benzyl alcohol [2] NC NI 1.4 0.4 1.8 
8 dl-Citronellol [1] NC I 2.0 2.2 4.2 
9 1-Decanol NC I 2.2 1.2 3.3 
10 Dihydromercenol [1] NC NI 1.3 0.2 1.6 
11 2,6-Dimethyl-4-heptanol NC NI 0.0 0.0 0.0 
12 Dipropylene glycol [2] NC NI 0.0 0.0 0.0 
13 Geraniol [3] NC NI 1.9 1.0 2.9 
14 Geranyl dihydrolinalol NC NI 1.4 0.8 2.3 
15 Geranyl linalol NC I 2.2 2.1 4.3 
16 α-Ionol NC NI 0.9 0.4 1.3 
17 β-Ionol NC NI 1.2 0.7 1.9 
18 Linalol [2] NC I 2.0 1.4 3.4 
19 p-Mentha-1,8-dien-7-ol NC NI 2.0 1.3 3.3 
20 2-Methyl-4-phenyl-2-butanol NC NI 1.3 0.3 1.6 
21 Phenylethyl alcohol [2] NC NI 0.7 0.2 0.9 
22 Isopropanol NC NI 0.8 0.0 0.8 
23 Isostearyl alcohol NC NI 1.6 1.0 2.6 
24 α-Terpineol [3] NC I 1.9 2.1 4.0 
25 p-tert-Butyl dihydrocinnamaldehyde NC NI 1.6 0.8 2.4 
26 Isobutyraldehyde NC NI 0.1 0.0 0.1 
27 Cinnamaldehyde NC I 2.0 1.7 3.7 
28 Citrathal NC NI 2.0 1.7 3.6 
29 Cyclamen aldehyde [4] NC I 2.0 1.4 3.4 
30 2,4-Decadienal NC I 2.3 2.5 4.8 
31 2,4-Dimethyl-3-cyclohexen-1-carboxaldehyde NC I 2.0 1.2 3.2 
32 3,7-Dimethyl-2,6-nondien-1-al (Ethyl citral) NC I 2.0 1.8 3.8 
33 2,4-Dimethyltetrahydrobenzaldehyde NC NI 1.9 0.9 2.8 
34 2-Ethylhexanal NC I 2.0 1.9 3.9 
35 Heptanal NC I 3.0 2.0 5.0 
36 2,4-Hexadienal NC I 3.6 3.5 7.1 
37 α-Hexyl cinnamic aldehyde [2] NC I 2.0 2.0 4.0 
38 Hydroxycitronellal [1] NC NI 0.9 0.2 1.1 
39 Lilestralis/lilial [2] NC NI 1.9 1.7 3.6 
40 3-Methylbutyraldehyde NC NI 1.6 1.3 2.8 
41 2,5-Methylene-6-propyl-3-cyclo-hexene-
carbaldehyde 
NC NI 1.8 0.6 2.4 
42 Nonanal NC I 2.0 1.4 3.4 
43 2-Phenylpropionaldehyde NC I 2.0 0.9 2.9 
44 p-Isopropylphenylacetaldehyde NC NI 1.3 0.9 2.3 
45 Salicylaldehyde NC NI 1.5 1.0 2.5 
46 Tetrahydrogeranial NC NI 1.9 0.7 2.6 
47 4-Tricyclo-decylindene-8-butanal NC I 2.1 1.2 3.3 
48 Methacrolein C I 2.0 2.1 4.1 
49 Erucamide NC NI 0.0 0.0 0.0 
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Table 7.2 Skin irritation data set of 139 organic chemicals 
 
Chemicala C/NC I/NI Erythema Oedema PII 
       
50 Diethylaminopropylamine C I b b b 
51 N,N-Dimethylbenzylamine NC I b b b 
52 Dimethyl-n-butylamine C I 4.0 1.1 5.1 
53 Dimethylisopropylamine C I 4.0 1.6 5.6 
54 Dimethyldipropylenetriamine C I b b b 
55 Heptylamine C I 4.0 2.7 6.7 
56 3-Methoxy propylamine C I 4.0 2.7 6.7 
57 Oleyl propylene diamine dioleate NC I 2.1 1.5 3.7 
58 2,4-Xylidine NC NI 1.0 0.4 1.4 
59 Allyl bromide C I 4.0 3.2 7.2 
60 2-Bromobutane NC NI 1.8 0.7 2.5 
61 1-Bromo-4-chlorobutane NC NI 0.0 0.0 0.0 
62 1-Bromo-2-chloroethane NC NI 1.8 0.5 2.3 
63 1-Bromo-4-fluorobenzene NC NI 0.3 0.0 0.3 
64 1-Bromohexane NC I 2.4 2.4 4.0 
65 1-Bromopentane NC I 2.7 1.8 4.5 
66 2-Bromopropane NC NI 1.4 0.0 1.4 
67 1,6-Dibromohexane NC NI 0.9 0.0 0.9 
68 1,3-Dibromopropane NC NI 1.9 0.0 1.9 
69 Phenethyl bromide NC NI 0.0 0.0 0.0 
70 Dichloromethane NC I 4.0 1.7 5.7 
71 Tetrachloroethylene NC I 4.0 1.7 5.7 
72 1,1,1-Trichloroethane NC I 3.7 1.5 5.2 
73 Trichloroethylene NC I 4.0 1.4 5.4 
74 Allyl heptanoate NC NI 1.7 0.4 2.1 
75 Allyl phenoxyacetate NC NI 0.3 0.1 0.4 
76 Benzyl acetate [2] NC NI 0.8 0.0 0.8 
77 Benzyl benzoate [1] NC NI 0.0 0.0 0.0 
78 Benzyl salicylate [1] NC NI 0.3 0.0 0.3 
79 Isobornyl acetate [1] NC I 2.0 2.0 4.0 
80 Butyl propanoate NC NI 1.1 0.0 1.1 
81 Diethyl phthalate [1] NC NI 0.0 0.0 0.0 
82 2-Ethylhexylpalmitate NC NI 0.6 0.0 0.6 
83 Ethyl tiglate NC NI 1.0 0.1 1.2 
84 Ethyl trimethyl acetate NC NI 0.4 0.0 0.4 
85 Glycolbromoacetate C I b b b 
86 Heptyl butyrate NC NI 1.5 0.2 1.7 
87 Hexyl salicylate [4] NC I 2.0 1.3 3.3 
88 Linalyl acetate [1] NC NI 1.9 1.8 3.7 
89 Methyl caproate NC NI 1.7 1.1 2.8 
90 Methyl laurate NC I 2.0 1.9 3.9 
91 Methyl linoleate NC NI 1.9 1.2 3.1 
92 Methyl 2-methylbutyrate NC NI 0.6 0.0 0.7 
93 Methyl palmitate NC I 2.6 2.0 4.6 
94 Methyl stearate NC NI 1.5 0.7 2.1 
95 Methyl trimethyl acetate NC NI 0.0 0.0 0.0 
96 Isopropyl myristate NC NI 1.0 0.2 1.2 
97 Isopropyl palmitate NC NI 1.2 0.2 1.4 
98 Isopropyl isostearate NC NI 0.1 0.0 0.1 
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Table 7.2 Skin irritation data set of 139 organic chemicals 
 
Chemicala C/NC I/NI Erythema Oedema PII 
       
99 α-Terpinyl acetate [2] NC I 2.0 2.3 4.3 
100 Eucalyptol NC NI 1.9 0.4 2.2 
101 Octanoic acid C I 3.0 1.4 4.5 
102 Isostearic acid NC I 1.9 2.4 4.3 
103 3-Chloro-4-fluoronitrobenzene NC NI 1.0 0.2 1.2 
104 Fluorobenzene NC NI 0.1 0.0 0.1 
105 2-Fluorotoluene NC NI 0.1 0.0 0.1 
106 cis-Cyclooctene NC NI 1.7 0.4 2.1 
107 1,9-Decadiene NC I 2.0 1.0 3.0 
108 1,5-Hexadiene NC NI 0.0 0.0 0.0 
109 1,13-Tetradecadiene NC NI 1.3 0.2 1.6 
110 Benzyl acetone NC NI 0.8 0.2 1.0 
111 Diacetyl NC NI 0.6 0.0 0.6 
112 cis-Jasmone NC NI 1.7 1.7 2.6 
113 Methyl lavender ketone (1-hydroxy-3-decanone) NC I 2.2 1.6 3.8 
114 2,3-Dichloropropionitrile NC I 2.0 0.0 2.0 
115 3-Diethylaminopropionitrile NC NI 0.0 0.0 0.0 
116 Carvacrol C I 4.0 1.7 5.7 
117 2-tert-Butylphenol C I 4.0 1.7 5.7 
118 Eugenol NC NI 1.9 1.0 2.9 
119 Guaiacol (2-methoxyphenol) NC NI 1.8 0.6 2.4 
120 4,4'-Methylene bis (2,6-di-tert-butyl phenol) NC NI 0.0 0.0 0.0 
121 Dimethyl disulphide NC NI 1.8 1.2 3.0 
122 Dipropyl disulphide NC I 2.6 0.0 2.6 
123 3-Mercapto-1-propanol NC NI 0.8 0.3 1.1 
124 4-(Methylthio)benzaldehyde NC NI 0.9 0.0 0.9 
125 6-Butyl-2,4-dimethyldihydropyrane NC NI 1.7 0.3 2.0 
126 Decylidene methyl anthranilate NC NI 1.5 0.5 2.1 
127 2,6-Dimethyl-2,4,6-octatriene NC I 2.0 1.0 3.0 
128 1-Formyl-1-methyl-4(4-methyl-3-penten-1-yl)-3-
cyclohexane 
NC I 2.0 1.3 3.3 
129 d-Limonene [2] NC NI 1.9 1.3 3.2 
130 Linalol oxide NC NI 2.0 0.6 2.6 
131 Cinnamyl alcohol [1] NC NI 0.0 0.0 0.0 
132 2,4-Dinitromethylaniline NC NI 0.0 0.0 0.0 
133 Dimethylbenzylcarbinyl acetate [1] NC NI 1.0 0.2 1.2 
134 Dodecanoic (lauric) acid NC NI 0.4 0.0 0.4 
135 2-Chloronitrobenzene NC NI 0.0 0.0 0.0 
136 3-Methyl phenol NC NI 0.0 0.0 0.0 
137 3,3'-Dithiopropionic acid NC NI 0.0 0.0 0.0 
138 4-Amino-1,2,4-triazole NC NI 0.0 0.0 0.0 
139 Tonalid NC NI 0.0 0.0 0.0 
 
Footnote to Table 7.2 
 
I = irritant; NC = non-corrosive; NI = non-irritant. 
 
aThe numbers in square brackets refer to the data sheet taken from the ECETOC Skin Irritation 
Databank in cases where there was more than one data sheet per chemical; bNot possible to 
calculate because some or all tissue scores were missing. 
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Table 7.3 pH data for 75 organic and inorganic chemicalsa 
 
Chemical C/NC EU CLASS pHb 
     
1 Benzyl chloroformate NC NC 2.5 
2 Fluorosulphonic acid C R34 0 
3 Nitric acid C R34 0 
4 Selenic acid C R34 0 
5 Sulphur monochloride C R34 5.2 
6 Trifluoroacetic acid C R34 0.8 
7 Acetic acid C R34 2.3 
8 Acetic anhydride C R34 2 
9 Ethylhexylamine C R35 12 
10 Acrylic acid C R34 2.1 
11 Aluminium bromide C R34 1.2 
12 Aluminium chloride C R34 3 
13 Ammonium hydrogen difluoride C R34 5.2 
14 Ammonium hydrogen sulphate C R34 0.8 
15 2-Anisoyl chloride C R34 0.7 
16 Antimony tribromide C R34 0.4 
17 Antimony trichloride C R34 0.3 
18 Dicyclohexylamine C R35 9.6 
19 Boron trifluoride-acetic acid C R34 1 
20 Bromoacetic acid C R34 1.4 
21 Butanoic anhydride C R35 3.1 
22 Chloroacetic acid C R34 1.4 
23 Cyanuric chloride C R35 1.7 
24 Cyclohexylamine C R34 12.3 
25 Dichloroacetic acid C R34 0.6 
26 Dichloroacetyl chloride C R34 0.5 
27 Dichlorophenyl phosphine C R34 0 
28 Diethylene triamine C R34 12 
29 Benzene sulphonyl chloride C R35 1.8 
30 Dimethyl carbamyl chloride C R34 2.3 
31 Crotonic acid C R35 2.3 
32 Dodecyl trichlorosilane C R34 0.5 
33 Ethylene diamine C R34 12.1 
34 Ferrous chloride C R34 2.1 
35 Fluroboric acid C R34 1.3 
36 Formic acid C R34 1.6 
37 Fumaryl chloride C R34 0.1 
38 Hydrobenzene sulphonic acid C R34 0.6 
39 Hydrogen bromide C R34 0.3 
40 Iodine monochloride C R34 0.8 
41 Lithium hydroxide C R34 11.8 
42 Mercaptoacetic acid C R34 0.3 
43 Octadecyl trichlorosilane C R34 0.3 
44 Octyl trichlorosilane C R34 0.1 
45 Phenylacetyl chloride C R34 0.9 
46 Phenyl trichlorosilane C R34 0 
47 Tetraethylene pentamine C R35 11.9 
48 Hydroxylamine sulphate C R35 3.6 
49 Potassium hydrogen sulphate C R34 0.9 
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Table 7.3 cont’d pH data for 75 organic and inorganic chemicalsa 
 
Chemical C/NC EU CLASS pHb 
     
50 Potassium hydroxide C R34 14 
51 Sodium hydrogen fluoride C R35 5.2 
52 Sodium hydroxide C R34 13.8 
53 Sulphuric acid C R34 0 
54 Sulphurous acid C R34 1.8 
55 Tetramethyl ammonium hydroxide C R34 13.6 
56 Thiophosphoryl chloride C R34 5.8 
57 Trichloroacetic acid C R34 0.7 
58 Trichlorotoluene NC NC 3.3 
59 Triethylene tetramine C R34 11.9 
60 Valeryl chloride C R34 0.5 
61 Ethyl triglycol methacrylate NC NC 4.5 
62 Nonyl acrylate NC NC 6.9 
63 Fuel additive NC NC 4.1 
64 Amphoteric surfactant NC NC 7.3 
65 Anionic surfactant NC NC 8.3 
66 Anionic surfactant NC NC 7.9 
67 Liquid bleach NC NC 4.5 
68 Liquid bleach NC NC 9.5 
69 Degreaser NC NC 7.3 
70 Dilutable cleaner NC NC 9.9 
71 Dilutable cleaner NC NC 3.8 
72 Concentrated organic cleaner NC NC 7.7 
73 3,3’-Dithiopropanoic acid NC NC 3.3 
74 Mercaptopropanol NC NC 6.4 
75 Benzalkonium chloride NC NC 4.9 
 
 
Footnote to Table 7.3 
 
C = corrosive (R34 = moderate corrosive; R35 = severe corrosive); NC = non-corrosive. 
 
aData are taken from Gordon (1994). 
bpH of 10% solution. 
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Table 7.4 Data for the 60 chemicals tested in the ECVAM Skin Corrosivity Study 
 
Chemical C/NC PII Erythema Oedema I/NI pHc EPISKIN 3m EPISKIN 1h EPISKIN 4h TER 2h TER 24h 
          
1 Hexanoic acid C a a a I 2.57 15.49 2.30 2.64 1.15 0.92 
2 1,2-Diaminopropane C a a a I 12.02 63.78 49.76 25.36 1.01 0.91 
3 Carvacrol C 5.7 4.0 1.7 I 4.91 126.04 16.17 16.28 6.50 2.91 
4 Boron trifluoride dihydrate C a a a I 0.57 2.26 3.79 3.43 0.58 0.54 
5 Methacrolein C 4.1 2.0 2.1 I 4.18 105.75 36.21 21.07 8.64 9.45 
6 Phenethyl bromide NC 0.0 0.0 0.0 NI 5.40 140.42 148.54 156.59 15.22 12.14 
7 3,3'-Dithiodipropionic acid NC 0.0 0.0 0.0 NI 3.22 98.31 108.10 99.79 14.41 16.35 
8 Isopropanol NC 0.8 0.8 0.0 NI 5.86 96.05 99.27 89.67 9.39 5.83 
9 2-Methoxyphenol (Guaiacol) NC 2.4 1.8 0.6 NI 4.86 143.83 16.27 8.87 11.73 9.40 
10 2,4-Xylidine (2,4-Dimethylaniline) NC 1.4 1.0 0.4 NI 8.73 117.38 54.50 39.40 9.18 3.32 
11 2-Phenylethanol (phenylethylalcohol) NC 0.9 0.7 0.2 NI 5.31 115.65 106.72 69.14 12.62 11.73 
12 Dodecanoic (lauric) acid NC 0.4 0.4 0.0 NI 4.72 106.41 121.01 112.69 18.13 16.11 
13 3-Methoxypropylamine C 6.7 4.0 2.7 I 11.78 50.87 41.83 17.60 1.34 1.04 
14 Allyl bromide C 7.2 4.0 3.2 I 3.15 117.84 28.23 22.46 4.61 4.58 
15 Dimethyldipropylenetriamine C b b b I 11.38 79.23 38.39 17.07 1.21 1.29 
16 Methyl trimethylacetate NC 0.0 0.0 0.0 NI 4.96 112.89 96.97 70.56 8.78 4.89 
17 Dimethylisopropylamine C 5.6 4.0 1.6 I 11.81 78.22 22.30 13.99 1.19 0.93 
18 Potassium hydroxide (10% aq.) C b b b I 13.76 64.19 15.30 11.11 1.14 1.30 
19 Tetrachloroethylene NC 5.7 4.0 1.7 I 7.13 104.55 91.00 55.96 15.42 3.23 
20 Ferric [iron (III)] chloride C a a a I 1.11 91.04 66.28 33.24 3.78 0.98 
21 Potassium hydroxide (5% aq.) NC 5.2 3.2 2.0 I 13.67 44.42 12.11 9.85 1.64 1.76 
22 Butyl propanoate NC 1.1 1.1 0.0 NI 4.57 102.89 117.33 77.09 4.63 3.62 
23 2-tert-Butylphenol C 5.7 4.0 1.7 I 8.17 93.16 8.09 8.17 4.61 9.11 
24 Sodium carbonate (50% aq.) NC 2.3 1.7 0.7 I 10.95 115.11 112.61 88.39 8.60 3.62 
25 Sulphuric acid (10% wt.) C a a a I 0.33 94.95 22.08 2.12 9.13 4.14 
26 Isostearic acid NC 4.3 1.9 2.4 I 4.78 103.39 94.21 108.30 21.27 18.22 
27 Methyl palmitate NC 4.6 2.6 2.0 I 5.69 104.63 104.59 99.06 21.58 22.50 
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Table 7.4 cont’d Data for the 60 chemicals tested in the ECVAM Skin Corrosivity Study 
 
Chemical C/NC PII Erythema Oedema I/NI pHc EPISKIN 3m EPISKIN 1h EPISKIN 4h TER 2h TER 24h 
          
28 Phosphorus tribromide C a a a I 0.12 3.55 14.34 11.87 0.60 0.72 
29 65/35 Octanoic/decanoic acids C a a a I 3.72 108.83 6.16 4.25 3.78 1.74 
30 4,4'-Methylene-bis-(2,6-ditert-
butylphenol) 
NC 0.0 0.0 0.0 NI 6.44 120.08 99.06 103.29 14.09 13.84 
31 2-Bromobutane NC 2.5 1.8 0.7 NI 3.89 132.81 121.21 55.02 5.09 4.67 
32 Phosphorus pentachloride C a a a I 0.80 43.34 15.25 3.28 0.69 0.67 
33 4-(Methylthio)-benzaldehyde NC 0.9 0.9 0.0 NI 6.38 134.39 176.61 161.64 12.51 13.16 
34 70/30 Oleine/octanoic acid NC a a a I 3.26 107.55 104.67 59.56 12.13 8.23 
35 Hydrogenated tallow amine NC 3.6 1.8 1.8 I 10.23 98.63 101.41 104.20 13.98 14.26 
36 2-Methylbutyric acid C 5.0 2.3 2.7 I 2.81 44.05 3.58 3.82 2.28 1.76 
37 Sodium undecylenate (34% aq.) NC 1.7 1.7 0.0 NI 8.98 122.64 34.37 12.22 2.64 1.24 
38 Tallow amine C b b b I 10.34 94.44 110.84 113.97 14.11 7.70 
39 2-Ethoxyethyl methacrylate NC 1.6 1.6 0.0 NI 9.52 135.96 200.93 178.77 9.39 8.76 
40 Octanoic acid (caprylic acid) C 4.5 3.0 1.4 I 3.67 80.19 4.20 3.17 14.75 5.92 
41 20/80 Coconut/palm soap NC 2.7 2.0 0.7 I 10.72 112.49 116.04 136.18 11.13 1.50 
42 2-Mercaptoethanol, Na salt (46% aq.) C 4.7 2.0 2.7 I 12.29 101.39 104.44 101.49 1.58 1.37 
43 Hydrochloric acid (14.4% wt.) C a a a I -0.61 73.57 3.29 3.55 4.67 1.18 
44 Benzyl acetone NC 1.0 0.8 0.2 NI 4.81 139.35 158.09 151.71 13.78 12.39 
45 Heptylamine C 6.7 4.0 2.7 I 11.88 97.22 355.39 348.54 0.87 0.98 
46 Cinnamaldehyde NC 3.7 2.0 1.7 I 4.03 129.99 118.92 64.14 14.79 11.32 
47 60/40 Octanoic/decanoic acids C 7.1 3.3 3.8 I 3.77 108.75 7.01 5.12 6.28 1.61 
48 Glycol bromoacetate (85%) C b b b I 1.98 95.55 3.80 3.98 8.67 5.67 
49 Eugenol NC 2.9 1.9 1.0 NI 3.68 136.42 91.06 49.02 11.11 9.56 
50 55/45 Octanoic/decanoic acids C 5.2 3.3 1.9 I 3.80 122.38 7.72 4.67 4.98 1.44 
51 Methyl laurate NC 3.9 2.0 1.9 I 5.67 110.30 101.50 115.60 16.20 8.08 
52 Sodium bicarbonate NC 0.1 0.1 0.0 NI 7.89 101.19 109.76 102.33 12.97 4.16 
53 Sulphamic acid NC a a a NI 0.70 101.44 25.02 2.53 8.86 4.07 
 209
Table 7.4 cont’d Data for the 60 chemicals tested in the ECVAM Skin Corrosivity Study 
 
Chemical C/NC PII Erythema Oedema I/NI pHc EPISKIN 3m EPISKIN 1h EPISKIN 4h TER 2h TER 24h 
          
54 Sodium bisulphite NC 1.0 1.0 0.0 NI 3.85 116.31 103.18 107.76 13.14 6.42 
55 1-(2-Aminoethyl)piperazine C a a a I 11.67 117.32 88.34 53.89 1.06 1.15 
56 1,9-Decadiene NC 3.0 2.0 1.0 I 4.15 116.16 116.28 129.68 14.76 3.39 
57 Phosphoric acid C a a a I 1.63 87.02 36.78 3.98 0.86 0.92 
58 10-Undecenoic acid NC 2.4 1.8 0.6 NI 3.88 104.41 72.22 53.90 21.49 21.68 
59 4-Amino-1,2,4-triazole NC 0.0 0.0 0.0 NI 5.92 107.66 106.11 107.30 13.27 14.31 
60 Sodium lauryl sulphate (20% aq.) NC 6.8 3.8 3.0 I 3.78 114.14 109.82 71.59 3.61 1.10 
 
 
Footnote to Table 7.4 
 
aData supplied to ECVAM in confidence by an industrial company. 
bNot possible to calculate because some or all of the tissue scores were missing. 
cpH measurements were obtained by BIBRA International (Croydon, UK) and refer to a 10% solution, unless specified otherwise. 
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Table 7.5 List of liquids containing ionisable groups 
Chemical Group C/NC Chemical Group C/NC 
        
15 2-Chloropropanoic acid acid C 3 2,3-Lutidine base NC 
18 2-Mercaptoethanoic acid acid C 4 2,3-Xylenol base C 
34 Acrylic acid acid C 25 3-Picoline base NC 
39 Butyric acid acid C 26 3-Toluidine base NC 
44 Cyclopropane COOH acid C 31 4-Picoline base NC 
48 Glycolic acid acid NC 38 Benzylamine base C 
49 Glyoxylic acid acid C 42 Cocoamine (dodecylamine) base C 
54 Iodoacetic acid acid C 53 Imidazole base NC 
56 Isobutyric acid acid C 66 Morpholine base C 
60 Lactic acid acid C 73 Pyridine base NC 
64 Methoxyacetic acid acid C 103 2,4-Xylidine base NC 
72 Propylphosphonic acid acid C 124 3-Diethylaminopropionitrile base NC 
74 Pyruvic acid acid C 126 3-Methoxypropylamine base C 
117 2-Methylbutyric acid acid C 131 4-Amino-1,2,4-triazole base NC 
229 Acetic acid acid C 158 Diethylaminopropylamine base C 
234 Bromoacetic acid acid  C 163 Dimethylisopropylamine base C 
236 Butanoic acid acid C 164 Dimethyl butylamine base C 
240 Chloroacetic acid acid C 184 Heptylamine base C 
241 Crotonic acid acid C 209 N,N-Dimethylbenzylamine base NC 
244 Dichloroacetic acid acid C 223 1,2-Diaminopropane base C 
250 Dimethylcarbamyl chloride acid C 224 1,4-Diaminobutane base C 
254 Formic acid acid C 225 2,3-Dimethylcyclohexylamine base C 
256 Hexanoic acid acid C 226 2-Ethylhexylamine base C 
260 Mercaptoacetic acid acid C 227 2-Mercaptoethanol base C 
268 Propanoic acid acid C 228 3-Diethylaminopropylamine base C 
272 Trichloroacetic acid acid C 237 Butylamine base C 
276 Trifluoroacetic acid acid C 243 Cyclohexylamine base C 
13 2-Butyn-1,4-diol alcohol C 247 Dicyclohexylamine base C 
17 2-Hydroxyethyl acrylate alcohol C 248 Diethylamine base C 
71 Propargyl alcohol alcohol C 249 Diethylene triamine base C 
95 Decanol alcohol NC 252 Ethanolamine base C 
106 2,6-Dimethyl-4-heptanol alcohol NC 253 Ethylene diamine base C 
116 2-Methyl-4-phenyl-2-butanol alcohol NC 269 Pyrrolidine base C 
118 2-Phenylethanol alcohol NC 271 Tributylamine base NC 
125 3-Mercapto-1-propanol alcohol NC 8 2,4-Xylenol phenol C 
139 α-Terpineol alcohol NC 10 2,5-Xylenol phenol C 
143 Benzyl alcohol alcohol NC 11 2,6-Xylenol phenol C 
150 Cinnamyl alcohol alcohol NC 16 2-Ethylphenol phenol NC 
159 Dihydromercenol alcohol NC 28 4-Methoxyphenol phenol NC 
166 Dipropylene glycol alcohol NC 63 3-Cresol phenol C 
167 dl-Citronellol alcohol NC 68 2-Cresol phenol C 
178 Geraniol alcohol NC 70 4-Cresol phenol C 
189 Isopropanol alcohol NC 80 3-Methoxyphenol phenol NC 
196 Linalol alcohol NC 81 4-Ethylphenol phenol NC 
197 Linalol oxide alcohol NC 82 Phenol phenol C 
215 p-Mentha-1,8-dien-7-ol alcohol NC 115 2-Methoxyphenol (guaiacol) phenol NC 
257 Hexanol alcohol NC 120 2-tert-Butylphenol phenol C 
264 Nonanol alcohol NC 127 3-Methyl phenol phenol NC 
277 Undecanol alcohol NC     
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Table 7.6 Performance of the SARs for skin irritation and corrosion 
 
 Model Sensitivity (95% CI) 
Specificity
(95% CI) 
Concordance
(95% CI) False positives (95% CI) 
False negatives 
(95% CI) 
SAR 1a 70 68 69 32 30 
 (60-79) (58-77) (62-75) (23-42) 21-40 
SAR 1b
 
66 62 64 38 34 
SAR 2c 100 95 98 5 0 
 (100-100) (86-100) (94-100) (0-14) (0-0) 
SAR 2d 100 95 98 5 0 
SAR 3e 91 82 88 18 9 
 (80-100) (59-100) (78-99) (0-41) (0-20) 
SAR 3f 91 73 85 27 9 
SAR 4g 95 32 56 68 5 
 (87 -100 ) ( 22-44 ) ( 46-66 ) ( 56-78 ) (0-13 ) 
SAR 4h 89 35 56 65 11 
 
 
Footnote to Table 7.6 
 
aStatistics based on the application of SAR 1 to its training set of 189 organic liquids; bCross-
validated statistics based on the 3-fold cross-validation of SAR 1; cStatistics based on the 
application of SAR 2 to its training set of 27 carboxylic acids and 19 alcohols; dCross-validated 
statistics based on the 3-fold cross-validation of SAR 2; eStatistics based on the application of 
SAR 3 to its training set of 34 organic bases; fCross-validated statistics based on the 3-fold 
cross-validation of SAR 3; gStatistics based on the application of SAR 4 to its training set of 98 
liquids; hCross-validated statistics based on the 3-fold cross-validation of SAR 4. 
 
The 95% confidence intervals were derived by bootstrap resampling the appropriate data set 
1000 times, except in the cases of SAR 1, for which only 100 bootstrap samples were obtained, 
due to the relatively large training set for this model. 
 
Shaded cells indicate ‘unsatisfactory’ Cooper statistics. 
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Table 7.7 Performance of the PMs for skin irritation and corrosion 
 
 Model Sensitivity (95% CI) 
Specificity
(95% CI) 
Concordance
(95% CI)s False positives (95% CI) 
False negatives 
(95% CI) 
PM 1a 86 100 89 0 14 
 (77-95) (100-100) (82-97) (0-0) (5-23) 
PM 1b 54 97 77 3 46 
PM 2c 82 86 83 14 18 
 (70-94) (68-100) (73-93) (0-32) (6-30) 
PM 2d 79 79 79 21 20 
PM 3e 88 85 86 15 12 
 (75-100) (73-97) (78-95) (3-27) (0-25) 
PM 3f 88 79 83 21 12 
PM 4g 76 93 80 7 24 
 (62-88) (78-100) (69-90) (0-22) (12-38) 
PM 4h 67 79 69 21 33 
PM 5i 88 77 82 23 12 
 (64-100) (60-89) (69-90) (11-40) (0-36) 
PM 5j 88 74 80 26 12 
 
 
Footnote to Table 7.7 
 
aStatistics based on the application of PM 1 to its training set of 75 chemicals; bStatistics based 
on the application of PM 1 to a test set of 53 chemicals; cStatistics are based on the application 
of PM 2 to its training set of 53 chemicals; dCross-validated statistics based on the 3-fold cross-
validation of PM 2; eStatistics based on the application of PM 3 to its training set of 59 
chemicals; fCross-validated statistics based on the 3-fold cross-validation of PM 3; gStatistics 
based on the application of PM 4 to its training set of 59 chemicals; hCross-validated statistics 
based on the 3-fold cross-validation of PM 4; iStatistics based on the application of PM 5 to its 
training set of 60 chemicals; jCross-validated statistics based on the 3-fold cross-validation of 
PM 5. 
 
The 95% confidence intervals were derived by bootstrap resampling the appropriate data set 
1000 times. 
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8.1 INTRODUCTION 
 
The ability of a chemical to penetrate across the tissue barriers of the eye, such as the 
conjunctiva, cornea and sclera, is an important consideration, not only in drug 
development, but also in chemical risk assessment. Various efforts have been made to 
model the permeabilities of ocular tissues by using in vitro methods (e.g. Goskonda et 
al., 1999) or computer-based methods (e.g. Yoshida & Topliss, 1996). The work 
described in this chapter, which is based on Worth & Cronin (2000b), had the following 
objectives: 
 
1) to determine whether a statistically-significant structure-permeability relationship 
(SPR) for predicting the transport of structurally diverse chemicals across the rabbit 
cornea could be developed on the basis of just two physicochemical properties - the 
logarithm of the octanol-water partition coefficient (logP) and molecular weight 
(MW). Such a model was sought because these physicochemical properties had been 
reported as significant predictors of skin permeability (Potts & Guy, 1992; Cronin et 
al., 1998). 
2) to identify additional physicochemical properties that are predictive of corneal 
permeability, and to use these as predictor variables in a SPR.  
3) to see if any relationships exist between the corneal permeability coefficients of 
chemicals and their abilities to cause eye lesions. 
 
8.2 METHOD 
 
8.2.1 In vitro permeability measurements 
 
Corneal permeability coefficients for 112 chemicals (Table 8.1) were taken from 
Prausnitz & Noonan (1998). In compiling the data set, Prausnitz & Noonan excluded 
any chemicals that had been reported to undergo active transport or to be chemically 
altered during transport. The permeability data for two macromolecules (cyclosporin A 
and inulin) were excluded from these analyses, because their large sizes (radii of 10Å 
and 14Å, respectively) were unrepresentative, and chemicals with radii greater than 
about 10Å cannot usually cross the cornea at measurable rates (Hamalainen et al., 
1997a). Another reason for excluding cyclosporin A in the development of SPRs is that 
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this macromolecule is extruded from the outer epithelial cells of the cornea by an efflux 
pump (Kawazu et al., 1999). The permeability data were collated from in vitro studies 
performed in a number of laboratories, so a certain amount of inter-laboratory 
variability in the data was expected. 
 
8.2.2 Calculation of physicochemical properties 
 
The logarithm of the octanol-water partition coefficient (logP) and the logarithm of 
aqueous solubility (in mol/l) were calculated by using the KOWWIN software 
(Syracuse Research Corporation, Syracuse, NY, USA). The Molconn-Z software (Hall 
Associates Consulting, Quincy, MA, USA) was used to calculate molecular weight 
(MW), the number of hydrogen-bond donors (nHD), the number of hydrogen bond 
acceptors (nHA), the number of potential hydrogen bonds (nH; nH = nHA + nHD), and the 
following topological indices: simple and valence path molecular connectivity of orders 
0 to 4, simple and valence difference connectivity indices of orders 0 to 4, and kappa 
indices of orders 0 to 3 (κ0−κ3). 
 
To calculate steric and molecular orbital descriptors, chemical structures were input as 
SMILES codes into the TSAR (version 3.2) molecular spreadsheet (Oxford Molecular 
Ltd. Oxford, England). The CORINA (version 3.21) program (Oxford Molecular Ltd., 
Oxford, England) converted the corresponding 2D structures into reasonable 3D 
conformations. These 3D structures were energy-minimised by using the COSMIC 
force field in TSAR. The 3D structure of each molecule was subsequently optimised by 
using the AM1 Hamiltonian (Dewar et al., 1985) in the VAMP (version 6.5) molecular 
orbital package (Oxford Molecular Ltd, Oxford, England). For each energy-optimised 
molecule, the following properties were calculated: the energies of the lowest 
unoccupied molecular orbital (LUMO) and the highest occupied molecular orbital 
(HOMO); molecular surface area and volume; lengths of the first, second and third 
inertial axes; dipole moment; and heat of formation. 
 
8.2.3 Statistical analyses 
 
All statistical analyses were performed with Minitab 11 for Windows (Minitab Inc., 
State College, PA, USA). Multiple linear regression (MLR) was applied to the data set 
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of 112 chemicals to derive two SPR models, one based on MW and logP, and the other 
based on logP, nH and κ3. The last three variables were identified by stepwise linear 
regression as the most significant predictors of the logarithm of the permeability 
coefficient (logKp) across the rabbit cornea.  
 
Before deriving the SPRs for corneal permeability, certain chemicals were removed 
from the training set, because they were outliers along one or more predictor variables. 
Removal of extreme observations from the independent variables prior to model 
development allows the domains of the eventual models to be defined with greater 
certainty. Outliers were defined as observations that were greater than Q3+1.5(Q3-Q1), 
or smaller than Q1-1.5(Q3-Q1), where Q1 and Q3 are the first and third quartiles (25th and 
75th percentiles), respectively. 
 
Cross-validated coefficients of determination [r2(cv)] for the SPRs were calculated by 
the leave-one-out cross-validation procedure, using a purpose-written Minitab macro 
(See Appendix A2). Cross-validated r2 values are considered to provide a more realistic 
indication of model predictivity than are conventional r2 values. The Minitab macro was 
also used to generate predicted values of corneal permeability, and a cross-validated 
standard error of the estimate (i.e. the mean standard error of the estimate, taken over all 
iterations of the leave-one-out procedure). 
 
The stabilities of the regression coefficients were assessed by performing a resampling 
routine, coded in the form of another Minitab macro (see Appendix A10). In each 
iteration of the routine, 20 chemicals were selected, at random and without replacement, 
from the training set, and MLR was performed with the physicochemical and 
permeability data for these 20 chemicals. This procedure was carried out 1000 times, 
each time storing the coefficients of the regression equation. The distribution of each 
parameter, taken over 1000 iterations, was then used to determine the variability of each 
parameter. Typically, the sampling distributions are expected to be approximately 
normal, or to at least consist of a single node. If a parameter distribution is observed to 
be multi-modal, this indicates that a single regression model is insufficient to fit the 
data.   
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To explore the possibility of relationships occurring between the corneal permeabilities 
of chemicals and their abilities to cause eye lesions, the predicted corneal permeability 
coefficients for 66 chemicals were compared with various eye irritation endpoints by 
using matrix and scatter plots. The endpoints examined were the bootstrap mean values 
of the WDS, conjunctival erythema, œdema and discharge, corneal opacity and area, the 
weighted corneal score (= 5 x opacity x area), and iritis (see chapter 5). 
 
8.3 RESULTS 
 
8.3.1 Prediction of corneal permeability from molecular weight and lipophilicity   
 
Before carrying out MLR on logP and MW, five chemicals (EDTA, mannitol, sucrose, 
the quaternary ammonium derivative of sulphonamide, and tobramycin) were removed 
from the training set, since these were outliers along logP. Application of MLR to the 
remaining 107 chemicals produced a two-variable SPR (Equation 8.1), which is 
significant at the 99.9% level. The domain of this SPR is defined by logP values in the 
range –2.2 to 4.2, and MW values from 17 to 468 g/mol: 
 
log Kp = 0.344 logP - 0.00321 MW- 4.73    (Equation 8.1) 
 
n = 107, s = 0.50, s(cv) = 0.50, r = 0.65, r2= 0.42, r2(cv) = 0.38 
F = 37.6 (p < 0.001), t(logP) = 8.6 (p < 0.001), t(MW) = -5.2 (p < 0.001) 
 
Resampling the data set of 107 chemicals (1000 times, 20 chemicals a time), and taking 
the median values of the parameter distributions, produced the following equation: 
 
log Kp = 0.355 logP – 0.00326 MW – 4.74 
 
The sampling distributions of the regression parameters are all approximately normal, 
with standard deviations of 0.106, 0.0015 and 0.38 for logP, MW and the constant, 
respectively. The estimates for the parameters are therefore considered to be stable. The 
two variables (logP and MW) are considered to be independent since they are not 
significantly correlated (r = 0.45). 
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As with any regression model, the statistical quality of the two-variable SPR can be 
improved by removing observations that are poorly predicted or exert a large influence 
on the regression parameters. For example, by removing two chemicals (ibuprofen and 
tetracaine) that are poorly predicted (i.e. have standardised residuals greater than 2), the 
r2 value increases from 0.42 to 0.51: 
 
log Kp = 0.390 logP - 0.00327 MW- 4.77 
 
n = 105, s = 0.46, s(cv) = 0.46, r = 0.71, r2= 0.51, r2(cv) = 0.47 
F = 52.6 (p < 0.001), t(logP) = 10.1 (p < 0.001), t(MW) = -6.2 (p < 0.001) 
 
8.3.2 Prediction of corneal permeability from lipophilicity, hydrogen bonding and 
molecular shape   
 
Stepwise regression analysis identified the three most significant variables (in order of 
decreasing significance) to be logP, nH and κ3. Before carrying out MLR on these 
variables, 17 chemicals were removed from the data set, because they were outliers 
along one or more of the three variables: acebutolol, alprenolol, atenolol, betaxolol, 
bevantolol, cromolyn, EDTA, labetalol, mannitol, metoprolol, nadolol diacetate, 
oxprenolol, sotalol, sucrose, the quaternary ammonium derivative of sulphonamide, 
tetracaine, and tobramycin.  
 
The regression of logKp against logP, nH and κ3 produced a three-variable SPR 
(Equation 8.2), which is significant at the 99.9 % level. The domain of this SPR is 
defined by logP values in the range –2.2 to 4.2, nH values from 2 to 13, and κ3 values 
from 0 to 6.  
 
log Kp = 0.230 logP - 0.0679 nH - 0.168 κ3 - 4.35   (Equation 8.2) 
 
n = 95, s = 0.46, s(cv) = 0.46,  r = 0.72,  r2 = 0.52, r2 (cv) = 0.47 
F = 33.0 (p < 0.001), t(logP) = 6.1 (p < 0.001), t(nH) = -3.9 (p < 0.001),  
t(κ3) = -3.5 (p = 0.001) 
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To assess the stability of the parameters in this model, the subset of 95 chemicals was 
resampled (1000 times, 20 chemicals a time). Taking the median values of the 
parameter distributions produced the following equation: 
 
log Kp = 0.229 logP - 0.0684 nH - 0.167 κ3 - 4.32 
 
The sampling distributions of the regression parameters are approximately normal, with 
standard deviations of 0.086, 0.044, 0.076 and 0.12 for logP, nH, κ3 and the constant, 
respectively. The estimates are therefore considered to be stable. In addition, there are 
no significant correlations between the three descriptor variables (rnH-logP =-0.31; rκ3-logP 
= 0.20; rnH- κ3 = 0.30), which provides further support for the stability of the model. 
 
8.3.3 Relationships between corneal permeability and eye irritation endpoints   
 
A subset of 66 chemicals (Table 8.2) was selected from an eye irritation data set of 92 
chemicals (Table 5.7) on the basis that the logP, κ3 and nH values of these chemicals 
fall within the domain of the SPR defined by Equation 8.2, which was used to predict 
their corneal permeability coefficients. Examination of a matrix plot (Figure 8.1) 
revealed no apparent relationship between predicted corneal permeability and the three 
conjunctival endpoints. The other eye irritation endpoints (corneal opacity and area, the 
weighted corneal score, the WDS, and iritis) showed a tendency for irritants to be 
located in the mid-range of corneal permeabilities. However, the matrix plot shows that 
the non-irritants also have intermediate values of corneal permeability, so it would 
appear difficult to distinguish between irritants and non-irritants on the basis of corneal 
permeability. These effects are most noticeable in the scatter plot of iritis against 
corneal permeability (Figure 8.2).  
 
8.4 DISCUSSION 
 
In this study, two mechanistically-based SPRs (Equations 8.1 and 8.2) were derived for 
predicting the corneal permeability coefficients of a diverse range of organic chemicals. 
The two models have statistically significant predictor variables, stable coefficients, and 
well-defined domains of application. While the two-variable SPR is more economical 
and user-friendly in terms of its predictor variables, the three-variable SPR produces a 
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better fit to the data, and provides more mechanistic insight into the transcorneal 
penetration process. 
 
The mathematical form of both SPRs was chosen to be linear, because in the absence of 
prior information, this is the simplest mathematical form to assume for any model. In 
support of this choice, scatter plots of logKp against each predictor variable did not  
indicate any non-linear dependencies. Furthermore, an SPR based only on logP and 
logP2 produced a poor fit (r2 = 0.27) to the reduced data set of 107 chemicals, and the 
inclusion of logP2 as a predictor variable (in addition to, or instead of, logP) in the two-
variable and three-variable SPRs did not improve their statistical quality.  
 
According to the two-variable model (Equation 8.1), corneal permeability increases 
with increasing lipophilicity (logP) and with decreasing molecular weight (MW), an 
approximate measure of molecular size. The importance of the latter variable is 
consistent with the observation that the diffusion parameters of hydrophilic drugs 
increase with decreasing molecular weight (Sasaki et al., 1997).  
 
The three-variable model (Equation 8.2) indicates that corneal permeability increases 
with increasing logP (lipophilicity), and with decreasing nH (hydrogen-bonding 
potential) and κ3. The last variable can be interpreted as a measure of the centrality of 
branching: the more linear a molecule, the greater its value of κ3, whereas the greater 
the degree of branching at the centre of the molecule, the smaller the value of κ3 (Hall 
& Kier, 1991). Consistent with the importance of κ3 is the observation that the rabbit 
corneal permeability of a series of local anæsthetics decreased with increasing 
molecular length (Igarashi et al., 1984). The lipophilic barrier is likely to be the corneal 
epithelium on the outer surface of the cornea, since this is a stratified epithelium 
comprising 5-7 layers of cells, inter-connected by tight junctions. The importance of nH 
could be a reflection of the barrier to diffusion provided by the corneal stroma, which 
accounts for about 90% of the cornea’s thickness (450 μm), and consists of a highly 
ordered array of collagen bundles. Thus, molecules that are sufficiently lipophilic to 
cross the epithelium will be further impeded if they engage in hydrogen bonding with 
the collagen matrix. The importance of the third variable (κ3) could also be a reflection 
that the stroma is a highly ordered matrix, the dimensions of which favour the transport 
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of non-linear molecules over linear ones, but it could also relate to the barrier properties 
of the epithelia on both sides of the cornea. 
 
In comparison with previous attempts to model corneal permeability (e.g. Yoshida & 
Topliss, 1986), the SPRs presented here have been based on a larger number of 
chemicals covering a broader range of chemical structures. For example, Yoshida & 
Topliss presented an SPR with a high r value (0.9), but this was derived from just 26 
chemicals, mostly steroids and β-blockers. The Yoshida & Topliss model is based on 
two predictors: logD and ΔlogP (where logD = the logarithm of the distribution 
coefficient at pH 7.65, and ΔlogP = logPoctanol – logPalkane). Data for logD can be found 
in the literature (e.g. Prausnitz & Noonan, 1998), but the measurements have generally 
been obtained at different pH values and are therefore incomparable. Data for ΔlogP are 
not so readily available, so in cases where these data were missing, Yoshida & Topliss 
used a solvation equation to predict ΔlogP from five other variables (R2, a term 
representing molar refraction; π2, a descriptor for dipolarity/polarisability; Σα2H and 
Σβ2H, descriptors for hydrogen bond acidity and basicity; and Vx, the characteristic 
volume of McGowan). Interestingly, according to Yoshida & Topliss, ΔlogP expresses 
mainly hydrogen-bonding acidity, which, in mechanistic terms, is related to the 
hydrogen-bonding predictor (nH) identified as significant by stepwise regression in this 
study. 
 
At first sight, the SPRs for corneal permeability do not appear to be as predictive as the 
SPRs reported above for skin permeability (Cronin et al., 1998; Potts & Guy, 1992). It 
should be noted, however, that the r2 values of the two SPRs for corneal permeability 
can be improved by removing additional chemicals from the training set (i.e. chemicals 
that are poorly predicted or exert an unduly large influence on the regression 
parameters). For example, the r2 value of the two-variable SPR can be increased from 
0.42 to 0.51 by removing just two chemicals (ibuprofen and tetracaine). Since the SPRs 
for skin permeability and for corneal permeability were based on different sets of 
chemicals, and possibly on data sets of differing quality, the statistical quality of the 
different models is not strictly comparable.  
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To better define the domains of the SPRs, a number of chemicals were removed from 
the training set before developing the models. The five chemicals removed before 
developing the two-variable SPR had extreme logP values. In the cases of EDTA, 
mannitol, sucrose, and tobramycin, these extreme values could be a result of the large 
numbers of hydrogen bonds formed, whereas the quaternary ammonium derivative of 
sulphonamide is an ionic species that does not exist in its non-ionised (permeable) form 
at the experimental pH of 7.0 (Prausnitz & Noonan, 1998). The same chemicals were 
also removed before developing the three-variable SPR, since this is also based on logP. 
In addition, a further 12 chemicals (acebutolol, alprenolol, atenolol, betaxolol, 
bevantolol, cromolyn, labetalol, metoprolol, nadolol diacetate, oxprenolol, sotalol and 
tetracaine) were removed before developing the three-variable SPR, since these were 
outliers along κ3. It is noteworthy that, with the exception of cromolyn and tetracaine, 
these chemicals are all β-adrenoceptor antagonists, 10 of which contain the following 
substructure: Ar-O-CH2-CH(OH)-CH2-NH-R, where Ar is an aromatic ring structure 
and R is an isopropyl or tert-butyl group. The other two chemicals (bevantolol and 
labetalol) have a very similar structure (in bevantolol, the R group is an ethylbenzene 
derivative, whereas in labetalol, there is no methoxy group). It therefore appears that the 
domain of the three-variable SPR excludes the family of β-blocking drugs.  
 
A number of chemical types were consistently under-predicted or over-predicted by the 
SPRs. For example, the glucose derivatives showed a tendency to be underpredicted,  
perhaps because they can traverse the cornea by facilitated transport in addition to 
passive diffusion. Evidence for a facilitated glucose transporter in the corneal 
epithelium was presented by Takahashi et al. (1996). The steroids were anomalous in 
that they are under-predicted by the two-variable SPR, and over-predicted by the three-
variable SPR. Since there are 10 steroids in the data set, it is acceptable, in principle, to 
derive a separate two-variable SPR for these substances (according to Topliss & 
Costello [1972], the ratio of observations to variables should be at least 5 to avoid the 
derivation of chance relationships). However, when MLR of logKp was performed 
against logP and MW, the residuals showed a significant degree of autocorrelation, and 
were not normally distributed, suggesting that the model could be unreliable, despite its 
reasonable r2 value of 0.68. It is noteworthy that the corneal permeability for the 10 
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steroids were all derived from a single reference (Schoenwald & Ward, 1978), which 
suggests that a systematic laboratory bias might be the reason from their anomalous 
behaviour. The corneal permeability coefficient of water was under-predicted by both 
SPRs. The under-prediction of water could be an artefact, possibly because no account 
had been taken of its high diffusion coefficient in the experimental set-up, with the 
result that the measured permeability coefficient was overestimated. Alternatively, there 
could be a mechanistic reason, related to the presence of water channels or small pores 
in the corneal membrane. Evidence for the presence of a water channel (aquaporin 5) in 
the corneal epithelium has been reported by Kang et al. (1999), and evidence for the 
presence of pores has been presented by Hamalainen et al. (1997a, 1997b). The 
permeabilities of two other small polar molecules were also under-predicted (butanol 
and glycerol), but the permeability of ethanolamine was over-predicted. 
 
Perhaps the most significant reason for poor predictions is that the permeability data 
(Table 8.1) were pooled from 20 primary literature sources, which almost certainly 
means that there were significant inter-laboratory differences in the experimental 
protocols used to obtain the permeability coefficients. The inherent variability of the 
experimental data will place a ceiling on the r2 value that can be obtained with any 
model, however well-chosen the predictor variables. An inspection of the original data 
showed that permeability measurements for the same chemical can vary by up to one 
order of magnitude, i.e. log Kp values were generally accurate within one log unit. The 
SPRs derived in this study have a standard error of the estimate (s) of about 0.5 log 
units, i.e. there is an uncertainty of about ± 1 log unit (the 95% confidence interval is 
approximately 2.s). Thus, the uncertainty in the predicted values is about the same as 
the uncertainty in the original data, which means that the SPRs are not overfitting the 
data. If the corneal permeability measurements had been obtained according to a 
standardised protocol, the SPRs would probably have been more accurate. 
 
In the pharmaceutical industry, SPRs for corneal permeability could be used to 
determine the delivery of potential drugs to the appropriate tissue in the eye. It has been 
shown that the corneal epithelium contains a greater proportion of paracellular space 
than either the conjunctiva or the sclera (Hamalainen et al., 1997a; 1997b). This 
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suggests that transcorneal transport is generally the rate-limiting step in drug delivery, 
and therefore the most appropriate step to model.  
 
From the results of this study, no obvious relationship could be identified between 
corneal permeability and several eye irritation endpoints (Figure 8.1). A relationship 
between corneal permeability and the corneal and iris endpoints was expected on the 
basis that chemicals with greater corneal permeabilities should be more likely to cause 
lesions in the cornea and iris than chemicals with smaller permeabilities. Ideally, this 
hypothesis would have been tested by comparing measured permeabilities against 
measured ocular effects. However, eye irritation data were not available for the 
Prausnitiz & Noonan permeability data set, and corneal permeabilities were not 
available for the eye irritation data set. Therefore, the hypothesis was tested by 
predicting the corneal permeabilities for those chemicals in the eye irritation data set 
that fell within the domain of the better SPR (Equation 8.2). The absence of the 
expected relationship could be due to the limited predictive quality of the SPR (r2 = 
52%), or there could be mechanistic reasons. In particular, the fact that non-irritating 
chemicals span the full range of corneal permeabilities (Figures 8.1 and 8.2) is not 
surprising, since not all chemicals that reach the cornea and iris are expected to exert 
toxic effects. In addition, the observation that chemicals with low predicted 
permeabilities are non-irritant is expected, on the basis that these chemicals are unable 
to reach the cornea and iris.  
 
8.5 CONCLUSIONS 
 
The analyses carried out in this study suggest that the corneal permeability coefficients 
of a diverse range of organic chemicals can be predicted by using two (logP and MW) 
or three (logP, nH and κ3) predictor variables. The SPRs are applicable to a diverse 
range of chemical classes, including glucose derivatives, steroids, sulphonamides, 
nitrogen-containing heterocycles, and anilines. Chemicals known to undergo 
metabolism (e.g. pro-drugs) or extrusion at the outer corneal surface (e.g. cyclosporin 
A) are excluded from the domains of the two SPRs. In addition, the family of β-
adrenoceptor antagonists is excluded from the domain of the three-variable SPR. The 
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two SPRs are probably modelling passive diffusion, and outliers are likely to be 
chemicals that permeate by means of specific transport mechanisms.  
 
The models presented in this study should be regarded as provisional, since their 
predictive capacities could probably be improved if they were reparameterised by using 
a sufficient amount of high-quality permeability data, obtained according to a single, 
standardised in vitro protocol. It remains to be seen, however, whether a single SPR will 
be capable of predicting the corneal permeabilities of a broad range of chemical 
structures with greater accuracy, or whether different class-specific SPRs will need to 
be developed. Depending on the availability of mechanistic information, it might also be 
possible to develop different SPRs to account for different modes of transcorneal 
penetration (passive transcellular diffusion, passive paracellular diffusion, passive 
carrier-mediated transport, and active transport). However, since it is unlikely that SPRs 
will be able to model the transcorneal transport of all types of substances (e.g. pro-drugs 
and formulations), it is suggested that SPRs are used in combination with in vitro tests, 
so that substances falling outside the domain of the SPRs are the only ones that would 
need to be tested in vitro.  
 
Finally, there appears to be some relationship between corneal permeability and the 
severity of lesions in the cornea and iris. However, the relationship does not appear to 
be sufficiently well-defined for reliable predictions to be made of eye irritation on the 
basis of corneal permeability alone. 
 
 
 226
Figure 8.1 Relationships between corneal permeability and eye irritation endpoints 
 
 
 227
Footnote to Figure 8.1 
 
WDS = weighted Draize score; ERYTHEMA = conjunctival erythema (redness); OEDEMA = 
conjunctival œdema (chemosis); DISCHARG = conjunctival discharge; OPACITY = corneal 
opacity; AREA = corneal area; IRITIS = iris lesion; WCS = weighted corneal score; log KP = 
logarithm of the corneal permeability coefficient. 
 
Each tissue score is a mean value, taken over three time-points (24h, 48h & 72h) and all rabbits 
in the experimental group. 
 
 
 
 
Figure 8.2 Relationship between corneal permeability and iritis 
 
 
 
Footnote to Figure 8.2 
 
1 = acetone; 3= isopropanol; 5 = γ-butyrolactone; 8 = furfuryl hexanol; 9 = pyridine; 11 = 
cyclohexene; 13 = 4-fluoroaniline; 19 = 2,2-dimethylbutanoic acid; 22 = 4-
carboxybenzaldehyde; 29 = methylthioglycolate; 33= glycidyl methacrylate;   35 = methyl 
cyanoacetate; 36 = ethylthioglycolate; 40 = butanone; 41 = methyl acetate; 43 = isobutanol; 44 
= butanol; 47 = diethylaminopropionitrile; 49 = 2-ethyl-1-hexanol; 57 = 2-methoxyethyl 
acrylate; 61 = hexanol 
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Table 8.1 Corneal permeability and physicochemical data for 112 chemicals 
  
No Chemical logKp logP MW  κ3 nH 
       
1 Acebutolol -6.07 1.19 336.4 8.7924 9 
2 Acetazolamide -6.02 -0.72 222.2 3.3241 11 
3 2-Benzoylamino-1,3,4-thiadiazole 5-sulphonamide -6.22 0.88 284.3 3.9958 11 
4 2-Isopentenyl amino 1,3,4-thiadiazole-5-
sulphonamide 
-6.25 1.00 276.3 4.0000 11 
5 N-Methylacetazolamide -5.64 -0.25 236.3 3.2727 10 
6 Alprenolol -4.54 2.81 249.4 6.6667 5 
7 Aniline -4.44 1.08 93.1 1.5000 3 
8 4-Aminoacetanilide -5.44 0.18 150.2 3.2653 6 
9 4-Aminoacetophenone -4.49 0.76 135.2 2.2857 4 
10 4-Aminobenzamide -5.77 -0.33 136.2 2.6509 6 
11 4-Aminobenzyl alcohol -4.77 0.16 123.2 2.0000 5 
12 4-Aminophenylethanol -4.70 0.65 137.2 2.6509 5 
13 4-Chloroaniline -4.46 1.72 127.6 1.8000 4 
14 4-Ethoxyaniline -4.51 1.65 137.2 2.6509 4 
15 4-Ethylaniline -4.57 2.11 121.2 2.0000 3 
16 4-Isopropylaniline -4.62 2.53 135.2 2.2857 3 
17 4-Methoxyaniline -4.46 1.16 123.2 2.0000 4 
18 4-Toluidine -4.52 1.62 107.2 1.8000 3 
19 Atenolol -5.96 -0.03 266.3 8.0000 9 
20 Benzolamide -6.85 0.12 320.4 3.9862 12 
21 Betaxolol -4.57 2.98 307.4 9.0369 6 
22 Bevantolol -4.27 2.68 345.4 7.6371 7 
23 Bromacetazolamide -6.17 -0.05 301.1 3.5918 12 
24 Bufuralol -4.14 3.43 261.4 3.9862 5 
25 Butanol -4.12 0.84 74.1 4.0000 2 
26 Chloramphenicol -5.17 0.92 323.1 5.3789 12 
27 Chlorzolamide -4.74 0.94 275.7 2.8311 9 
28 Cimetidine -6.15 0.57 252.3 5.9282 9 
29 Clonidine -4.36 1.89 230.1 2.5344 7 
30 Cocaine -5.21 2.17 303.4 3.4405 5 
31 Cortexolone -4.52 3.15 346.5 2.3706 6 
32 Corynanthine -4.96 2.11 354.4 2.9512 6 
33 Cromolyn -5.96 1.55 468.4 6.4784 14 
34 Cyclophosphamide -4.96 0.97 261.1 3.2727 9 
35 Deoxycorticosterone -4.40 3.12 330.5 2.4814 4 
36 2-Deoxyglucose -5.13 -2.17 164.2 1.7729 9 
37 1-Cyclopropyl 2-deoxyglucose -5.66 -0.95 204.2 2.0204 9 
38 1-Ethyl 2-deoxyglucose -5.54 -1.26 192.2 2.0833 9 
39 1-Isopropyl 2-deoxyglucose -5.74 -0.84 206.2 2.3432 9 
40 1-Methyl 2-deoxyglucose -5.34 -1.75 178.2 1.8595 9 
41 Dexamethasone -5.30 1.72 392.5 2.3951 9 
42 Dexamethasone-17-acetate -4.43 2.46 434.5 3.1074 9 
43 2,5-Dimethoxyaniline -4.48 1.24 153.2 2.2145 5 
44 Edetic acid (EDTA) -5.68 -3.86 292.2 12.4898 14 
45 Ethanolamine -6.30 -1.61 61.1 4.0000 5 
46 Ethoxyzolamide -4.25 2.08 258.3 2.8311 8 
47 2-Benzothiazole-sulphonamide -4.44 1.50 214.3 1.9200 7 
48 6-Hydroxy 2-benzothiazole-sulphonamide -5.25 1.02 230.3 2.1728 9 
49 6-Chloro 2-benzothiazole-sulphonamide -4.37 2.15 248.7 2.1728 8 
50 4,6-Dichloro 2-benzothiazole-sulphonamide -4.41 2.79 283.1 2.2400 9 
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Table 8.1 continued 
 
No Chemical logKp logP MW  κ3 nH 
       
51 6-Amino 2-benzothiazole-sulphonamide -5.17 0.59 229.3 2.1728 10 
52 6-Nitro 2-benzothiazole-sulphonamide -5.18 1.32 259.3 2.6514 9 
53 6-Hydroxyethoxy 2-benzothiazole-sulphonamide -5.82 0.61 274.3 3.2633 10 
54 6-Benzyloxy 2-benzothiazole-sulphonamide -4.33 3.29 320.4 4.0500 8 
55 6-Acetamido 2-benzothiazole-sulphonamide -5.33 0.61 271.3 3.2633 10 
56 Fluorometholone -4.77 2.06 376.5 2.2272 7 
57 Flurbiprofen -4.68 3.81 244.3 3.5262 4 
58 Flurbiprofen amide -4.66 2.93 243.3 3.5262 5 
59 Glycerol -5.35 -1.65 92.1 3.0000 6 
60 Hydrocortisone -5.07 1.62 362.5 2.4860 8 
61 Ibuprofen -5.66 3.79 206.3 4.1653 3 
62 Indomethacin -4.16 4.23 357.8 4.1353 6 
63 Labetalol -4.85 2.41 328.4 6.6824 10 
64 Levobunolol -4.77 2.48 291.4 5.2898 6 
65 Mannitol -5.62 -3.01 182.2 3.5156 12 
66 Methazolamide -5.59 -0.65 236.3 3.2727 10 
67 5-Imino-4-methyl-1,3,4 thiadiazoline-2-sulphonamide -6.11 0.36 194.2 1.9753 10 
68 Methylenedianiline -4.60 2.18 198.3 3.5000 6 
69 Metoprolol -4.55 1.69 267.4 8.0000 6 
70 MK-927 -5.34 0.86 338.5 3.6213 10 
71 Nadolol -5.85 1.17 309.4 5.5515 9 
72 Nadolol diacetate -5.32 2.77 393.5 8.3457 9 
73 Oxprenolol -4.55 1.83 265.4 7.3728 6 
74 Penbutolol -4.22 4.20 291.4 5.9504 5 
75 Phenylephrine -6.03 -0.21 167.2 3.1142 6 
76 Pilocarpine -4.77 0.24 208.3 2.3971 4 
77 Pindolol -5.00 1.48 248.3 4.2667 6 
78 Prednisolone -5.43 1.40 360.4 2.4860 8 
79 Prednisolone acetate -4.48 2.14 402.5 3.2770 8 
80 Procaine -5.38 1.99 236.3 5.4444 6 
81 Progesterone -4.70 3.67 314.5 2.2893 2 
82 Propanolol -4.47 2.60 259.3 4.7950 5 
83 Rauwolfine -5.04 1.88 326.4 1.4405 6 
84 SKF 72223 -4.31 1.91 193.2 2.0204 4 
85 SKF 86466 -4.15 2.87 195.7 2.0833 2 
86 SKF 86607 -4.10 1.10 191.3 1.3333 5 
87 Sotalol -6.15 0.37 272.4 6.6667 8 
88 Sucrose -5.37 -4.27 342.3 3.3833 19 
89 Sulphacetamide -6.00 -0.60 214.2 3.5918 8 
90 Quaternary ammonium derivative of sulphonamide -5.44 -2.85 229.3 4.5714 5 
91 2-Benzimidazole derivative of sulphonamide  -5.52 1.38 273.3 2.8800 7 
92 4-Chloro-N-methylbenzene derivative of sulphonamide -5.19 3.24 281.8 3.5262 5 
93 4-Chlorobenzene derivative of sulphonamide -5.26 2.78 267.7 3.4844 6 
94 Sulphanilamide -6.30 -0.55 172.2 2.5000 8 
95 Testosterone -4.38 3.27 288.4 1.9263 3 
96 Tetracaine -5.82 3.02 264.4 7.3728 5 
97 6-Sulphonamido-3-substituted-3-H-1,3,4-
thiadiazolo[2,3-C]-1,2,4-thiadiazole 
-5.10 1.61 313.4 3.0296 11 
98  3-Chloro derivative of chemical #97 -4.89 2.25 347.8 3.2766 12 
99  4-Chloro derivative of chemical #97 -5.08 2.25 347.8 3.2766 12 
100  4-Methoxy derivative of chemical #97 -5.35 1.69 343.4 3.5046 12 
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Table 8.1 continued 
 
No Chemical logKp logP MW  κ3 nH 
       
101  3-Methoxy derivative of chemical #97 -5.28 1.69 343.4 6.2457 12 
102  4-Hydroxy derivative of chemical #97 -6.46 1.13 329.4 5.6529 13 
103  3-Fluoro derivative of chemical #97 -5.19 1.81 331.4 5.6529 12 
104  4-Fluoro derivative of chemical #97 -5.39 1.81 331.4 5.6529 12 
105  4-Dimethylamino derivative of chemical #97 -5.24 1.79 356.4 6.4815 12 
106 Timolol -4.92 1.75 316.4 8.0222 10 
107 Tobramycin -6.28 -5.76 467.5 11.1600 29 
108 Triamcinolone acetonide -4.92 2.69 434.5 6.7804 9 
109 Trichlormethazolamide -4.62 0.70 339.6 4.9383 13 
110 Trifluormethazolamide -5.41 -0.24 290.2 4.9383 13 
111 Water -3.82 -0.57 17.0 2.0000 2 
112 Yohimbine -4.74 2.11 354.4 7.1111 6 
 
 
Footnote to Table 8.1 
 
κ3 = third-order kappa index; log Kp = logarithm of the corneal permeability coefficient; logP = 
logarithm of the octanol-water partition coefficient; MW = molecular weight; nH = number of 
potential hydrogen bonds. 
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Table 8.2 Data set of 66 chemicals for which predicted corneal permeability was compared with eye irritation  
 
 
 Chemical Redness Chemosis Discharge Opacity Area Iritis WCS WDS MW logP κ3 nH logKp 
               
1 Acetone 2.8 2.5 2.8 1.9 2.9 1.2 27.9 50.4 58.1 -0.24 0.000 1 -4.47 
2 Ethanol 2.1 1.3 0.7 1.1 1.3 0.4 7.4 18.0 46.1 -0.14 0.000 2 -4.52 
3 Isopropanol (propan-2-ol) 2.3 1.6 0.8 0.7 1.1 0.8 4.0 17.6 60.1 0.28 0.000 2 -4.42 
4 Isopropyl bromide 0.3 0.2 0.0 0.0 0.0 0.0 0.0 1.1 123.0 2.08 0.000 1 -3.94 
5 γ-Butyrolactone 2.2 2.1 1.3 1.9 2.2 0.8 21.0 36.2 86.1 -0.31 0.980 2 -4.72 
6 Cyclopentanol 2.0 1.9 1.0 1.2 1.4 0.0 8.9 18.7 86.1 1.15 0.980 2 -4.39 
7 Methylcyclopentane 0.8 0.1 0.2 0.0 0.0 0.0 0.0 2.3 84.2 3.1 0.980 0 -3.80 
8 Furfuryl hexanol 1.3 1.3 0.3 2.3 2.7 1.3 31.1 43.5 98.1 0.45 1.185 3 -4.65 
9 Pyridine 2.9 3.3 1.3 2.7 1.9 1.2 25.2 46.1 79.1 0.8 1.333 1 -4.46 
10 2-xylene  0.2 0.4 0.0 0.0 0.0 0.0 0.0 1.2 106.2 3.09 1.488 0 -3.89 
11 Cyclohexanol 2.4 2.5 2.2 2.9 4.0 1.2 58.2 78.6 100.2 1.23 1.500 2 -4.45 
12 Toluene 1.5 1.4 0.7 0.0 0.0 0.0 0.0 7.3 92.1 2.54 1.500 0 -4.02 
13 4-Fluoroaniline 2.7 2.2 1.6 1.6 4.0 0.6 31.5 47.4 111.1 1.28 1.800 4 -4.63 
14 Styrene 0.7 0.6 0.3 0.1 0.1 0.0 0.0 3.2 104.2 2.89 1.800 0 -3.99 
15 2,6-Dichlorobenzoyl chloride 2.6 1.6 1.7 1.0 2.2 0.0 10.8 22.3 209.5 2.73 1.975 4 -4.33 
16 3-Ethyltoluene 0.8 0.0 0.1 0.0 0.0 0.0 0.0 1.8 120.2 3.58 2.000 0 -3.86 
17 2,4-Difluoronitrobenzene 1.3 0.4 0.4 0.0 0.0 0.0 0.0 4.2 159.1 2.21 2.215 4 -4.49 
18 3-Chloro-4-fluoronitrobenzene 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 175.5 2.66 2.215 4 -4.38 
19 2,2-Dimethylbutanoic acid 2.0 0.7 1.1 1.5 4.0 0.5 30.0 40.0 116.2 1.94 2.222 3 -4.48 
20 4-Methylthiobenzaldehyde 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 152.2 2.31 2.286 2 -4.34 
21 1-Methylpropylbenzene 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 134.2 3.94 2.286 0 -3.83 
22 4-Carboxybenzaldehyde 3.0 1.3 1.3 1.8 3.1 1.4 27.6 46.1 150.1 1.59 2.500 4 -4.68 
23 4-Bromophenetole 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 201.1 3.46 2.651 1 -4.07 
24 3,3-Dimethylpentane 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.2 3.67 2.667 0 -3.95 
25 Methyl trimethyl acetate 0.6 0.3 0.1 0.0 0.0 0.0 0.0 1.9 116.2 1.74 2.813 2 -4.56 
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Table 8.2 continued  
 
 
 Chemical Redness Chemosis Discharge Opacity Area Iritis WCS WDS MW logP κ3 logP nH logKp 
                
26 2,2-Dimethyl-3-pentanol 0.8 0.3 0.0 0.8 0.6 0.0 2.1 4.5 116.2 -0.24 2.813 2.13 2 -4.47 
27 cis-Cyclooctene 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 110.2 -0.14 2.813 3.94 0 -3.92 
28 Glycerol 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 92.1 0.28 3.000 -1.65 6 -5.64 
29 Methylthioglycolate 2.4 1.8 1.3 2.2 1.9 0.9 20.7 36.4 106.1 2.08 3.000 0.32 3 -4.98 
30 1,2,3-Trimercaptopropane 1.3 1.5 0.3 0.0 0.0 0.0 0.0 6.2 140.3 -0.31 3.000 1.57 3 -4.70 
31 Ethyl trimethyl acetate 0.6 0.4 0.1 0.2 0.2 0.0 0.1 2.3 130.2 1.15 3.556 2.23 2 -4.57 
32 Ethyl-2-methyl acetoacetate 1.2 0.9 1.3 0.9 1.4 0.0 6.4 13.3 144.2 3.1 3.703 0.21 3 -5.13 
33 Glycidyl methacrylate 1.5 1.2 0.6 0.8 1.4 0.4 5.3 14.4 142.2 0.45 3.703 0.81 3 -4.99 
34 3-Methoxy-1,2-propanediol 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 106.1 0.8 3.840 -1.15 5 -5.60 
35 Methyl cyanoacetate 3.0 2.1 1.0 0.4 1.3 1.0 2.9 20.6 99.1 3.09 3.840 -0.47 3 -5.31 
36 Ethylthioglycolate 1.2 0.8 0.4 1.0 0.8 0.5 4.0 11.6 120.2 1.23 3.840 0.81 3 -5.01 
37 2-Methyl-1-pentanol 1.1 0.7 0.0 1.1 1.2 0.0 6.9 10.7 102.2 2.54 3.840 1.75 2 -4.73 
38 3-Methylhexane 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 100.2 1.28 3.840 3.71 0 -4.14 
39 Propylene glycol 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 76.1 2.89 4.000 -0.78 4 -5.47 
40 Butanone 2.1 2.2 2.3 1.3 1.7 0.6 10.6 27.0 72.1 2.73 4.000 0.26 1 -5.03 
41 Methyl acetate 2.2 2.1 1.8 1.3 1.3 0.8 8.4 25.1 74.1 3.58 4.000 0.37 2 -5.07 
42 3-Chloropropionitrile 0.6 0.3 0.2 0.7 0.4 0.1 1.5 4.5 89.5 2.21 4.000 0.6 3 -5.09 
43 Isobutanol 2.4 2.3 1.4 2.1 2.6 1.1 26.9 44.6 74.1 2.66 4.000 0.77 2 -4.98 
44 Butanol 2.4 2.1 1.6 2.0 2.4 0.7 24.2 40.3 74.1 1.94 4.000 0.84 2 -4.96 
45 1,3-Dibromopropane 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.3 201.9 2.31 4.000 2.5 2 -4.58 
46 2-Bromobutane 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.0 3.94 4.000 2.58 1 -4.50 
47 Diethylaminopropionitrile 3.0 2.6 2.4 3.5 1.7 1.0 29.0 50.1 126.2 1.59 4.500 0.53 2 -5.12 
48 Allyl methacrylate 0.8 0.3 0.2 0.0 0.1 0.0 0.0 2.7 126.2 3.46 4.500 2.12 2 -4.75 
49 2-Ethyl-1-hexanol 2.1 1.9 0.8 1.8 1.5 0.7 13.9 27.2 130.2 3.67 4.500 2.73 2 -4.61 
50 Ethyl acetate 1.2 0.6 0.3 0.4 0.3 0.1 0.7 5.5 88.1 1.74 5.333 0.86 2 -5.18 
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Table 8.2 continued  
 
 Chemical Redness Chemosis Discharge Opacity Area Iritis WCS WDS MW logP κ3 nH logKp 
               
51 1-Bromo-4-chlorobutane 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 171.5 2.9 5.333 3 -4.78 
52 1,4-Dibromobutane 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.4 215.9 2.99 5.333 2 -4.69 
53 1,5-Hexadiene 0.9 0.2 0.1 0.0 0.0 0.0 0.0 2.4 82.1 3.02 5.333 0 -4.55 
54 Bromopentane 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 151.0 3.14 5.333 1 -4.59 
55 2-Methylpentane 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.8 86.2 3.21 5.333 0 -4.51 
56 Cellosolve acetate 1.2 0.7 0.5 0.4 0.5 0.0 1.0 6.1 132.2 0.31 5.878 4 -5.54 
57 2-Methoxyethyl acrylate 2.3 2.7 1.4 1.9 1.0 0.6 9.4 25.5 128.2 1.05 5.878 2 -5.23 
58 Thiodiglycol 0.5 0.3 0.3 0.0 0.0 0.0 0.0 2.4 122.2 -0.62 6.000 5 -5.84 
59 2,4-Pentanediol 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 104.1 0.13 6.000 4 -5.60 
60 Methyl isobutyl ketone 
(4-methylpentan-2-one) 
0.8 0.2 0.0 0.1 0.1 0.0 0.0 2.1 100.2 1.16 6.000 1 -5.16 
61 Hexanol 2.7 2.5 2.5 2.2 2.9 1.3 31.7 53.7 102.2 1.82 6.000 2 -5.08 
62 1,5-Dibromopentane 0.6 0.3 0.0 0.0 0.0 0.0 0.0 1.8 229.9 3.48 6.000 2 -4.69 
63 Bromohexane 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 165.1 3.63 6.000 1 -4.59 
64 2-Ethoxyethyl methacrylate 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 158.2 1.49 6.400 3 -5.29 
65 Trifluoroethyl methacrylate 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 168.1 2.18 6.400 5 -5.26 
66 Ethyl thioethyl methacrylate 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 174.3 2.34 6.400 3 -5.09 
 
 
Footnote to Table 8.2 
 
κ3= third-order kappa index; logKp = logarithm of the corneal permeability, predicted with Equation 8.2; logP = logarithm of the octanol-water 
partition coefficient; MW= molecular weight; nH = number of hydrogen bonds; WCS = weighted corneal score; WDS = weighted Draize score. 
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9.1 OBJECTIVES 
 
The aim of the work presented in this chapter was to develop new models for predicting 
the eye irritation potential of organic chemicals. In particular, the following types of 
model were sought: a) SARs based on physicochemical properties that are easily 
calculated; b) PMs based on measured pH values; and c) PMs based on in vitro data. 
While the emphasis of this chapter is to describe the development and assessment of 
individual models, the integrated use of these models is discussed in Chapter 10. 
 
9.2 METHOD 
 
9.2.1 Collection and treatment of data 
 
For the development of SARs, a data set of 119 organic chemicals (Tables 9.1 & 9.2) 
was compiled by taking 82 chemicals from the ECETOC reference chemicals data bank 
for eye irritation (ECETOC, 1998a) and 37 chemicals from Spielmann et al. (1996). 
Chemicals were only included if they were predicted to be liquids at physiological 
temperature (37 °C). Chemicals predicted to be solids were excluded from the analyses, 
partly because the exposure of the rabbit eye to solids is not comparable to that of 
liquids (Balls et al., 1999), and partly because the irritant effects of solids may be 
caused by physical abrasion, rather than by chemical or biochemical effects. All 
chemicals were classified as eye irritants or non-irritants by applying EU and OECD 
classification criteria to the animal data (see chapter 2). The weighted Draize score 
(WDS) was calculated for the 82 ECETOC chemicals, but could not be calculated for 
the remaining chemicals since not all of the necessary tissue scores were reported by 
Spielmann et al. (1996). 
 
For the development of a PM based on pH data, a training set of 165 chemicals (Table 
9.3) was compiled from Régnier & Imbert (1992), and a test set of 49 chemicals (Table 
9.4) was taken from Balls et al. (1995). The pH data for these 49 chemicals were 
provided by BIBRA International (Croydon, UK). The pH values in the two data sets 
are based on measurements carried out in a 10% aqueous solution (w/v for solids and 
v/v for liquids). 
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For the development of PMs based on in vitro data, two validation study data sets were 
investigated. The first in vitro data set (Table 9.5) contains 59 of the 60 chemicals tested 
in the European Commission/British Home Office (EC/HO) validation study (Balls et 
al., 1995). One of the 60 chemicals, thiourea, was omitted from the data set because it is 
acutely toxic. In the validation study, 18 endpoints obtained with 9 test systems were 
examined. The analyses reported here are based on 15 of the in vitro endpoints, obtained 
with 7 test systems (EC/HO data for the HETCAM and NRU tests were omitted). The 
data analysed for each endpoint were the average values of measurements made in three 
or more laboratories, the raw data being taken from the ECVAM archive. The second in 
vitro data set (Table 9.6) contains 143 chemicals taken from a validation study carried 
out in Germany (Spielmann et al., 1996). Seven in vitro endpoints were investigated, 
one being the concentration of test chemical that causes 50% inhibition of neutral red 
uptake into 3T3 cells (IC50), and the other six being endpoints determined in the 
HETCAM test: the mean time for hæmorrhage (TH), lysis (TL) and coagulation (TC), 
using either the undiluted substance (TH100, TL100, TC100) or a 10% solution (TH10, 
TL10, TC10). These data were taken directly from Spielmann et al. (1996), and 
represent the mean values of measurements made in two or more laboratories. 
 
9.2.2 Calculation of physicochemical properties 
 
Physicochemical properties considered to be possible predictors of eye irritation 
potential were calculated from the molecular structures of the 119 chemicals, using the 
methods described in Chapters 6, 7 and 8. Briefly, logP and logS were calculated with 
the Syracuse Research Corporation KOWWIN and WS-KOWWIN software, 
respectively; molecular weight (MW) and surface tension (ST) were calculated with the 
Advanced Chemistry Development (ACD) ChemSketch software; and pKa values with 
the ACD pKa software. In the case of chemicals with more than one ionisable group, all 
pKa values were calculated. Calculations of molecular surface area (MSA), molecular 
volume (MV), dipole moment (DM), and of the energies (ELUMO and EHOMO) of the 
lowest unoccupied molecular orbital (LUMO) and the highest occupied molecular 
orbital (HOMO), were performed on energy-minimised structures in HyperChem 5.1 for 
Windows, as described in chapter 6. The molecular orbital energies were used to 
calculate two additional energy variables, hardness (η) and electronegativity (χ), by 
applying Equations 3.36 and 3.37, respectively (see Chapter 3). Finally, the first-order 
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difference molecular connectivity valence index (dV1) and the third-order kappa index 
(κ3) were calculated with Molconn-Z. The first of these connectivity indices, dV1, was 
found to discriminate between irritants and non-irritants (defined on the basis of a 
MMAS cut-off) in chapter 6, whereas κ3 was found to be a predictor of corneal 
permeability in chapter 8, and a predictor of the molar eye score by Kulkarni & 
Hopfinger (1999). 
 
9.2.3 Development of structure-activity relationships 
 
A preliminary inspection of the physicochemical data, using dot plots, scatter plots, and 
matrix plots, was performed to visually identify the best variables or pairwise 
combinations of variables capable of distinguishing between irritant and non-irritant 
chemicals. Any variable seen to separate irritants from non-irritants in a linear manner 
was subjected to one of the following statistical methods: linear discriminant analysis 
(LDA), binary logistic regression (BLR) or classification tree (CT) analysis. As 
described in chapter 4, the use of LDA is appropriate when the data in the two groups (I 
and NI) are normally distributed and have approximately equal variance-covariance 
matrices. If the data in one or both groups are not normally distributed, BLR can be 
used, provided that the residuals associated with the logistic model are normally 
distributed. If the assumptions of both LDA and BLR are violated, CT analysis can be 
used as a last resort. Any pairwise combination of variables seen to separate irritants 
from non-irritants by the formation of an embedded cluster was analysed by the 
sequential application of CSA and ECM, as described in chapter 6. LDA, BLR and CT 
analyses were performed with STATISTICA, whereas CSA and ECM were performed 
with purpose-written Minitab macros (Appendices A8 and A10). 
 
9.2.4 Development of prediction models 
 
A PM based on pH data was derived from a training set of 165 chemicals (Table 9.3) by 
CT analysis, as described in chapter 7. The performance of the resulting CM was 
assessed by applying the model both to its training set and to a test set of 49 chemicals 
(Table 9.4). 
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A preliminary inspection of the two in vitro data sets was performed to identify the best 
variables or pairwise combinations of variables capable of distinguishing between 
irritant and non-irritant chemicals, and PMs were developed by BLR or CT analysis. 
 
9.2.5 Assessment of classification models 
 
The predictive capacities of the two-group CMs were assessed in terms of their Cooper 
statistics, as described in chapter 7. 
 
9.3 RESULTS 
 
9.3.1 Comparison of EU and OECD classifications  
 
Table 9.1 shows that the application of EU and OECD classification criteria to the 
Draize rabbit data produces the same classifications of eye irritation potential for 104 of 
the 119 chemicals (i.e. 87%), with the EU risk phrase R36 corresponding to the OECD 
class B, and the EU risk phrase R41 corresponding to the OECD class A. However, due 
to the lower thresholds of the OECD system (see chapter 2), 15 of the 119 chemicals are 
classified as non-irritants by the EU system and as class B irritants by the OECD 
system. These chemicals are: 2-methyl-1-pentanol, cyclopentanol, ethanol, isopropanol, 
2-ethyl-1-hexanol, 2,2-dimethylbutanoic acid, ethylthioglycolate, butanal, ethylbutanal, 
isobutanal, paraformaldehyde, 3-cyclohexene-1-methanol, 2,5-dimethylhexanediol, 3,6-
dimethyloctanol, and 1-chloroctan-8-ol. In this study, the EU classifications (30 I and 
89 NI) were used for model development. 
 
9.3.2 Structure-activity relationships  
 
A preliminary inspection of the data revealed that MW was highly correlated with both 
MV and MSA in the data set of 119 chemicals (rMW-MV = 0.83 and rMW-MSA = 0.83), so 
the latter two variables were not considered further as predictor variables. Similarly, 
logS was not considered as a predictor variable, due to its high collinearity with logP (r 
= -0.98, p<0.01). A visual inspection of the data for the remaining variables indicated 
that a cut-off between irritant and non-irritant chemicals could be defined along MW 
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(Figure 9.1), whereas an elliptic boundary could be drawn in the two-dimensional space 
formed by dV1 and logP (Figure 9.2).  
 
Linear model based on molecular weight 
To illustrate that different classification models can be produced by using LDA, BLR 
and CT analysis, the results obtained by applying each of these methods to the MW data 
for 119 chemicals are briefly reported. Strictly, LDA is not appropriate, since the 
irritants are not normally distributed (as judged by the Lilliefors test).  However, if the 
normality condition is ignored, LDA produces a statistically significant (p<0.01) 
discriminant model with a cut-off value of 121 g/mol. The application of BLR produces 
the logistic model described by Equation 9.1, which is also statistically significant 
(p<0.01), and corresponds to a cut-off value of 77 g/mol (=1.996/0.026).  
 
pI = exp(1.996 - 0.026 MW) / {1+exp(1.996 - 0.026 MW)} (Equation 9.1) 
 
However, the residuals of this model are not normally distributed (they are bimodal), 
suggesting that the use of a logistic model is not appropriate. Using CT analysis as a last 
resort produces a cut-off of 137 g/mol, from which the following SAR can be 
formulated: 
  
MW ≤ 137 g/mol, then predict I; otherwise, predict NI. (SAR 1) 
 
The cut-off value 137 g/mol is illustrated in Figure 9.1, and the performance of SAR 1 
is summarised in Table 9.7. 
 
Elliptic model based on lipophilicity and molecular shape 
The application of CSA to the data set of 119 chemicals confirmed that embedded 
clustering is statistically significant (p < 0.01) along both logP and dV1. Following the 
removal of two irritant outliers (octanol [#29] and camphen [#114]), the application of 
ECM generated the elliptic model described by SAR 2. The 2D ellipse described by 
SAR 2 is illustrated in Figure 9.2, and the performance of the model is summarised in 
Table 9.7. 
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Classify an undiluted, organic liquid as an eye irritant if: 
(logP-0.66)2 / 1.212 + (dV1 + 1.22)2/ 1.122 ≤ 1 (SAR 2) 
 
Relationship between pKa and irritation potential 
Of the 119 organic liquids in Table 9.1, 47 chemicals (Table 9.2) are ionisable, and can 
be classified into the following groups: 3 acids (2 I, 1 NI), 33 alcohols (13 I, 20 NI), and 
12 bases (6 I, 6NI). Ten of the 47 chemicals have more than one ionisation centre and 
therefore more than one pKa value. Dot plots of the minimal pKa values for the 36 acids 
and alcohols, and of the maximal pKa values for the 12 bases, provided no evidence for 
a separation between irritants and non-irritants along pKa. 
 
9.3.3 Prediction models 
 
Prediction models based on pH data 
The distribution of pH values for irritants and non-irritants in the data set of 165 
chemicals is shown in Figure 9.3. It can be seen that irritants span a wide range of pH 
values from 0 to about 12, whereas the non-irritants span a much narrower range from 
about 3 to 9. Using the cut-off values generated by CT analysis, the following PM can 
be formulated: 
 
If pH < 3.2 or if pH > 8.6, then predict I; otherwise, predict NI. (PM 1) 
 
The Cooper statistics obtained by applying PM 1 to its training set and to an 
independent test set are summarised in Table 9.7. 
 
Prediction models based on in vitro data 
A preliminary inspection of the in vitro data from the EC/HO study (Balls et al., 1995) 
suggested that the four endpoints measured in the isolated rabbit eye (IRE) test (opacity 
and swelling at 1h and 4h) provide the best discrimination between irritants and non-
irritants (Figure 9.4). Following the removal of two outliers (2,2-dimethylbutanoic acid 
[#27] and ethanol [#41]), CT analysis produced the following PMs 2-5 for the IRE test. 
It is interesting to note that the two outliers are both classified differently under the EU 
and OECD systems, which is indicative of their borderline nature. 
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If opacity score at 1h > 0.9, then predict I; otherwise, predict NI. (PM 2) 
If opacity score at 4h > 1.7, then predict I; otherwise, predict NI. (PM 3) 
If swelling at 1h > 18%, then predict I; otherwise, predict NI.  (PM 4) 
If swelling at 4h > 23%, then predict I; otherwise, predict NI.  (PM 5) 
 
A preliminary inspection of the data from the German validation study (Spielmann et 
al., 1996) indicated that the separation between irritants and non-irritants was more 
apparent if the seven endpoints were expressed in logarithmic form (Figure 9.5). 
However, it was difficult to judge by visual inspection which endpoint or combination 
of endpoints provides the best discrimination. Therefore, forward stepwise BLR was 
applied to the data, using the generalised linear modelling module in STATISTICA 5.5 
for Windows. The seven endpoints entered the model in the following order: log(TH10), 
log(IC50), log(TC10), log(TC100), log(TH100), log(TL10), log(TL100). Only the first 
three variables are significant at the 99.9% level. The application of BLR to the most 
significant variable, log(TH10), produced a model whose residuals were bimodal. 
However, the application of BLR to the two most significant variables, log(TH10) and 
log(IC50), produced a model whose residuals were approximately normal. The two-
variable logistic model is given by Equation 9.2, and is illustrated in Figure 9.6: 
 
pI = exp(Z) / {1+exp(Z)} (Equation 9.2) 
 
where Z = 5.25 – 3.04 log(TH10) – 0.79 log(IC50) 
 
Figure 9.6 shows that a chemical is more likely to be an eye irritant if its log(IC50) 
value is low (i.e. if the chemical is cytotoxic to 3T3 cells) and if its log(TH10) value is 
low (i.e. if a 10% solution of the chemical produces rapid hæmorrhaging of the 
chorioallantoic membrane). From Equation 9.2, it follows that if Z > 0, then pI > 0.5 (i.e. 
the chemical is more likely to be irritant than non-irritant). Thus, the logistic model can 
be rewritten in the form of the following PM: 
 
If 3.04 log(TH10) + 0.79 log(IC50) < 5.25, predict I; otherwise, predict NI.  (PM 6) 
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PM 6 was developed from and applied to the data for 129 chemicals, since data were 
missing for 14 of the 143 chemicals. The performance of PMs 2-6 are summarised in 
Table 9.7.  
 
 
9.4 DISCUSSION 
 
In this chapter, several CMs for predicting eye irritation potential are reported. The 
classification models take the form of either SARs based on easily obtained or 
calculated physicochemical data, or PMs based on physicochemical or in vitro data. 
Since PMs are based on experimental measurements, it is important that the data used to 
develop the PMs have been obtained by application of a standardised protocol. The pH 
measurements analysed in this study are standardised in the sense that they refer to 
measurements obtained in a 10% aqueous solution. The in vitro data were taken from 
two validation studies in which the use of standardised protocols was a requirement for 
assessment of the in vitro methods. In addition, the data for the 3T3 NRU and 
HETCAM tests were subjected to independent quality control before being used in the 
German validation study.  
  
9.4.1 Contribution to existing knowledge 
 
The results obtained in this study are consistent with several findings made in previous 
SAR studies (see chapter 2). For example, the observation of a relationship between eye 
irritation potential and MW is consistent with the finding by Rosenkranz et al. (1998) 
that the mean MW of irritants is lower than the mean MW of non-irritants. Rosenkranz 
and colleagues did not, however, publish a PM based on MW. In addition, the lack of an 
apparent relationship between eye irritation potential and the orbital energy descriptors 
(EHOMO, ELUMO, electronegativity and hardness) is consistent with the conclusion made 
by Rosenkranz et al. (1998) that chemical reactivity is not necessary for eye irritation. 
The embedded clustering of irritants along logP has been reported previously by Cronin 
(1996), and also by the author (Worth & Fentem, 1999). The use of the molecular 
connectivity index dV1 as a predictor of eye irritation potential does not appear to have 
been reported before, other than by the author (Worth & Cronin, 2000a).   
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The possibility of a relationship between pKa and eye irritation potential was explored, 
because a relationship between pKa and the weighted corneal score was reported by 
Sugai et al. (1991) for a homogeneous set of salicylates. However, since no relationship 
could be found, it appears that pKa is not a useful predictor of eye irritation potential of  
heterogeneous sets of chemicals. 
 
The importance of DM (e.g. Barratt, 1997) was not confirmed for the heterogeneous set 
of chemicals investigated in this study. Again, this may be a property that is only 
predictive for relatively homogeneous groups of chemicals, such as the ‘neutral 
organics’ investigated by Barratt. In any case, DM is not an ideal predictor variable, 
since its calculated value is dependent on the conformation and electron distribution of 
the molecular structure, both of which vary according to the molecular modelling 
methods employed. Thus, the use of more ‘robust’ physicochemical properties 
variables, such as MW and logP, is preferable for the development of SARs. 
 
Contrary to expectation, the kappa index (κ3) was not found to be a useful predictor of 
eye irritation potential. The mean value for non-irritants (5.07) was found to be higher 
than the mean value for irritants (3.76), but there was significant overlap between the 
distributions of irritant an non-irritant κ3 values. Using the data for the 82 ECETOC 
chemicals, κ3 was found to be weakly, but significantly, correlated with the weighted 
Draize score (r = -0.3, p<0.01). The observation of an inverse relationship between κ3 
and the WDS is consistent with the inverse relationship found between the corneal 
permeability coefficient and κ3 (see chapter 8), but is inconsistent with the positive 
correlation reported by Kulkarni & Hopfinger (1999; see chapter 3). 
 
As far as the author is aware, a PM for eye irritation potential based on pH data alone 
has not been published (other than by Worth & Fentem, 1999), although Régnier & 
Imbert (1992) reported the combined use of pH and acid-alkaline reserve. In addition, a 
PM based on the isolated rabbit eye (IRE) test does not appear to have been published. 
In the EC/HO validation study, the IRE test was assessed entirely on the basis of its 
reproducibility and on the correlations between its four endpoints and the MMAS. At 
the time of the EC/HO study, the concept of the PM had not been developed, so the 
assessment of PMs did not form an integral part of interlaboratory validation studies. 
Any PM based on IRE data should be of regulatory interest, given that the IRE test is 
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accepted by the regulatory authorities in the United Kingdom as an alternative to the 
Draize eye test. 
 
The models developed on the basis of 3T3 NRU and HETCAM data represent a re-
analysis of the German validation study (Spielmann et al., 1996). In the validation 
study, stepwise LDA was used to identify the best (most discriminating) three endpoints 
for distinguishing between severe (R41) and non-severe (NI, R36) irritants as TC10, 
log(IC50) and TC100 (in decreasing order of statistical significance). In contrast, 
stepwise BLR was used in this study to identify the best three endpoints for 
distinguishing between irritants (R36 and R41) and non-irritants as log(TH10), 
log(IC50) and log(TC10). It should be noted that the in vitro data for the HETCAM and 
NRU tests are not normally distributed within groups, which may invalidate any 
conclusions drawn from the use of LDA to assess the statistical significance of the 
seven endpoints. 
 
9.4.2 Interpretation and assessment of the models 
 
The classification model based on MW (SAR 1) states that for an organic liquid to be 
irritating to the eye, it must have a molecular size below a certain threshold. The high 
sensitivity of 97% (Table 9.7) indicates that only a small proportion of irritant chemicals 
(3%) have a MW greater than the cut-off value of 137 g/mol. However, not all 
chemicals that are small enough to penetrate the eye are irritants, as reflected by the fact 
that 51% of the non-irritant chemicals also have a MW less than 137 g/mol (false 
positive rate = 51%). As a stand-alone model for predicting eye irritation potential, the 
performance of SAR is unsatisfactory - it is good at identifying known irritants, but this 
is at the expense of over-classifying known non-irritants. However, the model could be 
useful in the context of a tiered testing strategy (see § 9.4.3 below). 
 
A mechanistic interpretation of the elliptic model based on logP and dV1 is offered in 
chapter 6. Given that the sensitivity, specificity and concordance for this model (Table 
9.7) are all greater than 50%, SAR 2 could be regarded as an acceptable stand-alone 
model for predicting the eye irritation potential of organic liquids.  
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The PM based on pH (PM 1) has a clear mechanistic interpretation - chemicals that do 
not form acidic or basic solutions are unlikely to be irritating to the eye. This is reflected 
by the fact that the model correctly identifies 97% of the known non-irritants in its 
training set and 94% of the non-irritants in its test set. However, not all chemicals that 
have intermediate pH values in the range 3.2 to 8.6 are non-irritant, as reflected by the 
fact that 47% of the known irritants are under-classified as non-irritant. Thus, PM 1 
would be unsatisfactory as a stand-alone model, but may be useful when used in 
combination with other models (see § 9.4.3 below). 
 
The PMs based on IRE data (PMs 2-5) express the fact that eye irritation is associated 
with opacity and swelling in the cornea. These PMs identify 46-69% of the irritants, and 
89-100% of the non-irritants, in the training set of 57 chemicals. Of the four models, 
only PMs 4 and 5 can be regarded as satisfactory stand-alone models, since PMs 2 and 3 
have sensitivities that are not significantly greater than 50%. 
 
The PM based on the combined use of HETCAM and NRU tests (PM 6) indicates that 
irritant chemicals are generally more cytotoxic than non-irritants, and supports the use 
of the chorioallantoic membrane as a model for eye irritation. Given that the sensitivity, 
specificity and concordance of PM 6 (Table 9.7) are all greater than 50%, this model 
could be regarded as an acceptable stand-alone model. 
 
9.4.3 Strategic use of the models 
 
In the preceding discussion, the various classification models are judged in terms of 
their Cooper statistics (sensitivity, specificity and concordance), which is the 
conventional way of assessing two-group classification models in the field of alternative 
methods. Although different criteria may be adopted for the acceptability of models, 
depending on the toxicological endpoint they are designed to predict, a minimum set of 
conditions would be that the sensitivity, specificity and concordance for a stand-alone 
method should all be significantly greater than 50%. This would lead to the rejection of 
SAR 1 and PM 1 as stand-alone models. However, by integrating these models into a 
tiered testing strategy, their strengths can be combined without introducing their 
weaknesses. Thus, SAR 1 could be rephrased as follows: 
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MW > 137 g/mol, then predict NI; otherwise, make no prediction  (SAR 1b) 
 
In other words, SAR 1b is being used to identify non-irritants, but not irritants. This can 
be justified on the basis that even though SAR 1 only identifies 49% of the known non-
irritants in the data set, of those chemicals it does predict to be non-irritant, 98% of 
these predictions are correct. This is the same as saying that the negative predictivity of 
SAR 1 is 98%.  
 
Similarly, PM 1 could be recast as follows: 
 
If pH < 3.2 or if pH > 8.6, then predict I; otherwise, make no prediction (PM 1b) 
 
Thus, PM 1b is being used to identify irritants, but not non-irritants. This can be 
justified on the basis that even though PM 1b only identifies 53% of the known irritants 
in its training set, and 44% of the known irritants in a test set, 93% of the irritant 
predictions made by PM1b are correct in both the data sets. In other words, PM 1b has a 
positive predictivity of 93%. This approach is mechanistically reasonable, in that while 
chemicals at the extremes of the pH range are expected to be irritant, not all irritant 
chemicals are expected to act by a pH-dependent mechanism. Therefore, even 
chemicals with intermediate pH values could be irritant, which is clearly illustrated in 
Figure 9.3. 
 
The manner in which SAR 1b and PM1b should be integrated will depend on the 
underlying rationale of the tiered testing strategy. In the OECD testing strategies (see 
chapter 2), any chemical predicted to be toxic is classified without further testing, 
whereas chemicals predicted to be non-toxic undergo further testing until the absence of 
toxic potential is confirmed by conducting an animal experiment. However, tiered 
testing strategies could be developed according to a different rationale, as illustrated in 
Figure 9.7. In this approach, CMs with a high specificity (and high positive predictivity) 
are used to classify chemicals as irritants without further testing, whereas CMs with a 
high sensitivity (and high negative predictivity) are used to identify chemicals that are 
so unlikely to be irritant that they can be tested directly in the rabbit, without the need to 
conduct in vitro testing. Of course, if no model is available for any given step, or if the 
model is not applicable to the chemical in question, testing must proceed to the next 
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step. An evaluation of this approach, and of the OECD approach, is presented in chapter 
10. 
 
It follows from the preceding discussion that models designed for use in the context of a 
tiered testing strategy do not need to meet the same performance criteria as models 
intended for stand-alone use. In particular, a model with a sensitivity ≤ 50% may be 
useful, if it has a high specificity (and therefore a low false positive rate). Similarly, a 
model with a low specificity may be useful, as long as its sensitivity is high and its false 
negative rate is low. Bearing this in mind, a possible approach to the design of a tiered 
testing strategy would be to parameterise models based on suitable predictor variables in 
such a way that high sensitivities or specificities are ensured. In the case of ‘simple’ 
classification models, such as linear models based on a single predictor variable, cut-off 
values could be defined in terms of percentiles. For example, given the distributions of 
irritant and non-irritant chemicals along MW (Figure 9.1), one could choose the 95th 
percentile in the distribution of ‘irritant’ MWs to define the cut-off for the SAR as 134 
g/mol (instead of 137 g/mol). This cut-off would ensure that 95% of the irritant 
chemicals are correctly identified (sensitivity = 95%) and that 5% of the irritant 
chemicals are under-predicted (false negative rate = 5%). This ‘percentile approach’ 
was adopted in Worth & Fentem (1999), in which a fixed sensitivity of 75% was used to 
derive cut-off values along 17 in vitro endpoints for eye irritation potential.  
 
9.5 CONCLUSIONS 
 
It is concluded that: 
 
1) eye irritation potential can be predicted by using: a) SARs based on molecular size 
(MW), partitioning behaviour (logP), and molecular shape (dV1); and b) PMs based 
on pH, the degree of swelling and opacity in the IRE test, cytotoxicity (to 3T3 
fibroblasts), and the onset time of hæmorrhaging in the hen’s egg chorioallantoic 
membrane. 
2) CMs designed for incorporation into a tiered testing strategy do not need to be 
subjected to the same performance criteria as CMs intended for stand-alone use, and 
the parameters of these models could be derived by a percentile method. 
 248
Figure 9.1 Distribution of eye irritants and non-irritants by molecular weight 
 
 
 
 
Footnote to Figure 9.1 
 
I = irritant (EU risk phrase R36 or R41); NI = non-irritant 
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Figure 9.2 Embedded clustering of eye irritants  
 
 
 
 
 
Footnote to Figure 9.2 
 
Chemical # 29 = octanol; # 114 = camphen 
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Figure 9.3 Distribution of eye irritants and non-irritants by pH 
 
 
 
Footnote to Figure 9.3 
 
I = irritant (EU risk phrase R36 or R41); NI = non-irritant 
 
 
 
 251
Figure 9.4 Ability of the isolated rabbit eye test to discriminate between eye 
irritants and non-irritants 
 
 
 
 
 
Footnote to Figure 9.4 
 
Endpoints of the isolated rabbit eye test: OPACITY1 = corneal opacity score at 1h; 
OPACITY4 = corneal opacity score at 4h; SWELL1 = corneal swelling (%) at 1h; 
SWELL4 = corneal swelling (%) at 4h. 
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Figure 9.5 Endpoints of the HETCAM and neutral red uptake tests  
 
 
 
 
Footnote to Figure 9.5 
 
Endpoints of the HETCAM test: TC10 = time for coagulation with a 10% solution; 
TH10 = time for hæmorrhage with a 10% solution; TL10 = time for lysis with a 10% 
solution; TC100 = time for coagulation with the undiluted substance; TH100 = time for 
hæmorrhage with the undiluted substance; TL100 = time for lysis with the undiluted 
substance.  
Endpoint of the NRU test: IC50 = concentration causing a 50% reduction in neutral red 
uptake. 
 
All endpoints are expressed in logarithmic form. 
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Figure 9.6 Logistic model for eye irritation potential based on the HETCAM 
and neutral red uptake tests  
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Figure 9.7 Outline of a tiered testing strategy for eye irritation 
 
 
Step 1:  Apply a CM for I chemicals    ⇒  Predict as I 
  (e.g. PM 1b)      Stop testing 
⇓ 
No prediction 
⇓ 
Step 2:  Apply a CM for NI chemicals   ⇒  Predict as  NI 
  (e.g. SAR 1b)      Proceed to Step 4 
⇓ 
No prediction 
⇓ 
Step 3:  Apply a PM based on in vitro data  ⇒  Predict as  I 
  for I chemicals (e.g. PM 4b)    Stop testing 
  ⇓ 
  Predict as NI 
⇓ 
Step 4:  Perform Draize eye test    ⇒  Classify as I or NI 
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Table 9.1 Draize rabbit eye irritation data set for 119 organic liquids 
 
No Chemical Sourcea Erythema Chemosis Opacity Iritis Classification 
       EU OECD
         
1 3,3-Dimethylpentane ECETOC 0.0 0.0 0.0 0.0 NI NI 
2 3-Methylhexane ECETOC 0.1 0.0 0.0 0.0 NI NI 
3 2-Methylpentane ECETOC 0.3 0.0 0.0 0.0 NI NI 
4 1,9-Decadiene ECETOC 0.4 0.0 0.0 0.0 NI NI 
5 Dodecane ECETOC 0.4 0.0 0.0 0.0 NI NI 
6 1,5-Dimethylcyclooctadiene ECETOC 0.6 0.0 0.1 0.0 NI NI 
7 cis-Cyclooctene ECETOC 1.1 0.0 0.0 0.0 NI NI 
8 Methylcyclopentane ECETOC 0.8 0.1 0.0 0.0 NI NI 
9 1,5-Hexadiene ECETOC 0.9 0.2 0.0 0.0 NI NI 
10 4-Bromophenetole ECETOC 0.2 0.0 0.0 0.0 NI NI 
11 2-Xylene  ECETOC 1.2 1.7 0.0 0.0 NI NI 
12 1-Methylpropylbenzene ECETOC 0.3 0.0 0.0 0.0 NI NI 
13 3-Ethyltoluene ECETOC 0.8 0.0 0.0 0.0 NI NI 
14 2,4-Difluoronitrobenzene ECETOC 1.3 0.4 0.0 0.0 NI NI 
15 Styrene ECETOC 0.7 0.6 0.1 0.0 NI NI 
16 Toluene ECETOC 1.5 1.4 0.0 0.0 NI NI 
17 4-Fluoroaniline ECETOC 2.7 2.2 1.6 0.6 R36 B 
18 Pyridine ECETOC 2.9 3.3 2.7 1.2 R36 B 
19 3-Methoxy-1,2-propanediol ECETOC 0.0 0.0 0.0 0.0 NI NI 
20 2,4-Pentanediol ECETOC 0.4 0.0 0.0 0.0 NI NI 
21 Propylene glycol ECETOC 0.3 0.0 0.0 0.0 NI NI 
22 Glycerol ECETOC 0.3 0.0 0.0 0.0 NI NI 
23 Isomyristyl alcohol ECETOC 0.5 0.5 0.0 0.0 NI NI 
24 2,2-Dimethyl-3-pentanol ECETOC 0.8 0.3 0.8 0.0 NI NI 
25 2-Methyl-1-pentanol ECETOC 1.1 0.7 1.1 0.0 NI B 
26 Cyclopentanol ECETOC 2.0 1.9 1.2 0.0 NI B 
27 Ethanol ECETOC 2.1 1.3 1.1 0.4 NI B 
28 Isopropanol (propan-2-ol) ECETOC 2.3 1.6 0.7 0.8 NI B 
29 Octanol ECETOC 2.2 2.5 1.7 0.7 R36 B 
30 Furfuryl hexanol ECETOC 1.3 1.3 2.3 1.3 R36 B 
31 2-Ethyl-1-hexanol ECETOC 2.1 1.9 1.8 0.7 NI B 
32 Isobutanol ECETOC 2.4 2.3 2.1 1.1 R36 B 
33 Butanol ECETOC 2.4 2.1 2.0 0.7 R36 B 
34 Hexanol ECETOC 2.7 2.5 2.2 1.3 R36 B 
35 Butyl cellosolve(2-butoxyethanol) ECETOC 2.3 2.8 2.3 1.3 R36 B 
36 Cyclohexanol ECETOC 2.4 2.5 2.9 1.2 R36 B 
37 Methyl trimethyl acetate ECETOC 0.6 0.3 0.0 0.0 NI NI 
38 Ethyl trimethyl acetate ECETOC 0.6 0.4 0.2 0.0 NI NI 
39 Butyl acetate ECETOC 1.0 0.3 0.2 0.0 NI NI 
40 Cellosolve (2-ethoxyethyl) acetate ECETOC 1.2 0.7 0.4 0.0 NI NI 
41 Ethyl acetate ECETOC 1.2 0.6 0.4 0.1 NI NI 
42 Ethyl-2-methyl acetoacetate ECETOC 1.2 0.9 0.9 0.0 NI NI 
43 Methyl cyanoacetate ECETOC 3.0 2.1 0.4 1.0 R36 B 
44 Methyl acetate ECETOC 2.2 2.1 1.3 0.8 R36 B 
45 Ethyleneglycol diethylether ECETOC 0.0 0.0 0.0 0.0 NI NI 
46 Di-isobutyl ketone  
(2,6-dimethyl-4-heptanone) 
ECETOC 0.1 0.0 0.0 0.0 NI NI 
47 Methyl isobutyl ketone  
(4-methylpentan-2-one) 
ECETOC 0.8 0.2 0.1 0.0 NI NI 
 256
Table 9.1 continued 
 
No Chemical Sourcea Erythema Chemosis Opacity Iritis Classification 
       EU OECD
         
48 Methyl amyl ketone (heptanone) ECETOC 1.2 1.2 0.3 0.1 NI NI 
49 Methyl ethyl ketone (butanone) ECETOC 2.1 2.2 1.3 0.6 R36 B 
50 Acetone ECETOC 2.8 2.5 1.9 1.2 R36 B 
51 2-Bromobutane ECETOC 0.0 0.0 0.0 0.0 NI NI 
52 1-Bromo-4-chlorobutane ECETOC 0.0 0.0 0.0 0.0 NI NI 
53 Bromooctane ECETOC 0.0 0.0 0.0 0.0 NI NI 
54 Bromohexane ECETOC 0.0 0.0 0.0 0.0 NI NI 
55 Bromopentane ECETOC 0.6 0.0 0.0 0.0 NI NI 
56 1,6-Dibromohexane ECETOC 0.2 0.1 0.0 0.0 NI NI 
57 Isopropyl bromide ECETOC 0.3 0.2 0.0 0.0 NI NI 
58 1,4-Dibromobutane ECETOC 0.3 0.3 0.0 0.0 NI NI 
59 1,5-Dibromopentane ECETOC 0.6 0.3 0.0 0.0 NI NI 
60 1,3-Dibromopropane ECETOC 0.3 0.3 0.0 0.0 NI NI 
61 γ-Butyrolactone ECETOC 2.2 2.1 1.9 0.8 R36 B 
62 2,2-Dimethylbutanoic acid ECETOC 2.0 0.7 1.5 0.5 NI B 
63 2-Ethoxyethyl methacrylate ECETOC 0.0 0.0 0.0 0.0 NI NI 
64 Ethyl thioethyl methacrylate ECETOC 0.0 0.0 0.0 0.0 NI NI 
65 Nonyl acrylate ECETOC 0.0 0.0 0.0 0.0 NI NI 
66 Nonyl methacrylate ECETOC 0.0 0.0 0.0 0.0 NI NI 
67 Iso-octyl acrylate ECETOC 0.1 0.0 0.0 0.0 NI NI 
68 Heptyl methacrylate ECETOC 0.2 0.0 0.0 0.0 NI NI 
69 Trifluoroethyl methacrylate ECETOC 0.2 0.0 0.0 0.0 NI NI 
70 Allyl methacrylate ECETOC 0.8 0.3 0.0 0.0 NI NI 
71 Glycidyl methacrylate ECETOC 1.5 1.2 0.8 0.4 NI NI 
72 2-Methoxyethyl acrylate ECETOC 2.3 2.7 1.9 0.6 R36 B 
73 3-Chloropropionitrile ECETOC 0.6 0.3 0.7 0.1 NI NI 
74 Diethylaminopropionitrile ECETOC 3.0 2.6 3.5 1.0 R41 A 
75 2-Ethylhexylthioglycolate ECETOC 0.0 0.0 0.0 0.0 NI NI 
76 4-Methylthiobenzaldehyde ECETOC 0.1 0.1 0.0 0.0 NI NI 
77 Iso-octylthioglycolate ECETOC 0.1 0.0 0.0 0.0 NI NI 
78 Dipropyl disulphide ECETOC 0.4 0.0 0.0 0.0 NI NI 
79 Thiodiglycol ECETOC 0.5 0.3 0.0 0.0 NI NI 
80 1,2,3-Trimercaptopropane ECETOC 1.3 1.5 0.0 0.0 NI NI 
81 Ethylthioglycolate ECETOC 1.2 0.8 1.0 0.5 NI B 
82 Methylthioglycolate ECETOC 2.4 1.8 2.2 0.9 R36 B 
83 2,2,3-Trimethyl-3-cyclo-pentene-
1-acetaldehyde 
Spielmann 1.7 0.8 0.9 0.1 NI NI 
84 Silan 108 (trimethoxyoctyl silane) Spielmann 0.7 0.0 0.0 0.0 NI NI 
85 Silan 103  
(trimethoxypropyl silane) 
Spielmann 1.6 0.3 0.3 0.1 NI NI 
86 Methyltriglycol Spielmann 0.5 0.0 0.0 0.0 NI NI 
87 Ethylacrolein Spielmann 1.7 3.3 3.0 nd R41 A 
88 Polyethylene glycol butyl ether Spielmann 2.5 2.0 1.6 0.8 R36 B 
89 1,2-Epoxycyclooctane Spielmann 1.4 1.0 0.7 0.3 NI NI 
90 Methylacetate Spielmann 2.7 1.8 1.3 1.0 R36 B 
91 Polysolvan (butyl glycolate) Spielmann 2.6 1.5 1.8 0.9 R36 B 
92 α-Lactid Spielmann 0.9 1.2 0.0 0.0 NI NI 
93 Isopropyl acetoacetate Spielmann 1.5 0.7 0.2 0.2 NI NI 
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Table 9.1 continued 
 
No Chemical Sourcea Erythema Chemosis Opacity Iritis Classification 
       EU OECD
         
94 Butanal Spielmann 2.3 1.3 0.9 0.4 NI B 
95 3-Methoxybenzaldehyde Spielmann 0.1 0.0 0.0 0.0 NI NI 
96 Butanol Spielmann 2.9 3.0 2.1 1.0 R36 B 
97 Anisole Spielmann 3.0 1.7 0.7 0.7 R36 B 
98 4-Anisidine Spielmann 2.6 2.1 1.8 1.0 R36 B 
99 Ethylbutanal Spielmann 2.0 1.0 0.0 0.3 NI B 
100 Isobutanal Spielmann 2.0 1.3 1.1 0.4 NI B 
101 1,2-Epoxydodecane Spielmann 0.8 0.0 0.3 0.0 NI NI 
102 Isononylaldehyde Spielmann 0.6 0.3 0.0 0.0 NI NI 
103 2-Methyl-1-propanol Spielmann 2.5 1.5 1.0 0.3 R36 B 
104 2-Hydroxyisobutyric acid 
ethylester 
Spielmann 2.3 3.3 3.0 1.0 R41 A 
105 Paraformaldehyde (methanal) Spielmann 3.0 3.6 1.7 1.0 NI B 
106 3-Cyclohexene-1-methanol Spielmann 2.8 2.0 1.9 0.6 NI B 
107 4,4-Dimethyl-3-oxopentanenitrile Spielmann 0.1 0.1 0.0 0.0 NI NI 
108 2-Hydroxyisobutyric acid  Spielmann 2.3 4.0 4.0 nd R41 A 
109 Hexahydrofarnesyl acetone Spielmann 0.7 0.0 0.0 0.0 NI NI 
110 Trioxane Spielmann 1.7 0.3 0.0 0.1 NI NI 
111 Butyl carbamate Spielmann 2.9 2.0 1.3 1.0 R36 B 
112 Isobornyl acetate Spielmann 0.2 0.2 0.0 0.0 NI NI 
113 Acetoacetic acid glycolester Spielmann 2.0 1.3 0.9 0.6 NI NI 
114 Camphen (2,2-dimethyl-3-
methylene bicyclo 2.2.1 heptane) 
Spielmann 2.5 1.5 0.9 0.6 R36 B 
115 Methylpentynol Spielmann 2.0 2.0 1.0 0.3 R36 B 
116 2,5-Dimethylhexanediol Spielmann 2.3 1.8 1.0 0.3 NI B 
117 3,6-Dimethyloctanol Spielmann 1.6 0.5 1.0 0.0 NI B 
118 1-Chloroctan-8-ol Spielmann 2.0 0.6 1.0 0.3 NI B 
119 Isotridecanal Spielmann 0.2 0.0 0.0 0.0 NI NI 
 
 
Footnote to Table 9.1 
 
aECETOC (1998), Spielmann et al. (1996). 
A = severe irritant (OECD system); B = mild irritant (OECD system); nd= no data; NI = non-
irritant; R36 = mild irritant (EU system); R41 = severe irritant (EU system). 
 
Differences in the EU and OECD classification systems are indicated by shading. 
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Table 9.2 Physicochemical properties for the data set of 119 organic liquids 
 
No Chemical I/NI MW LogP dV1 pKa1 pKa2 pKa3
         
         
1 3,3-Dimethylpentane NI 100.2 3.67 -0.2929    
2 3-Methylhexane NI 100.2 3.71 -0.1062    
3 2-Methylpentane NI 86.2 3.21 -0.1442    
4 1,9-Decadiene NI 138.3 4.98 -0.7812    
5 Dodecane NI 170.3 6.23  0.0000    
6 1,5-Dimethylcyclooctadiene NI 136.2 4.82 -0.8133    
7 cis-Cyclooctene NI 110.2 3.94 -0.2644    
8 Methylcyclopentane NI 84.2 3.1 -0.0204    
9 1,5-Hexadiene NI 82.1 3.02 -0.7812    
10 4-Bromophenetole NI 201.1 3.46 -1.6650    
11 2-Xylene  NI 106.2 3.09 -1.0869    
12 1-Methylpropylbenzene NI 134.2 3.94 -1.0221    
13 3-Ethyltoluene NI 120.2 3.58 -1.0322    
14 2,4-Difluoronitrobenzene NI 159.1 2.21 -3.5352    
15 Styrene NI 104.2 2.89 -1.3066    
16 Toluene NI 92.1 2.54 -1.0035    
17 4-Fluoroaniline I 111.1 1.28 -2.0044 4.7   
18 Pyridine I 79.1 0.8 -1.0749 5.3   
19 3-Methoxy-1,2-propanediol NI 106.1 -1.15 -1.5057 13.6 15.3  
20 2,4-Pentanediol NI 104.1 0.13 -1.1686 14.7 15.6  
21 Propylene glycol NI 76.1 -0.78 -0.7974 14.4 15.8  
22 Glycerol NI 92.1 -1.65 -1.1962 13.5 14.9 16.1 
23 Isomyristyl alcohol NI 214.4 5.68 -0.9868 15.2   
24 2,2-Dimethyl-3-pentanol NI 116.2 2.13 -1.0046 15.3   
25 2-Methyl-1-pentanol NI 102.2 1.75 -0.6945 15.1   
26 Cyclopentanol NI 86.1 1.15 -0.4673 15.3   
27 Ethanol NI 46.1 -0.14 -0.1303 15.2   
28 Isopropanol (propan-2-ol) NI 60.1 0.28 -0.4153 15.3   
29 Octanol I 130.2 2.81 -0.6881 15.3   
30 Furfuryl hexanol I 98.1 0.45 -1.5912 14.0   
31 2-Ethyl-1-hexanol NI 130.2 2.73 -0.7563 15.1   
32 Isobutanol I 74.1 0.77 -0.5003 15.3   
33 Butanol I 74.1 0.84 -0.4278 15.2   
34 Hexanol I 102.2 1.82 -0.5883 15.4   
35 Butyl cellosolve (2-butoxyethanol) I 118.2 0.57 -1.1650 14.4   
36 Cyclohexanol I 100.2 1.23 -0.5370 15.3   
37 Methyl trimethyl acetate NI 116.2 1.74 -1.6992    
38 Ethyl trimethyl acetate NI 130.2 2.23 -1.7031    
39 Butyl acetate NI 116.2 1.85 -1.3617    
40 Cellosolve (2-ethoxyethyl) acetate NI 132.2 0.31 -1.9131    
41 Ethyl acetate NI 88.1 0.86 -1.1187    
42 Ethyl-2-methyl acetoacetate NI 144.2 0.21 -2.2473 12.0   
43 Methyl cyanoacetate I 99.1 -0.47 -1.7946 2.8   
44 Methyl acetate I 74.1 0.37 -1.0409    
45 Ethyleneglycol diethylether NI 118.2 0.77 -1.1968    
46 Di-isobutyl ketone  
(2,6-dimethyl-4-heptanone) 
NI 142.2 2.56 -1.2112    
47 Methyl isobutyl ketone  
(4-methylpentan-2-one) 
NI 100.2 1.16 -0.9911    
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Table 9.2 continued 
 
No Chemical I/NI MW LogP dV1 pKa1 pKa2 pKa3
         
         
48 Methyl amyl ketone (heptanone) NI 114.2 1.73 -0.9020    
49 Methyl ethyl ketone (butanone) I 72.1 0.26 -0.6864    
50 Acetone I 58.1 -0.24 -0.6240    
51 2-Bromobutane NI 137.0 2.58 0.0388    
52 1-Bromo-4-chlorobutane NI 171.5 2.9 0.3917    
53 Bromooctane NI 193.1 4.61 0.3484    
54 Bromohexane NI 165.1 3.63 0.3352    
55 Bromopentane NI 151.0 3.14 0.3244    
56 1,6-Dibromohexane NI 244.0 3.97 0.7219    
57 Isopropyl bromide NI 123.0 2.08 -0.0265    
58 1,4-Dibromobutane NI 215.9 2.99 0.6889    
59 1,5-Dibromopentane NI 229.9 3.48 0.7089    
60 1,3-Dibromopropane NI 201.9 2.5 0.6556    
61 γ-Butyrolactone I 86.1 -0.31 -0.9722    
62 2,2-Dimethylbutanoic acid NI 116.2 1.94 -1.5273 5.0   
63 2-Ethoxyethyl methacrylate NI 158.2 1.49 -2.5281    
64 Ethyl thioethyl methacrylate NI 174.3 2.34 -1.4107    
65 Nonyl acrylate NI 198.3 4.66 -2.0517    
66 Nonyl methacrylate NI 212.3 5.2 -2.1845    
67 Iso-octyl acrylate NI 184.3 4.09 -2.1516    
68 Heptyl methacrylate NI 184.3 4.22 -2.1008    
69 Trifluoroethyl methacrylate NI 168.1 2.18 -3.6654    
70 Allyl methacrylate NI 126.2 2.12 -2.2401    
71 Glycidyl methacrylate NI 142.2 0.81 -2.3688    
72 2-Methoxyethyl acrylate I 128.2 1.05 -2.1169    
73 3-Chloropropionitrile NI 89.5 0.6 -0.5506    
74 Diethylaminopropionitrile I 126.2 0.53 -1.1082 9.2   
75 2-Ethylhexylthioglycolate NI 204.3 3.68 -1.6108 8.2   
76 4-Methylthiobenzaldehyde NI 152.2 2.31 -1.1904    
77 Iso-octylthioglycolate NI 204.3 3.68 -1.6868 8.2   
78 Dipropyl disulphide NI 150.3 3.84 1.5529    
79 Thiodiglycol NI 122.2 -0.62 -0.4646 14.1 14.8  
80 1,2,3-Trimercaptopropane NI 140.3 1.57 0.2838 8.7 9.8 10.7 
81 Ethylthioglycolate NI 120.2 0.81 -1.1229 8.4   
82 Methylthioglycolate I 106.1 0.32 -1.0830 8.2   
83 2,2,3-Trimethyl-3-cyclo-pentene-1-
acetaldehyde 
NI 152.2 3.31 -1.5834    
84 Silan 108 (trimethoxyoctylsilane) NI 234.4 2.77 -1.7133    
85 Silan 103 (trimethoxypropylsilane) NI 164.3 0.31 -1.3920    
86 Methyltriglycol NI 164.2 -1.46 -2.4692 14.4   
87 Ethylacrolein I 84.1 1.23 -1.1034    
88 Polyethylene glycol butyl ether I 162.2 0.29 -1.9350 14.4   
89 1,2-Epoxycyclooctane NI 126.2 2.64 -0.5902    
90 Methylacetate I 74.1 0.37 -1.0409    
91 Polysolvan (butyl glycolate) I 132.2 0.38 -1.8180 13.0   
92 α-Lactid NI 144.1 1.65 -2.4773    
93 Isopropyl acetoacetate NI 144.2 0.21 -2.3002 11.7   
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Table 9.2 continued 
 
No Chemical I/NI MW LogP dV1 pKa1 pKa2 pKa3
         
         
94 Butanal NI 72.1 0.82 -0.6001    
95 3-Methoxybenzaldehyde NI 136.2 1.79 -2.4763    
96 Butanol I 74.1 0.84 -0.4278 15.2   
97 Anisole I 108.1 2.07 -1.6437    
98 4-Anisidine I 123.2 1.16 -1.9917 5.2   
99 Ethylbutanal NI 100.2 1.73 -0.8119    
100 Isobutanal NI 72.1 0.74 -0.7274    
101 1,2-Epoxydodecane NI 184.3 4.79 -0.7807    
102 Isononylaldehyde NI 142.2 3.2 -1.0415    
103 2-Methyl-1-propanol I 74.1 0.77 -0.5720 15.1   
104 2-Hydroxyisobutyric acid ethylester I 132.2 0.27 -2.0142 13.3   
105 Paraformaldehyde (methanal) NI 30.0 0.35 -0.1080    
106 3-Cyclohexene-1-methanol NI 112.2 1.91 -0.9760 15.2   
107 4,4-Dimethyl-3-oxopentanenitrile NI 125.2 0.28 -1.8293 10.3   
108 2-Hydroxyisobutyric acid  I 104.1 -0.2 -1.6922 4.0 16.6  
109 Hexahydrofarnesyl acetone NI 268.5 6.91 -1.5106    
110 Trioxane NI 90.1 -0.56 -1.1713    
111 Butyl carbamate I 117.1 0.96 -1.4850 -1.4 13.5  
112 Isobornyl acetate NI 196.3 3.86 -2.1031    
113 Acetoacetic acid glycolester NI 230.2 -1.73 -4.5517 9.9 10.6  
114 Camphen (2,2-dimethyl-3-
methylene bicyclo 2.2.1 heptane) 
I 136.2 4.35 -0.6003    
115 Methylpentynol I 98.1 0.94 -1.2887 13.3   
116 2,5-Dimethylhexanediol NI 146.2 1.6 -1.5143 14.7 15.3  
117 3,6-Dimethyloctanol NI 158.3 3.64 -0.9684 15.1   
118 1-Chloroctan-8-ol NI 164.7 3.06 -0.6731 15.2   
119 Isotridecanal NI 198.3 5.16 -1.1416    
 
 
Footnote to Table 9.2 
 
dV1 = the first-order difference valence connectivity index; I = irritant (EU criteria); logP = 
logarithm of the octanol-water partition coefficient; MW = molecular weight (g/mol); NI = non-
irritant (EU criteria); pKa(n) = the nth value of the negative logarithm of the acid dissociation 
constant. 
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Table 9.3 Training set of pH data for 165 chemicalsa 
 
No Chemical pHb EU class 
  
1 Acetic acid 2.50 R41 
2 Acrylic anhydride 3.10 R41 
3 Amino-11-undecenoic acid 7.10 NI 
4 Benzoic acid 2.60 R41 
5 Cekanoic C7 acid 4.00 R41 
6 Cekanoic C8 acid 4.20 R41 
7 Cekanoic C9 acid 4.30 R41 
8 Cekanoic C10 acid 4.20 R41 
9 Chlorhydric 2,5 N acid 2.00 R41 
10 Detartrant BS12 0.90 R41 
11 Dithiodipropionic acid 3.30 NI 
12 Methacrylic anhydride 3.20 R41 
13 N-Heptylamino-11-undecenoic acid 6.20 NI 
14 Potassium tetrafluoroborate 3.60 NI 
15 Sodium undecylenate 8.80 R36 
16 Sulphamic acid 0.90 R41 
17 Adamquat MC80 4.50 R36 
18 Dicyclopentenyloxyethyl acrylate 4.10 R36 
19 Hexyl acrylate 7.30 NI 
20 Iso-octyl acrylate 7.20 NI 
21 Methoxyethyl acrylate 5.40 R36 
22 Nonyl acrylate 6.90 R41 
23 Butanol 6.80 R36 
24 Glycerol 7.90 NI 
25 Isomyristic alcohol 6.30 NI 
26 Methanol 5.40 NI 
27 2-Methoxyethanol 5.90 NI 
28 Octanol 6.40 R41 
29 Propanol 5.80 NI 
30 Isopropanol 5.50 NI 
31 TLH (mixed heavy alcohols) 6.60 R41 
32 Acetic hydrazide 7.00 NI 
33 Ethyl carbazate 6.90 R36 
34 Methanesulphonamide 5.30 NI 
35 Methyl carbazate 7.00 NI 
36 Pivalic hydrazide 5.10 R36 
37 Propionic hydrazide 8.00 R36 
38 3(2-Methoxyethoxy)propylamine 11.50 R41 
39 Diethylaminopropylamine 11.90 R41 
40 Di-isopropylamine 11.70 R41 
41 Dimethylaminopropylamine 12.10 R41 
42 Dimethyl-N-butylamine 11.50 R41 
43 Dimethyldiethylpropylenediamine 11.70 R41 
44 Dimethyldipropylenetriamine 12.00 R41 
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Table 9.3 continued 
 
No Chemical pH  EU class 
  
45 Dimethylethylamine 11.10 R41 
46 Dimethylisopropylamine 12.20 R41 
47 Heptylamine 11.70 R41 
48 3-Methoxypropylamine 10.10 R41 
49 Tetramethylpropylenediamine 11.20 R41 
50 Triethanolamine 10.70 NI 
51 Benzylcumene 6.50 NI 
52 Benzylpentamethylbenzene 6.40 NI 
53 Benzyltoluene 5.60 NI 
54 Benzyltoluene/dibenzyltoluene 2.80 NI 
55 Bis(p-xylyl)phenylmethane 6.20 NI 
56 Dibenzylmesitylene 6.40 NI 
57 Dibenzyltoluene 6.60 NI 
58 Orthoxylyl-orthoxylene 6.30 NI 
59 Toluene 5.90 NI 
60 Esterol T 7.80 R41 
61 Metiloil A 3.80 NI 
62 Metiloil B 3.80 NI 
63 Metiloil C 3.70 NI 
64 1-Bromo-4-chlorobutane 4.10 NI 
65 Chloroform 6.00 NI 
66 1,4-Dibromobutane 3.90 NI 
67 Dibromodichlorodifluoroethane 3.10 R41 
68 1,6-Dibromohexane 6.90 NI 
69 1,5-Dibromopentane 4.30 NI 
70 1,3-Dibromopropane 3.80 NI 
71 Dibromotrichloroethane 2.70 R41 
72 Dichlorotoluene 4.70 NI 
73 Ethyl bromodifluoroacetate 1.00 R36 
74 Phenethyl bromide 4.40 NI 
75 Tetrachlorobenzyltoluene 5.90 NI 
76 Calcium sulphydrate 10.50 R41 
77 Dimethylsulphoxide 5.20 NI 
78 Dipropyl disulphide 5.80 NI 
79 Mercaptopropanol 6.40 R41 
80 4-Methylthiobenzaldehyde 6.20 NI 
81 Methylthiodichlorophosphine 0.00 R41 
82 Sodium methylmercaptide 12.00 R41 
83 Sodium methylmercaptide 12.00 R41 
84 TPS 20 5.90 NI 
85 TPS 27 4.70 NI 
86 TPS 32 5.90 NI 
87 TPS 37 4.90 NI 
88 Trimercaptopropane 4.60 R36 
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Table 9.3 continued 
 
No Chemical pH  EU class 
  
89 Allyl methacrylate 6.50 NI 
90 Dimethylaminoethyl methacrylate 8.80 R41 
91 Ethyltriglycol methacrylate 4.50 NI 
92 Glycidyl methacrylate 4.00 R36 
93 Heptyl methacrylate 7.00 NI 
94 Madquat MC 3.90 R36 
95 Methoxyethyl methacrylate 6.00 NI 
96 Nonyl methacrylate 6.70 NI 
97 Trifluoroethanol methacrylate 4.40 NI 
98 Chloro-3-propionitrile 4.30 NI 
99 Dichloroproprionitrile 2.50 R41 
100 Dimethylaminopropionitrile 10.10 R41 
101 Forafac 1028 3.50 R41 
102 Forafac 1033 1.80 R41 
103 Forafac 1057 4.30 NI 
104 Forafac 1110 D 4.20 NI 
105 Forafac 1159 5.30 R36 
106 Forafac 1183 N 6.20 NI 
107 Forafac 1185 D 3.60 NI 
108 Forafac 1187 5.60 NI 
109 Foralkyl AC8N 4.60 R36 
110 Foralkyl FH6-11A 4.60 NI 
111 Foralkyl MAC-8N 5.40 NI 
112 Foraperle 200 4.80 R36 
113 Foraperle 215 4.20 NI 
114 Foraperle 222 4.90 NI 
115 Foraperle 259 6.30 NI 
116 Foraperle 263 5.00 NI 
117 Foraperle 305 5.90 NI 
118 Foraperle 320 4.10 NI 
119 Foraperle 390A 5.30 NI 
120 Foraperle 390B 6.80 NI 
121 Foraperle 440 3.50 R36 
122 Foraperle B 208 5.90 NI 
123 Foraperle B 244 4.60 R36 
124 Perfluoroalkyl iodide 3.40 NI 
125 Perfluoroalkyl ethyl iodide 5.00 NI 
126 Perfluorohexyl iodide 3.50 NI 
127 Perfluorohexyl ethyl iodide 4.40 NI 
128 Perfluorooctyl bromide 9.20 NI 
129 Perfluorosulphochloride 3.20 NI 
130 Perfluoroethanesulphochloride 3.30 NI 
131 Orgasol 1002 6.00 NI 
132 Orgasol 2002 5.60 NI 
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Table 9.3 continued 
 
No Chemical pH  EU class 
  
133 Resin E561 3.90 NI 
134 Resin SR9 7.40 NI 
135 Additive A71 7.50 R36 
136 Inhibitor RHB 7.50 R36 
137 Sodium dodecyl sulphate 6.90 R41 
138 Dinoram C 10.70 R41 
139 Dinoram S 10.20 R41 
140 Dinoram SL 10.50 R41 
141 EXP 3830 D 4.20 R41 
142 Noram C 10.20 R41 
143 Noram S96 10.00 R41 
144 Noramac C26 6.40 R41 
145 Noramac S 5.80 R41 
146 Noramium M2SH 3 4.50 R41 
147 Polyram S 10.20 R41 
148 Remcopal 011 6.00 R36 
149 AC 302 B 8.16 NI 
150 AC 551 C 8.44 NI 
151 Adine BBH44 3.90 NI 
152 B92 7.40 R36 
153 Creosote 14130 7.00 NI 
154 DA 89 5.40 NI 
155 DE 917D 6.20 NI 
156 IDPA 7.00 NI 
157 Diurethane XPU 6734 4.00 NI 
158 Hexane 6.10 NI 
159 Resin C11 3.30 NI 
160 Sodium hydroxide  12.00 R41 
161 Triacetin 5.20 NI 
162 Tributyltin chloride 2.50 R41 
163 WAC 4.20 R36 
164 XT 7660 9.40 R41 
165 XT 7661 9.30 R41 
 
 
Footnote to Table 9.3 
 
aThe pH data and EU classifications were taken from Régnier & Imbert (1992). 
bMeasurements were made on a 10% solution. 
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Table 9.4 Test set of pH data for 49 chemicalsa 
 
No Chemical EU class pHb  
 
1 Sodium hydroxide I 12.66 
2 Benzalkonium chloride I 3.10 
3 Cetylpyridinium bromide I 4.81 
4 Captan 90 concentrate I 7.95 
5 Chlorhexidine I 10.12 
6 Cyclohexanol I 4.54 
7 Quinacrine I 3.77 
8 Promethazine HCl I 4.50 
9 4-Fluoroaniline I 9.02 
10 Triton X-100 I 7.18 
11 Acetone I 5.32 
12 Hexanol I 5.48 
13 1-Naphthalene acetic acid, Na salt I 3.34 
14 Sodium oxalate I 9.40 
15 Isobutanol I 5.72 
16 Imidazole I 10.32 
17 2-Ethyl hexanol NI 4.78 
18 4-Carboxybenzaldehyde I 3.12 
19 Methyl ethyl ketone I 5.51 
20 Pyridine I 9.85 
21 1-Naphthalene acetic acid NI 7.98 
22 2,2-Dimethylbutanoic acid NI 3.32 
23 γ-Butyrolactone I 4.51 
24 Octanol I 6.11 
25 Methyl acetate I 4.84 
26 L-Aspartic acid I 2.96 
27 Benzoyl-L-tartaric acid I 2.39 
28 Potassium cyanate I 10.08 
29 Isopropanol I 5.86 
30 Sodium perborate I 9.98 
31 Dibenzyl phosphate I 2.39 
32 2,5-Dimethylhexanediol NI 5.72 
33 Methyl cyanoacetate I 5.76 
34 Ethanol NI 6.24 
35 2,6-Dichlorobenzoyl chloride I 2.50 
36 Ammonium nitrate I 4.78 
37 Ethyl-2-methylacetoacetate NI 7.47 
38 Ethyl acetate NI 4.81 
39 Maneb I 8.39 
40 Fomesafen NI 3.99 
41 Tetraaminopyrimidine sulphate NI 2.49 
42 Toluene NI 5.67 
43 Butyl acetate NI 5.00 
44 Methyl isobutyl ketone NI 4.59 
45 Tween 20 NI 3.84 
46 Ethyl trimethyl acetate NI 4.75 
47 Methylcyclopentane NI 6.52 
48 Glycerol NI 5.46 
49 Polyethylene glycol 400 NI 3.65 
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Footnote to Table 9.4 
 
aThe 49 chemicals are a subset of the 60 chemicals tested in the EC/HO validation study on 
alternatives to the Draize eye test (Balls et al., 1995); the pH data were provided by BIBRA 
International (Surrey, UK). 
 
bMeasurements were made on a 10% solution. 
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Table 9.5 In vitro data set of 59 chemicalsa 
 
No Chemical EU  SM RBC IRE ICE FL EDE BCOP 
  class  Dlow Dmax H50 O1 O4 S1 S4 R O S   O P 
                  
1 Sodium hydroxide (10%) I 3.3 10000 57.7 3893 2.9 4.0 101.6 138.3 3.0 3.6 111.6 8.8 51.0 216.6 3.7 
2 Benzalkonium chloride (10%) I 2.6 5253 62.5 156 1.7 2.5 36.4 73.1 3.0 2.4 53.6 267.3 50.8 70.8 4.4 
3 Trichloroacetic acid (30%) I 3.2 10000 80.2 19294 3.4 3.7 24.0 77.4 3.0 4.0 92.5 348.8 51.0 212.4 3.4 
4 Cetylpyridinium bromide (10%) I 3.1 10000 57.1 64 0.8 1.9 17.9 43.5 2.3 1.9 28.0 259.3 26.0 23.0 3.4 
5 Cetylpyridinium bromide (6%) I 2.9 10000 62.3 109 0.6 1.8 21.4 32.0 2.4 1.3 28.6 257.0 26.3 29.5 2.8 
6 Benzalkonium chloride (5%) I 3.0 32500 63.5 360 1.3 3.0 32.3 99.2 2.5 2.4 45.2 267.0 48.7 64.9 4.2 
7 Captan 90 concentrate I nd 370 3.3 370 0.8 1.0 6.5 18.8 0.3 0.9 17.0 175.0 8.3 43.5 0.0 
8 Chlorhexidine I nd 700 23.7 440 1.3 2.7 26.8 69.2 3.0 3.8 78.4 175.0 51.0 111.5 0.2 
9 Cyclohexanol I 3.5 14000 2.5 9925 1.1 2.5 24.3 82.1 2.8 2.3 52.2 788.0 38.5 11.3 3.3 
10 Quinacrine I 3.0 10000 4.4 13750 0.0 0.2 7.1 8.0 1.1 0.8 8.6 375.0 21.0 1.5 0.0 
11 Promethazine HCl I 3.1 30250 32.9 419 1.5 2.3 44.1 89.8 2.7 2.4 56.9 38.8 51.0 121.7 0.0 
12 4-Fluoraniline I 3.5 7750 23.3 7730 1.2 2.3 27.8 64.4 3.0 2.1 46.6 773.7 50.7 15.7 1.0 
13 Triton X-100 (10%) I 3.3 100000 2.5 967 0.7 2.3 27.1 56.8 1.7 0.8 17.6 298.4 20.5 5.9 4.3 
14 Acetone I 5.2 100000 2.5 100000 0.4 1.1 15.3 31.9 1.8 1.1 20.0 687.3 36.4 78.7 3.0 
15 Hexanol I nd 2125 2.5 1125 0.7 2.7 18.6 48.3 2.3 2.3 46.8 508.2 39.4 13.3 3.2 
16 1-Naphthalene acetic acid, Na salt I 4.1 10150 2.5 10150 1.0 2.7 57.0 107.6 3.0 2.8 69.2 291.5 37.5 86.4 4.2 
17 Sodium oxalate I nd 6500 6.8 7000 0.0 0.0 7.3 9.7 0.6 0.3 8.8 337.5 51.0 11.6 0.2 
18 Isobutanol I 4.4 56250 2.5 33800 1.3 2.5 25.1 75.5 3.0 2.4 61.4 597.3 40.2 20.7 2.4 
19 Imidazole I 3.9 100000 54.6 21348 2.5 2.8 44.8 74.8 3.0 3.1 99.8 147.8 51.0 75.0 2.5 
20 Sodium lauryl sulphate (15%) I 2.8 7750 32.5 256 0.1 1.3 16.3 23.4 1.1 0.7 15.4 28.7 39.5 4.5 3.9 
21 2-Ethyl-1-hexanol NI nd 833 4.3 765 0.3 1.4 10.7 20.3 1.8 2.0 42.7 509.6 24.8 7.1 2.2 
22 4-Carboxybenzaldehyde I nd 1000 2.5 1000 0.3 0.4 6.2 13.0 1.2 1.3 26.4 175.0 46.7 77.4 0.1 
23 Methyl ethyl ketone I 4.8 100000 2.5 74527 0.9 2.4 21.2 61.3 2.7 2.4 42.4 441.1 38.1 52.6 1.2 
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Table 9.5 continued 
 
No Chemical EU  SM RBC IRE ICE FL EDE BCOP 
  class  Dlow Dmax H50 O1 O4 S1 S4 R O S   O P 
                  
24 Pyridine I 4.1 100000 58.7 48931 1.8 2.8 25.9 54.9 3.0 2.6 60.9 463.0 51.0 76.1 4.8 
25 1-Naphthalene acetic acid NI nd 3063 2.5 3063 0.3 0.9 12.0 13.7 1.3 1.0 21.3 212.5 49.8 76.6 0.1 
26 Benzalkonium chloride (1%) I 3.7 100000 49.2 1401 0.9 2.4 23.9 52.8 1.9 1.9 21.6 350.3 43.0 38.1 3.4 
27 2,2-Dimethylbutanoic acid NI nd 1145 3.2 1038 2.8 2.7 33.6 68.1 3.0 2.7 54.1 333.0 47.6 61.4 3.5 
28 γ-Butyrolactone I 4.5 100000 2.5 100000 0.3 1.7 21.4 38.3 1.6 1.7 22.2 231.9 23.9 32.5 1.9 
29 Octanol I nd 700 2.5 483 0.0 1.5 11.8 21.7 1.6 1.7 45.1 512.7 31.2 9.2 2.1 
30 Methyl acetate I 5.0 100000 2.5 84475 0.5 1.6 15.1 30.6 1.9 2.5 38.3 687.5 31.6 44.1 0.7 
31 L-Aspartic acid I 3.1 3000 39.3 1200 0.3 0.3 5.1 6.1 1.7 1.3 21.0 154.0 50.2 1.3 0.0 
32 Benzoyl-L-tartaric acid I 2.9 2025 45.5 2400 1.0 1.9 18.2 24.5 1.7 2.3 25.2 106.1 51.0 166.9 0.2 
33 Triton X-100 (5%)  I 3.5 100000 2.5 2175 0.6 2.0 19.7 33.0 1.3 0.7 22.8 417.7 20.5 6.0 4.8 
34 Potassium cyanate I 4.4 100000 14.0 100000 0.0 0.0 5.2 5.3 1.0 0.9 17.2 625.0 48.0 7.6 0.5 
35 Isopropanol I 5.0 100000 2.5 98250 1.3 1.9 16.0 35.8 2.0 1.8 35.5 718.5 40.0 20.0 2.5 
36 Sodium perborate I 2.8 2800 13.1 3800 0.0 0.0 3.2 5.5 0.8 0.7 12.1 200.1 28.2 10.9 5.8 
37 Dibenzyl phosphate I 2.9 3000 38.2 1563 0.5 1.1 9.5 16.5 1.9 1.4 23.0 136.5 49.7 376.5 0.1 
38 2,5-Dimethylhexanediol NI 4.8 100000 2.5 100000 0.3 0.4 15.3 16.5 2.1 1.7 23.5 625.0 27.3 11.1 0.6 
39 Methyl cyanoacetate I 3.4 30250 19.7 33844 0.1 0.7 5.0 6.9 0.5 0.6 16.0 766.3 48.3 12.3 0.0 
40 Sodium hydroxide (1%) I 4.4 100000 38.0 42001 1.0 2.8 50.2 93.5 1.5 1.9 33.2 129.3 50.1 94.9 3.7 
41 Ethanol NI 5.0 100000 2.5 100000 1.7 2.6 26.8 52.6 2.3 2.6 43.8 701.2 35.6 26.9 2.9 
42 2,6-Dichlorobenzoyl chloride I nd 700 23.0 650 0.8 1.9 8.5 21.1 2.0 1.1 18.2 1149.5 36.4 9.7 0.0 
43 Ammonium nitrate I 4.7 100000 3.0 100000 0.0 0.0 7.3 10.2 1.6 1.1 16.8 700.3 16.7 6.9 0.2 
44 Ethyl-2-methylacetoacetate NI 2.6 17500 8.0 17500 0.4 1.7 16.3 21.2 0.8 0.5 5.1 786.3 19.0 14.1 0.0 
45 Sodium lauryl sulphate (3%) NI 3.5 7503 29.1 1215 0.0 0.5 9.8 15.4 0.8 0.3 15.4 107.4 36.5 4.4 1.4 
46 Ethyl acetate NI 4.7 21375 2.5 21375 0.0 1.4 14.6 30.6 2.2 2.1 36.5 716.0 28.8 9.5 1.5 
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Table 9.5 continued 
 
No Chemical EU  SM RBC IRE ICE FL EDE BCOP 
  class  Dlow Dmax H50 O1 O4 S1 S4 R O S   O P 
                  
47 Maneb I nd 2578 25.0 3892 1.0 1.0 24.0 26.6 0.5 1.0 12.6 337.5 40.4 39.0 0.1 
48 Fomesafen NI nd 26250 19.0 1915 0.8 1.2 9.2 16.3 0.7 0.7 5.9 337.5 44.9 6.4 3.6 
49 Tetraaminopyrimidine sulphate NI 3.0 1000 21.0 1333 0.8 0.8 4.3 10.3 1.2 1.4 13.7 175.0 48.5 14.8 0.0 
50 Toluene NI nd 650 2.5 650 0.4 0.5 14.4 22.8 1.4 1.6 26.6 872.5 18.1 5.3 2.0 
51 Butyl acetate NI nd 1625 2.5 1625 0.0 0.3 6.6 14.7 1.1 2.1 25.7 693.5 24.1 5.9 1.9 
52 Trichloroacetic acid (3%) NI 4.2 100000 77.2 73188 0.7 0.8 8.1 18.5 2.0 1.9 26.4 764.8 35.0 74.5 0.1 
53 Methyl isobutyl ketone NI 2.9 10000 2.5 10000 0.3 1.6 18.2 34.2 2.4 2.3 31.1 840.5 21.6 6.6 0.4 
54 Tween 20 NI 3.4 100000 5.1 78400 0.0 0.3 13.5 15.9 1.2 0.6 11.7 876.0 nd 0.0 0.0 
55 Ethyl trimethyl acetate NI nd 1000 2.5 1000 0.0 0.8 6.6 12.0 1.1 0.7 11.6 873.5 18.5 5.1 0.8 
56 Methylcyclopentane NI nd 775 2.5 559 0.0 0.0 8.2 9.5 0.6 0.4 7.5 790.3 15.0 1.0 0.1 
57 Cetylpyridinium bromide (0.1%) NI 4.7 75500 2.5 10327 0.0 0.0 14.7 19.8 0.8 0.5 12.0 961.0 15.2 4.2 0.3 
58 Glycerol NI 4.9 100000 2.5 100000 0.0 0.3 7.7 7.6 1.1 0.6 13.4 1113.5 7.6 0.1 0.0 
59 Polyethylene glycol 400 NI 5.6 100000 2.5 100000 0.3 0.5 15.0 17.6 1.2 0.6 14.1 852.8 24.9 0.9 0.0 
 
Footnote to Table 9.5 
 
aThe in vitro data were obtained during the EC/HO validation study on alternatives to the Draize eye test (Balls et al., 1995). 
 
SM = silicon microphysiometer; RBC = red blood cell; IRE = isolated rabbit eye; ICE = isolated chicken eye; FL = fluorescein leakage; EDE = EYTEX 
Draize equaivalent score; IRE = isolated rabbit eye; BCOP = bovine corneal opacity and permeability. 
O1 = opacity at 1h; O4 = opacity at 4h; S1 = swelling at 1h; S4 = swelling at 4h; R = retention; O = opacity; S = swelling; P = permeability. 
nd = no data. See chapter 2 for further details on these in vitro endpoints. 
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Table 9.6 In vitro data for 143 chemicals obtained in the HETCAM and neutral 
red uptake testsa 
 
No Chemical EU class TC10 TH10 TL10 TC100 TH100 TL100 logIC50
          
1 Arcopal R41 204.0 50.1 119.6 169.1 26.6 80.1 -1.52 
2 Kuppler 43 R36 128.0 70.6 155.0 nd nd nd 0.05 
3 Hoe T 3761 NI 292.6 125.1 210.6 165.5 49.8 124.2 0.54 
4 Remoglan R41 116.5 25.1 126.1 100.1 16.7 85.3 -1.10 
5 Genagen NI 249.2 64.6 171.2 208.7 46.1 180.1 0.11 
6 Sept R41 301.0 54.2 178.8 5.5 19.8 114.9 -0.17 
7 RK Blau NI 301.0 301.0 216.4 nd nd nd 0.04 
8 Glycediol NI 301.0 187.7 301.0 301.0 92.0 301.0 0.95 
9 Hypo 36 NI 301.0 46.0 301.0 200.3 32.5 104.1 -1.73 
10 2,2,3-Trimethyl-3-cyclo-pentene-1-
acetaldehyde 
NI 301.0 144.8 300.8 200.7 28.6 100.2 -0.87 
11 Silan 167 NI 301.0 216.7 301.0 301.0 103.1 301.0 -0.95 
12 Silan 108 (trimethoxyoctylsilane) NI 301.0 141.7 224.0 215.5 54.9 183.7 0.02 
13 Hypo 20 NI 301.0 301.0 301.0 301.0 53.1 178.5 -1.50 
14 Ede 140 NI 301.0 198.3 301.0 301.0 160.9 301.0 2.99 
15 Silan 165 NI 301.0 280.4 301.0 301.0 157.3 148.4 0.18 
16 Olak R41 75.4 15.4 32.1 31.1 11.6 17.7 -0.64 
17 Silan 103 (trimethoxypropyl silane) NI 301.0 71.3 301.0 238.0 26.3 188.9 nd 
18 Olesulf R41 91.9 16.7 48.7 31.3 10.3 29.1 -0.78 
19 N-(2-methylphenyl)-
imidodicarbonimidic diamide 
R41 83.2 18.5 50.5 301.0 48.8 279.0 -0.24 
20 Ethiosan NI 301.0 301.0 301.0 nd nd nd nd 
21 Sodium dodecyl ether sulphate R36 182.8 16.4 50.1 57.0 11.8 30.5 -0.69 
22 Tocla R41 29.8 7.3 157.8 14.5 4.7 154.2 -0.83 
23 Methyltriglycol NI 253.7 52.4 268.4 30.0 12.1 160.7 1.23 
24 1-(2,6-Dimethylphenoxy)-2-propanol NI 193.2 119.6 180.5 156.8 38.3 122.2 -0.12 
25 4-([2-Sulphatoethyl]sulphonyl)-
aniline 
R41 18.1 8.4 11.7 195.0 85.0 146.2 -1.21 
26 Hyton R36 141.3 17.0 55.2 48.4 10.8 43.1 -0.58 
27 Caffeine sodium salicylate NI 293.8 54.6 116.8 84.6 13.0 38.1 0.70 
28 Phosphonat A NI 276.3 58.4 195.0 256.8 121.6 175.1 -0.19 
29 Mecre NI nd nd nd nd nd nd -0.08 
30 Ethylacrolein R41 301.0 30.0 301.0 44.4 11.9 183.3 -2.27 
31 2-Hydroxyethyliminodisodium 
acetate 
NI 244.8 29.5 88.3 97.0 18.7 195.3 0.99 
32 Hydo 98 R41 238.8 15.2 75.1 230.2 14.1 78.7 -1.21 
33 Hypo 45 NI 301.0 167.9 301.0 217.4 65.3 220.7 -1.69 
34 (-)Phenylephrine NI 169.5 119.3 266.8 301.0 82.2 210.0 -0.12 
35 p-Nitrobenzoic acid NI 165.4 134.9 142.5 301.0 301.0 301.0 0.17 
36 Hypo 54 R41 301.0 39.3 301.0 301.0 50.8 301.0 -1.81 
37 Piperazine NI 207.1 187.4 218.2 186.6 61.1 90.9 0.78 
38 Xanthinol nicotinate NI 301.0 37.2 161.7 191.1 40.7 57.0 0.88 
39 3-5-Dihydroxyacetophenone NI 301.0 55.7 301.0 nd nd nd -0.40 
40 Caffeine sodium benzoate NI 275.5 49.4 215.3 152.2 27.1 142.6 0.06 
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Table 9.6 continued 
 
No Chemical EU class TC10 TH10 TL10 TC100 TH100 TL100 logIC50
          
41 Genomoll  
(tris(2-chloroethyl)phosphate) 
NI 203.4 59.0 199.2 174.8 43.3 187.1 -0.21 
42 Phenylephrine hydrochloride NI 282.5 25.8 99.7 38.4 8.3 27.9 0.15 
43 1,2,6-Hexanetriol NI 301.0 24.4 159.0 85.7 18.3 49.3 1.22 
44 Silan 253 R41 301.0 117.4 301.0 106.8 24.8 219.9 -0.55 
45 Polyethylene glycol butyl ether R36 183.1 30.7 73.5 33.8 9.0 26.3 0.80 
46 β-Resorcylic acid  
(2,4-dihydroxybenzoic acid) 
R41 34.7 42.6 163.5 191.6 240.4 203.7 0.28 
47 Theophylline sodium acetate NI 220.0 26.3 198.8 299.3 93.7 155.2 0.42 
48 Theophylline sodium  NI 293.0 53.3 227.6 301.0 61.6 251.1 0.30 
49 Potato starch NI 215.4 212.3 301.0 301.0 227.6 301.0 1.78 
50 1,2-Epoxycyclooctane NI 301.0 87.5 301.0 301.0 164.3 248.4 0.05 
51 Methylacetate R36 301.0 38.3 301.0 69.5 6.8 54.1 0.98 
52 Polysolvan (butyl glycolate) R41 80.1 16.3 174.8 38.3 3.9 36.3 0.29 
53 Theobromine NI 301.0 301.0 301.0 301.0 301.0 301.0 -0.04 
54 α-Lactid NI 113.3 148.1 195.6 246.7 194.3 286.0 0.53 
55 Isopropyl acetoacetate NI 301.0 90.2 301.0 188.7 44.4 199.2 -0.06 
56 Hnol NI 301.0 279.3 301.0 301.0 238.3 172.3 -1.80 
57 (+)Phenylephrine NI 67.0 24.2 29.2 266.3 34.4 174.3 -0.02 
58 Polyhexamethylene guanidine R41 283.1 39.5 76.1 98.8 25.3 110.7 -2.02 
59 N-Acetyl methionine R41 198.1 167.0 104.0 219.7 301.0 178.5 0.76 
60 Potassium cyanate R41 67.0 19.1 60.6 40.3 22.3 77.5 -0.58 
61 Methyltetraglycol NI 301.0 127.3 222.7 56.8 7.5 165.1 1.58 
62 1,3-Dinitrobenzene R36 240.3 176.3 301.0 286.5 194.8 301.0 -1.16 
63 Butanal NI 201.0 55.2 190.7 6.7 11.6 62.6 0.20 
64 α-Ketoglutaric acid R41 27.2 11.0 46.2 16.9 9.2 27.4 0.37 
65 Sodium disilicate R41 31.7 5.8 14.7 72.8 23.1 48.1 1.64 
66 3-Methoxybenzaldehyde NI 301.0 111.8 301.0 108.3 31.2 198.1 -0.53 
67 Butanol R41 104.7 11.4 161.8 23.9 4.7 155.5 0.54 
68 L-Lysine monohydrate NI 301.0 39.6 96.9 177.7 22.2 72.4 0.75 
69 Anisole R41 301.0 136.9 230.7 32.3 18.7 38.2 0.15 
70 Sodium hydrogensulphate R41 60.8 30.9 41.7 42.4 29.9 26.8 0.60 
71 Triisooctylamine NI 301.0 269.7 301.0 166.1 52.8 219.4 -2.15 
72 4-Anisidine R36 259.0 69.8 301.0 286.3 64.7 178.3 -0.75 
73 Aspartic acid NI 301.0 220.2 261.1 301.0 301.0 301.0 0.51 
74 Ethylbutanal NI 301.0 190.7 301.0 62.8 14.1 37.0 0.18 
75 Potassium hexacyanoferrate II R41 92.8 29.1 55.7 137.5 100.1 196.9 1.19 
76 Isobutanal NI 301.0 232.8 301.0 18.6 19.2 19.4 0.12 
77 1,2-Epoxydodecane NI 301.0 176.2 301.0 301.0 120.4 216.0 -0.79 
78 1,2-Phenylenediamine (1,2-
benzenediamine) 
R36 125.9 29.9 138.4 197.1 56.4 174.9 -0.22 
79 L-Glutamic acid hydrochloride R41 103.8 30.2 190.6 69.8 37.9 206.6 0.48 
80 DTPA pentasodium salt R41 119.7 47.4 43.0 29.2 7.6 16.3 0.22 
81 Potassium hexacyanoferrate III NI 269.0 44.4 301.0 242.3 104.8 254.9 -0.24 
82 Sodium pyrosulphite R41 29.3 28.7 193.0 58.3 44.6 237.1 -0.20 
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Table 9.6 continued 
 
No Chemical EU class TC10 TH10 TL10 TC100 TH100 TL100 logIC50
          
83 Sodium cyanate NI 220.3 24.8 72.5 233.6 39.8 170.3 -0.73 
84 4-Chloro-4’-nitrodiphenylether NI 301.0 75.8 301.0 301.0 195.5 262.1 1.64 
85 4-Amino-5-methoxy-2-
methylbenzene sulphonic acid 
R41 92.7 143.5 169.4 90.4 216.7 110.8 nd 
86 Isononylaldehyde NI 301.0 301.0 301.0 301.0 89.2 148.1 -0.65 
87 Ammonium persulphate NI 301.0 167.0 223.4 109.8 31.6 174.8 -1.12 
88 4-Chloro-methanilic acid R41 41.9 29.4 137.1 143.9 179.3 273.5 0.60 
89 2-Methyl-1-propanol R41 72.0 24.7 33.5 18.9 6.7 24.8 0.45 
90 Diepoxide 126 NI 264.9 101.1 254.7 146.3 48.1 229.9 -0.29 
91 2-Hydroxyisobutyric acid ethyl ester R41 107.8 31.1 60.7 33.4 6.7 20.1 0.87 
92 Paraformaldehyde (methanal) R41 301.0 263.5 265.3 301.0 301.0 301.0 -2.13 
93 3-Cyclohexene-1-methanol R41 102.0 24.0 283.8 25.3 6.1 51.0 -0.24 
94 4,4-Dimethyl-3-oxopentanenitrile NI 301.0 42.3 301.0 301.0 173.8 125.3 0.32 
95 Methylphosphonic acid 
bis(oxianylmethyl) ester 
R41 181.7 33.1 165.8 69.7 13.5 116.2 -1.23 
96 Hexamethylene tetramine NI 301.0 172.0 175.3 190.8 20.9 162.8 -0.08 
97 3-Mercapto-1,2,4-triazole R36 301.0 36.7 301.0 301.0 301.0 301.0 -0.85 
98 Phenylthiourea NI 301.0 179.6 301.0 301.0 207.7 301.0 nd 
99 1,4-Dibutoxy-benzene R36 301.0 173.9 301.0 301.0 301.0 301.0 -0.93 
100 Ambuphylline NI 152.3 46.4 127.5 102.6 33.9 125.6 0.16 
101 2-Hydroxyisobutyric acid  R41 44.8 182.2 163.7 40.0 169.0 153.3 0.52 
102 Chlorhexidine R41 178.0 95.2 284.8 301.0 151.5 297.8 -2.09 
103 Iminodiacetic acid R41 217.0 174.5 283.0 194.2 170.2 255.4 0.64 
104 5-Methyl-1,3-4-thiadiazol-2-amine NI 301.0 301.0 301.0 301.0 301.0 301.0 0.77 
105 Chlorhexidine hydrochloride NI 66.3 231.7 180.9 301.0 237.0 301.0 -0.44 
106 1,2-Dodecanediol R41 301.0 171.0 301.0 301.0 110.2 262.2 -1.61 
107 Sodium monochloroacetate NI 301.0 172.8 230.0 76.4 26.2 207.3 -0.66 
108 Rubinrot Y NI 301.0 61.5 301.0 287.5 165.0 301.0 0.06 
109 Polyethylene glycol dimethylether NI 301.0 179.3 301.0 152.8 31.9 94.6 1.33 
110 Hexahydrofarnesyl acetone NI 301.0 195.1 301.0 301.0 101.3 182.3 nd 
111 Hoe MBF NI 301.0 301.0 301.0 301.0 290.7 301.0 0.08 
112 Sodium bisulphite NI 82.8 25.0 207.5 47.0 10.9 45.6 0.22 
113 TA 01946 alkylsilan NI 301.0 31.5 121.9 202.7 28.3 61.8 nd 
114 Trioxane NI 230.9 54.4 80.8 63.2 18.0 42.1 1.30 
115 Butyl carbamate R41 208.6 121.6 256.7 80.8 13.7 150.7 0.14 
116 Gadopentetic acid dimeglumine salt NI 289.9 266.5 122.4 258.3 221.7 152.3 1.48 
117 Sodium sulphite NI 110.6 73.4 163.1 130.4 59.7 124.2 -0.09 
118 Isobornyl acetate NI 301.0 124.9 301.0 301.0 44.3 212.6 -0.80 
119 Acetoacetic acid glycolester NI 301.0 205.7 301.0 269.3 177.8 281.0 0.24 
120 Camphen (2,2-dimethyl-3-methylene 
bicyclo 2.2.1 heptane) 
R36 301.0 149.1 141.8 301.0 217.5 191.0 -0.63 
121 Lial-111-glucoside R41 212.9 24.1 37.6 93.9 14.2 22.1 -0.65 
122 Isodecylglucoside R41 195.3 9.2 63.2 182.2 10.1 45.1 -0.38 
123 2-Pseudojonon NI 301.0 89.2 180.9 301.0 91.6 205.0 -1.23 
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Table 9.6 continued 
 
No Chemical EU class TC10 TH10 TL10 TC100 TH100 TL100 logIC50
          
124 Methylpentynol R41 84.1 27.8 180.3 15.7 13.6 164.9 0.49 
125 PO 2 NI 301.0 39.3 301.0 301.0 292.8 301.0 nd 
126 2,5-Dimethylhexanediol R41 301.0 52.9 191.2 126.5 20.8 167.6 0.81 
127 Sacyclo NI 301.0 98.8 301.0 301.0 69.4 301.0 nd 
128 C12/C14-Glucoside R41 301.0 46.4 76.5 101.4 29.0 39.2 -0.70 
129 1,6,7,12-Tetrachloro-3,4,9,10-
tetracarbonic acid anhydride 
NI 301.0 301.0 301.0 301.0 239.7 301.0 nd 
130 Diphocars R41 54.9 19.8 33.0 54.9 23.7 140.5 -0.39 
131 3,6-Dimethyloctanol R41 301.0 291.4 301.0 281.7 37.2 301.0 -0.32 
132 Napt NI 301.0 171.2 301.0 224.1 192.3 154.5 0.52 
133 B 25 NI 301.0 301.0 301.0 301.0 301.0 301.0 nd 
134 1-Chloroctan-8-ol R41 300.3 35.8 252.3 50.9 13.5 120.6 -0.85 
135 DC 8 NI 301.0 301.0 301.0 301.0 207.7 258.8 nd 
136 Bis-(3-triethoxysilylpropyl)-
tetrasulphide 
NI 301.0 172.5 301.0 301.0 113.9 301.0 nd 
137 Nitro-bis-octylamide NI 301.0 261.8 292.9 301.0 138.9 221.5 -0.56 
138 7-Acetoxyheptanal R41 301.0 229.3 301.0 113.7 66.9 143.2 -1.18 
139 4-Amino-azobenzene-4-sulphonic 
acid 
NI 301.0 301.0 301.0 301.0 301.0 301.0 0.39 
140 Oxol 9N NI 301.0 173.3 301.0 288.3 63.1 301.0 nd 
141 Isotridecanal NI 301.0 301.0 301.0 301.0 203.7 301.0 -0.14 
142 Cerium 2-ethylhexanoate NI 250.6 86.2 201.9 39.8 11.1 110.1 0.53 
143 Wessalith slurry R41 301.0 70.4 153.9 203.1 41.0 137.3 0.41 
 
 
Footnote to Table 9.6 
 
aThe in vitro data were taken from Spielmann et al. (1996). 
 
Effects observed in the hen’s egg chorioallantoic membrane: TC10 = detection time for 
coagulation with a 10% solution; TC100 = detection time for coagulation with a neat substance; 
TH10 = detection time for hæmorrhage with a 10% solution; TH100 = detection time for 
hæmorrhage with a neat substance; TL10 =detection time for lysis with a 10% solution; TL100 
= detection time for lysis with a neat substance. 
 
logIC50 = logarithm of concentration of test chemical resulting in 50% inhibition of neutral red 
uptake in 3T3 cells; nd = not determined. 
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Table 9.7 Performance of classification models for eye irritation potential 
 
 Model Sensitivity (95% CI) 
Specificity
(95% CI) 
Concordance
(95% CI) 
False positives 
(95% CI) 
False negatives 
(95% CI) 
SAR 1a 97 49 61 51 3 
 (90-100) (39-60) (53-71) (40-61) (0-10) 
SAR 2b 89 79 81 21 11 
 (78-100) (70-87) (74-88) (13-30) (0-22) 
PM 1c 53 97 76 3 47 
 (41-63) (93-100) (69-83) (0-17) (37-59) 
PM 1d 44 94 61 6 56 
PM 2e 46 100 63 0 54 
 (31-62) g (51-76) g (38-69) 
PM 3e 59 100 72 0 61 
 (43-75) g (60-84) g (16-40) 
PM 4e 56 94 68 6 44 
 (54-83) (74-100) (64-86) (0-26) (17-46) 
PM 5e 69 89 75 11 31 
 (55-84) (74-100) (64-86) (0-26) (16-45) 
PM 6f 67 79 74 21 33 
 (55-80) (69-88) (66-81) (12-31) (20-45) 
 
Footnote to Table 9.7 
 
aStatistics based on the application of SAR 1 to its training set of 119 chemicals; bStatistics 
based on the application of SAR 2 to its training set of 117 chemicals; cStatistics based on the 
application of PM 1 to its training set of 165 chemicals; dStatistics based on the application of 
PM 1 to a test set of 49 chemicals; eStatistics based on the application of the PM to its training 
set of 57 chemicals; fStatistics based on the application of PM 6 to its training set of 129 
chemicals; gNo variability because all NI chemicals in the data set were correctly identified. 
 
The 95% confidence intervals were derived by bootstrap resampling the appropriate data set 
1000 times. 
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Table 9.8 Variability in the parameters of an elliptic model for eye irritation 
 
parameter estimate 
based on full 
data set 
bootstrap 
mean 
bias bias-corrected 
estimate 
bootstrap 
lower 
95% CL 
bootstrap 
upper 
95% CL 
       
centroid 
along logP 
0.655 0.653 -0.002 0.657 0.439 0.867 
centroid 
along dV1 
-1.226 -1.233 -0.007 -1.219 -1.438 -1.028 
radial axis 
along logP 
1.174 1.137 -0.037 1.211 0.825 1.448 
radial axis 
along dV1 
1.090 1.063 -0.027 1.117 0.890 1.236 
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10.1 INTRODUCTION 
 
In chapters 7 and 9, various CMs for predicting acute skin and eye toxicity are reported. 
These models were developed and evaluated on the basis that they would be applied as 
stand-alone alternatives to animal experiments. In practice, however, such models are 
more likely to be used in the context of an integrated testing strategy, such as the OECD 
testing strategies described in chapter 2. The rationale behind the OECD approach is 
that alternative methods should be used to identify toxic substances, so that animal 
experiments are used mainly to confirm predictions of non-toxicity. An alternative 
rationale, proposed in chapter 9, is that models of high specificity (low false positive 
rate) could be used to identify toxic substances, whereas models of high sensitivity (low 
false negative rate) could be used to identify non-toxic substances. Chemicals predicted 
to be toxic do not undergo further testing, whereas chemicals predicted to be non-toxic 
are tested directly in animals. In this approach, models that identify toxic chemicals are 
used to terminate the testing process, whereas models that identify non-toxic substances 
are used to expedite the process (by skipping intermediate steps based on more time-
consuming and expensive alternative methods). 
 
The aim of the work presented in this chapter was to evaluate these two approaches to 
hazard classification. The OECD approach was evaluated by using models for skin 
irritation and corrosion reported in chapter 7, whereas the alternative approach was 
investigated by using models for eye irritation reported in chapter 9. This work 
represents a development of previous studies (Worth et al., 1998; Worth & Fentem, 
1999), which were communicated to the OECD Secretariat before the (then proposed) 
OECD testing strategies for eye and skin irritation/corrosion were accepted (OECD, 
1998). 
 
10.2 METHOD 
 
10.2.1 Evaluation of the OECD approach to hazard classification 
 
The OECD approach was evaluated by simulating possible outcomes obtained when a 
stepwise sequence of five alternative tests and one animal test (Figure 10.1) is applied to 
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a heterogeneous set of 51 chemicals (Table 10.1). The decision rules in steps 1 to 5 
(Figure 10.1) are based on CMs for skin irritation and corrosion presented in chapter 7.  
 
The 51 chemicals chosen for the evaluation form a subset of 60 test chemicals used in 
the ECVAM validation study on alternative methods for skin corrosion (Barratt et al., 
1998; Fentem et al., 1998), and were selected on the basis that the in vivo effects of each 
chemical were determined for the neat substance (since the models were parameterised 
to predict the effects of neat substances, not dilutions). The chemicals were classified 
for skin irritation and corrosion potential by applying EU classification criteria (see 
chapter 2) to the animal data.  
 
A number of simulations were performed to assess the effects of applying the different 
combinations of the six steps outlined in Figure 10.1 (each combination is referred to 
hereafter as a different sequence). Specifically, assessments were made of: a) six 
stepwise sequences for predicting whether chemicals are corrosive (and irritant), non-
corrosive and irritant, or non-corrosive and non-irritant; b) two sequences for predicting 
whether chemicals are corrosive or non-corrosive (without regard to irritation potential); 
and c) one sequence for predicting skin irritation potential (without regard to its 
corrosion potential). The outcome of each simulation was used to compare the ability of 
each stepwise sequence to predict EU classifications, and to reduce and refine the use of 
animals, with the corresponding ability of the EPISKIN test, when used as a stand-alone 
alternative method. 
 
10.2.2 Evaluation of an alternative approach to hazard classification 
 
The alternative approach was evaluated by simulating possible outcomes obtained when 
a stepwise sequence of alternative and animal tests (Figure 10.2) is applied to a 
heterogeneous set of 45 chemicals (Table 10.2). The decision rules in steps 1 to 3 
(Figure 10.2) are based on CMs presented in chapter 9.  
 
The 45 chemicals chosen for the evaluation form a subset of 60 test chemicals used in 
the EC/HO validation study on alternative methods for eye irritation (Balls et al., 1995), 
and were selected on the basis that the in vivo effects of each chemical were determined 
for the neat substance. One chemical, thiourea, was excluded because it was acutely 
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toxic to the rabbits. The chemicals were classified for eye irritation potential by 
applying EU classification criteria (see chapter 2) to the animal data.  
 
To assess the alternative approach to hazard classification, a simulation was performed 
to assess the effects of applying steps 1, 2 and 3 outlined in Figure 10.2. In step 1 of this 
sequence, a PM based on pH measurements is used as the high-specificity model for 
identifying irritant chemicals (but not non-irritants), and an elliptic SAR based on logP 
and dV1 is used as the high-sensitivity model for identifying non-irritants (but not 
irritants). The PM was applied in the first step, so that chemicals it predicted to be 
irritant would not proceed to subsequent steps, and the SAR was applied in the second 
step, so that chemicals it predicted to be non-irritant would undergo animal testing 
directly, skipping the in vitro test in the third step.  
 
The use of the OECD approach for the assessment of eye irritation potential was also 
simulated. In this case, the PMs based on pH measurements and isolated rabbit eye 
(IRE) data were applied (i.e. steps 1 and 3). The elliptic SAR (step 2) was omitted 
because this CM was being used to predict the absence of irritation potential, and was 
therefore redundant in a strategy based on the sequential elimination of chemicals 
predicted to be irritant.  
 
The outcome of each simulation was used to compare the ability of the corresponding 
stepwise sequence to predict EU classifications, and to reduce and refine the use of 
animals, with the corresponding ability of the IRE test, when used as a stand-alone 
method. 
 
 
10.3 RESULTS 
 
10.3.1 The OECD approach to hazard classification 
 
The predicted and known classifications of skin irritation and corrosion potential are 
given in Table 10.1. Predictions of corrosion potential made by the SAR in step 1 are 
only made for the 36 single chemicals that are organic liquids, since the domain of the 
SAR excludes inorganic substances, solids, and mixtures. 
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When used as a stand-alone test for skin irritation and corrosion, EPISKIN predicts the 
three classes of toxic potential (corrosive and irritant, non-corrosive and irritant, non-
corrosive and non-irritant) with an accuracy of 69% and a kappa statistic (chance-
corrected accuracy) of 53% (Table 10.3). If the 22 chemicals predicted to be non-
corrosive and non-irritant were subsequently tested on rabbits, three chemicals would be 
found to be corrosive, five irritant, and 14 to be non-corrosive and non-irritant (Table 
10.4). 
 
Although the effects of six stepwise sequences incorporating EPISKIN and other 
alternative models were investigated, only one sequence, in which the use of EPISKIN 
is preceded by the use of the pH test for corrosion (step 2), was found to achieve a 
greater accuracy (73%; Table 10.3). This can be related to the fact that two models, the 
SAR for corrosion (step 1) and the pH test for irritation (step 4) have relatively high 
false positive rates (Table 10.4), so the exclusion of these CMs from a stepwise 
sequence improves its predictive capacity. The effect on animal testing of the best 
sequence (steps 2-3-5) is essentially the same as the use of EPISKIN alone (steps 3-5), 
with two corrosive chemicals being tested on rabbits, rather than three (Table 10.4).  
 
When used as a stand-alone test for skin corrosion, EPISKIN has an accuracy of 86% 
and a kappa statistic of 72% (Table 10.3), predicting 21 chemicals to be corrosive 
(Table 10.4). Thus, if EPISKIN were used in sequence with the Draize eye test, the 30 
remaining chemicals predicted to be non-corrosive would be tested on rabbits. Four of 
these chemicals would be found to be corrosive, and 26 to be non-corrosive (Table 
10.4). If the pH test for corrosion is used in combination with EPISKIN (steps 2-3), a 
greater accuracy of 90% is obtained (Table 10.3), with just two corrosive chemicals 
being tested on rabbits, instead of four (Table 10.4). 
 
For the prediction of skin irritation potential, the use of EPISKIN alone is more 
predictive (accuracy of 73%) than its use in combination with the pH test (accuracy of 
61%). Again, this is because the pH test for irritation has a tendency to over-predict. 
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10.3.2 An alternative approach to hazard classification 
 
The predicted and known classifications of eye irritation potential are given in Table 
10.2. As a stand-alone method for predicting eye irritation potential, the IRE test 
discriminates between the 28 irritants and 17 non-irritants with an accuracy of 71% and 
a kappa statistic of 42% (Table 10.5), and predicts 29 of the 45 chemicals to be non-
irritant (Table 10.6). If the remaining 16 chemicals were tested on rabbits, six would be 
found irritant, and ten non-irritant.  
 
Adoption of the OECD approach to the tiered testing leads to the slightly increased 
accuracy of 73% (kappa statistic = 46%; Table 10.5), with five irritant and 10 non-
irritant chemicals being tested on rabbits (Table 10.6). Conversely, adoption of the 
alternative approach increases the accuracy to 76%, with six irritant and 12 non-irritant 
chemicals being tested on animals. 
 
10.4 DISCUSSION 
 
The results of this study show that stepwise approaches to hazard classification, in 
which alternative methods are applied before animal tests, provide a promising means 
of reducing and refining the use of animals, since fewer animal experiments need to be 
conducted, and of those chemicals tested in vivo, the majority are found to be non-toxic. 
The results also show that the sequential use of several alternative methods can be at 
least as predictive as the stand-alone use of a single in vitro test.  
 
The validity of these conclusions depends on the adequate performance of each 
alternative method included in the stepwise sequence. In particular, methods that over-
predict toxic potential may compromise the performance of strategies in which they are 
incorporated, since (according to the approaches evaluated) chemicals found to be toxic 
do not undergo further testing. Thus, when designing a tiered testing strategy, it is 
important that the models included should have low false positive rates (i.e. high 
specificities). For example, it might be decided that false positive rates should not 
exceed 10%. In general, models with lower false positive rates tend to have lower 
sensitivities. However, as discussed in chapter 9, even models with sensitivities less 
than or equal to 50% may be useful in the context of a tiered testing strategy, since it is 
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not important that any single model is capable of identifying a majority of the toxic 
chemicals in a test set, as long as there is a high degree of certainty associated with the 
positive predictions. 
 
In this study, the OECD approach to tiered testing was evaluated by using models for 
skin corrosion and eye irritation, whereas the alternative approach was examined by 
using models for eye irritation. The rationale behind the alternative approach is that 
some models are better suited for identifying toxic chemicals, whereas others are better 
suited for identifying non-toxic chemicals, due to the inescapable overlap between toxic 
and non-toxic chemicals along certain variables. Although such models may be 
unacceptable as stand-alone alternatives to animal experiments, their combined use 
should provide a means of exploiting their strengths while compensating for their 
weaknesses. In particular, it is foreseen that highly specific methods could be 
successfully combined with highly sensitive ones. The main difference between the 
alternative approach and the OECD approach concerns the consequence of negative 
predictions. In the OECD approach, further tests are conducted to confirm predictions of 
non-toxicity, which means that there is no useful role to be played by a model that only 
identifies non-toxic chemicals. In contrast, the alternative approach allows chemicals 
predicted to be non-toxic by an SAR in a screening step to skip the in vitro test in a 
subsequent step, thereby expediting the assessment process. In the case of the 45 
chemicals in Table 10.2, adoption of the OECD approach would lead to in vitro testing 
on 32 chemicals (Table 10.6), whereas adoption of the alternative approach would lead 
to in vitro testing on 22 chemicals. Thus, in the case of the chemicals and CMs studied 
here, adoption of the alternative approach reduces the burden of in vitro testing, without 
a concomitant reduction in predictive capacity or significant increase in animal testing.    
  
In practice, the desirability of adopting the alternative approach would depend on the 
time and expense required to perform the in vitro test, and the additional information 
this is expected to generate. In general, in vitro tests are included in testing strategies 
because they are expected to identify mechanisms of toxic action that are not detected 
by SARs and PMs based on physicochemical data. In such cases, the effect of skipping 
the in vitro test would be to place the burden of identifying toxic chemicals on the 
animal test, which is unsatisfactory from an animal welfare point-of-view.  
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Finally, it is important to note that the approaches to hazard classification evaluated in 
this study represent just two possible ways of integrating the use of different CMs; other 
designs are conceivable. For example, if each prediction of toxic and non-toxic potential 
were associated with a probability (e.g. a 70% probability of being corrosive), 
thresholds other than 50% could be chosen for the identification of toxic and non-toxic 
chemicals. In fact, models derived by logistic regression or linear discriminant analysis 
can be used to assign probabilities, but these are likely to be misleading if the 
assumptions of the statistical methods are not obeyed. Alternatively, the identification 
of toxic potential could proceed according to a ‘majority voting system’, in which 
predictions were made by several models, with classifications being assigned when a 
majority of models made the same prediction. The OECD approach has now been 
accepted in OECD Member States for the classification of industrial chemicals on the 
basis of their acute local toxicity (OECD, 1998). However, variations of this approach 
could be useful in the industrial setting for non-regulatory testing, for example as a 
means of priority setting during chemical development. 
 
10.5 CONCLUSIONS 
 
It is concluded that:  
 
a) testing strategies based on the sequential use of alternative methods prior to the use 
of animal methods provide an effective means of reducing and refining the use of 
animals, without compromising the ability to classify chemicals on the basis of toxic 
hazard.  
b) CMs incorporated into OECD-style testing strategies should have high specificities 
(i.e. low false positive rates), but do not necessarily need high sensitivities, if several 
complementary models are capable of identifying different groups of toxic 
chemicals. 
c) a CM of high sensitivity (but low specificity) can be combined with a CM of high 
specificity (but low sensitivity) to exploit the strengths, and compensate for the 
weaknesses, of the two models.  
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Figure 10.1 A tiered testing strategy for skin irritation and corrosion based on 
the OECD approach to hazard classification 
 
Step 1:  Apply SAR      ⇒  predict C and stop testing 
 ⇓ 
 NC or no SAR  
 ⇓ 
Step 2:  Apply PM based on pH data  ⇒  predict C and stop testing 
 ⇓ 
 NC or no pH data 
 ⇓ 
Step 3:  Apply PM based on EPISKIN data  ⇒  predict C and stop testing 
 ⇓ 
 NC 
 ⇓ 
Step 4:  Apply PM based on pH data  ⇒  predict I and stop testing 
 ⇓ 
 NI 
 ⇓ 
Step 5:  Apply PM based on EPISKIN data  ⇒  predict I and stop testing 
 ⇓ 
 NI 
 ⇓ 
Step 6:  Perform Draize skin test   ⇒  classify as C, I or NC & NI 
 
 
Footnote to Figure 10.1 
 
Step 1: If MP ≤ 37ºC and MW ≤ 123 g/mol, predict C; otherwise predict NC. 
Step 2: If pH < 2.4 or pH > 10.9, predict C; otherwise predict NC. 
Step 3: If EPISKIN viability at 4h < 36%, predict C; otherwise predict NC.   
Step 4: If pH < 4.4 or pH > 9.2, predict I; otherwise predict NI.   
Step 5: If EPISKIN viability at 4h < 67%, predict I; otherwise predict NI.  
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Figure 10.2 A tiered testing strategy for eye irritation based on an alternative  
approach to hazard classification 
 
 
Step 1:  Apply CM for I chemicals  ⇒  predict I and stop testing 
 (PM based on pH data)  
 ⇓ 
 no prediction  
 ⇓ 
Step 2: Apply CM for NI chemicals   ⇒  predict NI and go to step 4  
 (SAR based on logP and dV1) 
 ⇓ 
 no prediction  
 ⇓ 
Step 3:  Apply in vitro test   ⇒  predict I and stop testing 
 (PM based on IRE data)   
 ⇓ 
 NI 
 ⇓ 
Step 4: Perform Draize eye test   ⇒  classify as I or NI 
 
 
 
Footnote to Figure 10.2 
 
CM = classification model; IRE = isolated rabbit eye. 
 
Step 1: If pH < 3.2 or pH > 8.6, predict I; otherwise make no prediction. 
Step 2: If MP ≤ 37ºC and (logP-0.66)2 / 1.212 + (dV1 + 1.22)2/ 1.122 >1, predict NI; 
otherwise make no prediction. 
Step 3: If isolated rabbit eye swelling at 1h  > 18%, predict I; otherwise predict NI. 
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Table 10.1 Data set of 51 chemicals used to evaluate a tiered testing strategy 
for skin irritation and corrosion 
 
No Chemical Step 1 Step 2 Step 3 Step 4 Step 5 Draize 
test 
        
1 Hexanoic acid C NC C I I C & I 
2 1,2-Diaminopropane C C C I I C & I 
3 Carvacrol NC NC C I I C & I 
4 Boron trifluoride dihydrate np C C I I C & I 
5 Methacrolein C NC C I I C & I 
6 Phenethyl bromide NC NC NC I NI NC & NI 
7 3,3'-Dithiodipropionic acid NC NC NC I NI NC & NI 
8 Isopropanol C NC NC I NI NC & NI 
9 2-Methoxyphenol (Guaiacol) NC NC C I I NC & NI 
10 2,4-Xylidine (2,4-Dimethylaniline) NC NC NC I I NC & NI 
11 2-Phenylethanol (phenylethylalcohol) C NC NC I NI NC & NI 
12 Dodecanoic (lauric) acid NC NC NC I NI NC & NI 
13 3-Methoxypropylamine C C C I I C & I 
14 Allyl bromide C NC C I I C & I 
15 Dimethyldipropylenetriamine NC C C I I C & I 
16 Methyl trimethylacetate C NC NC I NI NC & NI 
17 Dimethylisopropylamine C C C I I C & I 
18 Tetrachloroethylene NC NC NC I I NC & I 
19 Ferric [iron (III)] chloride np C C I I C & I 
20 Butyl propanoate NC NC NC I NI NC & NI 
21 2-tert-Butylphenol NC NC C NI I C & I 
22 Isostearic acid np C C I I NC & I 
23 Methyl palmitate NC NC NC I NI NC & I 
24 Phosphorus tribromide NC NC NC I NI C & I 
25 65/35 Octanoic/decanoic acids np C C I I C & I 
26 4,4'-Methylene-bis-(2,6-ditert-butylphenol) NC NC NC I NI NC & NI 
27 2-Bromobutane NC NC NC I I NC & NI 
28 Phosphorus pentachloride np C C I I C & I 
29 4-(Methylthio)-benzaldehyde NC NC NC I NI NC & NI 
30 70/30 Oleine/octanoic acid np NC NC I I NC & I 
31 Hydrogenated tallow amine np NC NC I NI NC & I 
32 2-Methylbutyric acid C NC C I I C & I 
33 Tallow amine np NC NC I NI C & I 
34 2-Ethoxyethyl methacrylate NC NC NC I NI NC & NI 
35 Octanoic acid (caprylic acid) NC NC C I I C & I 
36 20/80 Coconut/palm soap np NC NC I NI NC & I 
37 Benzyl acetone NC NC NC I NI NC & NI 
38 Heptylamine C C NC I NI C & I 
39 Cinnamaldehyde NC NC NC I I NC & I 
40 60/40 Octanoic/decanoic acids np NC C I I C & I 
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Table 10.1 continued 
 
No Chemical Step 1 Step 2 Step 3 Step 4 Step 5 Draize 
test 
        
41 Eugenol NC NC NC I I NC & NI 
42 55/45 Octanoic/decanoic acids np NC C I I C & I 
43 Methyl laurate NC NC NC I NI NC & I 
44 Sodium bicarbonate np NC NC I NI NC & NI 
45 Sulphamic acid np C C I I NC & NI 
46 Sodium bisulphite np NC NC I NI NC & NI 
47 1-(2-Aminoethyl)piperazine NC C NC I I C & I 
48 1,9-Decadiene NC NC NC I NI NC & I 
49 Phosphoric acid np C C I I C & I 
50 10-Undecenoic acid NC NC NC I I NC & NI 
51 4-Amino-1,2,4-triazole C NC NC I NI NC & NI 
 
 
Footnote to Table 10.1 
 
Step 1: If MP ≤ 37ºC and MW ≤ 123 g/mol, predict C; otherwise predict NC. 
Step 2: If pH < 2.4 or pH > 10.9, predict C; otherwise predict NC. 
Step 3: If EPISKIN viability at 4h < 36%, predict C; otherwise predict NC.   
Step 4: If pH < 4.4 or pH > 9.2, predict I; otherwise predict NI.   
Step 5: If EPISKIN viability at 4h < 67%, predict I; otherwise predict NI. 
 
C = corrosive (R34 or R35); I = irritant (R38); NC = non-corrosive; NI = non-irritant; np = no 
prediction (chemical outside domain of SAR).  
 
Shading indicates the step at which the assessment would stop and a classification would be 
assigned to the chemical in the OECD-style tiered testing strategy (Figure 10.1). 
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Table 10.2 Data set of 45 chemicals used to evaluate a tiered testing strategy 
for eye irritation 
 
No Chemical Step 1 Step 2 Step 3 Draize test 
  
1 Cyclohexanol np np I I 
2 Parafluoraniline I np I I 
3 Acetone np np NI I 
4 Hexanol np NI I I 
5 Isobutanol (butan-2-ol) np np I I 
6 2-Ethyl-1-hexanol np NI NI NI 
7 Methyl ethyl ketone np np I I 
8 Pyridine I np I I 
9 2,2-Dimethylbutanoic acid np NI I NI 
10 γ-Butyrolactone np np I I 
11 Octanol np NI NI I 
12 Methyl acetate np np NI I 
13 Isopropanol (propan-2-ol) np np NI I 
14 Methyl cyanoacetate np NI NI I 
15 Ethanol np NI I NI 
16 2,6-Dichlorobenzoyl chloride I NI NI I 
17 Ethyl-2-methyl acetoacetate np np NI NI 
18 Ethyl acetate np np NI NI 
19 Toluene np NI NI NI 
20 Butyl acetate np np NI NI 
21 Methyl isobutyl ketone np np I NI 
22 Tween 20 np np NI NI 
23 Ethyl trimethyl acetate np NI NI NI 
24 Methylcyclopentane np NI NI NI 
25 Glycerol np NI NI NI 
26 Polyethylene glycol 400 np np NI NI 
27 Captan 90 concentrate np np I I 
28 Chlorhexidine I np I I 
29 Quinacrine np np I I 
30 Promethazine HCl np np I I 
31 1-Naphthalene acetic acid, Na salt np np I I 
32 Sodium oxalate I np I I 
33 Imidazole I np I I 
34 4-Carboxybenzaldehyde I np I I 
35 1-Naphthalene acetic acid np np I NI 
36 L-Aspartic acid I np I I 
37 Benzoyl-L-tartaric acid I np I I 
38 Potassium cyanate I np I I 
39 Sodium perborate I np I I 
40 Dibenzyl phosphate I np I I 
41 2,5-Dimethylhexanediol np np I NI 
42 Ammonium nitrate np np I I 
43 Maneb np np I I 
44 Fomesafen np np I NI 
45 Tetraaminopyrimidine sulphate I np I NI 
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Footnote to Table 10.2 
 
Step 1: If pH < 3.2 or pH > 8.6, predict I; otherwise make no prediction. 
Step 2: If MP ≤ 37ºC and (logP-0.66)2 / 1.212 + (dV1 + 1.22)2/ 1.122 >1, predict NI; otherwise 
make no prediction. 
Step 3: If isolated rabbit eye swelling at 1h  > 18%, predict I; otherwise predict NI. 
 
I = irritant (R36 or R41); NI = non-irritant; np = no prediction (model used to predict either the 
presence or the absence of irritation potential). 
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Table 10.3 Predictive abilities of stepwise sequences for skin irritation and  
corrosion compared with the stand-alone use of the EPISKIN test 
 
Endpoint(s) Test or stepwise sequence Sensitivity Specificity Concordance Kappa
      
Skin corrosion EPISKIN test (3→ 5) NA NA 69 53 
and irritation Steps: 1→ 2 → 3 → 4 → 5 NA NA 55 33 
 Steps: 1→ 2 → 3 → 5 NA NA 65 47 
 Steps: 1→ 2 → 4 → 5 NA NA 45 18 
 Steps: 1 → 3 → 5 NA NA 63 44 
 Steps: 1 → 4 → 5 NA NA 55 33 
 Steps: 2 → 3 → 5 NA NA 73 59 
      
Skin corrosion EPISKIN test (step 3) 82 90 86 72 
 Steps: 1 → 2 → 3 91 76 82 64 
 Steps: 2 → 3 91 90 90 80 
      
Skin irritation EPISKIN test (step 5)  74 70 73 46 
 Steps: 4 → 5  100 0 61 22 
 
 
Footnote to Table 10.3 
 
Step 1: If MP ≤ 37ºC and MW ≤ 123 g/mol, predict C; otherwise predict NC. 
Step 2: If pH < 2.4 or pH > 10.9, predict C; otherwise predict NC. 
Step 3: If EPISKIN viability at 4h < 36%, predict C; otherwise predict NC.   
Step 4: If pH < 4.4 or pH > 9.2, predict I; otherwise predict NI.   
Step 5: If EPISKIN viability at 4h < 67%, predict I; otherwise predict NI. 
 
NA = not applicable (‘sensitivity’ and ‘specificity’ are defined with respect to 2x2 contingency 
tables, not 3x3 tables).  
The most predictive test or sequence for each endpoint is shaded. All performance measures are 
expressed as percentages. 
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Table 10.4 Possible outcomes of  tiered testing strategies for skin irritation 
and corrosion 
 
 
Sequence of 
steps 
No of chemicals 
entering step 
Known toxic potential No of positive 
predictions 
No of true 
positives 
No of false 
positives 
 
Assessment of skin corrosion and irritation
   
 
Step 1 
Step 2 
Step 3 
Step 4 
Step 5 
Draize test 
 
51 
39 
30 
24 
0 
0 
 
22 C 9 I 20 NC & NI 
14 C 9 I 16 NC & NI 
7   C 8 I 15 NC & NI 
2   C 8 I 14 NC & NI 
- - - 
- - - 
 
12 
9 
6 
24 
0 
- 
 
8 
7 
5 
8 
0 
- 
 
4 
2 
1 
16 
0 
- 
Step 1 
Step 2 
Step 3 
Step 5 
Draize test 
51 
39 
30 
24 
17 
22 C 9 I 20 NC & NI 
14 C 9 I 16 NC & NI 
7   C 8 I 15 NC & NI 
2   C 8 I 14 NC & NI 
2   C 5 I 10 NC & NI 
12 
9 
6 
7 
- 
8 
7 
5 
3 
- 
4 
2 
1 
4 
- 
Step 2 
Step 3 
Step 5 
Draize test 
51 
38 
28 
21 
22 C 9 I 20 NC & NI 
11 C 8 I 19 NC & NI 
2   C 8 I 18 NC & NI 
2   C 5 I 14 NC & NI 
13 
10 
7 
- 
11 
9 
3 
- 
2 
1 
4 
- 
Step 3 
Step 5 
Draize test 
51 
30 
22 
22 C 9 I 20 NC & NI 
4   C 8 I 18 NC & NI 
3   C 5 I 14 NC & NI 
21 
8 
- 
18 
3 
- 
3 
5 
- 
 
Assessment of skin corrosion  
   
 
Step 1 
Step 2 
Step 3 
Draize test 
 
51 
39 
30 
24 
 
22 C      29 NC 
14 C  25 NC 
7   C  23 NC 
2   C       22 NC 
 
12 
9 
6 
- 
 
8 
7 
5 
- 
 
4 
2 
1 
- 
Step 2 
Step 3 
Draize test 
51 
38 
28 
22 C      29 NC 
11 C  27 NC 
2   C       26 NC 
13 
10 
- 
11 
9 
- 
2 
1 
- 
Step 2 
Draize test 
51 
30 
22 C      29 NC 
4   C       26 NC 
21 
- 
18 
- 
3 
- 
 
Assessment of skin irritation 
   
 
Step 4 
Step 5 
Draize test 
 
51 
1 
0 
 
31 I 20 NI 
1   I 0   NI 
- - 
 
50 
1 
- 
 
30 
1 
- 
 
20 
0 
- 
Step 5 
Draize test 
51 
22 
31 I 20 NI 
8   I 14 NI 
29 
- 
23 
- 
6 
- 
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Table 10.5 Predictive abilities of stepwise sequences for eye irritation compared  
with the stand-alone use of the isolated rabbit eye test 
 
 
Test or stepwise sequence Sensitivity Specificity Concordance Kappa  
     
Isolated rabbit eye test   79  59  71  42 
Steps: 1 → 3  
(OECD approach) 
82  59  73  46 
Steps: 1 → 2 → 3 
(alternative approach) 
79  71  76  52 
 
 
Footnote to Table 10.5 
 
Step 1: If MP ≤ 37ºC and (logP-0.66)2 / 1.212 + (dV1 + 1.22)2/ 1.122 >1, predict NI; 
 otherwise make no prediction.  
Step 2: If pH < 3.2 or pH > 8.6, predict I; otherwise make no prediction.  
Step 3: If isolated rabbit eye swelling at 1h  > 18%, predict I; otherwise predict NI. 
 
All performance measures are expressed as percentages. 
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Table 10.6 Possible outcomes of tiered testing strategies for eye irritation  
 
 
Sequence 
of steps 
No of chemicals 
entering step 
Known toxic 
potential 
No of I 
predictions 
No of true 
positives 
No of NI 
predictions 
No of true 
negatives 
 
Isolated rabbit eye test 
     
Step 3 
Draize test 
45 
16 
28 I 17 NI 
6   I 10 NI 
29 
- 
22 
- 
16 
- 
10 
- 
 
OECD approach 
     
Step 1 
Step 3 
Draize test 
45 
32 
15 
28 I 17 NI 
16 I 16 NI 
5   I 10 NI 
13 
17 
- 
12 
11 
- 
- 
15 
- 
- 
10 
- 
 
Alternative approach 
     
Step 1 
Step 2 
Step 3 
Draize test 
45 
32 
22 
18 
28 I 17 NI 
16 I 16 NI 
13 I 9   NI 
6   I 12 NI 
13 
- 
14 
- 
12 
- 
10 
- 
- 
10 
8 
- 
- 
7 
5 
- 
 
 
Footnote to Table 10.6 
 
Step 1: If pH < 3.2 or pH > 8.6, predict I; otherwise make no prediction.  
Step 2: If MP ≤ 37ºC and (logP-0.66)2 / 1.212 + (dV1 + 1.22)2/ 1.122 >1, predict NI; 
 otherwise make no prediction.  
Step 3: If isolated rabbit eye swelling at 1h  > 18%, predict I; otherwise predict NI. 
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11.1 INTRODUCTION 
 
The aim of this final chapter is to summarise the outcome of this research project, 
highlighting novel aspects and contributions to existing knowledge. In addition, some 
perspectives are offered regarding the ‘integrated approach to toxicity testing’, and an 
assessment is made of current research needs and future prospects in this field. 
 
11.2 SUMMARY OF THE THESIS 
 
The background to the research project is described in chapters 2-4: chapter 2 covers the 
underlying biology and toxicology, whereas chapters 3 and 4 describe relevant methods 
of computational chemistry and statistics, respectively. 
 
The main research findings are reported in chapters 5-10. Chapter 5 describes several 
applications of the bootstrap resampling method that have not been reported previously 
in the field of alternative toxicology. In particular, algorithms have been devised to 
provide a means of assessing the uncertainty in Cooper statistics that arises from 
chemical variation in the test set. The usefulness of these algorithms in validation 
studies has been illustrated by applying the algorithms to the high-quality data generated 
in a validation study. In addition, algorithms have been formulated to bootstrap the raw 
data obtained in the Draize eye and skin irritation tests, and the bootstrap distributions 
generated by these algorithms have been used to estimate the variability in the animal 
endpoints resulting from biological and temporal variation. These estimates are of value 
in placing an upper limit on the predictive capacity that can be expected of any model 
that aims to predict the results of the Draize skin or eye test. Furthermore, bootstrap 
distributions of specific tissue scores (such as conjunctival erythema) have been shown 
to provide a means of assessing whether or not chemicals are borderline (with respect to 
the boundaries imposed by regulatory classification systems), and the usefulness of this 
information has been discussed. 
 
Chapter 6 describes a novel statistical method that the author has termed ‘embedded 
cluster modelling’ (ECM). This method has been devised to generate elliptic models of 
biological activity from embedded data sets, and its usefulness has been illustrated by 
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deriving a model for eye irritation potential. The algorithm for ECM incorporates an 
option for bootstrapping the parameters of the elliptic model, so that the uncertainty 
associated with these parameters can be estimated.  
 
New models for acute dermal and ocular toxicity are presented in Chapters 7 and 9. In 
the development of these models, it was considered important that: a) the models should 
have a clear mechanistic basis; and b) should provide an objective means of predicting 
the toxic potential of chemicals. With respect to the second point, the models are 
considered to constitute an advance over previous work (see chapter 2), in which 
appropriate predictor variables were identified, but no explicit prediction models 
reported. In chapter 9, the method of ECM was used again to develop an SAR for eye 
irritation potential. 
 
Chapter 8 reports the development of two structure-permeability relationships (SPRs) 
for predicting the corneal penetration of chemicals. These represent an advance over 
previous attempts to model corneal penetration (considered to be the rate-limiting step 
for ocular penetration) in terms of their relative simplicity and broader domains of 
application. However, due to the variable quality of the data used, the predictive 
capacity of the models is necessarily limited. Nevertheless, the models themselves could 
provide the starting point for the further development of ocular SPRs. It was anticipated 
that the corneal permeabilities of chemicals could be used to predict their potencies in 
the Draize eye irritation test. However, the data examined did not provide strong 
evidence in support of this hypothesis. Similarly, in chapter 7, no apparent relationship 
was observed between the dermal penetration of chemicals and their potency in the 
Draize skin test. 
 
Whereas chapters 7 and 9 describe the development and assessment of individual 
classification models, chapter 10 focuses on the integrated use of some of these models 
in the context of tiered testing strategies for acute dermal and ocular toxicity. The 
simulations in chapter 7 represent a development of work already published by the 
author (Worth et al., 1998; Worth & Fentem, 1999). This approach to the assessment of 
tiered testing strategies had not been published previously. The main conclusion from 
the simulations is that the OECD approach to hazard identification provides a reliable 
means of reducing and refining animal testing, without compromising our ability to 
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identify toxic chemicals. The original work on which chapter 10 is based was 
communicated to the OECD Secretariat at a time when the (then proposed) OECD 
testing strategies for skin and eye irritation/corrosion were being discussed.  
 
11.3 PERSPECTIVES ON THE INTEGRATED APPROACH TO TOXICITY 
TESTING 
 
11.3.1 A unifying view of alternative methods, models and testing strategies 
 
When reviewing the literature in the field of this thesis, the author noted that different 
terms for (mathematical and statistical) models tend to be used, depending on the 
subject area (structure-activity relationship chemistry or in vitro toxicology). The 
emerging field of ‘integrated toxicity testing’ draws on both of these traditional subject 
areas, having imported the concepts of structure-activity relationship (SAR) and 
prediction model (PM), and introduced the concept of integrated testing strategy. 
Distinctions should be drawn between three types of model for predicting chemical 
toxicity, according to the nature of the predictor variable(s) in the model: a) SARs, 
based on physicochemical properties that can be calculated; b) PMs, based on 
physicochemical properties or in vitro endpoints that need to be determined 
experimentally; and c) integrated models (IMs), based on both physicochemical 
properties and in vitro endpoints. The distinction between SARs and PMs / IMs reflects 
the relative ease with which the predictor variables can be obtained. These models can 
be classification models or regression models (see chapter 4), depending on the nature 
of the response variable. Biokinetic (BK) and biodynamic (BD) models are treated as 
types of IM. BK models predict the time-dependent and tissue-dependent concentrations 
of chemicals resulting from the physiological processes of absorption, distribution, 
metabolism and excretion. In effect, BK models generate the internal dose levels to 
which target tissues and organs are exposed. BD models go one step further, by 
applying dose-response models to the target tissue/organ concentration to predict the 
level of response. 
 
The domain (range of application) of a model for predicting chemical toxicity is often 
restricted to one or more classes of chemicals, defined according to their structural 
and/or physicochemical properties. In contrast, an integrated testing strategy can be 
viewed as a more comprehensive decision-making tool, constructed from a range of 
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SARs, PMs, IMs, in such a way that predictions of an in vivo toxicological effect can be 
made for a broad range of chemical types with the greatest accuracy, efficiency, and 
animal welfare benefits. This description of the integrated testing strategy emphasises 
the fact that predictions are made by combining mathematical models (rather than 
computer-based and experimental methods) that extrapolate from the molecular and 
cellular levels to the level of the whole organism. The toxicological effect being 
predicted (e.g. skin irritation) could be represented by one or more of the endpoints (e.g. 
erythema and œdema) observed in an animal experiment, or by one or more clinical 
symptoms observed in humans. 
 
At present, integrated testing strategies are becoming accepted at the regulatory level as 
a means of reducing our reliance on existing animal procedures for hazard assessment, 
but not as a means of replacing them. Ultimately, there may be sufficient confidence in 
the predictions made by such strategies that the animal testing steps (used for 
confirmatory testing) could be omitted. Relevant to such a decision is the ongoing 
debate on the extent to which traditional animal models are relevant to the assessment of 
human health effects, and therefore whether the alternative models currently being 
designed to predict animal data will ultimately be of any use. However, if alternative 
methods are developed with a sound mechanistic basis, their usefulness may well 
outlive the use of current animal methods. This will almost certainly require the 
mathematical models associated with the alternative methods to be reparameterised, or 
even completely reformulated (in terms of their mathematical structure), but the 
predictor variables themselves should continue to be relevant. 
 
It is important to note that the integrated testing strategies discussed in this thesis are 
designed for hazard assessment, not risk assessment. Toxicological hazard refers to the 
inherent ability of a substance to cause an adverse effect in the body, whereas 
toxicological risk refers to the extent or incidence of an adverse effect under defined 
conditions of exposure (typically the exposure conditions of a societal group, such as 
workers or consumers). Hazard is often quantified by generating a dose-response curve, 
which is then used to determine the concentration (or dose) of test chemical required to 
produce a fixed response; for example, the LD50 value is the dose required to cause 50% 
mortality in an experimental group of animals subjected to a specified test protocol. In 
the EU and OECD hazard classification systems, chemicals are ranked according to 
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their LD50 values for certain toxicological endpoints (e.g. acute toxicity), whereas for 
other endpoints (e.g. skin and eye irritation/corrosion), a fixed dose procedure is 
adopted, and ranking is based on the severity or onset time of the response (recovery 
may also be taken into account). Thus, hazard assessment may or may not involve the 
generation of a dose-response curve. In contrast, risk assessment necessarily involves 
the generation (or mathematical simulation) of a dose-response (or exposure-incidence) 
curve, so that the extent or incidence of an adverse effect can be related to exposure. As 
a final point on this matter, it should be remembered that hazard classification schemes 
reflect the consensus of scientific expert groups, and may be altered in the light of 
scientific and technological progress, or in the interests of international harmonisation. 
Thus, any model that is developed for hazard classification will need to be 
reparameterised in the event of changes to the relevant classification system.     
 
11.3.2 How should the performance of integrated testing strategies be assessed ? 
 
To date, physicochemical and in vitro methods have been validated as stand-alone 
methods for predicting the results of specific animal experiments, but not as component 
parts in an integrated testing strategy. In the few regulations and guidelines for 
chemicals testing where integrated approaches are allowed for (e.g. OECD, 1998), it is 
clearly stated that any alternative method incorporated should have been validated. 
However, if the validation status of a method continues to depend on its stand-alone 
merits, some methods may never be accepted as components in a testing strategy. For 
example, an SAR based on pKa values, or a PM based on pH measurements, may not be 
capable of identifying a majority of corrosive chemicals, but if a high degree of 
confidence is associated with the corrosive predictions that it makes, then such a model 
can still play a useful role in a tiered testing strategy. It follows that different acceptance 
criteria should be applied during the validation of alternative methods, depending on 
whether they are intended as stand-alone replacements for an animal test, or as 
components of an integrated strategy. It is impossible to generalise as to what the 
acceptance criteria should be for any strategy, since this will depend on the nature of the 
toxicity testing (which varies from the labelling of industrial chemicals to the safety 
assessment of pharmaceuticals). However, a minimal requirement is that all the 
experimental data used should be reproducible (i.e. generated by reliable protocols). In 
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addition, it is recommended that the criteria for predictive performance should be set at 
realistic levels, taking into account the best possible predictivity that can be expected on 
theoretical grounds.  
 
Two possible approaches can be foreseen for the formal assessment of integrated testing 
strategies. Firstly, they could be assessed by the usual validation process. In this case, a 
successfully validated strategy would be one that had been fully stipulated (in terms of 
its basic design and component models) in advance of a validation study, and then 
subjected to an independent assessment in accordance with pre-defined acceptance 
criteria. Secondly, integrated strategies could be designed and assessed by using 
existing data, including data generated in previous validation studies of individual test 
methods. In practice, the second approach is more likely to be adopted, since testing 
strategies are, by their very nature, designed to accommodate the strengths and 
weaknesses of individual methods, so it is logical that the component parts of testing 
strategies should be assessed before the strategies themselves. If the second approach is 
adopted, a distinction should be drawn between strategies that have been evaluated 
(using data that were also used in their design), and those strategies that have been 
validated (using independent data).  
 
11.3.3 The reductionist nature of alternative methods and models 
 
The models and strategies discussed in this thesis are all based on the reductionist 
approach; that is, they aim to extrapolate from lower levels of biological organisation to 
the level of the whole organism. The philosophical doctrine of reductionism is so deeply 
engrained in scientific culture, and has formed the basis of so many successful theories, 
that it would be perverse to question its value. However, one could reasonably question 
whether reductionist models are sufficient to reproduce the toxicological effects 
observed in whole organisms. In recent years, it has become apparent that the properties 
of biological systems cannot always be explained in terms of the properties of their 
component parts alone. Biological systems are therefore said to be ‘complex systems’, 
because they exhibit effects that only emerge when many subprocesses interact. For 
example, the glycolytic cycle (in which the conversion of glucose to pyruvate is coupled 
with the production of the adenosine triphosphate and the reduced form of nicotinamide 
adenine dinucleotide) involves 10 enzymes, whose interactions (by feedback inhibition) 
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can cause oscillations in the concentrations of the glycolytic intermediates (Whitesides 
& Ismagilov, 1999). While the complexity of the glycolytic cycle has been modelled 
with a certain amount of success, it is not yet possible to simulate the behaviour of other 
biological systems, such as intracellular signalling networks that mediate the effects of 
extracellular chemicals (Weng et al., 1999). The inability to model such systems is 
partly due to an incomplete knowledge of their component parts, their functions and 
interconnections, and partly to an incomplete knowledge of the laws of complexity. 
Indeed, it is not even clear whether there are any general laws of complexity 
(Goldenfeld & Kadanoff, 1999). An important feature of complex systems is that in 
addition to producing regular patterns of behaviour, they can also produce chaotic 
patterns, under the appropriate conditions. Chaos is the sensitive dependence of a final 
result upon the initial conditions that bring it about. Due to the inescapable uncertainty 
in these initial conditions, the onset of chaos effectively means that the behaviour of a 
system rapidly becomes unpredictable, since the uncertainties grow exponentially with 
time.  
 
Given the complexity of biological systems, and our limited ability to model them, the 
question arises as to what extent the reductionist approach should be applied. In other 
words, how far up the hierarchy of biological organisation is it reasonable to 
extrapolate? Goldenfeld & Kadanoff (1999) advise the modeller to choose the ‘correct’ 
level of detail to catch the phenomenon of interest, and warn against the modelling of 
‘bulldozers with quarks’. So, is it reasonable to model the toxicological responses 
observed in living organisms from the properties of molecules? The responses modelled 
in this project were all acute local responses in the tissues of the skin and eye, and the 
ability to model these by using SARs can be related to the fact that the rate-limiting step 
in the production of the toxicological responses is the partitioning of the chemical into 
the target tissue. Thus, the author’s view is that SARs can be used to extrapolate from 
physicochemical properties to biological responses to the extent that these responses are 
‘driven’ by physical effects, such as partitioning. It seems less likely that SARs alone 
will successfully reproduce the various manifestations of systemic toxicity, especially 
when these are chronic effects, possibly depending on multiple exposures. For such 
effects, the additional use of in vitro models and the integration of in vitro data into 
biokinetic models should be of great value. This is not to say that SARs will have no 
role to play in such models, but only that their extrapolations will be less extensive. 
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They could be used, for example, to estimate the various biokinetic parameters that need 
to be incorporated into the larger mathematical frameworks of the biokinetic models. In 
addition, more emphasis could be placed on the use of SARs to model in vitro endpoints 
for defined subsets of chemicals.  
 
11.4 CURRENT RESEARCH NEEDS 
 
Strictly speaking, ‘integrated toxicity testing’ is not so much a new field of toxicology 
as a new approach to hazard and risk assessment. The need for this approach is widely 
acknowledged in the toxicological literature, but often little more than lip service is paid 
to it. A great deal of research is still required to form the scientific and technological 
basis for the design of detailed integrated strategies capable of predicting well-defined 
in vivo endpoints. In this section, a number of examples are given. 
 
11.4.1 Structure-activity relationship modelling 
 
In the field of SAR modelling, there is scope for the identification of descriptor 
variables that capture the essential features of specific biochemical processes. For 
example, one can envisage the development of new, and identification of existing, 
molecular connectivity indices suitable for identifying the substrates of specific 
proteins, such as membrane receptors, ion channels and enzymes. Topological 
descriptors (see chapter 3) have the advantage that they are non-empirical and easy to 
calculate. At present, a wide variety of connectivity descriptors have already been 
developed, so there is considerable scope for their further interpretation in the context of 
specific biochemical processes. Another interesting and potentially fruitful area of 
descriptor development concerns the use of information from infra-red spectra, since 
these serve as highly specific molecular ‘fingerprints’ (Benigni et al., 1999). 
 
11.4.2 In vitro toxicology  
 
In the field of in vitro toxicology, there is an ongoing need to develop and optimise 
protocols based on endpoints relevant to toxicological processes. For the prediction of 
skin and eye irritation, a wide range of systems have already been developed, so perhaps 
in these areas, the challenge is not so much new development, but the retrospective 
analysis of existing data and the refinement of existing systems. Similarly, for the 
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prediction of acute systemic toxicity, it is noteworthy that a recently completed multi-
centre study reported that the lethal concentrations of chemicals in (human) blood can 
be predicted from basal cytotoxicity measurements, regardless of the endpoint or cell 
type used (Clemedson et al., 2000). Given that a wealth of in vitro cytotoxicity data 
exists, the successful development of an integrated testing strategy for acute systemic 
toxicity appears to be a realistic, short-term goal. If such a strategy could successfully 
predict LC50 values (for the inhalation exposure route) and LD50 values (for the oral and 
dermal exposure routes), there would be a chance to significantly reduce animal testing 
in this area.  
 
Another field of toxicology that is ripe for the design and evaluation of integrated 
testing strategies is neurotoxicology. A wide variety of neurospecific endpoints have 
been developed (reviewed in Pentreath, 1999), so the details of an integrated approach 
for neurotoxicity testing could now be formulated. An encouraging development in this 
field is the demonstration that a biokinetic model could successfully extrapolate from 
critical neurotoxic concentrations in vitro to lowest effective doses in vivo (de Jongh et 
al., 1999). Thus, there is evidence that the integrated approach to hazard assessment, 
already accepted as a means of local toxicity testing, can also be applied to systemic 
toxicity testing. 
 
The prediction of other types of toxic effect represents a greater challenge. An example 
is embryotoxicity, which covers a diverse range of physiological and anatomical 
aberrations. In this case, it is important to distinguish between maternal toxicity and 
embryonic/fœtal toxicity, and to consider factors such as metabolism and placental 
transfer. An area of current research, in which the author is involved, is aimed at the 
development of novel in vitro endpoints for embryotoxic potential using embryonic 
stem (ES) cells (Bremer et al., 1999). This work has shown that it is possible to identify 
strongly embryotoxic substances (i.e. chemicals that adversely affect most, if not all, of 
the developing tissues) by using simple endpoints, such as cytotoxicity, or gene-
expression endpoints. However, further work is required to identify substances that 
exert their embryotoxic effects by tissue-specific mechanisms. 
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11.4.3 Modelling methods 
 
There is also a need for the further development and investigation of modelling 
methodologies. For example, most SARs have been developed for predicting the 
efficacies and toxicities of single chemical entities, and yet many substances of interest 
in toxicology, such as cosmetics and pharmaceuticals, are based on mixtures 
(formulations) of chemicals. Recently, Patel et al. (1999) reported the development of a 
method called ‘quantitative component analysis of mixtures’ (QCAM), which enables 
the toxicity profile of each component in a mixture to be extracted from knowledge of 
the relative concentrations of all components and the net toxicity of the entire mixture. 
Thus, QCAM models could provide a means of predicting the toxicities of new 
formulations (based on the same components). A slightly different challenge is posed by 
complex mixtures with undefined compositions, such as petroleum substances. To 
model this kind of mixture, Verburgh et al. (1996) developed a ‘blocking method’ in 
which components with similar physicochemical properties are treated together (as a 
block), and the toxicity of the mixture is calculated as a weighted average of the 
toxicities of the blocks.  
 
Another approach that merits further investigation is the combined use of traditional 
statistical methods (see chapter 4) and artificial neural networks (ANNs; Bishop, 1995). 
A common type of ANN is composed of a layered structure of ‘neurons’: an input layer, 
in which the descriptor data are represented; one or more hidden layers with a variable 
number of neurons; and an output layer, which is trained to match a target set of data 
representing the biological response. Each neuron in the hidden and output layers is 
connected to the neurons in the input and hidden layers, respectively. The direction and 
magnitude of the signal sent from one neuron to another (the connection weight) is a 
variable, and the sum total of all inputs to a neuron determines whether or not it will 
‘fire’ and therefore send outputs to neurons in the next layer. Training of the network 
involves the iterative setting of the connection weights, so that a given input (set of 
descriptor data) generates a desired output (response value). This type of ANN is called 
a feed-forward back-propagation network, because all connections are made in the 
forward direction (from the input layer to the output layer) and because the connection 
weights are set by a back-propagation algorithm. In terms of predictive performance, 
ANNs can outperform traditional statistical methods, without overfitting the training set 
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of data (Manallack & Livingstone, 1999). However, the model generated by an ANN is 
characterised in terms of its network architecture and its entire set of connection 
weights. Thus, ANN models are much less interpretable than traditional statistical 
models that take the form of explicit algorithms for converting descriptor data into a 
predicted response. One way of combining the strengths of ANNs and traditional 
statistical methods would be use the ANN as a variable selection method, to identify the 
best variables without having to specify the mathematical form of the model, and then 
to use the traditional methods to develop a simple and explicit statistical model. 
 
11.5 FUTURE PROSPECTS  
 
In the short term, one could expect the development of integrated toxicity testing to 
proceed mainly in terms of new and refined strategies for hazard assessment, with 
strategic approaches for risk assessment being developed later. Furthermore, as the 
scientific knowledge base expands, one could expect that current strategies based 
largely on empirical models will gradually give way to strategies based on mathematical 
models with a stronger theoretical basis. At that stage, the SARs and PMs of today will 
seem relatively crude, but they will have served a valuable temporary purpose, forming 
the scaffolds on which a more sophisticated predictive framework will ultimately be 
based. 
 
The greatest impact on the field of predictive toxicology is likely to come from the 
emerging fields of genomics and proteomics. Genomics is the study of the entire genetic 
make-up of an organism, whereas proteomics is the study of the entire protein 
complement of a cell or tissue at a particular stage in its development. Recent 
technological advances in these fields have made it possible to simultaneously measure 
the expression levels of thousands of different genes. It is therefore possible to predict 
the effects of chemicals on multiple gene expression, thereby integrating information at 
the genetic level. At the time of writing (June 2000), scientists working for the Human 
Genome Project reported that they had completed the sequencing of the entire human 
genome (Macilwain, 2000). Following this milestone achievement in biology, attention 
will focus on the interpretation of DNA sequences in terms of functional proteins and 
RNA molecules. Ultimately, this will create the entire knowledge base required to 
model biochemical systems, such as the intracellular pathways that mediate the effects 
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of extracellular signals, and the extracellular pathways that maintain homeostasis in the 
entire organism. Hopefully, advances in the study of complexity will provide the 
mathematical basis required to integrate this knowledge base in the form of complex 
models of living organisms. These models should not only reproduce the homeostatic 
state of an individual, but also predict the perturbations of that state, caused by the 
combined effects of environmental chemicals, pathogens and the genetic constitution, 
that mark the transition from normal physiology to pathophysiology. As argued by 
Spence & Aurora (1999), the full value of the human genome will only be exploited if 
we integrate. And if we ever reach that point in biology, there will be no place for 
animal testing in toxicology.    
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A1  CONSTRUCTION OF 2 x 2 CONTINGENCY TABLE AND 
CALCULATION OF COOPER STATISTICS 
 
# GLOBAL MACRO CTABLE.MAC 
# 
# Constructs 2x2 contingency table, performs Chi-square significance test and calculates  
# Cooper statistics 
#  
# MINITAB for Windows version 11 and above 
# 
# Place the chemical names in C1, the known classifications in C2 and the 
# predicted classifications in C4. 
# Type the symbol for toxic chemicals in C5(1) and the symbol for non-toxic chemicals in C6(1) 
# Type %ctable at the command line prompt. 
 
GMACRO 
CTABLE 
 
NAME C1='CHEMICAL' C2='OBSERVED' C3='PREDICTED' C5='ACTIVE' C6='INACTIVE' 
 
NOTE 
NOTE Have you entered the appropriate symbols in C5(1) and C6(1) ? 
NOTE 
YESNO K1 
IF K1=1 
 CALL TABLE 
ELSE 
 NOTE 
 NOTE Then please do so, and rerun the macro 
 EXIT 
ENDIF 
ENDMACRO 
 
GMACRO 
TABLE 
 
LET C4(2)=C5(1) 
LET C4(3)=C6(1) 
TEXT C4 C4 
LET K1=COUNT(C1) 
LET K2=0 
LET K3=0 
LET K4=0 
LET K5=0 
LET K6=0 
LET K7=0 
LET K8=0 
LET K9=0 
LET K10=0 
 
DO K10=1:K1 
 IF C2(K10)=C3(K10) 
  LET K2=K2+1                           # total no of correct predictions  
 ENDIF 
 IF C2(K10)=C3(K10) AND C3(K10)=C5(1) 
  LET K3=K3+1                           # no of true positives 
 ENDIF 
 IF C2(K10)=C3(K10) AND C3(K10)=C6(1) 
  LET K4=K4+1                           # no of true negatives 
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 ENDIF 
 IF C2(K10)~=C3(K10) AND C3(K10)=C5(1) 
  LET K5=K5+1                           # no of false positives 
 ENDIF 
 IF C2(K10)~=C3(K10) AND C3(K10)=C6(1) 
  LET K6=K6+1                            # no of false negatives 
 ENDIF 
ENDDO  
 
LET K7=K3+K6                            # total no of known positives 
LET K8=K4+K5                            # total no of known negatives 
LET K9=K3+K5                            # total no of positive predictions 
LET K10=K4+K6                          # total no of negative predictions   
DELETE 1 C5 C6 
LET C5(2)=K3 
LET C5(3)=K5 
LET C6(2)=K6 
LET C6(3)=K4 
LET C7(2)=K7 
LET C7(3)=K8 
LET C5(4)=K9 
LET C6(4)=K10 
LET K20=C5(4) 
LET K21=C6(4) 
LET C7(4)=C5(4)+C6(4) 
LET K11=C7(4) 
 
TEXT C5 C5 
TEXT C6 C6 
 
LET C5(1)=C4(2) 
LET C6(1)=C4(3) 
LET C5(5)="PREDICTED" 
LET C6(5)="PREDICTED" 
LET C8(2)="OBSERVED" 
LET C8(3)="OBSERVED" 
LET C6(7)="Sensitivity" 
LET C6(8)="Specificity" 
LET C6(9)="Concordance" 
LET C6(10)="Pos predict" 
LET C6(11)="Neg predict" 
LET C6(12)="False pos rate" 
LET C6(13)="False neg rate" 
LET C7(7)=(K3/K7)*100 
LET C7(8)=(K4/K8)*100 
LET C7(9)=(K2/K1)*100 
LET C7(10)=(K3/K9)*100 
LET C7(11)=(K4/K10)*100 
LET C7(12)=100-C7(8) 
LET C7(13)=100-C7(7) 
LET C10(1)=C5(2) 
LET C10(2)=C5(3) 
LET C11(1)=C6(2) 
LET C11(2)=C6(3) 
 
NUMERIC C10 C10 
NUMERIC C11 C11 
CHISQUARE C10 C11 
 
ENDMACRO 
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A2  LEAVE-ONE-OUT CROSS-VALIDATION DURING MULTIPLE 
REGRESSION 
 
# GLOBAL MACRO CVAL2.MAC 
# 
# Performs leave-one out cross-validation in two-variable multiple regression 
#  
# MINITAB for Windows version 11 and above 
# 
# Place the response in C1, and the two predictor variables in C2 and C3. 
# Type %cval2 at the command line prompt. 
 
GMACRO 
CVAL2 
 
NAME C1 = 'y' C2 = 'a' C3 = 'b' C5 = 'pred y' C6 = '(y-pred y)^2' C7 = '(y-mean y)^2' C8 = 'PRESS' C9 = 
'TSS' C10 ='r(cv)^2' 
NAME C20 = 'lower CL' C21 = 'upper CL' C22 = 'lower PL' C23 = 'upper PL' C24 ='RMS' C25 ='s' 
 
MEAN C1 K100 
LET K101 = COUNT (C1) 
REGRESS C1 2 C2 C3; 
  CONSTANT. 
 
DO K102 = 1 : K101 
 LET K103 = C2(K102) 
 LET K104 = C3(K102)  
 LET K105 = C1(K102)-K100 
 LET C7(K102) = K105**2 
 COPY C1 C2 C3 C12 C13 C14; 
  OMIT K102. 
 REGRESS C12 2 C13 C14; 
  CONSTANT; 
  MSE K120; 
  PREDICT K103 K104; 
  PFITS C99; 
  CLIMITS C100 C101; 
  PLIMITS C102 C103.   
 LET C5(K102)=C99 
 LET C20(K102)=C100 
 LET C21(K102)=C101 
 LET C22(K102)=C102 
 LET C23(K102)=C103 
 LET C24(K102)=K120 
 LET C25(K102)=SQRT(K120) 
 LET K106 = C1(K102)-C5(K102) 
 LET C6(K102) = K106**2 
ENDDO 
 
LET K107=SUM(C6) 
LET K108=SUM(C7) 
LET K109 = 1-(K107/K108) 
LET C8(1)=K107 
LET C9(1)=K108 
LET C10(1)=K109 
 
ENDMACRO 
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A3 CLUSTER SIGNIFICANCE ANALYSIS 
 
# GLOBAL MACRO CSA2.MAC 
# 
# Carries out cluster significance analysis on two variables 
#  
# MINITAB for Windows version 11 and above 
# 
# Place the chemical names (or numbers) in C1, chemical activities (0/1) 
# in C2, and the variables in C3 and C4. 
# Type %csa2 at the command line prompt. 
 
GMACRO 
Csa2 
 
NAME C1='CHEMICAL' C2='ACTIVITY' C3='DESCRIPTOR 1' C4='DESCRIPTOR 2'  
NAME C7='VARIANCE' C8='PROBABILITY' C9='LOWER 95% CL' C10='UPPER 95% CL' 
C20='DISTRIBUTION'   
NAME C21='RAND SUBSET1' C22='RAND SUBSET2' C23='SUBSETS' 
 
NOTE 
NOTE Do you wish to standardise the data in C3 and C4 ? 
NOTE 
YESNO K50 
IF K50=1 
 CENTRE C3-C4 C3-C4. 
ENDIF 
 
UNSTACK C3 C5-C6; 
 SUBSCRIPTS C2. 
 
LET K1=(STDEV (C6))**2 
LET C7(1)=K1 
 
ERASE C5 C6 
UNSTACK C4 C5-C6; 
 SUBSCRIPTS C2. 
 
LET K2=(STDEV (C6))**2 
LET C7(2)=K2 
LET K3=K1+K2 
LET C7(3)=K3 
LET K4=COUNT (C6) 
ERASE C5 C6 
 
LET C6(1)="1st variable" 
LET C6(2)="2nd variable" 
LET C6(3)="1st and 2nd" 
NOTE 
NOTE How many subsets do you want to sample? 
SET C23; 
 FILE "TERMINAL"; 
 NOBS=1. 
COPY C23 K5 
 
LET K6=0 
LET K7=0 
LET K8=0 
 
DO K9=1:K5 
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 SAMPLE K4 C3 C4 C21 C22 
 LET K10=(STDEV (C21))**2 
 LET K11=(STDEV (C22))**2 
 LET K12=K10+K11 
 LET C20(K9)=K12 
 IF K10<=K1 
  LET K6=K6+1 
 ENDIF 
 IF K11<=K2 
  LET K7=K7+1 
 ENDIF  
 IF K12<=K3 
  LET K8=K8+1  
 ENDIF 
ENDDO 
 
LET K13=K6/K5 
LET K14=K7/K5 
LET K15=K8/K5 
LET K16=(K13+K15)/2 
IF K13>K15 
 LET K17=K13-K15 
ELSE 
 LET K17=K15-K13 
ENDIF 
LET K18=2/K5 
LET K19=SQRT(K16*(1-K16)*K18) 
LET K20=K17/K19 
LET K21=SQRT((K13*(1-K13))/K5) 
LET K22=0.5/K5 
LET K23=(1.96*K21)+K22 
LET K24=SQRT((K14*(1-K14))/K5) 
LET K25=0.5/K5 
LET K26=(1.96*K24)+K25 
LET K27=SQRT((K15*(1-K15))/K5) 
LET K28=0.5/K5 
LET K29=(1.96*K27)+K28 
 
LET C8(1)=K13 
LET C8(2)=K14 
LET C8(3)=K15 
LET C9(1)=K13-K23 
LET C9(2)=K14-K26 
LET C9(3)=K15-K29 
LET C10(1)=K13+K23 
LET C10(2)=K14+K26 
LET C10(3)=K15+K29 
 
IF K20>=1.96 
 NOTE 
 NOTE The difference in the P-value caused by adding the second variable is 
 NOTE SIGNIFICANT at the 95% level 
ELSE 
 NOTE 
 NOTE The difference in the P-value caused by adding the second variable is 
 NOTE NOT SIGNIFICANT at the 95% level 
ENDIF 
 
ENDMACRO 
340 
 
A4 GENERALISED CLUSTER SIGNIFICANCE ANALYSIS 
 
# GLOBAL MACRO GCSA2.MAC 
# 
# Carries out generalised cluster significance analysis on two variables 
#  
# MINITAB for Windows version 11 and above 
# 
# Place the chemical names (or numbers) in C1, the activity in C2 
# and the variables in C3 and C4. 
# Type %gcsa2 at the command line prompt. 
 
GMACRO 
Gcsa2 
 
NAME C1='CHEMICAL' C2='ACTIVITY' C3='DESCRIPTOR 1' C4='DESCRIPTOR 2'  
NAME C5='WEIGHT' C6='WTD DESCRIP1' C7='WTD DESCRIP2' 
NAME C8='VARIANCE' C9='PROBABILITY' C10='95% C.I.'  C11='DISTRIBUTION'   
NAME C12='RESAMP WT' C13='RESAMP WT D1' C14='RESAMP WT D2' C15='SUBSETS' 
 
NOTE 
NOTE Do you wish to standardise the data in C3 and C4 ? 
NOTE 
YESNO K50 
IF K50=1 
 CENTRE C3-C4 C3-C4. 
ENDIF 
 
CENTRE C2 C5; 
 MINMAX 0 1.0. 
LET C6=C3*C5 
LET C7=C4*C5 
 
LET K1=(STDEV (C6))**2 
LET K2=(STDEV (C7))**2 
LET K3=K1+K2 
LET C8(1)=K1 
LET C8(2)=K2 
LET C8(3)=K3 
LET K4=COUNT(C1) 
 
ERASE C6-C7 
 
LET C7(1)="1st variable" 
LET C7(2)="2nd variable" 
LET C7(3)="1st and 2nd" 
 
NOTE 
NOTE How many times do you want to resample? 
SET C15; 
 FILE "TERMINAL"; 
 NOBS=1. 
COPY C15 K5 
 
LET K6=0 
LET K7=0 
LET K8=0 
 
DO K9=1:K5 
 SAMPLE K4 C5 C12 
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 LET C13=C3*C12 
 LET C14=C4*C12 
 LET K10=(STDEV (C13))**2 
 LET K11=(STDEV (C14))**2 
 LET K12=K10+K11 
 LET C11(K9)=K12 
 IF K10<=K1 
  LET K6=K6+1 
 ENDIF 
 IF K11<=K2 
  LET K7=K7+1 
 ENDIF  
 IF K12<=K3 
  LET K8=K8+1  
 ENDIF 
ENDDO 
 
LET K13=K6/K5 
LET K14=K7/K5 
LET K15=K8/K5 
LET K16=(K13+K15)/2 
IF K13>K15 
 LET K17=K13-K15 
ELSE 
 LET K17=K15-K13 
ENDIF 
 
LET K18=2/K5 
LET K19=SQRT(K16*(1-K16)*K18) 
LET K20=K17/K19 
LET K21=SQRT((K13*(1-K13))/K5) 
LET K22=0.5/K5 
LET K23=(1.96*K21)+K22 
LET K24=SQRT((K14*(1-K14))/K5) 
LET K25=0.5/K5 
LET K26=(1.96*K24)+K25 
LET K27=SQRT((K15*(1-K15))/K5) 
LET K28=0.5/K5 
LET K29=(1.96*K27)+K28 
 
LET C9(1)=K13 
LET C9(2)=K14 
LET C9(3)=K15 
LET C10(1)=K23 
LET C10(2)=K26 
LET C10(3)=K29 
 
IF K20>=1.96 
 NOTE 
 NOTE The difference in the P-value caused by adding the second variable is 
 NOTE SIGNIFICANT at the 95% level 
ELSE 
 NOTE 
 NOTE The difference in the P-value caused by adding the second variable is 
 NOTE NOT SIGNIFICANT at the 95% level 
ENDIF 
 
ENDMACRO 
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A5  BOOTSTRAP ANALYSIS OF COOPER STATISTICS I: APPLICATION OF 
THE STANDARD BOOTSTRAP METHOD 
 
# GLOBAL MACRO BOOT.MAC 
# 
# Estimates confidence intervals for two-group classification models 
#  
# MINITAB for Windows version 11 and above 
# 
# Place the chemical names, the known classifications in C2, and the predicted classifications 
# made by different labs/runs in column C3-C11. 
# Enter the symbols for toxic, non-toxic and non-qualifying chemicals in C13(1), C13(2) and C13(3) 
# Type %cval2 at the command line prompt. 
 
GMACRO 
boot 
 
NAME C1='CHEMICAL' C2='OBS CLASS' C3='PRED1' C4='PRED2' C5='PRED3' C6='PRED4'  
NAME C7='PRED5' C8='PRED6' C9='PRED7' C10='PRED8' C11='PRED9' 
NAME C13='TOXIC' C14='NON-TOXIC' C15='NON-QUALIFIER' 
 
NOTE 
NOTE Have you entered the appropriate symbols in C13(1), C14(1) and C15(1)? 
NOTE 
YESNO K1 
IF K1=1 
 CALL RESAMPLE 
ELSE 
 NOTE 
 NOTE Then please do so, and rerun the macro 
 EXIT 
ENDIF 
ENDMACRO 
 
GMACRO 
RESAMPLE 
 
NOTE 
NOTE How many labs/runs are there ? 
SET C100; 
 FILE "TERMINAL"; 
 NOBS=1. 
COPY C100 K7                              # no of labs/runs K7 
ERASE C100 
 
 
NAME C32='RAND OBS' C33='RAND PRED1' C34='RAND PRED2' C35='RAND PRED3' 
C36='RAND PRED4' 
NAME C37='RAND PRED5' C38='RAND PRED6' C39='RAND PRED7' C40='RAND PRED8' 
C41='RAND PRED9' 
NAME C45='CONCORD 1' C46='CONCORD 2' C47='CONCORD 3' C48='CONCORD 4' 
C49='CONCORD 5'  
NAME C50='CONCORD 6' C51='CONCORD 7' C52='CONCORD 8' C53='CONCORD 9' 
NAME C55='SENSITIV 1' C56='SENSITIV 2' C57='SENSITIV 3' C58='SENSITIV 4' C59='SENSITIV 
5' 
NAME C60='SENSITIV 6' C61='SENSITIV 7' C62='SENSITIV 8' C63='SENSITIV 9'  
NAME C65='SPECIFIC 1' C66='SPECIFIC 2' C67='SPECIFIC 3' C68='SPECIFIC 4' C69='SPECIFIC 5'  
NAME C70='SPECIFIC 6' C71='SPECIFIC 7' C72='SPECIFIC 8' C73='SPECIFIC 9' 
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LET K1=COUNT(C1)  
 
NOTE 
NOTE How many times do you want to resample? 
SET C100; 
 FILE "TERMINAL"; 
 NOBS=1. 
COPY C100 K3                              # K3 = no of bootstrap resamples 
ERASE C100 
 
DO K2=1:K3                                # start bootstrap routine 
 LET K8=0 
 LET K9=0 
 LET K12=0 
 LET K13=0 
 LET K14=0 
 LET K15=0 
 LET K16=0 
 LET K22=0 
 LET K23=0 
 LET K24=0 
 LET K25=0 
 LET K26=0 
 LET K32=0 
 LET K33=0 
 LET K34=0 
 LET K35=0 
 LET K36=0 
 LET K42=0 
 LET K43=0 
 LET K44=0 
 LET K45=0 
 LET K46=0 
 LET K52=0 
 LET K53=0 
 LET K54=0 
 LET K55=0 
 LET K56=0 
 LET K62=0 
 LET K63=0 
 LET K64=0 
 LET K65=0 
 LET K66=0 
 LET K72=0 
 LET K73=0 
 LET K74=0 
 LET K75=0 
 LET K76=0 
 LET K82=0 
 LET K83=0 
 LET K84=0 
 LET K85=0 
 LET K86=0 
 LET K92=0 
 LET K93=0 
 LET K94=0 
 LET K95=0 
 LET K96=0 
  
 LET K131=0          # correction for non-qualifying chemicals       
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 LET K132=0          # observed='toxic' 
 LET K133=0 
 LET K134=0 
 LET K135=0 
 LET K136=0 
 LET K137=0 
 LET K138=0 
 LET K139=0 
 
 LET K141=0          # correction for non-qualifying chemicals       
 LET K142=0          # observed='non-toxic' 
 LET K143=0 
 LET K144=0 
 LET K145=0 
 LET K146=0 
 LET K147=0 
 LET K148=0 
 LET K149=0 
 
 IF K7=1 
  SAMPLE K1 C2-C3 C32-C33; 
   REPLACE. 
 ENDIF 
 IF K7=2 
  SAMPLE K1 C2-C4 C32-C34; 
   REPLACE. 
 ENDIF 
 IF K7=3 
  SAMPLE K1 C2-C5 C32-C35; 
   REPLACE. 
 ENDIF 
 IF K7=4 
  SAMPLE K1 C2-C6 C32-C36; 
   REPLACE. 
 ENDIF 
 IF K7=5 
  SAMPLE K1 C2-C7 C32-C37; 
   REPLACE. 
 ENDIF 
 IF K7=6 
  SAMPLE K1 C2-C8 C32-C38; 
   REPLACE. 
 ENDIF 
 IF K7=7 
  SAMPLE K1 C2-C9 C32-C39; 
   REPLACE. 
 ENDIF 
 IF K7=8 
  SAMPLE K1 C2-C10 C32-C40; 
   REPLACE. 
 ENDIF 
 IF K7=9 
  SAMPLE K1 C2-C11 C32-C41; 
   REPLACE. 
 ENDIF 
 
 DO K4=1:K1                                 # start chemicals routine 
 IF C32(K4)=C13(1) 
  LET K8=K8+1 
 ENDIF 
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 IF C32(K4)=C14(1) 
  LET K9=K9+1 
 ENDIF 
  
 # LABORATORY 1 
 
  IF C32(K4)=C33(K4) 
   LET K12=K12+1                                                # total no of correct predictions  
  ENDIF 
  IF C32(K4)=C33(K4) AND C33(K4)=C13(1) 
   LET K13=K13+1                                                # no of true positives 
  ENDIF 
  IF C32(K4)=C33(K4) AND C33(K4)=C14(1) 
   LET K14=K14+1                                                # no of true negatives 
  ENDIF 
  IF C32(K4)=C13(1) AND C33(K4)=C15(1)       # correction for non-qualifiers 
   LET K131=K131+1 
  ENDIF 
  IF C32(K4)=C14(1) AND C33(K4)=C15(1)       # correction for non-qualifiers 
   LET K141=K141+1 
  ENDIF 
 
IF K7=1 
 GOTO 1 
ENDIF 
 
# LABORATORY 2 
 
  IF C32(K4)=C34(K4) 
   LET K22=K22+1                                               # total no of correct predictions  
  ENDIF 
  IF C32(K4)=C34(K4) AND C34(K4)=C13(1) 
   LET K23=K23+1                                              # no of true positives 
  ENDIF 
  IF C32(K4)=C34(K4) AND C34(K4)=C14(1) 
   LET K24=K24+1                                              # no of true negatives 
  ENDIF 
  IF C32(K4)=C13(1) AND C34(K4)=C15(1)     # correction for non-qualifiers 
   LET K132=K132+1 
  ENDIF 
  IF C32(K4)=C14(1) AND C34(K4)=C15(1)     # correction for non-qualifiers 
   LET K142=K142+1 
  ENDIF 
 
IF K7=2 
 GOTO 1 
ENDIF 
   
  # LABORATORY 3 
 
  IF C32(K4)=C35(K4) 
   LET K32=K32+1                                               # total no of correct predictions  
  ENDIF 
  IF C32(K4)=C35(K4) AND C35(K4)=C13(1) 
   LET K33=K33+1                                               # no of true positives 
  ENDIF   
  IF C32(K4)=C35(K4) AND C35(K4)=C14(1) 
   LET K34=K34+1                                               # no of true negatives 
  ENDIF 
  IF C32(K4)=C13(1) AND C35(K4)=C15(1)     # correction for non-qualifiers 
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   LET K133=K133+1 
  ENDIF 
  IF C32(K4)=C14(1) AND C35(K4)=C15(1)      # correction for non-qualifiers 
   LET K143=K143+1 
  ENDIF 
 
IF K7=3 
 GOTO 1 
ENDIF 
 
# LABORATORY 4 
 
  IF C32(K4)=C36(K4) 
   LET K42=K42+1                                              # total no of correct predictions  
  ENDIF 
  IF C32(K4)=C36(K4) AND C36(K4)=C13(1) 
   LET K43=K43+1                                              # no of true positives 
  ENDIF 
  IF C32(K4)=C36(K4) AND C36(K4)=C14(1) 
   LET K44=K44+1                                              # no of true negatives 
  ENDIF 
  IF C32(K4)=C13(1) AND C36(K4)=C15(1)     # correction for non-qualifiers 
   LET K134=K134+1 
  ENDIF 
  IF C32(K4)=C14(1) AND C36(K4)=C15(1)     # correction for non-qualifiers 
   LET K144=K144+1 
  ENDIF 
 
IF K7=4 
 GOTO 1 
ENDIF 
 
# LABORATORY 5 
 
  IF C32(K4)=C37(K4) 
   LET K52=K52+1                                              # total no of correct predictions  
  ENDIF 
  IF C32(K4)=C37(K4) AND C37(K4)=C13(1) 
   LET K53=K53+1                                              # no of true positives 
  ENDIF 
  IF C32(K4)=C37(K4) AND C37(K4)=C14(1) 
   LET K54=K54+1                                              # no of true negatives 
  ENDIF 
  IF C32(K4)=C13(1) AND C37(K4)=C15(1)     # correction for non-qualifiers 
   LET K135=K135+1 
  ENDIF 
  IF C32(K4)=C14(1) AND C37(K4)=C15(1)     # correction for non-qualifiers 
   LET K145=K145+1 
  ENDIF 
 
IF K7=5 
 GOTO 1 
ENDIF 
 
# LABORATORY 6 
 
  IF C32(K4)=C38(K4) 
   LET K62=K62+1                                              # total no of correct predictions  
  ENDIF 
  IF C32(K4)=C38(K4) AND C38(K4)=C13(1) 
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   LET K63=K63+1                                              # no of true positives 
  ENDIF 
  IF C32(K4)=C38(K4) AND C38(K4)=C14(1) 
   LET K64=K64+1                                              # no of true negatives 
  ENDIF 
  IF C32(K4)=C13(1) AND C38(K4)=C15(1)     # correction for non-qualifiers 
   LET K136=K136+1 
  ENDIF 
  IF C32(K4)=C14(1) AND C38(K4)=C15(1)     # correction for non-qualifiers 
   LET K146=K146+1 
  ENDIF 
   
IF K7=6 
 GOTO 1 
ENDIF 
 
# LABORATORY 7 
 
  IF C32(K4)=C39(K4) 
   LET K72=K72+1                                             # total no of correct predictions  
  ENDIF 
  IF C32(K4)=C39(K4) AND C39(K4)=C13(1) 
   LET K73=K73+1                                             # no of true positives 
  ENDIF 
  IF C32(K4)=C39(K4) AND C39(K4)=C14(1) 
   LET K74=K74+1                                             # no of true negatives 
  ENDIF 
  IF C32(K4)=C13(1) AND C39(K4)=C15(1)    # correction for non-qualifiers 
   LET K137=K137+1 
  ENDIF 
  IF C32(K4)=C14(1) AND C39(K4)=C15(1)    # correction for non-qualifiers 
   LET K147=K147+1 
  ENDIF 
 
IF K7=7 
 GOTO 1 
ENDIF 
 
# LABORATORY 8 
 
  IF C32(K4)=C40(K4) 
   LET K82=K82+1                                             # total no of correct predictions  
  ENDIF 
  IF C32(K4)=C40(K4) AND C40(K4)=C13(1) 
   LET K83=K83+1                                             # no of true positives 
  ENDIF 
  IF C32(K4)=C40(K4) AND C40(K4)=C14(1) 
   LET K84=K84+1                                             # no of true negatives 
  ENDIF 
  IF C32(K4)=C13(1) AND C40(K4)=C15(1)    # correction for non-qualifiers 
   LET K138=K138+1 
  ENDIF 
  IF C32(K4)=C14(1) AND C40(K4)=C15(1)    # correction for non-qualifiers 
   LET K138=K138+1 
  ENDIF 
     
IF K7=8 
 GOTO 1 
ENDIF 
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# LABORATORY 9 
 
  IF C32(K4)=C41(K4) 
   LET K92=K92+1                                              # total no of correct predictions  
  ENDIF 
  IF C32(K4)=C41(K4) AND C41(K4)=C13(1) 
   LET K93=K93+1                                              # no of true positives 
  ENDIF 
  IF C32(K4)=C41(K4) AND C41(K4)=C14(1) 
   LET K94=K94+1                                               # no of true negatives 
  ENDIF 
  IF C32(K4)=C13(1) AND C41(K4)=C15(1)      # correction for non-qualifiers 
   LET K139=K139+1 
  ENDIF 
  IF C32(K4)=C14(1) AND C41(K4)=C15(1)      # correction for non-qualifiers 
   LET K149=K149+1 
  ENDIF 
                       
MLABEL 1 
ENDDO                                                                # stop chemicals routine 
 
ERASE C32-C41 
 
# Laboratory 1 
 
 LET C45(K2)=(K12/(K1-K131-K141))*100      # concordance 
 LET C55(K2)=(K13/(K8-K131))*100                # sensitivity 
 LET C65(K2)=(K14/(K9-K141))*100                # specificity 
 
# Laboratory 2 
 
 LET C46(K2)=(K22/(K1-K132-K142))*100      # concordance 
 LET C56(K2)=(K23/(K8-K132))*100                # sensitivity 
 LET C66(K2)=(K24/(K9-K142))*100                # specificity 
 
# Laboratory 3 
 
 LET C47(K2)=(K32/(K1-K133-K143))*100      # concordance 
 LET C57(K2)=(K33/(K8-K133))*100                # sensitivity 
 LET C67(K2)=(K34/(K9-K143))*100                # specificity 
 
# Laboratory 4 
 
 LET C48(K2)=(K42/(K1-K134-K144))*100      # concordance 
 LET C58(K2)=(K43/(K8-K134))*100                # sensitivity 
 LET C68(K2)=(K44/(K9-K144))*100                # specificity 
 
# Laboratory 5 
 
 LET C49(K2)=(K52/(K1-K135-K145))*100      # concordance 
 LET C59(K2)=(K53/(K8-K135))*100                # sensitivity 
 LET C69(K2)=(K54/(K9-K145))*100                # specificity 
 
# Laboratory 6 
 
 LET C50(K2)=(K62/(K1-K136-K146))*100      # concordance 
 LET C60(K2)=(K63/(K8-K136))*100                # sensitivity 
 LET C70(K2)=(K64/(K9-K146))*100                # specificity 
 
IF K7=6 
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 GOTO 2 
ENDIF 
 
# Laboratory 7 
 
 LET C51(K2)=(K72/(K1-K137-K147))*100      # concordance 
 LET C61(K2)=(K73/(K8-K137))*100                # sensitivity 
 LET C71(K2)=(K74/(K9-K147))*100                # specificity 
 
IF K7=7 
 GOTO 2 
ENDIF 
 
# Laboratory 8 
 
 LET C52(K2)=(K82/(K1-K138-K148))*100      # concordance 
 LET C62(K2)=(K83/(K8-K138))*100                # sensitivity 
 LET C72(K2)=(K84/(K9-K148))*100                # specificity 
 
IF K7=8 
 GOTO 2 
ENDIF 
 
# Laboratory 9 
 
 LET C53(K2)=(K92/(K1-K139-K149))*100      # concordance 
 LET C63(K2)=(K93/(K8-K139))*100                # sensitivity 
 LET C73(K2)=(K94/(K9-K149))*100                # specificity 
 
MLABEL 2 
ENDDO                                                                # stop bootstrap routine  
 
# Average statistics over laboratories 
 
NAME C80='MEAN CONC' C81='MEAN SENS' C82='MEAN SPEC' 
 
IF K7=1 
 LET C80=C45 
 LET C81=C55 
 LET C82=C65 
ENDIF 
 
IF K7=2 
 LET C80=(C45+C46)/K7 
 LET C81=(C55+C56)/K7 
 LET C82=(C65+C66)/K7 
ENDIF 
 
IF K7=3 
 LET C80=(C45+C46+C47)/K7 
 LET C81=(C55+C56+C57)/K7 
 LET C82=(C65+C66+C67)/K7 
ENDIF 
 
IF K7=4 
 LET C80=(C45+C46+C47+C48)/K7 
 LET C81=(C55+C56+C57+C58)/K7 
 LET C82=(C65+C66+C67+C68)/K7 
ENDIF 
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IF K7=5 
 LET C80=(C45+C46+C47+C48+C49)/K7 
 LET C81=(C55+C56+C57+C58+C59)/K7 
 LET C82=(C65+C66+C67+C68+C69)/K7 
ENDIF 
 
IF K7=6 
 LET C80=(C45+C46+C47+C48+C49+C50)/K7 
 LET C81=(C55+C56+C57+C58+C59+C60)/K7 
 LET C82=(C65+C66+C67+C68+C69+C70)/K7 
ENDIF 
 
IF K7=7 
 LET C80=(C45+C46+C47+C48+C49+C50+C51)/K7 
 LET C81=(C55+C56+C57+C58+C59+C60+C61)/K7 
 LET C82=(C65+C66+C67+C68+C69+C70+C71)/K7 
ENDIF 
 
IF K7=8 
 LET C80=(C45+C46+C47+C48+C49+C50+C51+C52)/K7 
 LET C81=(C55+C56+C57+C58+C59+C60+C61+C62)/K7 
 LET C82=(C65+C66+C67+C68+C69+C70+C71+C72)/K7 
ENDIF 
 
IF K7=9 
 LET C80=(C45+C46+C47+C48+C49+C50+C51+C52+C53)/K7 
 LET C81=(C55+C56+C57+C58+C59+C60+C61+C62+C63)/K7 
 LET C82=(C65+C66+C67+C68+C69+C70+C71+C72+C73)/K7 
ENDIF 
 
NAME C20='BOOTSTRAP MEAN' C21='LOWER CL' C22='UPPER CL' 
 
LET C19(1)="CONCORDANCE" 
LET C19(2)="SENSITIVITY" 
LET C19(3)="SPECIFICITY" 
 
LET K101=MEAN(C80) 
LET K102=MEAN(C81) 
LET K103=MEAN(C82) 
 
LET C20(1)=K101 
LET C20(2)=K102 
LET C20(3)=K103  
  
LET K110=STDEV(C80) 
LET K111=STDEV(C81) 
LET K112=STDEV(C82) 
LET K120=1.96*K110 
LET K121=1.96*K111 
LET K122=1.96*K112 
 
LET C21(1)=K101-K120 
LET C21(2)=K102-K121 
LET C21(3)=K103-K122 
LET C22(1)=K101+K120 
LET C22(2)=K102+K121 
LET C22(3)=K103+K122 
 
ENDMACRO 
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A6  BOOTSTRAP ANALYSIS OF COOPER STATISTICS II: APPLICATION 
OF THE BIAS-CORRECTED PERCENTILE METHOD 
 
# GLOBAL MACRO BIAS.MAC 
# 
# Applies the bias-corrected percentile bootstrap method to bootstrap distributions 
# of Cooper statistics generated by BOOT.MAC  
# 
# MINITAB for Windows version 11 and above 
# 
# Place the bootstrap distribution of Cooper statistics in C1  
# Type %bias at the command line prompt. 
 
 
GMACRO 
bias 
 
NAME C1='Bootstrap distribution' C3='PERCENTILES'  
 
LET K1=COUNT(C1) 
 
NOTE 
NOTE What is the value of the Cooper statistic based on the original sample ? 
NOTE 
SET C10;  
 FILE "TERMINAL"; 
 NOBS=1. 
COPY C10 K100 
 
LET K2=0 
 
DO K3=1:K1 
 IF C1(K3)>K100 
  LET K2=K2+1 
 ENDIF 
ENDDO 
 
# calculate p, proportion of times that bootstrap estimate > original sample estimate 
 
LET K4=K2/K1                 
 
# calculate Zp, value of normal distribution exceeded with probability p 
 
LET K4=1-K4 
 
INVCDF K4 K5; 
 NORMAL 0.0 1.0. 
 
# calculate proportion of standard normal distribn less than (2Zp-1.96) 
 
LET K6=(2*K5)-1.96 
CDF K6 K8; 
 NORMAL 0.0 1.0. 
 
 
# calculate proportion of standard normal distribn less than (2Zp+1.96) 
 
LET K6=(2*K5)+1.96 
CDF K6 K9; 
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 NORMAL 0.0 1.0. 
 
LET C3(1)=K8    # lower cumulative probability 
LET C3(2)=K9    # upper cumulative probability 
LET C3(3)=0.5    # median 
 
LET K8=K8*100 
LET K9=K9*100 
 
LET K10=MINIMUM(C1) 
LET K11=MAXIMUM(C1) 
LET K12=K11/10 
 
SET C10 
 1( K10 : K11 / 5 )1 
 END. 
 
LET C10=ROUN(C10) 
 
HISTOGRAM C1; 
 CUMULATIVE; 
 PERCENT; 
 MIDPOINT; 
 CONNECT; 
 AXIS 1; 
 AXIS 2; 
 TICK 1 C10; 
 TICK 2 K8 K9 50; 
 GRID 2; 
 GRID 1. 
 
ENDMACRO 
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A7 BOOTSTRAP ANALYSIS OF DRAIZE TEST SKIN SCORES 
 
  
# GLOBAL MACRO PII.MAC 
# 
# Bootstrap resampling of Draize skin scores 
#  
# MINITAB for Windows version 11 and above 
# 
# Place the chemical names in C1, and the tissue scores in columns C2-C37, as indicated in column 
headings  (e.g. Ery12 = erythema score in rabbit no 1 at the second time-point). Maximum of 6 rabbits. 
# Type %pii at the command line prompt. 
 
GMACRO 
PII 
 
NAME C1='Chemical' 
NAME C2='Ery11' C3='Ery12' C4='Ery13' 
NAME C5='Oed11' C6='Oed12' C7='Oed13' 
NAME C8='Ery21' C9='Ery22' C10='Ery23' 
NAME C11='Oed21' C12='Oed22' C13='Oed23' 
  
NAME C50='Erythema' C51='Oedema' 
NAME C60='Resamp Eryth' C61='Resamp Oed' C62='Resamp PII' 
 
NOTE 
NOTE How many rabbits (1-6) ? 
SET C100; 
 FILE "TERMINAL"; 
 NOBS=1. 
COPY C100 K1                                                              # no of rabbits K1 
ERASE C100 
 
IF K1=1 
 GOTO 1 
ELSEIF K1=2 
 GOTO 2 
ELSEIF K1=3 
 GOTO 3 
ELSEIF K1=4 
 GOTO 4 
ELSEIF K1=5 
 GOTO 5 
ELSEIF K1=6 
 GOTO 6 
ENDIF 
 
MLABEL 1                               # One rabbit 
COPY C2-C4 M1 
COPY C5-C7 M2 
GOTO 10 
 
MLABEL 2                                # Two rabbits 
COPY C2-C4, C8-C10 M1 
COPY C5-C7, C11-C13 M2 
GOTO 10 
 
MLABEL 3                                # Three rabbits 
NAME C14='Ery31' C15='Ery32' C16='Ery33' 
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NAME C17='Oed31' C18='Oed32' C19='Oed33' 
 
COPY C2-C4, C8-C10, C14-C16 M1 
COPY C5-C7, C11-C13, C17-C19 M2 
GOTO 10 
 
MLABEL 4                   # Four rabbits 
NAME C20='Ery41' C21='Ery42' C22='Ery43' 
NAME C23='Oed41' C24='Oed42' C25='Oed43' 
COPY C2-C4, C8-C10, C14-C16, C20-C22 M1 
COPY C5-C7, C11-C13, C17-C19, C23-C25 M2 
GOTO 10 
 
MLABEL 5                  # Five rabbits 
NAME C20='Ery41' C21='Ery42' C22='Ery43' 
NAME C23='Oed41' C24='Oed42' C25='Oed43' 
NAME C26='Ery51' C27='Ery52' C28='Ery53' 
NAME C29='Oed51' C30='Oed52' C31='Oed53' 
COPY C2-C4, C8-C10, C14-C16, C20-C22, C26-C28 M1 
COPY C5-C7, C11-C13, C17-C19, C23-C25, C29-C31 M2 
GOTO 10 
 
MLABEL 6                   # Six rabbits 
NAME C20='Ery41' C21='Ery42' C22='Ery43' 
NAME C23='Oed41' C24='Oed42' C25='Oed43' 
NAME C26='Ery51' C27='Ery52' C28='Ery53' 
NAME C29='Oed51' C30='Oed52' C31='Oed53' 
NAME C32='Ery61' C33='Ery62' C34='Ery63' 
NAME C35='Oed61' C36='Oed62' C37='Oed63' 
COPY C2-C4, C8-C10, C14-C16, C20-C22, C26-C28, C32-C34 M1 
COPY C5-C7, C11-C13, C17-C19, C23-C25, C29-C31, C35-C37 M2 
GOTO 10 
 
MLABEL 10                                  
TRANSPOSE M1 M11 
TRANSPOSE M2 M12 
COPY M11 C50 
COPY M12 C51 
LET K1=3*K1 
 
NOTE 
NOTE How many times do you want to resample? 
SET C100; 
 FILE "TERMINAL"; 
 NOBS=1. 
COPY C100 K3                                             # K3 = no of bootstrap resamples 
ERASE C100 
 
DO K2=1:K3                                                 # start bootstrap routine 
 SAMPLE K1 C50-C51 C55-C56; 
  REPLACE. 
 LET C60(K2)=MEAN(C55) 
 LET C61(K2)=MEAN(C56) 
 LET C62(K2)=C60(K2)+C61(K2)                       
ENDDO                                                        # stop bootstrap routine   
 
LET K10=MEAN(C60) 
LET K11=MEAN(C61) 
LET K12=MEAN(C62) 
LET K15=STDEV(C60) 
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LET K16=STDEV(C61) 
LET K17=STDEV(C62) 
 
LET K18=MEDIAN(C60) 
LET K19=MEDIAN(C61) 
LET K20=MEDIAN(C62) 
LET C1(4)="Erythema" 
LET C1(5)="Oedema" 
LET C1(6)="PII" 
LET C2(4)=K10 
LET C2(5)=K11 
LET C2(6)=K12  
LET C3(4)=K15 
LET C3(5)=K16 
LET C3(6)=K17  
LET C4(4)=K10-(1.96*K15) 
LET C4(5)=K11-(1.96*K16) 
LET C4(6)=K12-(1.96*K17)  
LET C5(4)=K10+(1.96*K15) 
LET C5(5)=K11+(1.96*K16) 
LET C5(6)=K12+(1.96*K17)  
LET C7(4)=K18 
LET C7(5)=K19 
LET C7(6)=K20  
 
STATS C60-C62; 
 QONE C70-C72. 
LET C8(4)=C70 
LET C8(5)=C71 
LET C8(6)=C72 
 
ERASE C70-C72 
 
STATS C60-C62; 
 QTHREE C70-C72. 
LET C9(4)=C70 
LET C9(5)=C71 
LET C9(6)=C72 
 
ERASE C70-C72 
 
TEXT C2 C2 
TEXT C3 C3 
TEXT C4 C4 
TEXT C5 C5 
TEXT C7 C7 
TEXT C8 C8 
TEXT C9 C9 
 
LET C2(3)="mean" 
LET C3(3)="std err" 
LET C4(3)="lower CI" 
LET C5(3)="upper CI" 
LET C7(3)="median" 
LET C8(3)="Q1" 
LET C9(3)="Q3" 
 
ENDMACRO 
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A8 BOOTSTRAP ANALYSIS OF DRAIZE TEST EYE SCORES 
 
# GLOBAL MACRO MMAS.MAC 
# 
# Bootstrap resampling of Draize eye scores 
#  
# MINITAB for Windows version 11 and above 
# 
# Place the chemical names in C1, and the tissue scores in columns C2-C109, as indicated. 
# (e.g. red12 = redness score in rabbit no 1 at the secondtime-point). Maximum of 6 rabbits. 
# Type %mmas at the command line prompt. 
 
GMACRO 
MMAS 
 
NAME C1='Chemical' 
NAME C2='red11' C3='red12' C4='red13' 
NAME C5='red21' C6='red22' C7='red23' 
NAME C8='red31' C9='red32' C10='red33' 
NAME C11='red41' C12='red42' C13='red43' 
NAME C14='red51' C15='red52' C16='red53' 
NAME C17='red61' C18='red62' C19='red63'  
 
NAME C20='chem11' C21='chem12' C22='chem13' 
NAME C23='chem21' C24='chem22' C25='chem23' 
NAME C26='chem31' C27='chem32' C28='chem33' 
NAME C29='chem41' C30='chem42' C31='chem43' 
NAME C32='chem51' C33='chem52' C34='chem53' 
NAME C35='chem61' C36='chem62' C37='chem63'  
 
NAME C38='dis11' C39='dis12' C40='dis13' 
NAME C41='dis21' C42='dis22' C43='dis23' 
NAME C44='dis31' C45='dis32' C46='dis33' 
NAME C47='dis41' C48='dis42' C49='dis43' 
NAME C50='dis51' C51='dis52' C52='dis53' 
NAME C53='dis61' C54='dis62' C55='dis63'  
 
NAME C56='opac11' C57='opac12' C58='opac13' 
NAME C59='opac21' C60='opac22' C61='opac23' 
NAME C62='opac31' C63='opac32' C64='opac33' 
NAME C65='opac41' C66='opac42' C67='opac43' 
NAME C68='opac51' C69='opac52' C70='opac53' 
NAME C71='opac61' C72='opac62' C73='opac63'  
 
NAME C74='area11' C75='area12' C76='area13' 
NAME C77='area21' C78='area22' C79='area23' 
NAME C80='area31' C81='area32' C82='area33' 
NAME C83='area41' C84='area42' C85='area43' 
NAME C86='area51' C87='area52' C88='area53' 
NAME C89='area61' C90='area62' C91='area63'  
 
NAME C92='iris11' C93='iris12' C94='iris13' 
NAME C95='iris21' C96='iris22' C97='iris23' 
NAME C98='iris31' C99='iris32' C100='iris33' 
NAME C101='iris41' C102='iris42' C103='iris43' 
NAME C104='iris51' C105='iris52' C106='iris53' 
NAME C107='iris61' C108='iris62' C109='iris63'  
 
NAME C115='redness' C116='chemosis' C117='discharge' C118='opacity' C119='area' C120='iris' 
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NAME C125='resamp red' C126='resamp chem' C127='resamp dis' C128='resamp opac' C129='resamp 
area' C130='resamp iris' 
 
NOTE 
NOTE How many rabbits (1-6) ? 
SET C200; 
 FILE "TERMINAL"; 
 NOBS=1. 
COPY C200 K1                              # no of rabbits K1 
ERASE C200 
 
IF K1=1 
 GOTO 1 
ELSEIF K1=2 
 GOTO 2 
ELSEIF K1=3 
 GOTO 3 
ELSEIF K1=4 
 GOTO 4 
ELSEIF K1=5 
 GOTO 5 
ELSEIF K1=6 
 GOTO 6 
ENDIF 
 
MLABEL 1                # One rabbits 
COPY C2-C4 M1 
COPY C20-C22 M2 
COPY C38-C40 M3 
COPY C56-C58 M4 
COPY C74-C76 M5 
COPY C92-C94 M6 
GOTO 10 
 
MLABEL 2                # Two rabbits 
COPY C2-C7 M1 
COPY C20-C25 M2 
COPY C38-C43 M3 
COPY C56-C61 M4 
COPY C74-C79 M5 
COPY C92-C97 M6 
GOTO 10 
 
MLABEL 3                # Three rabbits 
COPY C2-C10 M1 
COPY C20-C28 M2 
COPY C38-C46 M3 
COPY C56-C64 M4 
COPY C74-C82 M5 
COPY C92-C100 M6 
GOTO 10 
 
MLABEL 4     # Four rabbits 
COPY C2-C13 M1 
COPY C20-C31 M2 
COPY C38-C49 M3 
COPY C56-C67 M4 
COPY C74-C85 M5 
COPY C92-C103 M6 
GOTO 10 
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MLABEL 5    # Five rabbits 
COPY C2-C16 M1 
COPY C20-C34 M2 
COPY C38-C52 M3 
COPY C56-C70 M4 
COPY C74-C88 M5 
COPY C92-C106 M6 
GOTO 10 
 
MLABEL 6     # Six rabbits 
COPY C2-C19 M1 
COPY C20-C37 M2 
COPY C38-C55 M3 
COPY C56-C73 M4 
COPY C74-C91 M5 
COPY C92-C109 M6 
GOTO 10 
 
MLABEL 10                                  
TRANSPOSE M1 M11 
TRANSPOSE M2 M12 
TRANSPOSE M3 M13 
TRANSPOSE M4 M14 
TRANSPOSE M5 M15 
TRANSPOSE M6 M16 
COPY M11 C115 
COPY M12 C116 
COPY M13 C117 
COPY M14 C118 
COPY M15 C119 
COPY M16 C120 
 
LET K1=3*K1 
 
NOTE 
NOTE How many times do you want to resample? 
SET C200; 
 FILE "TERMINAL"; 
 NOBS=1. 
COPY C200 K3                                               # K3 = no of bootstrap resamples 
ERASE C200 
 
DO K2=1:K3                                                    # start bootstrap routine 
 SAMPLE K1 C115-C120 C125-C130; 
  REPLACE. 
 LET C140(K2)=MEAN(C125)    # redness distribution 
 LET C141(K2)=MEAN(C126)    # chemosis distribution 
 LET C142(K2)=MEAN(C127)    # discharge distribution 
 LET C143(K2)=MEAN(C128)    # opacity distribution 
 LET C144(K2)=MEAN(C129)    # area distribution 
 LET C145(K2)=MEAN(C130)    # iritis distribution 
ENDDO                                                            # stop bootstrap routine   
 
LET C146=(2*(C140+C141+C142))+(5*(C143*C144))+(5*C145)   # MMAS distribution 
 
NAME C140='red dist' C141='chem dist' C142='disc dist' C143='opac dist' 
NAME C144='area dist' C145='iris dist' C146='MAS dist' 
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LET K10=MEAN(C140) 
LET K11=MEAN(C141) 
LET K12=MEAN(C142) 
LET K13=MEAN(C143) 
LET K14=MEAN(C144) 
LET K15=MEAN(C145) 
LET K16=MEAN(C146) 
  
LET K17=STDEV(C140) 
LET K18=STDEV(C141) 
LET K19=STDEV(C142) 
LET K20=STDEV(C143) 
LET K21=STDEV(C144) 
LET K22=STDEV(C145) 
LET K23=STDEV(C146) 
 
LET K25=MEDIAN(C140) 
LET K26=MEDIAN(C141) 
LET K27=MEDIAN(C142) 
LET K28=MEDIAN(C143) 
LET K29=MEDIAN(C144) 
LET K30=MEDIAN(C145) 
LET K31=MEDIAN(C146) 
 
LET K32=MAXIMUM(C140) 
LET K33=MAXIMUM(C141) 
LET K34=MAXIMUM(C142) 
LET K35=MAXIMUM(C143) 
LET K36=MAXIMUM(C144) 
LET K37=MAXIMUM(C145) 
LET K38=(2*(K32+K33+K34))+(5*(K35*K36))+(5*K37)   
 
LET C1(4)="redness" 
LET C1(5)="chemosis" 
LET C1(6)="discharge" 
LET C1(7)="opacity" 
LET C1(8)="area" 
LET C1(9)="iritis" 
LET C1(10)="MMAS" 
 
LET C2(4)=K10 
LET C2(5)=K11 
LET C2(6)=K12 
LET C2(7)=K13 
LET C2(8)=K14 
LET C2(9)=K15 
LET C2(10)=K16 
  
LET C3(4)=K17 
LET C3(5)=K18 
LET C3(6)=K19 
LET C3(7)=K20 
LET C3(8)=K21 
LET C3(9)=K22  
LET C3(10)=K23  
 
LET C4(4)=K10-(1.96*K17) 
LET C4(5)=K11-(1.96*K18) 
LET C4(6)=K12-(1.96*K19) 
LET C4(7)=K13-(1.96*K20) 
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LET C4(8)=K14-(1.96*K21) 
LET C4(9)=K15-(1.96*K22) 
LET C4(10)=K16-(1.96*K23) 
  
LET C5(4)=K10+(1.96*K17) 
LET C5(5)=K11+(1.96*K18) 
LET C5(6)=K12+(1.96*K19) 
LET C5(7)=K13+(1.96*K20) 
LET C5(8)=K14+(1.96*K21) 
LET C5(9)=K15+(1.96*K22)  
LET C5(10)=K16+(1.96*K23)  
 
LET C7(4)=K25 
LET C7(5)=K26 
LET C7(6)=K27  
LET C7(7)=K28 
LET C7(8)=K29 
LET C7(9)=K30  
LET C7(10)=K31  
 
STATS C140-C146; 
 QONE C150-C156. 
LET C8(4)=C150 
LET C8(5)=C151 
LET C8(6)=C152 
LET C8(7)=C153 
LET C8(8)=C154 
LET C8(9)=C155 
LET C8(10)=C156 
 
ERASE C150-C156 
 
STATS C140-C146; 
 QTHREE C150-C156. 
LET C9(4)=C150 
LET C9(5)=C151 
LET C9(6)=C152 
LET C9(7)=C153 
LET C9(8)=C154 
LET C9(9)=C155 
LET C9(10)=C156 
 
LET C10(4)=K32 
LET C10(5)=K33 
LET C10(6)=K34 
LET C10(7)=K35 
LET C10(8)=K36 
LET C10(9)=K37 
LET C10(10)=K38 
 
ERASE C150-C156 
 
TEXT C2 C2 
TEXT C3 C3 
TEXT C4 C4 
TEXT C5 C5 
TEXT C7 C7 
TEXT C8 C8 
TEXT C9 C9 
TEXT C10 C10 
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LET C2(3)="mean" 
LET C3(3)="std err" 
LET C4(3)="lower CI" 
LET C5(3)="upper CI" 
LET C7(3)="median" 
LET C8(3)="Q1" 
LET C9(3)="Q3" 
LET C10(3)="max" 
 
ENDMACRO 
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A9 EMBEDDED CLUSTER MODELLING 
 
# GLOBAL MACRO ECM2.MAC 
# 
# Carries out embedded cluster modelling on two variables 
#  
# MINITAB for Windows version 11 and above 
# 
# Place the chemical names (or numbers) in C1, the activity (0/1) in C2 
# and the variables in C3 and C4. 
# Type %ecm2 at the command line prompt. 
 
GMACRO 
ECM2 
 
NAME C1='CHEMICAL' C2='ACTIVITY (0/1)' C3='DESCRIP 1' C4='DESCRIP 2'  
NAME C11='CENTROID' C12='RADIUS'  
NAME C21='ACTIVE 1' C23='ACTIVE 2'  
LET C10(1)="descrip 1" 
LET C10(2)="descrip 2" 
 
LET K1=COUNT (C1) 
 
NOTE 
NOTE Do you wish to rotate the axes by PCA (y/n) ? 
NOTE 
YESNO K50 
IF K50=1 
 CALL ROTATE 
ELSE 
 CALL CONTINUE 
ENDIF 
 
ENDMACRO 
 
GMACRO 
ROTATE 
 
NAME C51='PC1' C52='PC2' 
 
UNSTACK C3 C20 C21; 
 SUBSCRIPTS C2. 
ERASE C20 
UNSTACK C4 C22 C23; 
 SUBSCRIPTS C2. 
ERASE C22 
 
PCA C21 C23; 
 NCOMPONENTS 2; 
 COVARIANCE; 
 COEFFICIENTS C51-C52. 
 
COPY C3-C4 C90-C91 
ERASE C3-C4 
NAME C3='ROTATED 1' C4='ROTATED 2'  
 
DO K2=1:K1 
 LET K100=C90(K2)*C51(1) 
 LET K101=C91(K2)*C51(2) 
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 LET K103=K100+K101 
 LET C3(K2)=K103 
 LET K105=C90(K2)*C52(1) 
 LET K106=C91(K2)*C52(2) 
 LET K108=K105+K106 
 LET C4(K2)=K108 
ENDDO 
 
CALL CONTINUE 
ENDMACRO 
 
GMACRO 
CONTINUE 
 
UNSTACK C3 C20 C21; 
 SUBSCRIPTS C2. 
ERASE C20 
UNSTACK C4 C22 C23; 
 SUBSCRIPTS C2. 
ERASE C22 
 
LET K3=MEAN(C21) 
LET K4=MEAN(C23) 
LET K6=STDEV(C21) 
LET K7=STDEV(C23) 
LET K9=1.96*K6 
LET K10=1.96*K7 
 
LET C11(1)=K3 
LET C11(2)=K4 
LET C12(1)=K9 
LET C12(2)=K10 
 
NAME C7='PRED ACTIVITY' 
NAME C8='PRED (XVAL)' 
 
DO K2=1:K1 
 LET K12=(C3(K2)-K3)**2 
 LET K13=(C4(K2)-K4)**2 
 LET K15=K12/(K9**2) 
 LET K16=K13/(K10**2) 
 LET K18=K15+K16 
 IF K18<=1 
  LET C7(K2)=1 
 ELSE 
  LET C7(K2)=0 
 ENDIF 
ENDDO 
 
# Cross-validation routine 
 
NAME C32='XVAL ACT' C33='XVAL 1' C34='XVAL 2'  
 
DO K2=1:K1 
 COPY C2-C4 C32-C34; 
  OMIT K2. 
 UNSTACK C33 C40 C41; 
  SUBSCRIPTS C32. 
 ERASE C40 
 UNSTACK C34 C42 C43; 
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  SUBSCRIPTS C32. 
 ERASE C42 
 LET K3=MEAN(C41) 
 LET K4=MEAN(C43) 
 LET K6=STDEV(C41) 
 LET K7=STDEV(C43) 
 LET K9=1.96*K6 
 LET K10=1.96*K7 
 LET K12=(C3(K2)-K3)**2 
 LET K13=(C4(K2)-K4)**2 
 LET K15=K12/(K9**2) 
 LET K16=K13/(K10**2) 
 LET K18=K15+K16 
 IF K18<=1 
  LET C8(K2)=1 
 ELSE 
  LET C8(K2)=0 
 ENDIF 
ENDDO 
 
NOTE 
NOTE Do you wish to bootstrap the parameter estimates (y/n) ? 
NOTE 
YESNO K50 
IF K50=1 
 CALL RESAMPLE 
ELSE 
 EXIT 
ENDIF 
 
ENDMACRO 
 
GMACRO 
RESAMPLE 
NOTE 
NOTE How many times do you wish to resample ? 
NOTE 
SET C50; 
 FILE "TERMINAL"; 
 NOBS=1. 
COPY C50 K50 
LET K60=SUM(C2) 
 
NAME C14='LOWER CENTROID' C15='UPPER CENTROID' C16='LOWER RADIUS' C17='UPPER 
RADIUS' 
NAME C22='RESAMP ACT1' C24='RESAMP ACT2'  
NAME C42='CENTROID1 DISTRIBN' C43='CENTROID2 DISTRIBN' 
NAME C45='RADIUS1 DISTRIBN' C46='RADIUS2 DISTRIBN'  
 
DO K2=1:K50 
 SAMPLE K60 C21 C23 C22 C24 ; 
  REPLACE. 
 LET C42(K2)=MEAN(C22) 
 LET C43(K2)=MEAN(C24) 
 LET C45(K2)=1.96*STDEV(C22) 
 LET C46(K2)=1.96*STDEV(C24) 
ENDDO 
 
LET K70=MEAN(C42) 
LET K71=MEAN(C43) 
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LET K73=MEAN(C45) 
LET K74=MEAN(C46) 
 
LET C14(1)=K70-(1.96*STDEV(C42)) 
LET C14(2)=K71-(1.96*STDEV(C43)) 
LET C15(1)=K70+(1.96*STDEV(C42)) 
LET C15(2)=K71+(1.96*STDEV(C43)) 
LET C16(1)=K73-(1.96*STDEV(C45)) 
LET C16(2)=K74-(1.96*STDEV(C46)) 
LET C17(1)=K73+(1.96*STDEV(C45)) 
LET C17(2)=K74+(1.96*STDEV(C46)) 
 
ENDMACRO 
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A10 BOOTSTRAP ANALYSIS OF REGRESSION PARAMETERS  
 
# GLOBAL MACRO REG2.MAC 
# 
# Performs bootstrap resampling of the parameters in two-variable 
# regression 
#  
# MINITAB for Windows version 11 and above 
# 
# Place the chemical names in C1, the response in C2, and the predictor 
# variables in C3 and C4. 
# Type %reg2 at the command line prompt. 
 
GMACRO 
REG2 
 
NAME C1='CHEMICAL' C2='RESPONSE' C3='DESCRIPTOR 1' C4='DESCRIPTOR 2'  
NAME C9='CONSTANT' C10='COEFF 1' C11='COEFF 2' C15='CONST' C16='COEFF1' 
C17='COEFF2' 
 
NOTE 
NOTE How many observations do you want to sample? 
SET C20; 
 FILE "TERMINAL"; 
 NOBS=1. 
COPY C20 K1 
 
NOTE 
NOTE How many times do you want to resample? 
SET C20; 
 FILE "TERMINAL"; 
 NOBS=1. 
COPY C20 K2 
 
DO K5=1:K2 
 SAMPLE K1 C2 C3 C4 C22 C23 C24 
 REGRESS C22 2 C23 C24; 
  COEFFICIENTS C30; 
  CONSTANT. 
 LET K6=C30(1) 
 LET K7=C30(2) 
 LET K8=C30(3) 
 LET C15(K5)=K6 
 LET C16(K5)=K7 
 LET C17(K5)=K8 
ENDDO 
 
LET C8(1)="median" 
LET C8(2)="std dev" 
 
LET C9(1)=MEDIAN(C15) 
LET C10(1)=MEDIAN(C16) 
LET C11(1)=MEDIAN(C17) 
LET C9(2)=STDEV(C15) 
LET C10(2)=STDEV(C16) 
LET C11(2)=STDEV(C17) 
 
ENDMACRO 
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